Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Homme And NotS. Fahn

List of bibliographic references

Number of relevant bibliographic references: 2326.
Ident.Authors (with country if any)Title
000009 Maya Ando [Japon] ; Manabu Funayama [Japon] ; YUANZHE LI [Japon] ; Kenichi Kashihara [Japon] ; Yoshitake Murakami [Japon] ; Nobutaka Ishizu [Japon] ; Chizuko Toyoda [Japon] ; Katsuhiko Noguchi [Japon] ; Takashi Hashimoto [Japon] ; Naoki Nakano [Japon] ; Ryogen Sasaki [Japon] ; Yasumasa Kokubo [Japon] ; Shigeki Kuzuhara [Japon] ; Kotaro Ogaki [Japon] ; Chikara Yamashita [Japon] ; Hiroyo Yoshino [Japon] ; Taku Hatano [Japon] ; Hiroyuki Tomiyama [Japon] ; Nobutaka Hattori [Japon]VPS35 Mutation in Japanese Patients with Typical Parkinson's Disease
000032 Katsunobu Sugihara [Japon] ; Hirofumi Maruyama [Japon] ; Hiroyuki Morino [Japon] ; Ryosuke Miyamoto [Japon] ; Hiroki Ueno [Japon] ; Masayasu Matsumoto [Japon] ; Ryuji Kaji [Japon] ; Hiroshi Kitaguchi [Japon] ; Motohiro Yukitake [Japon] ; Yasuto Higashi [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Yuishin Izumi [Japon] ; Hideshi Kawakami [Japon]The Clinical Characteristics of Spinocerebellar Ataxia 36: A Study of 2121 Japanese Ataxia Patients
000053 Raymond S. Schwartz [Australie] ; Glenda M. Halliday [Australie] ; Dennis J. Cordato [Australie] ; Jillian J. Kril [Australie]Small-Vessel Disease in Patients with Parkinson's Disease: A Clinicopathological Study
000055 Hiroshi Furushima [Japon] ; Takayoshi Shimohata [Japon] ; Hideaki Nakayama [Japon] ; Tetsutaro Ozawa [Japon] ; Masaomi Chinushi [Japon] ; Yoshifusa Aizawa [Japon] ; Masatoyo Nishizawa [Japon]Significance and Usefulness of Heart Rate Variability in Patients with Multiple System Atrophy
000056 Ozlem Celebi [Turquie] ; Ca Gbreve N Mesut Temucin [Turquie] ; Bulent Elibol [Turquie] ; Esen Saka [Turquie]Short Latency Afferent Inhibition in Parkinson's Disease Patients with Dementia
000060 Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Miriam Bömelburg [Allemagne] ; Frank Marzinzik [Allemagne] ; Georg Ebersbach [Allemagne] ; Thomas Müller [Allemagne]Severe Gastrointestinal Complications in Patients With Levodopa/Carbidopa Intestinal Gel Infusion
000066 Yoshihiko Furusawa [Japon] ; Yohei Mukai [Japon] ; Yoko Kobayashi [Japon] ; Takashi Sakamoto [Japon] ; Miho Murata [Japon]Role of the External Oblique Muscle in Upper Camptocormia for Patients with Parkinson's Disease
000106 Michael S. Okun [États-Unis]Parkinson's Disease Patients Cannot Get Their Dopamine Replacement: The 8-Sinemet Limit
000120 Julia Richter [Allemagne] ; Silke Appenzeller [Allemagne] ; Ole Ammerpohl [Allemagne] ; G. Deuschl [Allemagne] ; Steffen Paschen [Allemagne] ; Norbert Brüggemann [Allemagne] ; Christine Klein [Allemagne] ; Gregor Kuhlenb Umer [Allemagne]No Evidence for Differential Methylation of α-Synuclein in Leukocyte DNA of Parkinson's Disease Patients
000125 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Domenico Errico [Italie] ; Marianna Amboni [Italie] ; Anna Maria Barbarulo [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]Neuropsychological Correlates of Theory of Mind in Patients with Early Parkinson's Disease
000149 Vinko Palada [Allemagne] ; Sandra Stiern [Allemagne] ; Nicola Glockle [Allemagne] ; Pilar Gomez-Garre [Espagne] ; Fatima Carrillo [Espagne] ; Pablo Mir [Espagne] ; Krzysztof Szczaluba [Pologne] ; Michele Tinazzi [Italie] ; Domenico Ajena [Italie] ; Marta Romani [Italie] ; Enza Maria Valente [Italie] ; Ulrich Müller [Allemagne] ; Peter Bauer [Allemagne] ; Olaf Riess [Allemagne] ; Thomas Ott [Allemagne] ; Kathrin Grundmann [Allemagne]Lack of Sequence Variations in THAP1 Gene and THAP1-Binding Sites in TOR1A Promoter of DYT1 Patients
000152 Heike Stockner [Autriche] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Atbin Djamshidian [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Petra Katschnig [Royaume-Uni, Autriche] ; Klaus Seppi [Autriche] ; John Dickson [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; Kailash P. Bhatia [Royaume-Uni]Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
000158 Christian R. Baumann [Suisse] ; Lukas L. Imbach [Suisse] ; Heide Baumann-Vogel [Suisse] ; Mechtild Uhl [Suisse] ; Johannes Sarnthein [Suisse] ; Oguzkan Sürücü [Suisse]Interleaving Deep Brain Stimulation for a Patient With Both Parkinson's Disease and Essential Tremor
000160 Tanja Schmitz-Hübsch [Allemagne] ; Oleksandr Eckert [Allemagne] ; Uwe Schlegel [Allemagne] ; Thomas Klockgether [Allemagne] ; Sabine Skodda [Allemagne]Instability of Syllable Repetition in Patients with Spinocerebellar Ataxia and Parkinson's Disease
000163 Ivan Rektor [République tchèque] ; David Goldemund [République tchèque] ; Petr Bednarik [République tchèque] ; Katerina Sheardova [République tchèque] ; Zuzana Michalkova [République tchèque] ; Sabina Telecka [République tchèque] ; Michal Dufek [République tchèque] ; Irena Rektorova [République tchèque]Impairment of Brain Vessels May Contribute to Mortality in Patients With Parkinson's Disease
000171 Alisdair Mcneill [Royaume-Uni] ; Raquel Duran [Royaume-Uni] ; Christos Proukakis [Royaume-Uni] ; Jose Bras [Royaume-Uni] ; Derralyn Hughes [Royaume-Uni] ; Atuhl Mehta [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers
000173 Jorge Luis Guerrero Camacho [Mexique] ; Nancy Monroy Jaramillo [Mexique] ; Petra Yescas Gomez [Mexique] ; Mayela Rodriguez Violante [Mexique] ; Catherine Boll Woehrlen [Mexique] ; Ma. Elisa Alonso Vilatela [Mexique] ; Marisol Lopez Lopez [Mexique]High Frequency of Parkin Exon Rearrangements in Mexican-Mestizo Patients with Early-Onset Parkinson's Disease
000179 Megumi Shimizu [Japon] ; Yukihisa Suzuki [Japon] ; Motohiro Kiyosawa [Japon] ; Masato Wakakura [Japon] ; Kenji Ishii [Japon] ; Kiichi Ishiwata [Japon] ; Manabu Mochizuki [Japon]Glucose Hypermetabolism in the Thalamus of Patients with Hemifacial Spasm
000188 Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Luigi Luppariello [Italie] ; Ilaria Lista [Italie] ; Riccardo Tranfaglia [Italie] ; Alfonso Fasano [Italie] ; Marina Picillo [Italie] ; Carmine Vitale [Italie] ; Gabriella Santangelo [Italie] ; Valeria Agosti [Italie] ; Alessandro Lavarone [Italie] ; Giuseppe Sorrentino [Italie]Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment
000195 Giovanni Defazio [Italie] ; Giovanni Abbruzzese [Italie] ; Maria Stella Aniello [Italie] ; Roberta Di Fede [Italie] ; Marcello Esposito [Italie] ; Giovanni Fabbrini [Italie] ; Paolo Girlanda [Italie] ; Rocco Liguori [Italie] ; Lucio Marinelli [Italie] ; Davide Martino [Italie] ; Francesca Morgante [Italie] ; Lucio Santoro [Italie] ; Michele Tinazzi [Italie] ; Alfredo Berardelli [Italie]Eye Symptoms in Relatives of Patients with Primary Adult-Onset Dystonia
000204 Jennifer G. Goldman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bryan Bernard [États-Unis] ; Travis R. Stoub [États-Unis] ; Christopher G. Goetz [États-Unis] ; Leyla Detoledo-Morrell [États-Unis]Entorhinal Cortex Atrophy Differentiates Parkinson's Disease Patients With and Without Dementia
000205 Wolf-Julian Neumann [Allemagne] ; Julius Huebl [Allemagne] ; Christof Brucke [Allemagne] ; Maria Herrojo Ruiz [Allemagne] ; Andreas Kupsch [Allemagne] ; Gerd-Helge Schneider [Allemagne] ; Andrea A. Kuhn [Allemagne]Enhanced Low-Frequency Oscillatory Activity of the Subthalamic Nucleus in a Patient with Dystonia
000218 Jinyoung Youn [Corée du Sud] ; JIN WHAN CHO [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; Gyeong-Moon Kim [Corée du Sud] ; SUNG TAE KIM [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]Diffusion Tensor Imaging of Freezing of Gait in Patients with White Matter Changes
000221 Francesca Morgante [Italie] ; Mark J. Edwards [Royaume-Uni] ; Alberto J. Espay [États-Unis] ; Alfonso Fasano [Italie] ; Pablo Mir [Espagne] ; Davide Martino [Italie, Royaume-Uni]Diagnostic Agreement in Patients with Psychogenic Movement Disorders
000229 Atbin Djamshidian [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Yanosh Sanotsky [Ukraine] ; Stephen Sharman [Royaume-Uni] ; Yuriy Matviyenko [Ukraine] ; Thomas Foltynie [Royaume-Uni] ; Rosanna Michalczuk [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Ludmyla Fedoryshyn [Ukraine] ; Karen M. Doherty [Royaume-Uni] ; Yuriy Filts [Ukraine] ; Marianna Selikhova [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Eileen Joyce [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Bruno B. Averbeck [Royaume-Uni, États-Unis]Decision Making, Impulsivity, and Addictions: Do Parkinson's Disease Patients Jump to Conclusions?
000244 Elisabeth Ruppert [France] ; Benjamin Cretin [France] ; Christelle Meyer [France] ; Ulker Kilic-Huck [France] ; Patrice Bourgin [France]Characterization of Periodic Upper Limb Movement Disorder in a Patient With Restless Arms Syndrome
000255 Natalia Palacios [États-Unis] ; XIANG GAO [États-Unis] ; Marjorie L. Mccullough [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Roma Shah [États-Unis] ; Susan Gapstur [États-Unis] ; Alberto Ascherio [États-Unis]Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women
000263 Holly A. Shill [États-Unis] ; Charles H. Adler [États-Unis] ; Thomas G. Beach [États-Unis] ; Lih-Fen Lue [États-Unis] ; John N. Caviness [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Lucia I. Sue [États-Unis] ; Douglas G. Walker [États-Unis]Brain Biochemistry in Autopsied Patients with Essential Tremor
000268 Hans-Holger Capelle [Allemagne] ; Christian Blahak [Allemagne] ; Christoph Schrader [Allemagne] ; Hansjorg Baezner [Allemagne] ; Marwan I. Hariz [Suède, Royaume-Uni] ; Tommy Bergenheim [Suède] ; Joachim K. Krauss [Allemagne]Bilateral Deep Brain Stimulation for Cervical Dystonia in Patients with Previous Peripheral Surgery
000286 Elena V. Semenova [Russie] ; Maria I. Shadrina [Russie] ; Pyotr A. Slominsky [Russie] ; Irina A. Ivanova-Smolenskaya [Russie] ; Gulbakhar Bagyeva [Russie] ; Sergei N. Illarioshkin [Russie] ; Svetlana A. Limborska [Russie]Analysis of PARK2 Gene Exon Rearrangements in Russian Patients with Sporadic Parkinson's Disease
000289 Natalia Palacios [États-Unis] ; XIANG GAO [États-Unis] ; Eilis O'Reilly [États-Unis] ; Michael Schwarzschild [États-Unis] ; Marjorie L. Mccullough [États-Unis] ; Tinisha Mayo [États-Unis] ; Susan M. Gapstur [États-Unis] ; Alberto A. Ascherio [États-Unis]Alcohol and Risk of Parkinson's Disease in a Large, Prospective Cohort of Men and Women
000295 Esteban Pena [Espagne] ; Cristina Fernandez [Espagne]Abnormal DAT SCAN in a Patient with Parkinsonism after a Midbrain Ischemic Lesion
000300 Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse]A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
000302 Wooyoung Jang [Corée du Sud] ; HYUK SUNG KWON [Corée du Sud] ; Joong-Seok Kim [Corée du Sud] ; JIN HWAN CHO [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]A Parkinson's Disease Patient with Camptocormia Caused by an Esophageal Hiatal Hernia
000303 Rosa Guerrero-Lopez [Espagne] ; Pedro J. Garcia-Ruiz [Espagne] ; Beatriz G. Giraldez [Espagne] ; Carmen Duran-Herrera [Espagne] ; Maria Rosa Querol-Pascual [Espagne] ; Jose Maria Ramirez-Moreno [Espagne] ; Sebastian Mas [Espagne] ; Jose M. Serratosa [Espagne]A New SCARB2 Mutation in a Patient With Progressive Myoclonus Ataxia Without Renal Failure
000310 Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale
000326 Carmine Vitale [Italie] ; Vincenzo Marcelli [Italie] ; Teresa Furia [Italie] ; Gabriella Santangelo [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Roberto Allocca [Italie] ; Marianna Amboni [Italie] ; Elio Marciano [Italie] ; Paolo Barone [Italie]Vestibular Impairment and Adaptive Postural Imbalance in Parkinsonian Patients with Lateral Trunk Flexion
000328 Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada]Ventricular Dilatation and Brain Atrophy in Patients with Parkinson's Disease with Incipient Dementia
000333 Ji E. Lee [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]Uric Acid as a Potential Disease Modifier in Patients with Multiple System Atrophy
000341 Francisco Grandas [Espagne] ; Carlos Fernandez-Carballal [Espagne] ; Juan Guzman-De-Villoria [Espagne] ; Israel Ampuero [Espagne]Treatment of a Dystonic Storm With Pallidal Stimulation in a Patient With PANK2 Mutation
000349 James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease
000350 Hana Srovnalova [République tchèque] ; Radek Marecek [République tchèque] ; Irena Rektorova [République tchèque]The Role of the Inferior Frontal Gyri in Cognitive Processing of Patients with Parkinson's Disease: A Pilot rTMS Study
000351 Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark]The Risk of Valvular Regurgitation in Patients with Parkinson's Disease Treated with Dopamine Receptor Agonists
000353 Magdalena Eriksson Domellöf [Suède] ; Eva Elgh [Suède] ; Lars Forsgren [Suède]The Relation Between Cognition and Motor Dysfunction in Drug-Naive Newly Diagnosed Patients with Parkinson's Disease
000355 Sook K. Song [Corée du Sud] ; Ji E. Lee [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; JONG DOO LEE [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]The Pattern of Cortical Atrophy in Patients with Parkinson's Disease According to Cognitive Status
000356 Alexandra Gaenslen [Allemagne] ; Irene Swid [Allemagne] ; Inga Liepelt-Scarfone [Allemagne] ; Jana Godau [Allemagne] ; Daniela Berg [Allemagne]The Patients' Perception of Prodromal Symptoms Before the Initial Diagnosis of Parkinson's Disease
000367 Chiara Criscuolo [Pays-Bas, Italie] ; Anna De Rosa [Italie] ; Anna Guacci [Italie] ; Erik J. Simons [Pays-Bas] ; Guido J. Breedveld [Pays-Bas] ; Silvio Peluso [Italie] ; Giampiero Volpe [Italie] ; Alessandro Filla [Italie] ; Ben A. Oostra [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas] ; Giuseppe De Michele [Italie]The LRRK2 R1441 C Mutation is More Frequent Than G2019S in Parkinson's Disease Patients from Southern Italy
000369 Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni]The Impact of Non-Motor Symptoms on Health-Related Quality of Life of Patients with Parkinson's Disease
000370 Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; Pinar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
000377 Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis]Thalamic Neuronal and EMG Activity in Psychogenic Dystonia Compared with Organic Dystonia
000382 YI GUO [République populaire de Chine] ; Wei-Dong Le [États-Unis] ; Joseph Jankovic [États-Unis] ; Hua-Rong Yang [République populaire de Chine] ; Hong-Bo Xu [République populaire de Chine] ; Wen-Jie Xie [États-Unis] ; ZHI SONG [République populaire de Chine] ; HAO DENG [République populaire de Chine, États-Unis]Systematic Genetic Analysis of the PITX3 Gene in Patients with Parkinson Disease
000385 Han-Joon Kim [Corée du Sud] ; Beom S. Jeon [Corée du Sud] ; Jee-Young Lee [Corée du Sud] ; JI YOUNG YUN [Corée du Sud]Survival of Korean Patients with Multiple System Atrophy
000395 Alessandra Scontrini [Italie] ; Antonella Conte [Italie] ; Giovanni Fabbrini [Italie] ; Carlo Colosimo [Italie] ; Flavio Di Stasio [Italie] ; Gina Ferrazzano [Italie] ; Alfredo Berardelli [Italie]Somatosensory Temporal Discrimination Tested in Patients Receiving Botulinum Toxin Injection for Cervical Dystonia
000402 Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada]Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion
000404 Jonas Alex Morales Saute [Brésil] ; Andrew Chaves Feitosa Da Silva [Brésil] ; Alexandre Pastoris Muller [Brésil] ; Gisele Hansel [Brésil] ; Alexandre Silva De Mello [Brésil] ; Fábio Maeda [Brésil] ; Leonardo Vedolin [Brésil] ; Maria Luiza Saraiva-Pereira [Brésil] ; Diogo Onofre Souza [Brésil] ; Javier Arpa [Espagne] ; Ignacio Torres-Aleman [Espagne] ; Luis Valmor Cruz Portela [Brésil] ; Laura Bannach Jardim [Brésil]Serum Insulin-Like System Alterations in Patients with Spinocerebellar Ataxia Type 3
000405 Beth A. Belluscio [États-Unis] ; LILY JIN [États-Unis] ; Veronica Watters [États-Unis] ; Tiffany H. Lee [États-Unis] ; Mark Hallett [États-Unis]Sensory Sensitivity to External Stimuli in Tourette Syndrome Patients
000415 Alfonso Fasano [Italie] ; Alessandro Di Matteo [Italie] ; Carmine Vitale [Italie] ; Giovanna Squintani [Italie] ; Laura Ferigo [Italie] ; Federica Bombieri [Italie] ; Gabriella Santangelo [Italie] ; Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Michele Tinazzi [Italie]Reversible Pisa Syndrome in Patients with Parkinson's Disease on Rasagiline Therapy
000428 John W. Winkelman [États-Unis] ; Richard K. Bogan [États-Unis] ; Markus H. Schmidt [États-Unis] ; John D. Hudson [États-Unis] ; Sarah E. Derossett [États-Unis] ; Christina E. Hill-Zabala [États-Unis]Randomized Polysomnography Study of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome
000432 Marina Svetel [Serbie] ; Tatjana Pekmezovic [Serbie] ; Aleksandra Tomic [Serbie] ; Nikola Kresojevic [Serbie] ; Aleksandra Potrebic [Serbie] ; Rada Jesic [Serbie] ; Vladimir S. Kostic [Serbie]Quality of Life in Patients with Treated and Clinically Stable Wilson's Disease
000452 Gun-Marie Hariz [Suède] ; Patricia Limousin [Royaume-Uni] ; Stephen Tisch [Australie] ; Marjan Jahanshahi [Royaume-Uni] ; Anncristine Fjellman-Wiklund [Suède]Patients' Perceptions of Life Shift After Deep Brain Stimulation for Primary Dystonia-A Qualitative Study
000453 Phillip Fletcher [Royaume-Uni] ; Alison Leake [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni]Patients with Parkinson's Disease Dementia Stay in the Hospital Twice as Long as Those without Dementia
000454 Marcus M. Unger [Allemagne] ; Jens C. Möller [Allemagne] ; Katharina Mankel [Allemagne] ; Katrin Schmittinger [Allemagne] ; Karla M. Eggert [Allemagne] ; Maria Stamelou [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Katharina Bohne [Allemagne] ; Maren Bodden [Allemagne] ; Geert Mayer [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes J. Tebbe [Allemagne]Patients with Idiopathic Rapid-Eye-Movement Sleep Behavior Disorder Show Normal Gastric Motility Assessed by the 13C-Octanoate Breath Test
000456 Roberto Cilia [Canada, Italie] ; SANG SOO CHO [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; JI HYUN KO [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada]Pathological Gambling in Patients with Parkinson's Disease is Associated with Fronto-Striatal Disconnection: A Path Modeling Analysis
000469 Salima Assami [Algérie] ; Hamid Azzedine [France] ; Sonia Nouioua [Algérie] ; Emeline Mundwiller [France] ; Soulaiman Mahoui [Algérie] ; Samira Makri ; Meriam Djemai [Algérie] ; Djamel Grid [France] ; Alexis Brice [France] ; Tarik Hamadouche [Algérie] ; Giovanni Stevanin [France] ; Meriem Tazir [Algérie]Pantothenate Kinase-Associated Neurodegeneration: Clinical Description of 10 Patients and Identification of New Mutations
000474 Avigayil Ribner [Israël] ; Gheona Altarescu [Israël] ; Ari Zimran [Israël] ; Deborah Elstein [Israël]Osteopontin Polymorphic Susceptibility Factor for Parkinson's Disease Among Patients with Gaucher Disease
000477 Claudia Wenzel [Allemagne] ; Ulrich Wurster [Allemagne] ; Kirsten R. Müller-Vahl [Allemagne]Oligoclonal Bands in Cerebrospinal Fluid in Patients with Tourette's Syndrome
000480 Malene Flensborg Damholdt [Danemark] ; Per Borghammer [Danemark] ; Lars Larsen [Danemark] ; Karen Stergaard [Danemark]Odor Identification Deficits Identify Parkinson's Disease Patients with Poor Cognitive Performance
000499 Miryam Carecchio [Royaume-Uni, Italie] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; HEIDI CHAN [Royaume-Uni] ; Robin Lachmann [Royaume-Uni] ; Philip J. Lee [Royaume-Uni] ; Elaine Murphy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Movement Disorders in Adult Surviving Patients with Maple Syrup Urine Disease
000527 Giulia Longoni [Italie] ; Federica Agosta [Italie] ; Vladimir S. Kostic [Serbie] ; Tanja Stojkovic [Serbie] ; Elisabetta Pagani [Italie] ; Tatjana Stosic-Opincal [Serbie] ; Massimo Filippi [Italie]MRI Measurements of Brainstem Structures in Patients with Richardson's Syndrome, Progressive Supranuclear Palsy-Parkinsonism, and Parkinson's Disease
000530 Andrea Ciammola [Italie] ; Jenny Sassone [Italie] ; Monica Sciacco [Italie] ; Niccol E. Mencacci [Italie] ; Michela Ripolone [Italie] ; Caterina Bizzi [Italie] ; Clarissa Colciago [Italie] ; Maurizio Moggio [Italie] ; Gianfranco Parati [Italie] ; Vincenzo Silani [Italie] ; Gabriella Malfatto [Italie]Low Anaerobic Threshold and Increased Skeletal Muscle Lactate Production in Subjects with Huntington's Disease
000531 Inga Suttrup [Allemagne] ; Denise Oberdiek [Allemagne] ; Judith Suttrup [Allemagne] ; Nani Osada [Allemagne] ; Stefan Evers [Allemagne] ; Martin Marziniak [Allemagne]Loss of Sensory Function in Patients with Idiopathic Hand Dystonia
000532 Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Frances [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France]Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies
000537 Mathias Toft [Norvège] ; Bard Lilleeng [Norvège] ; Jon Ramm-Pettersen [Norvège] ; Inger Marie Skogseid [Norvège] ; Vidar Gundersen [Norvège] ; Remo Gerdts [Norvège] ; Lena Pedersen [Norvège] ; Mona Skjelland [Norvège] ; Geir Ketil R Ste [Norvège] ; Espen Dietrichs [Norvège]Long-Term Efficacy and Mortality in Parkinson's Disease Patients Treated with Subthalamic Stimulation
000551 Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Frank Marzinzik [Allemagne]Jejunal Levodopa Infusion in Long-Term DBS Patients with Parkinson's Disease
000553 Giovanna Zorzi [Italie] ; Federica Zibordi [Italie] ; Luisa Chiapparini [Italie] ; Enrico Bertini [Italie] ; Lidia Russo [Italie] ; Antonio Piga [Italie] ; Filomena Longo [Italie] ; Barbara Garavaglia [Italie] ; Domenico Aquino [Italie] ; Mario Savoiardo [Italie] ; Alessandra Solari [Italie] ; Nardo Nardocci [Italie]Iron-Related MRI Images in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deferiprone: Results of a Phase II Pilot Trial
000563 Ho-Won Lee [Corée du Sud] ; Jihye Choi [Corée du Sud] ; Kyoungho Suk [Corée du Sud]Increases of Pentraxin 3 Plasma Levels in Patients with Parkinson's Disease
000565 Jarosław Marusiak [Pologne] ; Anna Jaskolska [Pologne] ; Sławomir Budrewicz [Pologne] ; Magdalena Koszewicz [Pologne] ; Artur Jaskolski [Pologne]Increased Muscle Belly and Tendon Stiffness in Patients with Parkinson's Disease, as Measured by Myotonometry
000568 Meng-Ting Wang [Taïwan] ; Pei-Wen Lian [Taïwan] ; Chin-Bin Yeh [Taïwan] ; Che-Hung Yen [Taïwan] ; Kao-Hsing Ma [Taïwan] ; Agnes L. F. Chan [Taïwan]Incidence, Prescription Patterns, and Determinants of Antipsychotic Use in Patients with Parkinson's Disease
000570 Angelo Antonini [Italie] ; Chiara Siri [Italie] ; Gabriella Santangelo [Italie] ; Roberto Cilia [Italie] ; Michele Poletti [Italie] ; Margherita Canesi [Italie] ; Alessandra Caporali [Italie] ; Francesca Mancini [Italie] ; Gianni Pezzoli [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie] ; Paolo Barone [Italie]Impulsivity and Compulsivity in Drug-Naïve Patients with Parkinson's Disease
000572 Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Carla Cordivari [Royaume-Uni]Immediate Response to Botulinum Toxin Injections in Patients with Fixed Dystonia
000581 Maria Sierra [Espagne] ; Isabel Gonzalez-Aramburu [Espagne] ; Pascual Sanchez-Juan [Espagne] ; Coro Sanchez-Quintana [Espagne] ; Jose Miguel Polo [Espagne] ; Jose Berciano [Espagne] ; Onofre Combarros [Espagne] ; Jon Infante [Espagne]High Frequency and Reduced Penetrance of LRRK2 G2019S Mutation Among Parkinson's Disease Patients in Cantabria (Spain)
000584 Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni]Health-Related Quality-of-Life Scales in Parkinson's Disease: Critique and Recommendations
000592 Omar S. Mian [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] ; Brian L. Day [Royaume-Uni]Gait in SWEDDs Patients: Comparison with Parkinson's Disease Patients and Healthy Controls
000603 Adam Rosenblatt [États-Unis] ; Brahma V. Kumar [États-Unis] ; Russell L. Margolis [États-Unis] ; Claire S. Welsh [États-Unis] ; Christopher A. Ross [États-Unis]Factors Contributing to Institutionalization in Patients with Huntington's Disease
000605 Deborah A. Hall [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; WENTING ZHANG [États-Unis] ; Flora Tassone [États-Unis] ; Elaine Spector [États-Unis] ; Gary Zerbe [États-Unis] ; Paul J. Hagerman [États-Unis] ; Bichun Ouyang [États-Unis] ; Maureen A. Leehey [États-Unis]FMR1 Gray-Zone Alleles: Association with Parkinson's Disease in Women?
000617 Giovanni Albani [Italie] ; Nadia El Assawy [Italie] ; Stefania Cattaldo [Italie] ; Marilena De Gennaro [Italie] ; Francesca Gregorini [Italie] ; Luca Pradotto [Italie] ; Alessandro Mauro [Italie]Electrogastrographyc Activity in Parkinson's Disease Patients With and Without Motor Fluctuations
000619 Richard A. Walsh [Canada] ; Anthony E. Lang [Canada]Early-Onset Tardive Dyskinesia in a Neuroleptic-Naive Patient Exposed to Low-Dose Quetiapine
000624 Tahir Nazir [Royaume-Uni] ; Alexander M. Thomson [Royaume-Uni]Domestic Violence and Mistreatment in Patients with Parkinsonism: Case Reports, Mechanisms, and Discussion
000629 Zang-Hee Cho [Corée du Sud] ; Se-Hong Oh [Corée du Sud] ; Jong-Min Kim [Corée du Sud] ; Sung-Yeon Park [Corée du Sud] ; Dae-Hyuk Kwon [Corée du Sud] ; Hye-Jin Jeong [Corée du Sud] ; Young-Bo Kim [Corée du Sud] ; Je-Geun Chi [Corée du Sud] ; Chan-Woong Park [Corée du Sud] ; John Iii Huston [États-Unis] ; Kendall H. Lee [États-Unis] ; Beom S. Jeon [Corée du Sud]Direct Visualization of Parkinson's Disease by In Vivo Human Brain Imaging Using 7.0T Magnetic Resonance Imaging
000641 Aida Ormazabal [Espagne] ; Mercedes Serrano [Espagne] ; Angels Garcia-Cazorla [Espagne] ; Jaume Campistol [Espagne] ; Rafael Artuch [Espagne] ; Pedro Castro De Castro [Espagne] ; Estíbaliz Barredo-Valderrama [Espagne] ; Judith Armstrong [Espagne] ; Claudio Toma [Espagne] ; Bru Cormand [Espagne]Deletion in the Tyrosine Hydroxylase Gene in a Patient with a Mild Phenotype
000643 Diane Ruge [Royaume-Uni] ; Stephen Tisch [Royaume-Uni, Australie] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni]Deep Brain Stimulation Effects in Dystonia: Time Course of Electrophysiological Changes in Early Treatment
000645 Helen Ling [Royaume-Uni] ; Mark Braschinsky [Estonie] ; Pille Taba [Estonie] ; Siiri-Merike Luus [Estonie] ; Karen Doherty [Royaume-Uni] ; Anna Hotter [Autriche] ; Werner Poewe [Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]Decades of Delayed Diagnosis in 4 Levodopa-Responsive Young-Onset Monogenetic Parkinsonism Patients
000648 Thomas Müller [Allemagne] ; Siegfried Muhlack [Allemagne]Cysteinyl-Glycine Reduction as Marker for Levodopa-Induced Oxidative Stress in Parkinson's Disease Patients
000650 José L. Garcia-Gimenez [Espagne] ; Fabián Sanchis-Gomar [Espagne] ; Federico V. Pallardo [Espagne]Could Thiazolidinediones Increase the Risk of Heart Failure in Friedreich's Ataxia Patients?
000651 Hiroki Nishibayashi [Japon] ; Mitsuhiro Ogura [Japon] ; Koji Kakishita [Japon] ; Satoshi Tanaka [Japon] ; Yoshihisa Tachibana [Japon] ; Atsushi Nambu [Japon] ; Hitoshi Kita [États-Unis] ; Toru Itakura [Japon]Cortically Evoked Responses of Human Pallidal Neurons Recorded During Stereotactic Neurosurgery
000665 Thomas Opladen [Allemagne] ; Georg Hoffmann [Allemagne] ; Friederike Hörster [Allemagne] ; Anne-B Rbel Hinz [Allemagne] ; Katharina Neidhardt [Allemagne] ; Christine Klein [Allemagne] ; Nicole Wolf [Pays-Bas]Clinical and Biochemical Characterization of Patients with Early Infantile Onset of Autosomal Recessive GTP Cyclohydrolase I Deficiency without Hyperphenylalaninemia
000667 Oliver H. H. Gerlach [Pays-Bas] ; Ania Winogrodzka [Pays-Bas] ; Wim E. J. Weber [Pays-Bas]Clinical Problems in the Hospitalized Parkinson's Disease Patient: Systematic Review
000676 Daniel Weiss [Allemagne] ; Rathinaswamy B. Govindan [États-Unis] ; Albrecht Rilk [Allemagne] ; Tobias Wachter [Allemagne] ; Sorin Breit [Allemagne] ; Leopold Zizlsperger [Allemagne] ; Thomas Haarmeier [Allemagne] ; Christian Plewnia [Allemagne] ; Rejko Kruger [Allemagne] ; Alireza Gharabaghi [Allemagne]Central Oscillators in a Patient with Neuropathic Tremor: Evidence from Intraoperative Local Field Potential Recordings
000677 Ferdinando Squitieri [Italie] ; Mouna Esmaeilzadeh [Suède] ; Andrea Ciarmiello [Italie] ; Joseph Jankovic [États-Unis]Caudate Glucose Hypometabolism in a Subject Carrying an Unstable Allele of Intermediate CAG33 Repeat Length in the Huntington's Disease Gene
000680 Yasumasa Kokubo [Japon] ; Satoru Morimot [Japon] ; Akihiro Shindo [Japon] ; Yoshihumi Hirokawa [Japon] ; Taizo Shiraishi [Japon] ; Yuko Saito [Japon] ; Shigeo Murayama [Japon] ; Shigeki Kuzuhara [Japon]Cardiac 123I-Metalodobenzylguanidine Scintigraphy and Lewy Body Pathology in a Patient with Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex of Kii, Japan
000681 Nin P. S. Bajaj [Royaume-Uni] ; Maria Knöbel [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]Can Spiral Analysis Predict the FP-CIT SPECT Scan Result in Tremulous Patients?
000682 Morinobu Seki [Japon] ; Kazushi Takahashi [Japon] ; Atsuo Koto [Japon] ; Ban Mihara [Japon] ; Yoko Morita [Japon] ; Kazuo Isozumi [Japon] ; Kouichi Ohta [Japon] ; Kazuhiro Muramatsu [Japon] ; Jun Gotoh [Japon] ; Keiji Yamaguchi [Japon] ; Yutaka Tomita [Japon] ; Hideki Sato [Japon] ; Yoshihiro Nihei [Japon] ; Satoko Iwasawa [Japon] ; Norihiro Suzuki [Japon]Camptocormia in Japanese Patients with Parkinson's Disease: a Multicenter Study
000691 Maja Kojovic [Royaume-Uni, Slovénie] ; Antonio Caronni [Royaume-Uni, Italie] ; Matteo Bologna [Royaume-Uni, Italie] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni]Botulinum Toxin Injections Reduce Associative Plasticity in Patients with Primary Dystonia
000692 Arianna Guidubaldi [Italie] ; Alfonso Fasano [Italie] ; Tamara Lalongo [Italie] ; Carla Piano [Italie] ; Maurizio Pompili [Italie] ; Roberta Masciana [Italie] ; Luisa Siciliani [Italie] ; Mario Sabatelli [Italie] ; Anna Rita Bentivoglio [Italie]Botulinum Toxin A Versus B in Sialorrhea: A Prospective, Randomized, Double-Blind, Crossover Pilot Study in Patients with Amyotrophic Lateral Sclerosis or Parkinson's Disease
000719 Dimitri Anastasopoulos [Royaume-Uni, Grèce] ; Nafsica Ziavra [Royaume-Uni] ; Eugenia Sawidou [Grèce] ; Peter Bain [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni]Altered Eye-to-Foot Coordination in Standing Parkinsonian Patients During Large Gaze and Whole-Body Reorientations
000720 Maria Graciela Cersosimo [Argentine] ; Claudia Perandones [Argentine] ; Federico Eduardo Micheli [Argentine] ; Gabriela Beatriz Raina [Argentine] ; Ana Maria Beron [Argentine] ; Gustavo Nasswetter [Argentine] ; Martin Radrizzani [Argentine] ; Eduardo Elias Benarroch [États-Unis]Alpha-Synuclein Immunoreactivity in Minor Salivary Gland Biopsies of Parkinson's Disease Patients
000721 Carsten Eggers [Allemagne] ; Deniz Kahraman [Allemagne] ; Gereon R. Fink [Allemagne] ; Matthias Schmidt [Allemagne] ; Lars Timmermann [Allemagne]Akinetic-Rigid and Tremor-Dominant Parkinson's Disease Patients Show Different Patterns of FP-CIT Single Photon Emission Computed Tomography
000722 Marcelo Chouza [Espagne] ; Pablo Arias [Espagne] ; Susana Vinas [Espagne] ; Javier Cudeiro [Espagne]Acute Effects of Whole-Body Vibration at 3, 6, and 9 Hz on Balance and Gait in Patients with Parkinson's Disease
000730 Catherine L. Gallagher [États-Unis] ; Bradley T. Christian [États-Unis] ; James E. Holden [États-Unis] ; Onofre T. Dejesus [États-Unis] ; Robert J. Nickles [États-Unis] ; Laura Buyan-Dent [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Sandra J. Harding [États-Unis] ; Charles K. Stone [États-Unis] ; Barb Mueller [États-Unis] ; Sterling C. Johnson [États-Unis]A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease
000733 Samar S. Ayache [France] ; Rechdi Ahdab [France] ; Pierre Brugieres [France] ; Jean-François Ejzenbaum [France] ; François-Jérôme Authier [France] ; Gilles Fenelon [France] ; Jean-Pascal Lefaucheur [France]A Reappraisal of Long-Latency Abdominal Muscle Reflexes in Patients with Propriospinal Myoclonus
000741 E. H. Reynolds [Royaume-Uni] ; D. G. Healy [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]A Film of Patients with Movement Disorders Made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson
000754 David A. Gallagher [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni]What Are the Most Important Nonmotor Symptoms in Patients with Parkinson's Disease and Are We Missing Them?
000764 Roser Pons [Grèce] ; Mercedes Serrano [Espagne] ; Aida Ormazabal [Espagne] ; Claudio Toma [Espagne] ; Angels Garcia-Cazorla [Espagne] ; Estela Area [États-Unis] ; Marta Ribases [Espagne] ; Emmanuel Kanavakis [Grèce] ; Kaliopi Drakaki [Grèce] ; Aristotelis Giannakopoulos [Grèce] ; Irene Orfanou [Grèce] ; Sotiris Youroukos [Grèce] ; Bru Cormand [Espagne] ; Rafael Artuch [Espagne]Tyrosine Hydroxylase Deficiency in Three Greek Patients with a Common Ancestral Mutation
000766 CHAE WON SHIN [Corée du Sud] ; HEE JIN KIM [Corée du Sud] ; SUNG SUP PARK [Corée du Sud] ; SUNG YEUN KIM [Corée du Sud] ; JI YEON KIM [Corée du Sud] ; BEOM SEOK JEON [Corée du Sud]Two Parkinson's Disease Patients With α-Synuclein Gene Duplication and Rapid Cognitive Decline
000771 Francisco De Assis Aquino Gondim [Brésil] ; Helida A. Costa [Brésil] ; Tauily C. D. Taunay [Brésil] ; Gisele R. De Oliveira [Brésil] ; Jamile Magalhaes Ferreira [Brésil] ; Francisco H. Rola [Brésil]Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson's Disease
000774 CHUL HYOUNG LYOO [Corée du Sud] ; YOUNG HOON RYU [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Topographical Distribution of Cerebral Cortical Thinning in Patients with Mild Parkinson's Disease Without Dementia
000786 HYE YOUNG SUNG [Corée du Sud] ; Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; In-Uk Song [Corée du Sud] ; Sung-Woo Chung [Corée du Sud] ; Dong-Won Yang [Corée du Sud] ; YU KYUNG CHO [Corée du Sud] ; JAE MYUNG PARK [Corée du Sud] ; IN SEOK LEE [Corée du Sud] ; SANG WOO KIM [Corée du Sud] ; In-Sik Chung [Corée du Sud] ; Myung-Gyu Choi [Corée du Sud]The Prevalence and Patterns of Pharyngoesophageal Dysmotility in Patients with Early Stage Parkinson's Disease
000820 Philippa Carter [Australie] ; Jenny Downs [Australie] ; Ami Bebbington [Australie] ; Simon Williams [Australie] ; Peter Jacoby [Australie] ; Walter E. Kaufmann [États-Unis] ; Helen Leonard [Australie]Stereotypical Hand Movements in 144 Subjects with Rett Syndrome from the Population-Based Australian Database
000827 Hélio A. G. Teive [Brésil] ; Renato P. Munhoz [Brésil] ; Salmo Raskin [Brésil] ; Walter O. Arruda [Brésil] ; Luciano De Paola [Brésil] ; Lineu C. Werneck [Brésil] ; Tetsuo Ashizawa [États-Unis]Spinocerebellar Ataxia Type 10: Frequency of Epilepsy in a Large Sample of Brazilian Patients
000829 Constance Flamand-Rouviere [France] ; Emilie Guettard [France] ; Caroline Moreau [France] ; Nadia Bahi-Buisson [France] ; Vassili Valayannopoulos [France] ; David Grabli [France] ; Jacques Motte [France] ; Diana Rodriguez [France] ; Agathe Roubertie [France] ; Lisa Maintigneux [France] ; Isabelle Kemlin [France] ; Irène Ceballos-Picot [France] ; David Adams [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders
000832 I-Jin Yeh [Canada, Taïwan] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada]Somatosensory Evoked Potentials Recorded from the Human Pedunculopontine Nucleus Region
000838 V. Di Lazzaro [Italie] ; F. Pilato [Italie] ; P. Granone [Italie] ; A. Sestito [Italie] ; T. Pirronti [Italie]Shortness of Breath in a Parkinson's Disease Patient
000839 Stephany Fulda [Allemagne] ; Marie E. Beitinger [Allemagne] ; Simone Reppermund [Allemagne, Australie] ; Juliane Winkelmann [Allemagne] ; Thomas C. Wetter [Allemagne, Suisse]Short-Term Attention and Verbal Fluency is Decreased in Restless Legs Syndrome Patients
000852 Kathrine Rugbjerg [Danemark] ; S Ren Friis [Danemark] ; Thomas L. J Rgensen [Danemark] ; Beate Ritz [États-Unis] ; Lise Korbo [Danemark] ; J Rgen H. Olsen [Danemark]Risk for Parkinson's Disease Among Patients with Osteoarthritis: A Danish Cohort Study
000862 Daniele Lo Coco [Italie] ; Federico Piccoli [Italie] ; Vincenzo La Bella [Italie]Restless Legs Syndrome in Patients with Amyotrophic Lateral Sclerosis
000863 XIANG GAO [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Eilis J. O'Reilly [États-Unis] ; HAO WANG [États-Unis] ; Alberto Ascherio [États-Unis]Restless Legs Syndrome and Parkinson's Disease in Men
000864 Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis]Reply: Based on the Available Randomized Trial Patients Should Say No to Glutathione for Parkinson's Disease
000868 Marcus M. Unger [Allemagne] ; Katja Hattemer [Allemagne] ; Jens C. Möller [Allemagne] ; Katrin Schmittinger [Allemagne] ; Katharina Mankel [Allemagne] ; Karla Eggert [Allemagne] ; Konstantin Strauch [Allemagne] ; Johannes J. Tebbe [Allemagne] ; Boris Keil [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes T. Heverhagen [Allemagne] ; Susanne Knake [Allemagne]Real-time Visualization of Altered Gastric Motility by Magnetic Resonance Imaging in Patients with Parkinson's Disease
000875 YEW CHIEN VOON [Malaisie] ; Wan Nur Nafisah Wan Yahya Mmed [Malaisie] ; Shariful Hasan [Malaisie] ; Norlinah Mohamed Ibrahim [Malaisie]Pyridostigmine-Induced Dystonic Blepharospasm in a Patient With Ocular Myasthenia Gravis
000877 Alfonso Fasano [Italie] ; Mauro Pettorruso [Italie] ; Lucia Ricciardi [Italie] ; Gianluigi Conte [Italie] ; Anna Rita Bentivoglio [Italie]Punding in Parkinson's Disease: The Impact of Patient's Awareness on Diagnosis
000888 MYUNG SIK LEE [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; YOON HO CHOI [Corée du Sud]Primary Progressive Freezing Gait in a Patient with CO-Induced Parkinsonism
000889 Anne S. Söhn [Allemagne] ; Nicola Glöckle [Allemagne] ; Andrea Duarte Doetzer [Allemagne] ; Günther Deuschl [Allemagne] ; Ute Felbor [Allemagne] ; Helge R. Topka [Allemagne] ; Ludger Schöls [Allemagne] ; Olaf Riess [Allemagne] ; Peter Bauer [Allemagne] ; Ulrich Müller [Allemagne] ; Kathrin Grundmann [Allemagne]Prevalence of THAPI Sequence Variants in German Patients with Primary Dystonia
000901 Raquel Duran [Espagne] ; Francisco J. Barrero [Espagne] ; Blas Morales [Espagne] ; Juan D. Luna [Espagne] ; Manuel Ramirez [Espagne] ; Francisco Vives [Espagne]Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment
000904 Erich Talamoni Fonoff [Brésil] ; Ywzhe Sifuentes Almeida De Oliveira [Brésil] ; Santiago Driollet [Brésil] ; Griselda Jarra Garrido [Brésil] ; Daniel Ciampi De Andrade [Brésil] ; Flávio Sallem [Brésil] ; Egberto Reis Barbosa [Brésil] ; Manoel Jacobsen Teixeira [Brésil]Pet Findings in Reversible Improvement of Olfactory Dysfunction After STN Stimulation in a Parkinson's Disease Patient
000909 Chadwick W. Christine [États-Unis] ; Elisabeth R. Garwood [États-Unis] ; Lauren E. Schrock [États-Unis] ; Daniel E. Austin [États-Unis] ; Charles E. Mcculloch [États-Unis]Parkinsonism in Patients with a History of Amphetamine Exposure
000910 Rebecca M. Wolf Gilbert [États-Unis] ; Stanley Fahn [États-Unis] ; Hiroshi Mitsumoto [États-Unis] ; Lewis P. Rowland [États-Unis]Parkinsonism and Motor Neuron Diseases: Twenty-Seven Patients with Diverse Overlap Syndromes
000913 Marios Politis [Royaume-Uni] ; Kit Wu [Royaume-Uni] ; Sophie Molloy [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Paola Piccini [Royaume-Uni]Parkinson's Disease Symptoms: The Patient's Perspective
000917 Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Marco Onofrj [Italie]Paradoxical Kinesia in Parkinsonian Patients Surviving Earthquake
000918 Emilia Gatto [Argentine]Pantothenate Kinase-Associated Neurodegeneration: Novel Mutations in the PANK2 Gene in an Argentinean Young Woman
000921 Tiphaine Rouaud [France] ; Thibaut Dondaine [France] ; Sophie Drapier [France] ; Claire Haegelen [France] ; François Lallement [France] ; Julie Peron [France] ; Sylvie Raoul [France] ; Paul Sauleau [France] ; Marc Verin [France]Pallidal Stimulation in Advanced Parkinson's Patients with Contraindications for Subthalamic Stimulation
000932 Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Masaoki Iwanami [Japon] ; Koichi Hirata [Japon]Olfactory Dysfunction in Japanese Patients with Idiopathic REM Sleep Behavior Disorder: Comparison of Data Using the University of Pennsylvania Smell Identification Test and Odor Stick Identification Test for Japanese
000933 Randolph Stephenson [États-Unis] ; David Houghton [États-Unis] ; Sri Sundarararjan [États-Unis] ; Richard L. Doty [États-Unis] ; Matthew Stem [États-Unis] ; Sharon X. Xie [États-Unis] ; Andrew Siderowf [États-Unis]Odor Identification Deficits are Associated with Increased Risk of Neuropsychiatric Complications in Patients with Parkinson's Disease
000938 WON TAE YOON [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; Hee-Young Shin [Corée du Sud] ; Seung-Tae Lee [Corée du Sud] ; Chang-Seok Ki [Corée du Sud]Novel PANK2 Gene Mutations in Korean Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting Unilateral Dystonic Tremor
000940 HUIJUAN LI [République populaire de Chine] ; MEIFEN ZHANG [République populaire de Chine] ; LING CHEN [République populaire de Chine] ; JUNE ZHANG [République populaire de Chine] ; ZHONG PEI [République populaire de Chine] ; AILING HU [République populaire de Chine] ; QING WANG [République populaire de Chine]Nonmotor Symptoms Are Independently Associated With Impaired Health-Related Quality of Life in Chinese Patients With Parkinson's Disease
000952 Simona Binelli [Italie] ; Pamela Agazzi [Italie] ; Laura Canafoglia [Italie] ; Vidmer Scaioli [Italie] ; Ferruccio Panzica [Italie] ; Elisa Visani [Italie] ; Giuseppe Di Fede [Italie] ; Giorgio Giaccone [Italie] ; Alberto Bizzi [Italie] ; Orso Bugiani [Italie] ; Guiliano Avanzini [Italie] ; Fabrizio Tagliavini [Italie] ; Silvana Franceschetti [Italie]Myoclonus in Creutzfeldt-Jakob Disease: Polygraphic and Video-Electroencephalography Assessment of 109 Patients
000961 Victor Peralta [Espagne] ; Maria S. Campos [Espagne] ; Elena Garcia De Jalon [Espagne] ; Manuel J. Cuesta [Espagne]Motor Behavior Abnormalities in Drug-Naïve Patients with Schizophrenia Spectrum Disorders
000976 Emanuele Cereda [Italie] ; Michela Barichella [Italie] ; Carlo Pedrolli [Italie] ; Gianni Pezzoli [Italie]Low-Protein and Protein-Redistribution Diets for Parkinson's Disease Patients with Motor Fluctuations: A Systematic Review
000980 Laura Cif [France] ; Xavier Vasques [France] ; Victoria Gonzalez [France] ; Patrice Ravel [France] ; Brigitte Biolsi [France] ; Gwenaelle Collod-Beroud [France] ; Sylvie Tuffery-Giraud [France] ; Hassan Elfertit [France] ; Mireille Claustres [France] ; Philippe Coubes [France]Long-Term Follow-Up of DYT1 Dystonia Patients Treated by Deep Brain Stimulation: An Open-Label Study
000995 Marcelo Merello [Argentine] ; Natalia Fantacone [Argentine] ; Jorge Balej [Argentine]Kinematic Study of Whole Body Center of Mass Position During Gait in Parkinson's Disease Patients with and Without Festination
000A00 Tobias B Umer [Allemagne] ; Götz Thomalla [Allemagne] ; Johan Kroeger [Allemagne] ; Melanie Jonas [Allemagne] ; Christian Gerloff [Allemagne] ; Friedhelm Christoph Hummel [Allemagne] ; Kirsten Müller-Vahl [Allemagne] ; Alfons Schnitzler [Allemagne] ; Hartwig Roman Siebner [Danemark] ; Michael Orth [Allemagne] ; Alexander Münchau [Allemagne]Interhemispheric Motor Networks are Abnormal in Patients with Gilles de la Tourette Syndrome
000A06 Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
000A10 Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada]Incidence of Parkinson's Disease Among Hospital Patients with Methamphetamine-Use Disorders
000A17 Nebojša M. Lalic [Serbie] ; Nataša Dragasevic [Serbie] ; Elka Stefanova [Serbie] ; Aleksandra Jotic [Serbie] ; Katarina Lalic [Serbie] ; Tanja Milicic [Serbie] ; Igor Petrovic [Serbie] ; Marija Macesic [Serbie] ; Vladimir S. Kostic [Serbie]Impaired Insulin Sensitivity and Secretion in Normoglycemic Patients with Spinocerebellar Ataxia Type 1
000A18 MYUNG SIK LEE [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; MYUNG JUN LEE [Corée du Sud] ; Jaeeun Sim [Corée du Sud] ; Hanna Cho [Corée du Sud] ; YUN HO CHOI [Corée du Sud]Impaired Finger Dexterity in Patients with Parkinson's Disease Correlates with Discriminative Cutaneous Sensory Dysfunction
000A20 Melanie Jonas [Allemagne] ; Götz Thomalla [Allemagne] ; Katja Biermann-Ruben [Allemagne] ; Hartwig Roman Siebner [Danemark, Allemagne] ; Kirsten Müller-Vahl [Allemagne] ; Tobias B Umer [Allemagne] ; Christian Gerloff [Allemagne] ; Alfons Schnitzler [Allemagne] ; Michael Orth [Allemagne] ; Alexander Münchau [Allemagne]Imitation in Patients with Gilles de la Tourette Syndrome: A Behavioral Study
000A24 German Moris [Espagne] ; M Nica Arias [Espagne] ; Maria Valle Lopez [Espagne] ; Victoria Alvarez [Espagne]Hyperintensity in the Basis Pontis: Atypical Neuroradiological Findings in a Woman with FXTAS
000A25 BO ZHOU [République populaire de Chine] ; QIN CHEN [République populaire de Chine] ; QIN ZHANG [République populaire de Chine] ; LEI CHEN [République populaire de Chine] ; QIYONG GONG [République populaire de Chine] ; HUIFANG SHANG [République populaire de Chine] ; HEHAN TANG [République populaire de Chine] ; DONG ZHOU [République populaire de Chine]Hyperactive Putamen in Patients with Paroxysmal Kinesigenic Choreoathetosis: A Resting-State Functional Magnetic Resonance Imaging Study
000A32 Inbal Maidan [Israël] ; Meir Plotnik [Israël] ; Anat Mirelman [Israël, États-Unis] ; Aner Weiss [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis]Heart Rate Changes During Freezing of Gait in Patients with Parkinson's Disease
000A33 Kirsten Müller-Vahl [Allemagne] ; Ines Dodel [Allemagne] ; Norbert Müller [Allemagne] ; Alexander Münchau [Allemagne] ; Jens Peter Reese [Allemagne] ; Monika Balzer-Geldsetzer [Allemagne] ; Richard Dodel [Allemagne] ; Wolfgang H. Oertel [Allemagne]Health-Related Quality of Life in Patients with Gilles de la Tourette's Syndrome
000A42 Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis]Gene Therapy for Parkinson's Disease
000A47 XIN LIU [République populaire de Chine] ; Shu-Shan Zhang [République populaire de Chine] ; Deng-Fu Fang [République populaire de Chine] ; Ming-Yi Ma [République populaire de Chine] ; Xiao-Yan Guo [République populaire de Chine] ; YUAN YANG [République populaire de Chine] ; Hui-Fang Shang [République populaire de Chine]GCH1 Mutation and Clinical Study of Chinese Patients with Dopa-responsive Dystonia
000A55 LI CAO [République populaire de Chine] ; LAN ZHENG [République populaire de Chine] ; Wei-Guo Tang [République populaire de Chine] ; QIN XIAO [République populaire de Chine] ; TING ZHANG [République populaire de Chine] ; Hui-Dong Tang [République populaire de Chine] ; Song-Bin He [République populaire de Chine] ; Xi-Jin Wang [République populaire de Chine] ; Jian-Qing Ding [République populaire de Chine] ; Sheng-Di Chen [République populaire de Chine]Four Novel Mutations in the GCH1 Gene of Chinese Patients with Dopa-Responsive Dystonia
000A56 Rwei-Ling Yu [Taïwan] ; Ruey-Meei Wu [Taïwan] ; Chun-Hwei Tai [Taïwan] ; Chin-Hsien Lin [Taïwan] ; Mau-Sun Hua [Taïwan]Feeling-of-Knowing in Episodic Memory in Patients with Parkinson's Disease with Various Motor Symptoms
000A64 Kunio Kawamura [Japon] ; Takayoshi Shimohata [Japon] ; Hideaki Nakayama [Japon] ; Masahiko Tomita [Japon] ; Tetsutaro Ozawa [Japon] ; Masatoyo Nishizawa [Japon]Factors Influencing the Cognitive Function in Patients with Multiple System Atrophy
000A67 Simon Zhomitsky [Canada] ; Emmanuel Stip [Canada] ; Tania Pampoulova [Canada] ; Elie Rizkallah [Canada] ; Olivier Lipp [Canada] ; Lahcen Aït Bentaleb [Canada] ; Jean-Pierre Chiasson [Canada] ; Stéphane Potvin [Canada]Extrapyramidal Symptoms in Substance Abusers with and Without Schizophrenia and in Nonabusing Patients with Schizophrenia
000A72 Rogério Beato [Brésil] ; Débora P. Maia [Brésil] ; Antônio Lucio Jr Teixeira [Brésil] ; Francisco Cardoso [Brésil]Executive Functioning in Adult Patients with Sydenham's Chorea
000A76 Lior Greenbaum [Israël] ; Anna Alkelai [Israël] ; Amihai Rigbi [Israël] ; Yoav Kohn [Israël] ; Bernard Lerer [Israël]Evidence for Association of the GLI2 Gene with Tardive Dyskinesia in Patients with Chronic Schizophrenia
000A91 Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis]Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson's Disease Patients with Motor Fluctuations
000A95 Valerio Pisani [Italie] ; Vincenzo Moschella [Italie] ; Monica Bari [Italie] ; Filomena Fezza [Italie] ; Salvatore Galati [Italie] ; Giorgio Bernardi [Italie] ; Paolo Stanzione [Italie] ; Antonio Pisani [Italie] ; Mauro Maccarrone [Italie]Dynamic Changes of Anandamide in the Cerebrospinal Fluid of Parkinson's Disease Patients
000A97 Matthew Rizzo [États-Unis] ; Ergun Y. Uc [États-Unis] ; Jeffrey Dawson [États-Unis] ; Steven Anderson [États-Unis] ; Robert Rodnitzky [États-Unis]Driving Difficulties in Parkinson's Disease
000B06 Alberto Albanese [Italie] ; Stefania Lalli [Italie]Distinguishing Scan Without Evidence of Dopaminergic Depletion Patients with Asymmetric Resting Tremor from Parkinson's Disease: A Clinical Diagnosis of Dystonia is Required
000B07 Petra Schwingenschuh [Royaume-Uni, Autriche] ; Diane Ruge [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carmen Terranova [Royaume-Uni] ; Petra Katschnig [Royaume-Uni, Autriche] ; Fatima Carrillo [Espagne] ; Laura Silveira-Moriyama [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Georg K Gi [Royaume-Uni] ; Francisco J. Palomar [Espagne] ; Penelope Talelli [Royaume-Uni] ; John Dickson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Pablo Mir [Espagne] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Distinguishing SWEDDs Patients with Asymmetric Resting Tremor from Parkinson's Disease: A Clinical and Electrophysiological Study
000B13 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Danilo De Gaspari [Italie] ; Leonilda Bilo [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie]Differential Neuropsychological Profiles in Parkinsonian Patients With or Without Vascular Lesions
000B19 Takeshi Inoue [Japon] ; Mayumi Kitagawa [Japon] ; Teruaki Tanaka [Japon] ; Shin Nakagawa [Japon] ; Tsukasa Koyama [Japon]Depression and Major Depressive Disorder in Patients with Parkinson's Disease
000B25 Sandra Paglionico [Italie] ; Gennarina Arabia [Italie] ; Domenico Pirritano [Italie] ; Aldo Quattrone [Italie] ; Angelo Lavano [Italie] ; Marisa De Rose [Italie]Deep Brain Stimulation in a Patient with Isolated Mixed Tremor
000B33 Giovanni Mostile [États-Unis, Italie] ; Joseph P. Giuffrida [États-Unis] ; Octavian R. Adam [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis]Correlation Between Kinesia System Assessments and Clinical Tremor Scores in Patients with Essential Tremor
000B37 Barbara Jasinska-Myga [États-Unis, Pologne] ; Jennifer Kachergus [États-Unis] ; Carles Vilarino-Güell [États-Unis] ; Christian Wider [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Mounir Kefi [Tunisie] ; Lefkos T. Middleton [Royaume-Uni] ; Lianna Ishihara-Paul [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Rim Amouri [Tunisie] ; SAMIA BEN YAHMED [Tunisie] ; SAMIA BEN SASSI [Tunisie] ; Mourad Zouari [Tunisie] ; Ghada El Euch [Tunisie] ; Owen A. Ross [États-Unis] ; Faycal Hentati [Tunisie] ; Matthew J. Farrer [États-Unis]Comprehensive Sequencing of the LRRK2 Gene in Patients with Familial Parkinson's Disease from North Africa
000B44 Flavio Nobili [Italie] ; Claudio Campus [Italie] ; Dario Amaldi [Italie] ; Fabrizio De Carli [Italie] ; Gaia Cabassi [Italie] ; Andrea Brugnolo [Italie] ; Barbara Dessi [Italie] ; Silvia Morbelli [Italie] ; Gianmario Sambuceti [Italie] ; Giovanni Abbruzzese [Italie] ; Guido Rodriguez [Italie]Cognitive-Nigrostriatal Relationships in De Novo, Drug-Naïve Parkinson's Disease Patients: A [I-123]FP-CIT SPECT Study
000B60 Hans-Holger Capelle [Allemagne] ; Christian Blahak [Allemagne] ; Christoph Schrader [Allemagne] ; Hansjörg Baezner [Allemagne] ; Thomas M. Kinfe [Allemagne] ; Jan Herzog [Allemagne] ; Reinhard Dengler [Allemagne] ; Joachim K. Krauss [Allemagne]Chronic Deep Brain Stimulation in Patients with Tardive Dystonia Without a History of Major Psychosis
000B63 Jia-Yi Li [Suède] ; Elisabet Englund [Suède] ; Hakan Widner [Suède] ; Stig Rehncrona [Suède] ; Anders Björklund [Suède] ; Olle Lindvall [Suède] ; Patrik Brundin [Suède]Characterization of Lewy Body Pathology in 12- and 16-Year-Old Intrastriatal Mesencephalic Grafts Surviving in a Patient With Parkinson's Disease
000B66 Thomas T. Barnikol [Allemagne] ; Norbert B. A. Pawelczyk [Allemagne] ; Utako B. Barnikol [Allemagne] ; Jens Kuhn [Allemagne] ; Doris Lenartz [Allemagne] ; Volker Sturm [Allemagne] ; Peter A. Tass [Allemagne] ; Hans-Joachim Freund [Allemagne]Changes in Apraxia After Deep Brain Stimulation of the Nucleus Basalis Meynert in a Patient With Parkinson Dementia Syndrome
000B68 Chen-San Su [Taïwan] ; Wen-Neng Chang [Taïwan] ; Shu-Hua Huang [Taïwan] ; Chun-Chung Lui [Taïwan] ; Tai-Long Pan [Taïwan] ; Chen-Hsien Lu [Taïwan] ; Yao-Chung Chuang [Taïwan] ; Chi-Ren Huang [Taïwan] ; Nei-Wen Tsai [Taïwan] ; Mei-Jen Hsieh [Taïwan] ; Chiung-Chih Chang [Taïwan]Cerebrotendinous Xanthomatosis Patients With and Without Parkinsonism: Clinical Characteristics and Neuroimaging Findings
000B96 Emily Rosenthal [États-Unis] ; Laura Brennan [États-Unis] ; SHARON XIE [États-Unis] ; HOWARD HURTIG [États-Unis] ; Joshua Milber [États-Unis] ; Daniel Weintraub [États-Unis] ; Jason Karlawish [États-Unis] ; Andrew Siderowf [États-Unis]Association Between Cognition and Function in Patients With Parkinson Disease With and Without Dementia
000C19 Joana Guimaraes [Portugal] ; Augusta Vieira-Coelho [Portugal] ; Maria Jose Rosas [Portugal] ; Eduardo Moura [Portugal] ; Rui Vaz [Portugal] ; Carolina Garrett [Portugal]Acute Renal Failure in Patients with Bilateral Deep Brain Stimulation
000C21 Ellison Fernando Cardoso [Brésil] ; Felipe Fregni [États-Unis] ; Fernanda Martins Maia [Brésil] ; Luciano M. Melo [Brésil] ; Joao R. Sato [Brésil] ; Antonio Cesario Jr Cruz [Brésil] ; Edno Tales Bianchi [Brésil] ; Danilo Botelho Fernandes [Brésil] ; Mário Luiz Ribeiro Monteiro [Brésil] ; Egberto Reis Barbosa [Brésil] ; Edson Jr Amaro [Brésil]Abnormal Visual Activation in Parkinson's Disease Patients
000C27 E. Ray Dorsey [États-Unis] ; Tiffini S. Voss [États-Unis] ; David R. Shprecher [États-Unis] ; Lisa M. Deuel [États-Unis] ; Christopher A. Beck [États-Unis] ; Irenita F. Gardiner [États-Unis] ; Margaret A. Coles [États-Unis] ; Richard S. Burns [États-Unis] ; Frederick J. Marshall [États-Unis] ; Kevin M. Biglan [États-Unis]A U.S. Survey of Patients with Parkinson's Disease: Satisfaction with Medical Care and Support Groups
000C28 Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Marina Picillo [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Roberto Erro [Italie] ; Alessandro Iavarone [Italie]A Two-Year Follow-Up Study of Executive Dysfunctions in Parkinsonian Patients with Freezing of Gait at On-State
000C33 Tobias Warnecke [Allemagne] ; Thomas Duning [Allemagne] ; Anja Schirmacher [Allemagne] ; Siawoosh Mohammadi [Allemagne] ; Wolfram Schwindt [Allemagne] ; Hubertus Lohmann [Allemagne] ; Rainer Dziewas [Allemagne] ; Michael Deppe [Allemagne] ; E. Bernd Ringelstein [Allemagne] ; Peter Young [Allemagne]A Novel Splice Site Mutation in the SPG7 Gene Causing Widespread Fiber Damage in Homozygous and Heterozygous Subjects
000C35 Kerstin Ziegler [Allemagne] ; Frauke Schroeteler [Allemagne] ; Andres O. Ceballos-Baumann [Allemagne] ; Urban M. Fietzek [Allemagne]A New Rating Instrument to Assess Festination and Freezing Gait in Parkinsonian Patients
000C37 Prançois Vacherot [France] ; Shahram Attarian [France] ; Marianne Vaugoyeau [France] ; Jean-Philippe Azulay [France]A Motor Cortex Excitability and Gait Analysis on Parkinsonian Patients
000C43 Ji E. Lee [Corée du Sud] ; Bosuk Park [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]A Comparison of Gray and White Matter Density in Patients with Parkinson's Disease Dementia and Dementia with Lewy Bodies Using Voxel-Based Morphometry
000C44 Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Bum [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni]A Comparison of Depression, Anxiety, and Health Status in Patients with Progressive Supranuclear Palsy and Multiple System Atrophy
000C45 Giovanni Merlino [Italie] ; Simone Lorenzut [Italie] ; Gian Luigi Gigli [Italie] ; Giulio Romano [Italie] ; Domenico Montanaro [Italie] ; Alessandro Moro [Italie] ; Mariarosaria Valente [Italie]A Case-Control Study on Restless Legs Syndrome in Nondialyzed Patients with Chronic Renal Failure
000C47 Joo-Hyun Seo [Corée du Sud] ; SEOK WOO YONG [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Ji E. Lee [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]A Case-Control Study of Multiple System Atrophy in Korean Patients
000C62 Wey-Yil Lin [Taïwan] ; Chin-Chang Huang [Taïwan] ; Hong-Shiu Chang [Taïwan] ; Hung-Chou Kuo [Taïwan] ; Yih-Ru Wu [Taïwan]Various Movement Disorders in a Patient with Sjögren Syndrome
000C65 Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]Validation of the Freezing of Gait Questionnaire in Patients with Parkinson's Disease
000C71 Marco Y. C. Pang [Hong Kong] ; Margaret K. Y. Mak [Hong Kong]Trunk Muscle Strength, But Not Trunk Rigidity, Is Independently Associated with Bone Mineral Density of the Lumbar Spine in Patients with Parkinson's Disease
000C76 Takashi Satoh [Japon] ; Toshiyuki Takahashi [Japon] ; Koh Iwasaki [Japon] ; Hideaki Tago [Japon] ; Takashi Seki [Japon] ; Nobuo Yaegashi [Japon] ; Muneshige Tobita [Japon] ; Hiroyuki Arai [Japon]Traditional Chinese Medicine on Four Patients with Huntington's Disease
000C85 Matthew Menza [États-Unis] ; Roseanne Defronzo Dobkin [États-Unis] ; Humberto Marin [États-Unis] ; Margery H. Mark [États-Unis] ; Michael Gara [États-Unis] ; Steven Buyske [États-Unis] ; Karina Bienfait [États-Unis] ; Allison Dicke [États-Unis]The Impact of Treatment of Depression on Quality of Life, Disability and Relapse in Patients with Parkinson's Disease
000D09 Katja Ritz [Pays-Bas] ; Justus L. Groen [Pays-Bas] ; Jose J. M. Kruisdijk [Pays-Bas] ; Frank Baas [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; Marina A. J. Tijssen [Pays-Bas]Screening for Dystonia Genes DYT1, 11 and 16 in Patients with Writer's Cramp
000D13 Nadège Limousin [France] ; Eric Konofal [France] ; Elias Karroum [France] ; Ebba Lohmann [France] ; Ioannis Theodorou [France] ; Alexandra Dürr [France] ; Isabelle Amulf [France]Restless Legs Syndrome, Rapid Eye Movement Sleep Behavior Disorder, and Hypersomnia in Patients with Two Parkin Mutations
000D18 Gottfried Kranz [Autriche] ; Dietrich Haubenberger [Autriche] ; Bemhard Voller [Autriche] ; Martin Posch [Autriche] ; Peter Schnider [Autriche] ; Eduard Auff [Autriche] ; Thomas Sycha [Autriche]Respective Potencies of Botox® and Dysport® in a Human Skin Model : A Randomized, Double-blind Study
000D23 Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie]Relative Preservation of Thalamic Centromedian Nucleus in Parkinsonian Patients with Dystonia
000D24 Joseph Jankovic [États-Unis] ; Christopher Kenney [États-Unis] ; Susanne Grafe [Allemagne] ; Roman Goertelmeyer [Allemagne] ; George Comes [Allemagne]Relationship Between Various Clinical Outcome Assessments in Patients with Blepharospasm
000D25 Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie]Rehabilitation Treatment of Gait in Patients with Parkinson's Disease with Freezing: A Comparison Between Two Physical Therapy Protocols Using Visual and Auditory Cues with or Without Treadmill Training
000D26 Hiroshi Kataoka [Japon] ; Josep Dalmau [États-Unis] ; Toshiaki Taoka [Japon] ; Satoshi Ueno [Japon]Reduced N-Acetylaspartate in the Basal Ganglia of a Patient with Anti-NMDA Receptor Encephalitis
000D38 Andrew Mckeon [États-Unis] ; J. Eric Ahlskog [États-Unis] ; James H. Bower [États-Unis] ; Keith A. Josephs [États-Unis] ; Joseph Y. Matsumoto [États-Unis]Psychogenic Tremor : Long Term Prognosis in Patients with Electrophysiologically-Confirmed Disease
000D41 Marcondes C. Jr Franca [Brésil] ; Anelyssa D'Abreu [Brésil] ; Anamarli Nucci [Brésil] ; Fernando Cendes [Brésil] ; Iscia Lopes-Cendes [Brésil]Progression of Ataxia in Patients with Machado-Joseph Disease
000D43 Gregory M. Pontone [États-Unis] ; James R. Williams [États-Unis] ; Karen E. Anderson [États-Unis] ; Gary Chase [États-Unis] ; Susanne A. Goldstein [États-Unis] ; Stephen Grill [États-Unis] ; Elaina S. Hirsch [États-Unis] ; Susan Lehmann [États-Unis] ; John T. Little [États-Unis] ; Russell L. Margolis [États-Unis] ; Peter V. Rabins [États-Unis] ; Howard D. Weiss [États-Unis] ; Laura Marsh [États-Unis]Prevalence of Anxiety Disorders and Anxiety Subtypes in Patients with Parkinson's Disease
000D55 Jee-Young Lee [Corée du Sud] ; Woong-Woo Lee [Corée du Sud] ; JI SOO KIM [Corée du Sud] ; HEE JIN KIM [Corée du Sud] ; Jin-Kyung Kim [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Perverted Head-Shaking and Positional Downbeat Nystagmus in Patients With Multiple System Atrophy
000D57 Terri K. Pogoda [États-Unis] ; Irene E. Cramer [États-Unis] ; Mark Meterko [États-Unis] ; HAI LIN [États-Unis] ; Ann Hendricks [États-Unis] ; Robert G. Holloway [États-Unis] ; Martin P. Charns [États-Unis]Patient and Organizational Factors Related to Education and Support Use by Veterans with Parkinson's Disease
000D58 David Devos [France]Patient Profile, Indications, Efficacy and Safety of Duodenal Levodopa Infusion in Advanced Parkinson's Disease
000D59 Paul Wicks [États-Unis] ; Graeme J. A. Macphee [Royaume-Uni]Pathological Gambling Amongst Parkinson's Disease and ALS Patients in an Online Community (PatientsLikeMe.com)
000D68 Mariachiara Sensi [Italie] ; Michele A. Cavallo [Italie] ; Rocco Quatrale [Italie] ; Silvio Sarubbo [Italie] ; Sara Biguzzi [Italie] ; Cristian Lettieri [Italie] ; Jay G. Capone [Italie] ; Valeria Tugnoli [Italie] ; Maria Rosaria Tola [Italie] ; Roberto Eleopra [Italie]Pallidal Stimulation for Segmental Dystonia: Long Term Follow Up of 11 Consecutive Patients
000D69 Angelika Nebe [Allemagne] ; Georg Ebersbach [Allemagne]Pain Intensity On and Off Levodopa in Patients with Parkinson's Disease
000D70 Clecio Godeiro-Junior [Brésil] ; Patricia M. De Carvalho-Aguiar [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Sonia M. A. Silva [Brésil] ; Vanderci Borges [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Henrique Ballalai Ferraz [Brésil]PINK1 Mutations in a Brazilian Cohort of Early-Onset Parkinson's Disease Patients
000D74 Alberto J. Espay [États-Unis] ; Linda M. Goldenhar [États-Unis] ; Valerie Voon [États-Unis] ; Anette Schrag [Royaume-Uni] ; Noël Burton [États-Unis] ; Anthony E. Lang [Canada]Opinions and Clinical Practices Related to Diagnosing and Managing Patients with Psychogenic Movement Disorders: An International Survey of Movement Disorder Society Members
000D79 Johannes Levin [Allemagne] ; Siegbert Krafczyk [Allemagne] ; Peter Valkovic [Slovaquie] ; Thomas Eggert [Allemagne] ; Jens Claassen [Allemagne] ; Kai Bötzel [Allemagne]Objective Measurement of Muscle Rigidity in Parkinsonian Patients Treated with Subthalamic Stimulation
000D84 Erika Driver-Dunckley [États-Unis] ; Donald Connor [États-Unis] ; Joe Hentz [États-Unis] ; Marwan Sabbagh [États-Unis] ; Nina Silverberg [États-Unis] ; Jose Hernandez [États-Unis] ; Linda Vedders [États-Unis] ; Virgilio Gerald Evidente [États-Unis] ; Holly Shill [États-Unis] ; John Caviness [États-Unis] ; Charles Adler [États-Unis]No Evidence for Cognitive Dysfunction or Depression in Patients with Mild Restless Legs Syndrome
000D91 Katrin Bürk [Allemagne] ; Marie-Louise Farecki [Allemagne] ; Georg Lamprecht [Allemagne] ; Guenter Roth [Allemagne] ; Patrice Decker [Allemagne] ; Michael Weller [Suisse] ; Hans-Georg Rammensee [Allemagne] ; Wolfang Oertel [Allemagne]Neurological Symptoms in Patients with Biopsy Proven Celiac Disease
000D98 A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schroder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne]Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers
000E01 Félix Javier Jimenez-Jimenez [Espagne] ; Lluisa Rubio [Espagne] ; Marisol Calleja [Espagne] ; Hortensia Alonso-Navarro [Espagne] ; Laura Turpin-Fenoll [Espagne] ; José Francisco Plaza-Nieto [Espagne] ; Belén Pilo-De-La-Fuente [Espagne] ; Pedro J. Garcia-Ruiz [Espagne] ; José A. G. Agundez [Espagne]Motor Performance in Patients with Restless Legs Syndrome
000E04 Sebastian Paus [Allemagne] ; Franziska Gadow [Allemagne] ; Michael Knapp [Allemagne] ; Christine Klein [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]Motor Complications in Patients Form the German Competence Network on Parkinson's Disease and the DRD3 Ser9Gly Polymorphism
000E09 Elan D. Louis [États-Unis] ; Eileen Rios [États-Unis] ; Claire Henchcliffe [États-Unis]Mirror Movements in Patients with Essential Tremor
000E12 Maria G. Cersosimo [Argentine] ; Gabriela B. Raina [Argentine] ; Eduardo E. Benarroch [États-Unis] ; Fabian Piedimonte [Argentine] ; Gabriela Gonzalez Aleman [Argentine] ; Federico E. Micheli [Argentine]Micro Lesion Effect of the Globus Pallidus Internus and Outcome with Deep Brain Stimulation in Patients with Parkinson Disease and Dystonia
000E23 Sophie Molloy [Royaume-Uni] ; Thais Minett [Brésil] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni]Levodopa Use and Sleep in Patients with Dementia with Lewy Bodies
000E28 Cyrus P. Zabetian [États-Unis] ; Mitsutoshi Yamamoto [Japon] ; Alexis N. Lopez [États-Unis] ; Hiroshi Ujike [Japon] ; Ignacio F. Mata [États-Unis] ; Yuishin Izumi [Japon] ; Ryuji Kaji [Japon] ; Hirofumi Maruyama [Japon] ; Hiroyuki Morino [Japon] ; Masaya Oda [Japon] ; Carolyn M. Hutter [États-Unis] ; Karen L. Edwards [États-Unis] ; Gerard D. Schellenberg [États-Unis] ; Debby W. Tsuang [États-Unis] ; Dora Yearout [États-Unis] ; Eric B. Larson [États-Unis] ; Hideshi Kawakami [Japon]LRRK2 Mutations and Risk Variants in Japanese Patients with Parkinson's Disease
000E32 Roy Elbers [Pays-Bas] ; Erwin E. H. Van Wegen [Pays-Bas] ; Lynn Rochester [Royaume-Uni] ; Victoria Hetherington [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; Anne-Marie Willems [Belgique] ; Diana Jones [Royaume-Uni] ; Gert Kwakkel [Pays-Bas]Is Impact of Fatigue an Independent Factor Associated with Physical Activity in Patients with Idiopathic Parkinson's Disease?
000E37 Satoru Morimoto [Japon] ; Shigeki Kuzuhara [Japon] ; Yasumasa Kokubo [Japon]Increased Oxidative Stress in Patients with Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex in the Kii Peninsula, Japan
000E47 Stefano Zoccolella [Italie] ; Claudia Dell'Aquila [Italie] ; Giovanni Abruzzese [Italie] ; Angelo Antonini [Italie] ; Ubaldo Bonuccelli [Italie] ; Margherita Canesi [Italie] ; Silvano Cristina [Italie] ; Roberta Marchese [Italie] ; Claudio Pacchetti [Italie] ; Roberto Zagaglia [Italie] ; Giancarlo Logroscino [Italie] ; Giovanni Defazio [Italie] ; Paolo Lamberti [Italie] ; Paolo Livrea [Italie]Hyperhomocysteinemia in Levodopa-Treated Patients with Parkinson's Disease Dementia
000E52 Thomas Müller [Allemagne] ; Wilfried Kuhn [Allemagne]Homocysteine Levels After Acute Levodopa Intake in Patients with Parkinson's Disease
000E53 Richard M. Camicioli [Canada] ; Thomas P. Bouchard [Canada] ; Martin J. Somerville [Canada]Homocysteine Is Not Associated with Global Motor or Cognitive Measures in Nondemented Older Parkinson's Disease Patients
000E59 MYUNG SIK LEE [Corée du Sud] ; WON JOO KIM [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; SEON JEONG KIM [Corée du Sud]Giant Somatosensory Evoked Potential in a Patient with Shaking TIA
000E61 Maria G. Macedo [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; YUE FANG [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Martine Visser [Pays-Bas] ; Burcu Anar [Pays-Bas] ; Antonella Uras [Pays-Bas] ; Justus L. Groen [Pays-Bas] ; Patrizia Rizzu [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Peter Heutink [Pays-Bas]Genotypic and Phenotypic Characteristics of Dutch Patients with Early Onset Parkinson's Disease
000E62 Ming-Jen Lee [Taïwan] ; Ignacio F. Mata [États-Unis] ; Chin-Hsien Lin [Taïwan] ; Kai-Yuan Tzen [Taïwan] ; Sarah J. Lincoln [États-Unis] ; Rebecca Bounds [États-Unis] ; Paul J. Lockhart [Australie] ; Mary M. Hulihan [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ruey-Meei Wu [Taïwan]Genotype-Phenotype Correlates in Taiwanese Patients with Early-Onset Recessive Parkinsonism
000E75 Yasuyuki Okuma [Japon] ; Satoshi Kamei [Japon] ; Akihiko Morita [Japon] ; Fumihito Yoshii [Japon] ; Toshimasa Yamamoto [Japon] ; Shiori Hashimoto [Japon] ; Hiroya Utsumi [Japon] ; Taku Hatano [Japon] ; Nobutaka Hattori [Japon] ; Miyuki Matsumura [Japon] ; Kazushi Takahashi [Japon] ; Shigeru Nogawa [Japon] ; Yuka Watanabe [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon]Fatigue in Japanese Patients with Parkinson's Disease: A Study Using Parkinson Fatigue Scale
000E78 Ji E. Lee [Corée du Sud] ; Hae-Won Shin [Corée du Sud] ; Kyung S. Kim [Corée du Sud] ; Young H. Sohn [Corée du Sud]Factors Contributing to the Development of Restless Legs Syndrome in Patients with Parkinson Disease
000E81 Pierre-François Pradat [France] ; Gaelle Bruneteau [France] ; Elisabetta Munerati [France] ; François Salachas [France] ; Nadine Le Forestier [France] ; Lucette Lacomblez [France] ; Timothee Lenglet [France] ; Vincent Meininger [France]Extrapyramidal Stiffness in Patients with Amyotrophic Lateral Sclerosis
000E83 Lina Shehadeh [États-Unis] ; Georgia Mitsi [États-Unis] ; Nikhil Adi [États-Unis] ; Nanette Bishopric [États-Unis] ; Spyridon Papapetropoulos [États-Unis]Expression of Lewy Body Protein Septin 4 in Postmortem Brain of Parkinson's Disease and Control Subjects
000E92 Livia Brusa [Italie] ; Enrico Finazzi Agro [Italie] ; Filomena Petta [Italie] ; Francesco Sciobica [Italie] ; Sara Torriero [Italie] ; Emanuele Lo Gerfo [Italie] ; Cesare Iani [Italie] ; Paolo Stanzione [Italie] ; Giacomo Koch [Italie]Effects of Inhibitory rTMS on Bladder Function in Parkinson's Disease Patients
000E97 Elizabeth L. Stegemöller [États-Unis] ; Tanya Simuni [États-Unis] ; Colum Mackinnon [États-Unis]Effect of Movement Frequency on Repetitive Finger Movements in Patients with Parkinson's Disease
000F08 Vincenzo Rizzo [Italie] ; Irene Arico [Italie] ; Claudia Mastroeni [Italie] ; Francesca Morgante [Italie] ; Giovanna Liotta [Italie] ; Paolo Girlanda [Italie] ; Rosalia Silvestri [Italie] ; Angelo Quartarone [Italie]Dopamine Agonists Restore Cortical Plasticity in Patients with Idiopathic Restless Legs Syndrome
000F18 Adam Zaidel [Israël] ; Alexander Spivak [Israël] ; Lavi Shpigelman [Israël] ; Hagai Bergman [Israël] ; Zvi Israel [Israël]Delimiting Subterritories of the Human Subthalamic Nucleus by Means of Microelectrode Recordings and a Hidden Markov Model
000F25 Evangelia Delikanaki-Skaribas [États-Unis] ; Marilyn Trail [États-Unis] ; William Wai-Lun Wong [États-Unis] ; Eugene C. Lai [États-Unis]Daily Energy Expenditure, Physical Activity, and Weight Loss in Parkinson's Disease Patients
000F26 Thomas Müller [Allemagne] ; Wilfried Kuhn [Allemagne]Cysteine Elevation in Levodopa-Treated Patients with Parkinson's Disease
000F31 Kelvin L. Chou [États-Unis] ; Melissa M. Amick [États-Unis] ; Margaret Gagner [États-Unis]Contrast Sensitivity in Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation
000F40 Gabriel Robert [France] ; Dominique Drapier [France] ; Marc Verin [France] ; Bruno Millet [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]Cognitive Impulsivity in Parkinson's Disease Patients: Assessment and Pathophysiology
000F42 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Francesca Verde [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson's Disease
000F47 Jason P. Covy [États-Unis] ; WUXING YUAN [États-Unis] ; Elisa A. Waxman [États-Unis] ; Howard I. Hurtig [États-Unis] ; Vivianna M. Van Deerlin [États-Unis] ; Benoit I. Giasson [États-Unis]Clinical and Pathological Characteristics of Patients with Leucine-Rich Repeat Kinase-2 Mutations
000F49 Maria Elisa Alonso [Mexique] ; Adriana Ochoa [Mexique] ; Marie-Catherine Boll [Mexique] ; Ana Luisa Sosa [Mexique] ; Petra Yescas [Mexique] ; Marisol Lopez [Mexique] ; Rosario Macias [Mexique] ; Itziar Familiar [États-Unis] ; Astrid Rasmussen [États-Unis]Clinical and Genetic Characteristics of Mexican Huntington's Disease Patients
000F53 Sibel Ertan [Turquie] ; Derya Uluduz [Turquie] ; Sibel Ozekmekci [Turquie] ; Günes Kiziltan [Turquie] ; Turan Ertan [Turquie] ; Cengiz Yalcinkaya [Turquie] ; Cigdem Ozkara [Turquie]Clinical Characteristics of 49 Patients with Psychogenic Movement Disorders in a Tertiary Clinic in Turkey
000F67 Martin Witt [Allemagne] ; Katja Bormann [Allemagne] ; Volker Gudziol [Allemagne] ; Kerstin Pehlke [Allemagne] ; Kathrin Barth [Allemagne] ; Amir Minovi [Allemagne] ; Antje H Hner [Allemagne] ; Heinz Reichmann [Allemagne] ; Thomas Hummel [Allemagne]Biopsies of Olfactory Epithelium in Patients with Parkinson's Disease
000F68 Elena Urrestarazu [Espagne] ; Jorge Iriarte [Espagne] ; Manuel Alegre [Espagne] ; Pedro Clavero [Espagne] ; Mari Cruz Rodnguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; José A. Obeso [Espagne] ; Julio Artieda [Espagne]Beta Activity in the Subthalamic Nucleus During Sleep in Patients with Parkinson's Disease
000F93 Edward J. Newman [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Accuracy of Parkinson's Disease Diagnosis in 610 General Practice Patients in the West of Scotland
000F94 Ana Djarmati [Allemagne] ; Johann Hagenah [Allemagne] ; Kathrin Reetz [Allemagne] ; Susen Winkler [Allemagne] ; Maria Isabel Behrens [Chili] ; Heike Pawlack [Allemagne] ; Katja Lohmann [Allemagne] ; Alfredo Ramirez [Allemagne] ; Vera Tadic [Allemagne] ; Norbert Brüggemann [Allemagne] ; Daniela Berg [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; Ferdinand Binkofski [Allemagne] ; Vladimir S. Kostic [Serbie] ; Jens Volkmann [Allemagne] ; Thomas Gasser [Allemagne] ; Christine Klein [Allemagne]ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls
001009 Seyedmehdi Shojaee [Iran] ; Farzad Sina [Iran] ; Niloofar Farboodi [Iran] ; Zeinab Fazlali [Iran] ; Farzaneh Ghazavi [Iran] ; SEYED ALI GHORASHI [Iran] ; Khosro Parsa [Iran] ; Homa Sadeghi [Iran] ; Gholam-Ali Shahidi [Iran] ; Mostafa Ronaghi [États-Unis] ; Elahe Elahi [Iran]A Clinic-Based Screening of Mutations in Exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's Disease Patients
001017 Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada]rCBF Changes Associated with PPN Stimulation in a Patient with Parkinson's disease : A PET Study
001022 Anne Marthe Meppelink [Pays-Bas] ; Janneke Koerts [Pays-Bas] ; Maarten Borg [Pays-Bas] ; Klaus Leonard Leenders [Pays-Bas] ; Teus Van Laar [Pays-Bas]Visual Object Recognition and Attention in Parkinson's Disease Patients with Visual Hallucinations
001026 Pablo Martinez-Martin [Espagne] ; Eduardo Tolosa [Espagne] ; Basilio Hernandez [Espagne] ; Xavier Badia [Espagne]Validation of the "QUICK" Questionnaire : A Tool for Diagnosis of "Wearing-Off" in Patients with Parkinson's Disease
001031 Seong-Beom Koh [Corée du Sud] ; Jee-Hoon Roh [Corée du Sud] ; JI HYUN KIM [Corée du Sud] ; Kyungmi Oh [Corée du Sud] ; Byung-Jo Kim [Corée du Sud] ; Gui-Sang Kim [Corée du Sud] ; Byung-Kyu Park [Corée du Sud] ; Se-Ju Kim [Corée du Sud] ; Joon-Shik Yoon [Corée du Sud]Ultrasonographic Findings of Shoulder Disorders in Patients with Parkinson's Disease
001035 Olalla Bello [Espagne] ; Jose Andres Sanchez [Espagne] ; Miguel Fernandez-Del-Olmo [Espagne]Treadmill Walking in Parkinson's Disease Patients : Adaptation and Generalization Effect
001062 Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada]The G2019S LRRK2 Mutation in Brazilian Patients with Parkinson's Disease : Phenotype in Monozygotic Twins
001086 Robert A. Hauser [États-Unis] ; Lisa M. Shulman [États-Unis] ; Joel M. Trugman [États-Unis] ; John W. Roberts [États-Unis] ; Akihisa Mori [Japon] ; Rocco Ballerini [États-Unis] ; Neil M. Sussman [États-Unis]Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor Fluctuations
001090 Cyril Gitiaux [France] ; Emmanuel Roze [France] ; Kiyoka Kinugawa [France] ; Constance Flamand-Rouviere [France] ; Nathalie Boddaert [France] ; Emmanuelle Apartis [France] ; Vassili Valayannopoulos [France] ; Guy Touati [France] ; Jacques Motte [France] ; David Devos [France] ; Karine Mention [France] ; Dries Dobbelaere [France] ; Diana Rodriguez [France] ; Agathe Roubertie [France] ; Brigitte Chabrol [France] ; Francois Feillet [France] ; Marie Vidailhet [France] ; Nadia Bahi-Buisson [France]Spectrum of Movement Disorders Associated with Glutaric Aciduria Type 1 : A Study of 16 Patients
001094 Julio Lopez-Bastida [Espagne] ; Lilisbeth Perestelo-Perez [Espagne] ; Fernando Monton-Alvarez [Espagne] ; Pedro Serrano-Aguilar [Espagne]Social Economic Costs and Health-Related Quality of Life in Patients with Degenerative Cerebellar Ataxia in Spain
001101 Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Teus Van Laar [Pays-Bas] ; Chuanchieh Hsu [États-Unis] ; Wemer Poewe [Autriche] ; Roger M. Lane [États-Unis]Rivastigmine Versus Placebo in Hyperhomocysteinemic Parkinson's Disease Dementia Patients
001102 Jean-Sébastien Vidal [France] ; Marie Vidailhet [France] ; Alexis Elbaz [France] ; Pascal Derkinderen [France] ; Christophe Tzourio [France] ; Annick Alperovitch [France]Risk Factors of Multiple System Atrophy : A Case-Control Study in French Patients
001104 Marcel J. H. Aries [Belgique] ; Hans Debruyne [Belgique] ; Sebastiaan Engelborghs [Belgique] ; Nathalie Le Bastard [Belgique] ; Nore Somers [Belgique] ; Dagmar Gorissen [Belgique] ; Barbara A. Pickut [Belgique] ; Peter Paul De Deyn [Belgique]Reversal of Head Drop After Discontinuation of Olanzapine in a DLB Patient
001109 Francisco Coria [Espagne] ; Maria Del Puig Cozar-Santiago [Espagne]Rasagiline Improves Freezing in a Patient with Primary Progressive Freezing Gait
001117 Wouter B. Reedijk [Pays-Bas] ; Monique A. Van Rijn [Pays-Bas] ; Karin Roelofs [Pays-Bas] ; Jolien P. Tuijl [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas]Psychological Features of Patients with Complex Regional Pain Syndrome Type I Related Dystonia
001128 Alison La Pean [États-Unis] ; Neal Jeffries [États-Unis] ; Chelsea Grow [États-Unis] ; Bernard Ravina [États-Unis] ; Nicholas A. Di Prospero [États-Unis]Predictors of Progression in Patients with Friedreich Ataxia
001143 Rebecca E. Ready [États-Unis] ; Melissa Mathews [États-Unis] ; Anne Leserman [États-Unis] ; Jane S. Paulsen [États-Unis]Patient and Caregiver Quality of Life in Huntington's Disease
001155 Pierre J. Blanchet [Canada] ; Romana Popovici [Canada] ; Francine Guitard [Canada] ; Pierre H. Rompre [Canada] ; Claude Lamarche [Canada] ; Gilles J. Lavigne [Canada]Pain and Denture Condition in Edentulous Orodyskinesia : Comparisons with Tardive Dyskinesia and Control Subjects
001159 Tim Anderson [Nouvelle-Zélande] ; Linda Luxon [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; C. David Marsden ; Adolfo Bronstein [Royaume-Uni]Oculomotor Function in Multiple System Atrophy : Clinical and Laboratory Features in 30 Patients
001171 Tomasz Litwin [Pologne] ; Grazyna Gromadzka [Pologne] ; Anna Członkowska [Pologne]Neurological Presentation of Wilson's Disease in a Patient After Liver Transplantation
001172 Sylvia Boesch [Autriche] ; Brigitte Sturm [Autriche] ; Sascha Hering [Autriche] ; Barbara Scheiber-Mojdehkar [Autriche] ; Hannes Steinkellner [Autriche] ; Hans Goldenberg [Autriche] ; Werner Poewe [Autriche]Neurological Effects of Recombinant Human Erythropoietin in Friedreich's Ataxia : A Clinical Pilot Trial
001177 Ji-Feng Guo [République populaire de Chine] ; BIN XIAO [République populaire de Chine] ; BING LIAO [République populaire de Chine] ; Xue-Wei Zhang [République populaire de Chine] ; Li-Luo Nie [République populaire de Chine] ; Yu-Hu Zhang [République populaire de Chine] ; LU SHEN [République populaire de Chine] ; HONG JIANG [République populaire de Chine] ; KUN XIA [République populaire de Chine] ; QIAN PAN [République populaire de Chine] ; Xin-Xiang Yan [République populaire de Chine] ; Bei-Sha Tang [République populaire de Chine]Mutation Analysis of Parkin, PINK1, DJ-1 and ATP13A2 Genes in Chinese Patients with Autosomal Recessive Early-Onset Parkinsonism
001182 Teresa Temudo [Portugal] ; Elisabete Ramos [Portugal] ; Karin Dias [Portugal] ; Clara Barbot [Portugal] ; Jose P. Vieira [Portugal] ; Ana Moreira [Portugal] ; Eulalia Calado [Portugal] ; Ines Carrilho [Portugal] ; Guiomar Oliveira [Portugal] ; Antonio Levy [Portugal] ; Maria Fonseca [Portugal] ; Alexandra Cabral [Portugal] ; Pedro Cabral [Portugal] ; Joao P. Monteiro [Portugal] ; Luis Borges [Portugal] ; Roseli Gomes [Portugal] ; Manuela Santos [Portugal] ; Jorge Sequeiros [Portugal] ; Patricia Maciel [Portugal]Movement Disorders in Rett Syndrome : An Analysis of 60 Patients with Detected MECP2 Mutation and Correlation with Mutation Type
001186 Susanne A. Schneider [Royaume-Uni] ; Penelope Talelli [Royaume-Uni] ; Binith J. Cheeran [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Motor Cortical Physiology in Patients and Asymptomatic Carriers of Parkin Gene Mutations
001189 Sylvie Piacentini [Italie] ; Luigi Romito [Italie] ; Angelo Franzini [Italie] ; Alberto Granato [Italie] ; Giovanni Broggi [Italie] ; Alberto Albanese [Italie]Mood Disorder Following DBS of the Left Amygdaloid Region in a Dystonia Patient with a Dislodged Electrode
001191 Donatella Ottaviani [Italie] ; Dorina Tiple [Italie] ; Antonio Suppa [Italie] ; Carlo Colosimo [Italie] ; Giovanni Fabbrini [Italie] ; Massimo Cincotta [Italie] ; Giovanni Defazio [Italie] ; Alfredo Berardelli [Italie]Mirror Movements in Patients with Parkinson's Disease
001198 Roy C. Martin [États-Unis] ; Ozioma C. Okonkwo [États-Unis] ; Joni Hill [États-Unis] ; H. Randall Griffith [États-Unis] ; Kristen Triebel [États-Unis] ; Alfred Bartolucci [États-Unis] ; Anthony P. Nicholas [États-Unis] ; Ray L. Watts [États-Unis] ; Natividad Stover [États-Unis] ; Lindy E. Harrell [États-Unis] ; David Clark [États-Unis] ; Daniel C. Marson [États-Unis]Medical Decision-Making Capacity in Cognitively Impaired Parkinson's Disease Patients Without Dementia
001201 Beata Tarnacka [Pologne] ; Wojciech Szeszkowski [Pologne] ; Marek Golebiowski [Pologne] ; Anna Czlonkowska [Pologne]MR Spectroscopy in Monitoring the Treatment of Wilson's Disease Patients
001210 Mercedes Serrano [Espagne] ; Belen Perez-Duenas [Espagne] ; Aida Ormazabal [Espagne] ; Rafael Artuch [Espagne] ; Jaume Campistol [Espagne] ; Rosa J. Torres [Espagne] ; Angels Garcia-Cazorla [Espagne]Levodopa Therapy in a Lesch-Nyhan Disease Patient : Pathological, Biochemical, Neuroimaging, and Therapeutic Remarks
001218 Rocco Agostino [Italie] ; Loredana Dinapoli [Italie] ; Nicola Modugno [Italie] ; Ennio Iezzi [Italie] ; Bruno Gregori [Italie] ; Vincenzo Esposito [Italie] ; Pantaleo Romanelli [Italie] ; Alfredo Berardelli [Italie]Ipsilateral Sequential Arm Movements After Unilateral Subthalamic Deep-Brain Stimulation in Patients with Parkinson's Disease
001225 Guilherme G. Riccioppo Rodrigues [Brésil] ; Ruth H. Walker [États-Unis] ; Alexis Brice [France] ; Cécile Cazeneuve [France] ; Odile Russaouen [France] ; Helio A. G. Teive [Brésil] ; Renato Puppi Munhoz [Brésil] ; Nilson Becker [Brésil] ; Salmo Raskin [Brésil] ; Lineu Cesar Wemeck [Brésil] ; Wilson Marques Junior [Brésil] ; Vitor Tumas [Brésil]Huntington's Disease-Like 2 in Brazil-Report of 4 Patients
001230 Alfonso Fasano [Italie] ; Caria Piano [Italie] ; Celestino De Simone [Italie] ; Beatrice Cioni [Italie] ; Daniela Di Giuda [Italie] ; Massimiliano Zinno [Italie] ; Antonio Daniele [Italie] ; Mario Meglio [Italie] ; Alessandro Giordano [Italie] ; Anna Rita Bentivoglio [Italie]High Frequency Extradural Motor Cortex Stimulation Transiently Improves Axial Symptoms in a Patient with Parkinson's Disease
001232 WON YONG LEE [Corée du Sud] ; WON TAE YOON [Corée du Sud] ; HEE YOUNG SHIN [Corée du Sud] ; SEONG HEE JEON [Corée du Sud] ; Poong-Lyul Rhee [Corée du Sud]Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease
001240 Patricia De Carvalho Aguiar [Brésil] ; Patricia Silva Lessa [Brésil] ; Clecio Godeiro Junior [Brésil] ; Orlando Barsottini [Brésil] ; Andre Carvalho Felicio [Brésil] ; Vanderci Borges [Brésil] ; Sonia Maria De Azevedo Silva [Brésil] ; Roberta Arb Saba [Brésil] ; Henrique Ballalai Ferraz [Brésil] ; Carlos A. Moreira-Filho [Brésil] ; Luiz Augusto F. Andrade [Brésil]Genetic and Environmental Findings in Early-onset Parkinson's Disease Brazilian Patients
001242 Evelien Huisman [Pays-Bas] ; Harry B. M. Uylings [Pays-Bas] ; Piet V. Hoogland [Pays-Bas, Afrique du Sud]Gender-Related Changes in Increase of Dopaminergic Neurons in the Olfactory Bulb of Parkinson's Disease Patients
001247 Marianna Amboni [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Marina Picillo [Italie] ; Paolo Barone [Italie]Freezing of Gait and Executive Functions in Patients with Parkinson's Disease
001262 Barbara Leinweber [Allemagne] ; J. Carsten Möller [Allemagne] ; Andre Scherag [Allemagne] ; Ulrike Reuner [Allemagne] ; Peter Günther [Allemagne] ; Christoph J. G. Lang [Allemagne] ; Hartmut H. J. Schmidt [Allemagne] ; Christoph Schrader [Allemagne] ; Oliver Bandmann [Royaume-Uni] ; Anna Czlonkowska [Pologne] ; Wolfgang H. Oertel [Allemagne] ; Harald Hefter [Allemagne]Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German Patients with Treated Wilson's Disease
001264 Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Vanessa K. Hinson [États-Unis] ; Lucia M. Blasucci [États-Unis] ; Jennifer Zimmerman [États-Unis] ; WENQING FAN [États-Unis] ; Tiffany Nguyen [États-Unis] ; Ann Hsu [États-Unis]Evaluating Parkinson's Disease Patients at Home : Utility of Self-Videotaping for Objective Motor, Dyskinesia, and ON-OFF Assessments
001265 Samuel A. Frank [États-Unis] ; Renee Wilson [États-Unis] ; Robert G. Holloway [États-Unis] ; Carol Zimmerman [États-Unis] ; Derick R. Peterson [États-Unis] ; Karl Kieburtz [États-Unis] ; Scott Y. H. Kim [États-Unis]Ethics of Sham Surgery : Perspective of Patients
001266 Thomas Müller [Allemagne] ; Dirk Woitalla [Allemagne] ; Oliver Goetze [Allemagne, Suisse] ; Christoph Erdmann [Allemagne]Entacapone Improves Absorption of a Coadministered Salt in Patients with Parkinson's Disease
001268 Mia T. Minen [États-Unis] ; Elan D. Louis [États-Unis]Emergence of Parkinson's Disease in Essential Tremor : A Study of the Clinical Correlates in 53 Patients
001269 Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada]Elevated Serotonin Transporter Binding in Depressed Patients with Parkinson's Disease : A Preliminary PET Study with [11C]DASB
001283 Thomas A. Buckley [États-Unis] ; Chris Pitsikoulis [États-Unis] ; Chris J. Hass [États-Unis]Dynamic Postural Stability During Sit-to-Walk Transitions in Parkinson Disease Patients
001287 Julie H. Carter [États-Unis] ; Barbara J. Stewart [États-Unis] ; Karen S. Lyons [États-Unis] ; Patricia G. Archbold [États-Unis]Do Motor and Nonmotor Symptoms in PD Patients Predict Caregiver Strain and Depression?
001290 Nathalie Chastan [France] ; Bertrand Debono [France] ; David Maltete [France] ; Jacques Weber [France]Discordance Between Measured Postural Instability and Absence of Clinical Symptoms in Parkinson's Disease Patients in the Early Stages of the Disease
001298 Sierra Farris [États-Unis] ; Paul Ford [États-Unis] ; Joseph Demarco [États-Unis] ; Monique L. Giroux [États-Unis]Deep Brain Stimulation and the Ethics of Protection and Caring for the Patient with Parkinson's Dementia
001304 Alice Nieuwboer [Belgique]Cueing for Freezing of Gait in Patients with Parkinson's Disease : A Rehabilitation Perspective
001305 Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong]Cued Task-Specific Training is Better Than Exercise in Improving Sit-to-Stand in Patients with Parkinson's Disease : A Randomized Controlled Trial
001308 Laura Avanzino [Royaume-Uni, Italie] ; Davide Martino [Royaume-Uni, Italie] ; Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Susanne A. Schneider [Royaume-Uni] ; Giovanni Abbruzzese [Italie] ; Giovanni Defazio [Italie] ; Anette Schrag [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni]Cortical Excitability is Abnormal in Patients with the "Fixed Dystonia" Syndrome
001310 Stephen Tisch [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni]Cortical Evoked Potentials from Pallidal Stimulation in Patients with Primary Generalized Dystonia
001325 Minori Enomoto [Japon] ; Yuichi Inoue [Japon] ; Kazuyoshi Namba [Japon] ; Takashi Munezawa [Japon] ; Masato Matsuura [Japon]Clinical Characteristics of Restless Legs Syndrome in End-Stage Renal Failure and Idiopathic RLS Patients
001326 Daisy L. Whitehead [Royaume-Uni] ; Ann D. M. Davies [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni] ; Christopher J. Turnbull [Royaume-Uni]Circadian Rest-Activity Rhythm Is Altered in Parkinson's Disease Patients with Hallucinations
001338 Pablo Martinez-Martin [Espagne] ; Susana Arroyo [Espagne] ; Jose Manuel Rojo-Abuin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Belen Frades [Espagne] ; Jesus De Pedro Cuesta [Espagne]Burden, Perceived Health Status, and Mood Among Caregivers of Parkinson's Disease Patients
001340 Blanca Ramirez-Ruiz [Espagne] ; Maria-José Marti [Espagne] ; Eduardo Tolosa [Espagne] ; Carlos Falcon [Espagne] ; Nuria Bargallo [Espagne] ; Francesc Valldeoriola [Espagne] ; Carme Junque [Espagne]Brain Response to Complex Visual Stimuli in Parkinson's Patients with Hallucinations : A Functional Magnetic Resonance Imaging Study
001342 Anna L. Bartels [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Brain Imaging in Patients with Freezing of Gait
001343 Eric J. Pappert [États-Unis] ; Terry Germanson [Canada]Botulinum Toxin Type B vs. Type A in Toxin-Naïve Patients with Cervical Dystonia : Randomized, Double-Blind, Noninferiority Trial
001351 Claudia Schmidt [Allemagne] ; Birgit Herting [Allemagne] ; Silke Prieur [Allemagne] ; Susann Junghanns [Allemagne] ; Katherine Schweitzer [Allemagne] ; Heinz Reichmann [Allemagne] ; Daniela Berg [Allemagne] ; Tjalf Ziemssen [Allemagne]Autonomic Dysfunction in Patients with Progressive Supranuclear Palsy
001360 Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France]Are Parkin Patients Particularly Suited for Deep-Brain Stimulation?
001370 CHUL HYOUNG LYOO [Corée du Sud] ; Holger Prokisch [Allemagne] ; Thomas Meitinger [Allemagne] ; SEUNG YEOB LEE [Corée du Sud] ; DO HYOUN KIM [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Anticholinergic-Responsive Gait Freezing in a Patient with Pantothenate Kinase-Associated Neurodegeneration
001374 Kenichi Kashihara [Japon] ; Takaki Imamura [Japon]Amantadine May Reverse Punding in Parkinson's Disease- : Observation in a Patient
001375 Alessandro M. De Nunzio [Italie] ; Antonio Nardone [Italie] ; Daniele Picco [Italie] ; Jan Nilsson [Italie] ; Marco Schieppati [Italie]Alternate Trains of Postural Muscle Vibration Promote Cyclic Body Displacement in Standing Parkinsonian Patients
001384 Marcin Lesniak [Pologne] ; Anna Czlonkowska [Pologne] ; Joanna Seniow [Pologne]Abnormal Antisaccades and Smooth Pursuit Eye Movements in Patients with Wilson's Disease
001391 Claudia Cagnoli [Italie] ; Alessandro Brussino [Italie] ; Luca Sbaiz [Italie] ; Eleonora Di Gregorio [Italie] ; Cristiana Atzori [Italie] ; Paola Caroppo [Italie] ; Laura Orsi [Italie] ; Nicola Migone [Italie] ; Carlo Buffa [Italie] ; Daniele Imperiale [Italie] ; Alfredo Brusco [Italie]A Previously Undiagnosed Case of Gerstmann-Sträussler-Scheinker Disease Revealed by Prnp Gene Analysis in Patients with Adult-Onset Ataxia
001393 Cecilia Marelli ; Laura Canafoglia ; Federica Zibordi ; Claudia Ciano ; Elisa Visani ; Giovanna Zorzi ; Barbara Garavaglia ; Chiara Barzaghi ; Alberto Albanese ; Paola Soliveri ; Massimo Leone ; Ferruccio Panzica ; Vidmer Scaioli ; Alessandro Pincherle ; Nardo Nardocci ; Silvana FranceschettiA Neurophysiological Study of Myoclonus in Patients with DYT11 Myoclonus-Dystonia Syndrome
001407 Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne]Valvular heart disease in parkinson's disease patients treated with dopamine agonists : A reader-blinded monocenter echocardiography study
001408 Dominic Jamora [Singapour, Philippines] ; Shih-Hui Lim [Singapour] ; Andrew Pan [Singapour] ; Louis Tan [Singapour] ; Eng-King Tan [Singapour]Valproate-induced parkinsonism in epilepsy patients
001410 Yael Manor [Israël] ; Nir Giladi [Israël] ; Alma Cohen [Israël] ; Dan M. Fliss [Israël] ; Jacob T. Cohen [Israël]Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with parkinson's disease
001411 Santiago Perez Lloret [Argentine] ; Gabriel Piran Arce [Argentine] ; Malco Rossi [Argentine] ; Maria Laura Caivano Nemet [Argentine] ; Paz Salsamendi [Argentine] ; Marcelo Merello [Argentine]Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease
001416 Anne-Marie Willems [Belgique] ; Alice Nieuwboer [Belgique] ; Fabienne Chavret [Belgique] ; Kaat Desloovere [Belgique] ; René Dom [Belgique] ; Lynn Rochester [Royaume-Uni] ; Gert Kwakkel [Pays-Bas] ; Erwin Van Wegen [Pays-Bas] ; Diana Jones [Royaume-Uni]Turning in parkinson's disease patients and controls : The effect of auditory cues
001424 Brenda L. Den Oudsten [Pays-Bas] ; Guus L. Van Heck [Pays-Bas] ; Jolanda De Vries [Pays-Bas]The suitability of patient-based measures in the field of Parkinson's disease : A systematic review
001438 Kelvin L. Chou [États-Unis] ; Maria L. Moro-De-Casillas [États-Unis] ; Melissa M. Amick [États-Unis] ; Leora L. Borek [États-Unis] ; Joseph H. Friedman [États-Unis]Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's
001439 Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa
001441 Ville Pursiainen [Finlande] ; Tarja H. Haapaniemi [Finlande] ; Juha T. Korpelainen [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande]Sweating in parkinsonian patients with wearing-off
001443 Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni]Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease
001446 Michael Schüpbach [France] ; Ebba Lohmann [France] ; Mathieu Anheim [France] ; Suzanne Lesage [France] ; Virginie Czernecki [France] ; Sadek Yaici [France] ; Yulia Worbe [France] ; Perrine Charles [France] ; Marie-Laure Welter [France] ; Pierre Pollak [France] ; Alexandra Dürr [France] ; Yves Agid [France] ; Alexis Brice [France]Subthalamic nucleus stimulation is efficacious in patients with parkinsonism and LRRK2 mutations
001449 Leonardo Bonilha [États-Unis] ; Paulien M. De Vries [Pays-Bas] ; Diana J. Vincent [États-Unis] ; Chris Rorden [États-Unis] ; Paul S. Morgan [Royaume-Uni] ; Mark W. Hurd [États-Unis] ; Nada Besenski [États-Unis] ; Kenneth J. Bergmann [États-Unis] ; Vanessa K. Hinson [États-Unis]Structural white matter abnormalities in patients with idiopathic dystonia
001452 Christopher D. Herzog [États-Unis] ; Biplob Dass [États-Unis] ; James E. Holden [États-Unis] ; James Iii Stansell [États-Unis] ; Mehdi Gasmi [États-Unis] ; Mark H. Tuszynski [États-Unis] ; Raymond T. Bartus [États-Unis] ; Jeffrey H. Kordower [États-Unis]Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys
001463 Joaquim Ferreira [Portugal] ; Joao Maia Silva [Portugal] ; Rita Freire [Portugal] ; Joao Pignatelli [Portugal] ; Leonor Correia Guedes [Portugal] ; Alexandra Feijo [Portugal] ; Mario Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; Joao Costa [Portugal] ; Ana Noronha [Portugal] ; Russell Hewett [Portugal] ; A. Marques Gomes [Portugal] ; J. L. Cime De Castro [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]Skin cancers and precancerous lesions in Parkinson's disease patients
001469 Francesca Gilio [Italie] ; Antonio Suppa [Italie] ; Matteo Bologna [Italie] ; Cinzia Lorenzano [Italie] ; Giovanni Fabbrini [Italie] ; Alfredo Berardelli [Italie]Short-term cortical plasticity in patients with dystonia : A study with repetitive transcranial magnetic stimulation
001481 Andrew Siderowf [États-Unis] ; Danna Jennings [États-Unis] ; James Connolly [États-Unis] ; Richard L. Doty [États-Unis] ; Kenneth Marek [États-Unis] ; Matthew B. Stern [États-Unis]Risk Factors for Parkinson's Disease and Impaired Olfaction in Relatives of Patients with Parkinson's Disease
001483 Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Sung-Chul Lim [Corée du Sud] ; Jae-Young Ahn [Corée du Sud] ; In-Uk Song [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Bum-Soo Kim [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: A possible association with oral midodrine treatment
001484 Emmanuel Roze [France] ; Valérie Cochen [France] ; Sophie Sangla [France] ; Thierry Bienvenu [France] ; Anne Roubergue [France] ; Smaranda Leu-Semenescu [France] ; Marie Vidaihet [France]Rett syndrome : An overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, parkinsonism, and dystonia?
001488 Anja Weyer [Allemagne] ; Michael Abele [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Beate Schoch [Allemagne] ; Markus Frings [Allemagne] ; Dagmar Timmann [Allemagne] ; Thomas Klockgether [Allemagne]Reliability and validity of the scale for the assessment and rating of ataxia : A study in 64 ataxia patients
001490 Thomas Eckert [États-Unis, Allemagne] ; Andrew Feigin [États-Unis] ; Daniel E. Lewis [États-Unis] ; Vijay Dhawan [États-Unis] ; Steven Frucht [États-Unis] ; David Eidelberg [États-Unis]Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging
001496 Anna-Gerlind Postma [Pays-Bas] ; Mart A. A. M. Heesters [Pays-Bas] ; Teus Van Laar [Pays-Bas]Radiotherapy to the Salivary Glands as Treatment of Sialorrhea in Patients with Parkinsonism
001509 Yevgeniy Kuznetsov [Canada] ; Abdesslem Khiat [Canada] ; Pierre J. Blanchet [Canada] ; Yvan Boulanger [Canada]Proton magnetic resonance spectroscopy study of dyskinesia patients
001518 Anna Modoni [Italie] ; Maria Fiorella Contarino [Italie] ; Anna Rita Bentivoglio [Italie] ; Elisabetta Tabolacci [Italie] ; Massimo Santoro [Italie] ; Maria Lucia Calcagni [Italie] ; Pietro A. Tonali [Italie] ; Giovanni Neri [Italie] ; Gabriella Silvestri [Italie]Prevalence of spinocerebellar ataxia type 2 mutation among italian parkinsonian patients
001519 Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Lisa Clayton [Royaume-Uni] ; Kazuo Abe [Japon] ; Yoshio Tsuboi [Japon] ; Dough Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Ubaldo Bonuccelli [Italie] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Annette Hand [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; William Ondo [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni]Prevalence of nonmotor symptoms in parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
001521 Elan D. Louis [États-Unis] ; Steven J. Frucht [États-Unis]Prevalence of essential tremor in patients with Parkinson's disease vs. parkinson-plus syndromes
001526 Michael Macht [Allemagne] ; Yvonne Kaussner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Karla Maria Eggert [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Heiner Ellgring [Allemagne]Predictors of freezing in Parkinson's disease: A survey of 6,620 patients
001532 Marco Bove [Italie] ; Giampaolo Brichetto [Italie] ; Giovanni Abbruzzese [Italie] ; Roberta Marchese [Italie] ; Marco Schieppati [Italie]Postural responses to continuous unilateral neck muscle vibration in standing patients with cervical dystonia
001533 Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon]Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating Parkinsonian patients
001542 Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Pablo Mir [Royaume-Uni, Espagne] ; Carla Cordivari [Royaume-Uni] ; Juzar Hooker [Royaume-Uni] ; John Dickson [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Patients With Adult-Onset Dystonic Tremor Resembling Parkinsonian Tremor Have Scans Without Evidence of Dopaminergic Deficit (SWEDDs)
001544 Josef Parvizi [États-Unis] ; Jeffrey Joseph [États-Unis] ; Daniel Z. Press [États-Unis] ; Jeremy D. Schmahmann [États-Unis]Pathological laughter and crying in patients with multiple system atrophy-cerebellar type
001552 Jill L. Ostrem [États-Unis] ; William J. Jr Marks [États-Unis] ; Monica M. Volz [États-Unis] ; Susan L. Heath [États-Unis] ; Philip A. Starr [États-Unis]Pallidal deep brain stimulation in patients with cranial-cervical dystonia (meige syndrome)
001562 Francesca Del Sorbo [Italie] ; Antonio E. Elia [Italie] ; Gabriella De Joanna [Italie] ; Luigi M. Romito [Italie] ; Barbara Garavaglia [Italie] ; Alberto Albanese [Italie]Normal cardiovascular reflex testing in patients with parkin disease
001569 Katie Kompoliti [États-Unis] ; YAPING CHU [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Jeffrey H. Kordower [États-Unis]Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient
001571 Anna L. Bartels [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Neuroinflammation in the pathophysiology of parkinson's disease : Evidence from animal models to human in vivo studies with [11C]-PK11195 PET
001578 Melissa J. Nirenberg [États-Unis] ; Jenny Libien [États-Unis] ; Jean-Paul Vonsattel [États-Unis] ; Stanley Fahn [États-Unis]Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation
001581 Michael W. M. Schupbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltete [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France]Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus
001583 Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada]Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation
001587 JI YOUN KIM [Corée du Sud] ; SEONG TAE KIM [Corée du Sud] ; SEONG HEE JEON ; WON YONG LEE [Corée du Sud]Midbrain transcranial sonography in Korean patients with parkinson's disease
001588 Heike Stockner [Autriche] ; Martin Sojer [Autriche] ; Klaus Seppi K [Autriche] ; Joerg Mueller [Autriche] ; Gregor K. Wenning [Autriche] ; Christoph Schmidauer [Autriche] ; Werner Poewe [Autriche]Midbrain sonography in patients with essential tremor
001592 Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne]Meta-analysis of heart valve abnormalities in parkinson's disease patients treated with dopamine agonists
001603 Chiara Balducci [Italie] ; Laura Pierguidi [Italie] ; Emanuele Persichetti [Italie] ; Lucilla Parnetti [Italie] ; Michele Sbaragli [Italie] ; Carmelo Tassi [Italie] ; Aldo Orlacchio [Italie] ; Paolo Calabresi [Italie] ; Tommaso Beccari [Italie] ; Aroldo Rossi [Italie]Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
001629 Stephany Fulda [Allemagne] ; Thomas C. Wetter [Allemagne]Is Daytime Sleepiness a Neglected Problem in Patients with Restless Legs Syndrome?
001632 Elan D. Louis [États-Unis] ; Lakeisha M. Applegate [États-Unis] ; Eileen Rios [États-Unis]Interest in participating in clinical research : A study of essential tremor patients
001636 Walter A. Rocca [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Alexis Elbaz [États-Unis, France] ; Brandon R. Grossardt [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Daniel J. Schaid [États-Unis] ; Demetrius M. Maraganore [États-Unis]Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease
001638 Yew-Long Lo [Singapour] ; Elan D. Louis [États-Unis] ; Stephanie Fook-Chong [Singapour] ; Eng-King Tan [Singapour]Impaired motor imagery in patients with essential tremor : A case control study
001654 Vanessa K. Lim [Nouvelle-Zélande]Health Related Quality of Life in patients with dystonia and their caregivers in New Zealand and Australia
001661 Anna Jelaso Langerveld [États-Unis] ; Daniel Mihalko [États-Unis] ; Cari Delong [États-Unis] ; Jeff Walburn [États-Unis] ; Charles F. Ide [États-Unis]Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients
001662 Ettore Accolla [Italie] ; Elena Caputo [Italie] ; Filippo Cogiamanian [Italie] ; Filippo Tamma [Italie] ; Simona Mrakic-Sposta [Italie] ; Sara Marceglia [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Marco Locatelli [Italie] ; Alberto Priori [Italie]Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation
001674 Elliot L. Dimberg [États-Unis] ; Sheila E. Crowe [États-Unis] ; Joel M. Trugman [États-Unis] ; Russell H. Swerdlow [États-Unis] ; M. Beatriz Lopes [États-Unis] ; T. David Bourne [États-Unis] ; Ted M. Burns [États-Unis]Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm
001677 Siegfried Muhlack [Allemagne] ; Jacub Welnic [Allemagne] ; Dirk Woitalla [Allemagne] ; Thomas Müller [Allemagne]Exercise improves efficacy of levodopa in patients with Parkinson's disease
001684 Julie Zyss [France] ; Jing Xie-Brustolin [France] ; Philippe Ryvlin [France] ; Stephane Peysson [France] ; Albert Beschet [France] ; Dominique Sappey-Marinier [France] ; Marc Hermier [France] ; Stéphane Thobois [France]Epilepsia partialis continua with dystonic hand movement in a patient with a malformation of cortical development
001689 Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox [Allemagne] ; Torsten Roscher [Allemagne] ; Dieter Schremmer [Allemagne] ; Ariel Gordin [Allemagne]Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing-off
001690 PRAMOD KUMAR PAL [Inde] ; PONNATHPUR SATISH LAKSHMI [Inde] ; Muninarayanappa Nirmala [Inde]Efficacy and complication of botulinum toxin injection in palatal myoclonus : Experience from a patient
001705 Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohammed A. Ahmed [Égypte] ; Nageh Foly [Égypte] ; Ahmed Hamdy [Égypte]Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: Preliminary results
001710 Paolo Martinelli [Italie] ; Giovanni Rizzo [Italie] ; David Manners [Italie] ; Caterina Tonon [Italie] ; Fabio Pizza [Italie] ; Claudia Testa [Italie] ; Cesa Scaglione [Italie] ; Bruno Barbiroli [Italie] ; Raffaele Lodi [Italie]Diffusion-weighted imaging study of patients with essential tremor
001716 Francisco Javier Carod-Artal [Brésil] ; Antonio Pedro Vargas [Brésil] ; Pablo Martinez-Martin [Espagne]Determinants of quality of life in Brazilian patients with Parkinson's disease
001752 Keisuke Suzuki [Japon] ; Yasuyuki Okuma [Japon] ; Nobutaka Hattori [Japon] ; Satoshi Kamei [Japon] ; Fumihito Yoshii [Japon] ; Hiroya Utsumi [Japon] ; Yasuo Iwasaki [Japon] ; Mutsumi Iijima [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon]Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale
001756 Kenta Sato [Japon] ; Ryuji Kaji [Japon] ; Sadayuki Matsumoto [Japon] ; Satoshi Goto [Japon]Cell type-specific neuronal loss in the putamen of patients with multiple system atrophy
001758 Petra Schwingenschuh [Autriche] ; Karoline Wenzel [Autriche] ; Petra Katschnig [Autriche] ; Ronald Saurugg [Autriche] ; Erwin Ott [Autriche]Case of a palatal tic resembling palatal tremor in a patient with tourette syndrome
001763 Claudia Trenkwalder [Allemagne] ; Heike Benes [Allemagne] ; Ludger Grote [Suède] ; Svenja Happe [Allemagne] ; Birgit Högl [Autriche] ; Johannes Mathis [Suisse] ; Gerda M. Saletu-Zyhlarz [Autriche] ; Ralf Kohnen [Allemagne]Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome : Results from a multicenter, randomized, active controlled trial
001767 Richard M. Trosch [États-Unis] ; Charles H. Adler [États-Unis] ; Eric J. Pappert [États-Unis]Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm : Results from an open-label, dose-escalation safety study
001770 James G. Colebatch [Australie]Bereitschaftspotential and movement-related potentials : Origin, significance, and application in disorders of human movement
001787 Shalom Michaeli [États-Unis] ; Gulin Öz [États-Unis] ; Dennis J. Sorce [États-Unis] ; Michael Garwood [États-Unis] ; Kamil Ugurbil [États-Unis] ; Stacv Majestic [États-Unis] ; Paul Tuite [États-Unis]Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts
001799 JI YOUN KIM [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; Hun-Jong Dhong [Corée du Sud]Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease
001807 Marie-Laure Mille [États-Unis] ; Marjorie Johnson Hilliard [États-Unis] ; Katherine M. Martinez [États-Unis] ; Tanya Simuni [États-Unis] ; Mark W. Rogers [États-Unis]Acute effects of a lateral postural assist on voluntary step initiation in patients with Parkinson's disease
001811 Eduardo Tolosa [Espagne] ; Thierry Vander Borght [Belgique] ; Emilio Moreno [Espagne]Accuracy of DaTSCAN (123I-Ioflupane) SPECT in Diagnosis of Patients with Clinically Uncertain Parkinsonism : 2-Year Follow-Up of an Open-Label Study
001813 Chul H. Lyoo [Corée du Sud] ; SEUNG YEOB LEE [Corée du Sud] ; TAE JIN SONG [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Abnormal temporal discrimination threshold in patients with multiple system atrophy
001815 Tobias B Umer [Allemagne] ; Cüneyt Demiralay [Allemagne] ; Ute Hidding [Allemagne] ; Rosalia Bikmullina [Allemagne] ; Rick C. Helmich [Allemagne] ; Silke Wunderlich [Allemagne] ; John Rothwell [Royaume-Uni] ; Joachim Liepert [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Alexander Munchau [Allemagne]Abnormal plasticity of the sensorimotor cortex to slow repetitive transcranial magnetic stimulation in patients with Writer's cramp
001816 Elisabeth M. J. Foncke [Pays-Bas] ; Johan N. Van Der Meer [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; Marina A. J. Tijssen [Pays-Bas]Abnormal low frequency drive in myoclonus-dystonia patients correlates with presence of dystonia
001821 Spiridon Papapetropoulos [États-Unis] ; Jennifer Friedman [États-Unis] ; Craig Blackstone [États-Unis] ; Gary I. Kleiner [États-Unis] ; Brian C. Bowen [États-Unis] ; Carlos Singer [États-Unis]A progressive, fatal dystonia-parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
001823 Dietrich Haubenberger [Autriche] ; Silvia Bonelli [Autriche] ; Christoph Hotzy [Autriche] ; Petra Leitner [Allemagne] ; Peter Lichtner [Allemagne] ; Doris Samal [Autriche] ; Regina Katzenschlager [Autriche] ; Atbin Djamshidian [Autriche] ; Thomas Brücke [Autriche] ; Michaela Steffelbauer [Autriche] ; Christian Bancher [Autriche] ; Josef Grossmann [Allemagne] ; Gerhard Ransmayr [Autriche] ; Tim M. Strom [Allemagne] ; Thomas Meitinger [Allemagne] ; Thomas Gasser [Allemagne] ; Eduard Auff [Autriche] ; Alexander Zimprich [Autriche]A novel LRRK2 mutation in an austrian cohort of patients with parkinson's disease
001829 Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni]A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
001833 Gabriella Santangelo [Italie] ; Luigi Trojano [Italie] ; Carmine Vitale [Italie] ; Marta Ianniciello [Italie] ; Marianna Amboni [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]A Neuropsychological Longitudinal Study in Parkinson's Patients With and Without Hallucinations
001848 William M. Mcdonald [États-Unis] ; Paul E. Holtzheimer [États-Unis] ; Michael Haber [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Kimberly Mcwhorter [États-Unis] ; Mahlon Delong [États-Unis]Validity of the 30-item geriatric depression scale in patients with Parkinson's disease
001850 Summer C. Wolfrath [États-Unis] ; Amy R. Borenstein [États-Unis] ; Skai Schwartz [États-Unis] ; Robert A. Hauser [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis]Use of nutritional supplements in Parkinson's disease patients
001851 Louis C. S. Tan [Singapour] ; Puay-Ngoh Lau [Singapour] ; Roland Dominic G. Jamora [Singapour] ; Edwin S. Y. Chan [Singapour]Use of complementary therapies in patients with Parkinson's disease in singapore
001853 Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni]Upregulation of dopamine D2 receptors in dopaminergic drugnaive patients with Parkin gene mutations
001878 HONGLEI CHEN [États-Unis] ; Shumin M. Zhang [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Miguel A. Hernan [États-Unis] ; Alberto Ascherio [États-Unis]Survival of Parkinson's disease patients in a large prospective cohort of male health professionals
001879 Massimo Cincotta [Italie] ; Fabio Giovannelli [Italie] ; Alessandra Borgheresi [Italie] ; Fabrizio Balestrieri [Italie] ; Paola Vanni [Italie] ; Aldo Ragazzoni [Italie] ; Gaetano Zaccara [Italie] ; Ulf Ziemann [Allemagne]Surface electromyography shows increased mirroring in parkinson's disease patients without overt mirror movements
001881 Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT
001885 William G. Ondo [États-Unis] ; Yavuz Silay [États-Unis] ; Mike Almaguer [États-Unis] ; Joseph Jankovic [États-Unis]Subthalamic deep brain stimulation in patients with a previous pallidotomy
001892 Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas]Striatal dopa and glucose metabolism in PD patients with freezing of gait
001901 Michela Barichella [Italie] ; Agnieszka Marczewska [Italie] ; Roberta De Notaris [Italie] ; Antonella Vairo [Italie] ; Cinzia Baldo [Italie] ; Andrea Mauri [Italie] ; Chiara Savardi [Italie] ; Gianni Pezzoli [Italie]Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease
001902 Martina Rinnerthaler [Autriche] ; Joerg Mueller [Autriche] ; Viktor Weichbold [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Social stigmatization in patients with cranial and cervical dystonia
001903 Juan Carlos Gomez-Esteban [Espagne] ; Juan Jose Zarranz ; Elena Lezcano ; Fernando Velasco ; Roberto Ciordia ; Idoia Rouco ; Jose Losada ; Iker BilbaoSleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease
001913 Erika Driver-Dunckley [États-Unis] ; Virgilio Gerald H. Evidente [États-Unis] ; Charles H. Adler [États-Unis] ; Renee Hillman [États-Unis] ; Jose Hernandez [États-Unis] ; Geoffrey Fletcher [États-Unis] ; Mark K. Lyons [États-Unis]Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation
001916 Tanja Schmitz-Hübsch [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laszlo Baliko [Hongrie] ; Sylvia Boesch [Autriche] ; Sara Bonato [Belgique] ; Roberto Fancellu [Italie] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Jun-Suk Kang [Allemagne] ; Berry Kremer [Pays-Bas] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Sylvie Romano [Italie] ; Lodger Schols [Allemagne] ; Sandra Szymanski [Allemagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Elzbieta Zdzienicka [Pologne] ; Alexandra Dürr [France] ; Thomas Klockgether [Allemagne]Reliability and validity of the international cooperative ataxia rating scale : A study in 156 spinocerebellar ataxia patients
001917 Martine Visser [Pays-Bas] ; Albert F. G. Leentjens [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas]Reliability and validity of the beck depression inventory in patients with Parkinson's disease
001921 Nam-Jong Paik [Corée du Sud] ; Kyle Seo [Corée du Sud] ; HEE CHUL EUN [Corée du Sud]Reduced potency after refrigerated storage of botulitum toxin A : Human extensor digitorum brevis muscle study
001926 Kevin M. Biglan [États-Unis] ; Steven Schwid [États-Unis] ; Shirley Eberly [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Tamar Goren [Israël] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Sandra Plumb [États-Unis] ; Andrew Siderowf [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis]Rasagiline improves quality of life in patients with early Parkinson's disease
001928 Angelo Antonini [Italie] ; Silvana Tesei [Italie] ; Anna Zecchinelli [Italie] ; Paolo Barone [Italie] ; Danilo De Gaspari [Italie] ; Margherita Canesi [Italie] ; Giorgio Sacilotto [Italie] ; Nicoletta Meucci [Italie] ; Claudio Mariani [Italie] ; Gianni Pezzoli [Italie]Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression : Effect on quality of life
001931 Delia Lorenz [Allemagne] ; Daniel Schwieger [Allemagne] ; Hans Moises [Allemagne] ; Günther Deuschl [Allemagne]Quality of life and personality in essential tremor patients
001938 Mariana Spitz [Brésil] ; Alexandre Aluizio Costa Machado [Brésil] ; Rodrigo Do Carmo Carvalho [Brésil] ; Fernanda Martins Maia [Brésil] ; Monica Santoro Haddad [Brésil] ; Dagoberto Calegaro [Brésil] ; Milberto Scaff [Brésil] ; Egberto Reis Barbosa [Brésil]Pseudoathetosis : Report of three patients
001940 Agnieszka Marczewska [Italie] ; Roberta De Notaris [Italie] ; Sabina Sieri [Italie] ; Michela Barichella [Italie] ; Elisabetta Fusconi [Italie] ; Gianni Pezzoli [Italie]Protein intake in parkinsonian patients using the EPIC food frequency questionnaire
001950 Maurizio Avanzi [Italie] ; Mario Baratti [Italie] ; Silvia Cabrini [Italie] ; Elena Uber [Italie] ; Gianni Brighetti [Italie] ; Flavio Bonfa [Italie]Prevalence of pathological gambling in patients with Parkinson's disease
001952 Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Masahiro Miyake [Japon] ; Kenichi Yasui [Japon] ; Kenji Nakashima [Japon]Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease
001954 Alessandro Paluzzi [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; XUGUANG LIU [Royaume-Uni] ; John Yianni [Royaume-Uni] ; Kumar Kumarendran [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni]Pregnancy in dystonic women with in situ deep brain stimulators
001958 Marco Bove [Italie] ; Lucio Marinelli [Italie] ; Laura Avanzino [Italie] ; Roberta Marchese [Italie] ; Giovanni Abbruzzese [Italie]Posturographic analysis of balance control in patients with essential tremor
001962 Sergio Bagnato [Italie] ; Rocco Agostino [Italie] ; Nicola Modugno [Italie] ; Angelo Quartarone [Italie] ; Alfredo Berardelli [Italie]Plasticity of the motor cortex in Parkinson's disease patients On and Off therapy
001964 Mattia Gambarin [Italie] ; Angelo Antonini [Italie] ; Giuseppe Moretto [Italie] ; Paolo Bovi [Italie] ; Silvia Romito [Italie] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie]Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease : Case report
001967 Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lledo [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne]Pergolide versus levodopa monotherapy in early Parkinson's disease patients : The PELMOPET study
001968 Paula R. Arantes [Brésil] ; Ellison F. Cardoso [Brésil] ; Maria A. Barreiros [Brésil] ; Manoel J. Teixeira [Brésil] ; Marcia R. Goncalves [Brésil] ; Egberto R. Barbosa [Brésil] ; Sukhi Shergill Sukwinder [Royaume-Uni] ; Claudia C. Leite [Brésil] ; Edson Jr Amaro [Brésil, Royaume-Uni]Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation
001971 Jonathan W. Mink [États-Unis] ; John Walkup [États-Unis] ; Kirk A. Frey [États-Unis] ; Peter Como [États-Unis] ; Danielle Cath [Pays-Bas] ; Mahlon R. Delong [États-Unis] ; Gerald Erenberg [États-Unis] ; Joseph Jankovic [États-Unis] ; Jorge Juncos [États-Unis] ; James F. Leckman [États-Unis] ; Neal Swerdlow [États-Unis] ; Veerle Visser-Vandewalle [Pays-Bas] ; Jerrold L. Vitek [États-Unis]Patient selection and assessment recommendations for deep brain stimulation in tourette syndrome
001975 Sarah T. Camargos [Brésil] ; Antonio L. Jr Teixeira [Brésil] ; Francisco Cardoso [Brésil]Parkinsonism associated with basal ganglia cryptococcal abscesses in an immunocompetent patient
001982 Spiridon Papapetropoulos [États-Unis] ; Carlos Singer [États-Unis]Painless legs moving toes in a patient with wilson's disease
001984 Chiara Criscuolo [Italie] ; Giampiero Volpe [Italie] ; Anna De Rosa [Italie] ; Andrea Varrone [Italie] ; Roberta Marongiu [Italie] ; Pietro Mancini [Italie] ; Elena Salvatore [Italie] ; Bruno Dallapiccola [Italie] ; Alessandro Filla [Italie] ; Enza Maria Valente [Italie] ; Giuseppe De Michele [Italie]PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism
001987 Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada]Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies
001989 Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis]Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
001990 Peter Feys [Belgique] ; Werner F. Helsen [Belgique] ; Sabine Verschueren [Belgique] ; Stephan P. Swinnen [Belgique] ; Isabel Klok [Belgique] ; Ann Lavrysen [Belgique] ; Bart Nuttin [Belgique] ; Pierre Ketelaer [Belgique] ; XUGUANG LIU [Royaume-Uni]Online movement control in multiple sclerosis patients with tremor : Effects of tendon vibration
001A06 Blanca Ramirez-Ruiz [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Martf [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne]Neuropsychological deficits in parkinson's disease patients with visual hallucinations
001A07 Marcelo Merello [Argentine] ; Eduardo Tenca [Argentine] ; Daniel Cerquetti [Argentine]Neuronal activity of the zona incerta in Parkinson's disease patients
001A21 Stephan Klebe [Allemagne] ; Günther Deuschl [Allemagne] ; Henning Stolze [Allemagne]Methylphenidate fails to improve gait and muscle tone in patients with sporadic and hereditary spastic paraplegia
001A24 Ute Hidding [Allemagne] ; Tobias B Umer [Allemagne] ; Hartwig Roman Siebner [Allemagne] ; Cüneyt Demiralay [Allemagne] ; Carsten Buhmann [Allemagne] ; Thomas Weyh [Allemagne] ; Christian Moll [Allemagne] ; Wolfgang Hamel [Allemagne] ; Alexander Münchau [Allemagne]MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced parkinson's disease
001A34 Omit Chiba-Falek [États-Unis] ; Grisel J. Lopez [États-Unis] ; Robert L. Nussbaum [États-Unis]Levels of alpha-synuclein mRNA in sporadic parkinson disease patients
001A37 Hubertus J. A. Van Hedel [Suisse] ; Daniel Waldvogel [Suisse] ; Volker Dietz [Suisse]Learning a high-precision locomotor task in patients with Parkinson's disease
001A50 Julie Leegwater-Kim [États-Unis] ; Elan D. Louis [États-Unis] ; Seth L. Pullman [États-Unis] ; Alicia G. Floyd [États-Unis] ; Sarah Borden [États-Unis] ; Carol B. Moskowitz [États-Unis] ; Lawrence S. Honig [États-Unis]Intention tremor of the head in patients with essential tremor
001A56 Mandy Miller Koop [États-Unis] ; Amy Andrzejewski [États-Unis] ; Bruce C. Hill [États-Unis] ; Gary Heit [États-Unis] ; Helen M. Bronte-Stewart [États-Unis]Improvement in a quantitative measure of bradykinesia after microelectrode recording in patients with Parkinson's disease during deep brain stimulation surgery
001A61 Satoshi Goto [Japon] ; Kazumichi Yamada [Japon] ; Hideki Shimazu [Japon] ; Nagako Murase [Japon] ; Kazuhito Matsuzaki [Japon] ; Tetsuya Tamura [Japon] ; Shinji Nagahiro [Japon] ; Jun-Ichi Kuratsu [Japon] ; Ryuji Kaji [Japon]Impact of bilateral pallidal stimulation on DYT1-generalized dystonia in Japanese patients
001A65 Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Narihiro Hara [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon]Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations
001A66 Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Narihiro Hara [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon]Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations
001A68 Aileen K. Ho [Royaume-Uni] ; Anna O. G. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]Huntington's disease patients have selective problems with insight
001A69 Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada]Homozygous and heterozygous PINK1 mutations : Considerations for diagnosis and care of parkinson's disease patients
001A80 Joseph J. Higgins [États-Unis] ; Roni Q. Lombardi [États-Unis] ; Joanna Pucilowska [États-Unis] ; Joseph Jankovic [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Leo Verhagen [États-Unis]HS1-BP3 gene variant is common in familial essential tremor
001A84 Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis]Gilles de la tourette syndrome : Patient's knowledge and concern of adverse effects
001A87 Angelo Antonini [Italie] ; Stefano Goldwurm [Italie] ; Riccardo Benti [Italie] ; Holger Prokisch [Allemagne] ; Monika Ebhardt [Allemagne] ; Roberto Cilia [Italie] ; Michela Zini [Italie] ; Andrea Righini [Italie] ; Giovanni Cossu [Italie] ; Gianni Pezzoli [Italie]Genetic, clinical, and imaging characterization of one patient with late- onset, slowly progressive, pantothenate kinase-associated neurodegeneration
001A88 Paola Valentino [Italie] ; Grazia Annesi [Italie] ; Innocenza C. Ciro Candiano [Italie] ; Ferdinanda Annesi [Italie] ; Donatella Civitelli [Italie] ; Patrizia Tarantino [Italie] ; Francesco Naso [Italie] ; Patrizia Spadafora [Italie] ; Sara Carrideo [Italie] ; Elvira V. De Marco [Italie] ; Domenico Consoli [Italie] ; Mario Zappia [Italie] ; Antonio Gambardella [Italie] ; Aldo Quattrone [Italie]Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern
001A92 Roberta Marongiu [Italie] ; Daniele Ghezzi [Italie] ; Tamara Ialongo [Italie] ; Francesco Soleti [Italie] ; Antonio Elia [Italie] ; Stefania Cavone [Italie] ; Alberto Albanese [Italie] ; Maria Concetta Altavista [Italie] ; Paolo Barone [Italie] ; Livia Brusa [Italie] ; Pietro Cortelli [Italie] ; Lucia Petrozzi [Italie] ; Cesa Scaglione [Italie] ; Paolo Stanzione [Italie] ; Michele Tinazzi [Italie] ; Massimo Zeviani [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie] ; Enza Maria Valente [Italie] ; Barbara Garavaglia [Italie]Frequency and phenotypes of LRRK2 G2019S mutation in italian patients with Parkinson's disease
001A93 Natasa T. Dragasevic [Serbie] ; Biljana Culjkovic [Serbie] ; Christine Klein [Allemagne] ; Aleksandar Ristic [Serbie] ; Milica Keckarevic [Serbie] ; Ivan Topisirovic [Serbie] ; Slobodanka Vukosavic [Serbie] ; Marina Svetel [Serbie] ; Norman Kock [Allemagne] ; Elka Stefanova [Serbie] ; Stanka Romac [Serbie] ; Vladimir S. Kostic [Serbie]Frequency analysis and clinical characterization of different types of spinocerebellar ataxia in serbian patients
001A98 Marko Korosec [Slovénie] ; Ignac Zidar [Slovénie] ; Dik Reits [Pays-Bas] ; Craig Evinger [États-Unis] ; Frans Vanderwerf [Pays-Bas]Eyelid movements during blinking in patients with Parkinson's disease
001B00 Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Expectation and the placebo effect in parkinson's disease patients with subthalamic nucleus deep brain stimulation
001B01 Isaac Shpirer [Israël] ; Ala Miniovitz [Israël] ; Colin Klein [Israël] ; Richard Goldstein [Israël] ; Tatiana Prokhorov [Israël] ; Jack Theitler [Israël] ; Lea Pollak [Israël] ; Jose Martin Rabey [Israël]Excessive daytime sleepiness in patients with parkinson's disease : A polysomnography study
001B13 Jean-Pascal Lefaucheur [France] ; Isabelle Menard-Lefaucheur [France] ; Patrick Maison [France] ; Sophie Baudic [France] ; Pierre Cesaro [France] ; Marc Peschanski [France] ; Anne-Catherine Bachoud-Levi [France]Electrophysiological deterioration over time in patients with huntington's disease
001B16 J. Antonelle Demarcaida [États-Unis] ; Steven R. Schwid [États-Unis] ; William B. White [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Karl Kieburtz [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis]Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline
001B18 David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Ian Mckeith [Royaume-Uni] ; Peter Paul De Deyn [Belgique] ; Dag Aarsland [Norvège] ; Chuanchieh Hsu [États-Unis] ; Roger Lane [États-Unis]Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
001B22 Tanya Y. Gurevich [Israël] ; Herzel Shabtai [Israël] ; Amos D. Korczyn [Israël] ; Ely S. Simon [États-Unis] ; Nir Giladi [Israël]Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia
001B38 Lena Elisabeth Hjermind [Danemark] ; Lis Gitte Johannsen [Danemark] ; Nenad Blau [Suisse] ; Ron Allan Wevers [Pays-Bas] ; Christoph-Burkhard Lucking [Allemagne] ; Jens Michael Hertz [Danemark] ; Lars Friberg [Danemark] ; Lisbeth Regeur [Danemark] ; J Rgen Erik Nielsen [Danemark] ; Sven Asger S Rensen [Danemark]Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?
001B62 PHIL HYU LEE [Corée du Sud] ; SEUNG HYEON YEO [Corée du Sud] ; HYUN JOON KIM [Corée du Sud] ; HYO YOUNG YOUM [Corée du Sud]Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy
001B64 Afsane Riazi [Royaume-Uni] ; Stefan J. Cano [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Jane L. Bradley [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni]Coordinating outcomes measurement in ataxia research : Do some widely used generic rating scales tick the boxes?
001B65 Claudia Trenkwalder [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Andreas Kupsch [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Juergen Koester [Allemagne] ; Juergen Reess [Allemagne]Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome
001B66 Lauren H. Craig [États-Unis] ; Anna Svircev [États-Unis] ; Michael Haber [États-Unis] ; Jorge L. Juncos [États-Unis]Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease
001B68 William G. Ondo [États-Unis] ; Mike Almaguer [États-Unis] ; Helen Cohen [États-Unis]Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation
001B74 Carmen Cristea Janvin [Norvège] ; Jan Petter Larsen [Norvège] ; David P. Salmon [États-Unis] ; Douglas Galasko [États-Unis] ; Kenneth Hugdahl [Norvège] ; Dag Aarsland [Norvège]Cognitive profiles of individual patients with Parkinson's disease and dementia : Comparison with dementia with lewy bodies and Alzheimer's disease
001B78 Hiroyuki Tomiyama [Japon] ; YUANZHE LI [Japon] ; Manabu Funayama [Japon] ; Kazuko Hasegawa [Japon] ; Hiroyo Yoshino [Japon] ; Shin-Ichiro Kubo [Japon] ; Kenichi Sato [Japon] ; Tatsuya Hattori [Japon] ; Chin-Song Lu [Taïwan] ; Rivka Inzelberg [Israël] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Rim Amouri [Tunisie] ; Neziha Gouider-Khouja [Tunisie] ; Faycal Hentati [Tunisie] ; Yasuko Hatano [Japon] ; MEI WANG [Japon] ; Yoko Imamichi [Japon] ; Koichi Mizoguchi [Japon] ; Hiroaki Miyajima [Japon] ; Fumiya Obata [Japon] ; Tatsushi Toda [Japon] ; Matthew J. Farrer [États-Unis] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries
001B80 Liesl M. Allcock [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] ; David J. Burn [Royaume-Uni]Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension : Autonomic symptom and demographic comparison
001B84 Servane Mouton [France] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Philippe Damier [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France]Chorea induced by globus pallidus externus stimulation in a dystonic patient
001B89 Milos Ljubisavljevic [Serbie, Émirats arabes unis] ; Aleksandra Kacar [Serbie] ; Sladjan Milanovic [Serbie] ; Marina Svetel [Serbie] ; Vladimir S. Kostic [Serbie]Changes in cortical inhibition during task-specific contractions in primary writing tremor patients
001B96 PHIL HYU LEE [Corée du Sud] ; JI WON KIM [Corée du Sud] ; OH YOUNG BANG [Corée du Sud] ; IN SOO JOO [Corée du Sud] ; Seok-Nam Yoon [Corée du Sud] ; Kyoon Huh [Corée du Sud]Cardiac 123I-MIBG scintigraphy in patients with essential tremor
001C10 Cornelius G. Bachmann [Allemagne] ; Claudia Trenkwalder [Allemagne]Body weight in patients with Parkinson's disease
001C15 Marcelo Merello [Argentine] ; Silvina Carpintiero [Argentine] ; Angel Cammarota [Argentine] ; Francisco Meli [Argentine] ; Ramon Leiguarda [Argentine]Bilateral mirror writing movements (mirror dystonia) in a patient with writer's cramp : Functional correlates
001C36 Marc J. Mentis [États-Unis] ; Dominique Delalot [États-Unis] ; Hassan Naqvi [États-Unis] ; Mark F. Gordon [États-Unis] ; Mark Gudesblatt [États-Unis] ; Christine Edwards [États-Unis] ; Luke Donatelli [États-Unis] ; Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis]Anticholinesterase effect on motor kinematic measures and brain activation in parkinson's disease
001C39 Anna Rita Bentivoglio [Italie] ; Antonio Daniele [Italie] ; Alberto Albanese [Italie] ; Pietro Attilio Tonali [Italie] ; Alfonso Fasano [Italie]Analysis of blink rate in patients with blepharospasm
001C43 Pablo Mir [Royaume-Uni, Espagne] ; Francesca Gilio [Italie] ; Mark Edwards [Royaume-Uni] ; Maurizio Inghilleri [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections
001C45 Christopher G. Goetz [États-Unis] ; Joanne Wuu [États-Unis] ; Linda Curgian [États-Unis] ; Sue Leurgans [États-Unis]Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients
001C46 Paolo Ragonese [Italie] ; Marco D'Amelio [Italie] ; Graziella Callari [Italie] ; Giuseppe Salemi [Italie] ; Letterio Morgante [Italie] ; Giovanni Savettieri [Italie]Age at menopause predicts age at onset of Parkinson's disease
001C61 Update on the management of motor complications in Parkinson's disease
001C73 Imad Ghorayeb [France] ; Federica Provini [Italie] ; Bernard Bioulac [France] ; Francois Tison [France]Unusual nocturnal motor restlessness in a patient with spinocerebellar ataxia 3
001C77 Bart P. C. Van De Warrenburg [Pays-Bas] ; Maaike Bakker [Pays-Bas, Suisse] ; Berry P. H. Kremer [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; John H. J. Allum [Suisse]Trunk sway in patients with spinocerebellar ataxia
001D17 Nico J. Diederich [Luxembourg (pays)] ; Michel Vaillant [Luxembourg (pays)] ; Mike Leischen [Luxembourg (pays)] ; Giovanna Mancuso [Luxembourg (pays)] ; Serge Golinval [Luxembourg (pays)] ; Romain Nati [Luxembourg (pays)] ; Marc Schlesser [Luxembourg (pays)]Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients
001D18 Kirn R. Kessler [Allemagne] ; Diane Ruge [Allemagne] ; Tihomir V. Ilic [Allemagne] ; Ulf Ziemann [Allemagne]Short latency afferent inhibition and facilitation in patients with writer's cramp
001D20 Antonio L. Jr Teixeira [Brésil] ; Melissa M. Guimaraes [Brésil] ; Marco Aurélio Romano-Silva [Brésil] ; Francisco Cardoso [Brésil]Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism
001D22 Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis]Role of surgery in the treatment of motor complications
001D23 Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis]Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations
001D25 Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Manuel A. Gonzalez [États-Unis] ; Eugene L. Roberts [États-Unis] ; Abraham Lieberman [États-Unis]Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine : Report of a case series
001D39 Allison Fleming [États-Unis] ; Karon F. Cook [États-Unis] ; Naomi D. Nelson [États-Unis] ; Eugene C. Lai [États-Unis]Proxy reports in Parkinson's disease : Caregiver and patient self-reports of quality of life and physical activity
001D44 Henning Stolze [Allemagne] ; Stephan Klebe [Allemagne] ; Christoph Baecker [Allemagne] ; Christiane Zechlin [Allemagne] ; Lars Friege [Allemagne] ; Sabine Pohle ; Günther Deuschl [Allemagne]Prevalence of gait disorders in hospitalized neurological patients
001D51 Lorraine N. Clark [États-Unis] ; Angelique Nicolai [États-Unis] ; Shehla Afridi [États-Unis] ; Juliette Harris [États-Unis] ; Helen Mejia-Santana [États-Unis] ; Lisa Strug [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Howard Andrews [États-Unis] ; Cheryl Waters [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Richard Mayeux [États-Unis] ; Ruth Ottman [États-Unis] ; K. Marder [États-Unis]Pilot association study of the β-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity
001D53 Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Patient-perceived involvement and satisfaction in Parkinson's disease : Effect on therapy decisions and quality of life
001D54 Katherine Widnell [États-Unis]Pathophysiology of motor fluctuations in Parkinson's disease
001D65 Chon-Haw Tsai [Taïwan] ; Fang-Chia Chang [Taïwan] ; Chin-Song Lu [Taïwan] ; Shih-Tseng Lee [Taïwan] ; Yu-Ting Huang [Taïwan] ; Ming-Kuei Lu [Taïwan] ; Rou-Shayn Chen [Taïwan] ; TONY WU [Taïwan] ; Jiann-Der Lee [Taïwan] ; Yi-Hsin Weng [Taïwan] ; Hsiu-Chen Chang [Taïwan]Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease
001D68 Cheryl Waters [États-Unis]Other pharmacological treatments for motor complications and dyskinesias
001D72 William G. Ondo [États-Unis] ; DEJIAN LAI [États-Unis]Olfaction testing in patients with tremor-dominant Parkinson's disease : Is this a distinct condition?
001D73 José L. Giroud-Benitez [Pays-Bas] ; Ali Akyol [Cuba] ; Egberto Barbosa [Turquie] ; Onno Schaap [Brésil] ; Herma C. Van Der Linde [Pays-Bas] ; Emilia Martignoni [Pays-Bas] ; Leonardo Lopiano [Italie] ; Paolo Lamberti [Italie] ; Emiliana Fincati [Italie] ; Angelo Antonini [Italie] ; Fabrizio Stocchi [Italie] ; Pasquale Montagna [Italie] ; Ferdinando Squitieri [Italie] ; Paolo Marini [Italie] ; Giovanni Abbruzzese [Italie] ; Giovanni Fabbrini [Italie] ; Roberto Marconi [Italie] ; Alessio Dalla Libera [Italie] ; Giorgio Trianni [Italie] ; Marco Guidi [Italie] ; Antonio De Gaetano [Italie] ; Gustavo Boff Maegawa [Italie] ; Antonino De Leo [Brésil] ; Virgilio Gallai [Italie] ; Giulia De Rosa [Italie] ; Nicola Vanacore [Italie] ; Giuseppe Meco [Italie] ; Cornelia M. Van Duijn [Italie] ; Ben A. Oostra [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Vincenzo BonifatiNovel parkin mutations detected in patients with early-onset Parkinson's disease
001D76 Yu-Hu Zhang [République populaire de Chine] ; Bei-Sha Tang [République populaire de Chine] ; Ai-Ling Zhao [République populaire de Chine] ; KUN XIA [République populaire de Chine] ; Zhi-Gao Long [République populaire de Chine] ; Ji-Feng Guo [République populaire de Chine] ; Shawn K. Westaway [États-Unis] ; Susan J. Hayflick [États-Unis]Novel compound heterozygous mutations in the PANK2 gene in a chinese patient with atypical pantothenate kinase- associated neurodegeneration
001D78 Charles H. Adler [États-Unis]Nonmotor complications in Parkinson's disease
001D81 Richard M. Dubinsky [États-Unis]No going home for hospitalized Huntington's disease patients
001D89 Anjum Misbahuddin [Royaume-Uni] ; Mark R. Placzek [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni] ; Steve Gschmeissner [Royaume-Uni] ; Giampietro Schiavo [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Mutant torsina, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells
001D92 Joseph Jankovic [États-Unis]Motor fluctuations and dyskinesias in Parkinson's disease : Clinical manifestations
001D93 ZHI LIU [Japon] ; Ryuji Sakakibara [Japon] ; Takeo Odaka [Japon] ; Tomoyuki Uchiyama [Japon] ; Tomoyuki Uchiyama [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; Masato Asahina [Japon] ; Kazuya Yamaguchi [Japon] ; Taketo Yamaguchi [Japon] ; Takamichi Hattori [Japon]Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients
001D95 Carsten Saft [Allemagne] ; Jochen Zange [Allemagne] ; Jiirgen Andrich [Allemagne] ; Klaus Müller [Allemagne] ; Katrin Lindenberg [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Matthias Vorgerd [Allemagne] ; Peter H. Kraus [Allemagne] ; Horst Przuntek [Allemagne] ; Ludger Schols [Allemagne]Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
001E04 Inger Marie Skogseid [Norvège] ; Jo R Islien [Norvège] ; Bj Rgulf Claussen [Norvège] ; Emilia Kerty [Norvège]Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia
001E07 Pasquale Striano [Italie] ; Fiore Manganelli [Italie] ; Patrizia Boccella [Italie] ; Anna Perretti [Italie] ; Salvatore Striano [Italie]Levetiracetam in patients with cortical myoclonus : A clinical and electrophysiological study
001E18 Peter Feys [Belgique, Royaume-Uni] ; Werner F. Helsen [Belgique] ; XUGUANG LIU [Royaume-Uni] ; Bart Nuttin [Belgique] ; Ann Lavrysen [Belgique] ; Stephan P. Swinnen [Belgique] ; Pierre Ketelaer [Belgique]Interaction between eye and hand movements in multiple sclerosis patients with intention tremor
001E27 Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment
001E32 Atul Pathak [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure
001E37 Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ryuji Kaji [Japon] ; Katsuhito Yasuno [Japon] ; Hideshi Kawakami [Japon]Glutathione-S-transferase-1 and interleukin-1β gene polymorphisms in Japanese patients with Parkinson's disease
001E40 Manuela Contin [Italie] ; Paolo Martinelli [Italie] ; Mirella Mochi [Italie] ; Roberto Riva [Italie] ; Fiorenzo Albani [Italie] ; Agostino Baruzzi [Italie]Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease
001E42 Julie-Christine Levesque [Canada] ; André Parent [Canada]GABAergic interneurons in human subthalamic nucleus
001E47 Hans-Christian Jabusch [Allemagne] ; Dorothea Zschucke [Allemagne] ; Alexander Schmidt [Allemagne] ; Stephan Schuele [États-Unis] ; Eckart Altenmüller [Allemagne]Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients
001E51 Catherine L. Wielinski [États-Unis] ; Cordelia Erickson-Davis [États-Unis] ; Rose Wichmann [États-Unis] ; Maria Walde-Douglas [États-Unis] ; Sotirios A. Parashos [États-Unis]Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes
001E58 Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind study
001E64 Julie Carrier [Canada] ; Sonia Frenette [Canada] ; Jacques Montplaisir [Canada] ; Jean Paquet [Canada] ; Caroline Drapeau [Canada] ; Jocelyn Morettini [Canada]Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints
001E65 Paolo Lamberti [Italie] ; Stefano Zoccolella [Italie] ; Giovanni Iliceto [Italie] ; Elio Armenise [Italie] ; Angela Fraddosio [Italie] ; Michele De Mari [Italie] ; Paolo Livrea [Italie]Effects of levodopa and COMT inhibitors on plasma Homocysteine in Parkinson's disease patients
001E66 Anna Lena Törnqvist [Suède] ; Lucyna Schalen [Suède] ; Stig Rehncrona [Suède]Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation
001E67 Paulo S. Boggio [Brésil] ; Felipe Fregni [États-Unis] ; Felix Bermpohl [États-Unis] ; Carlos G. Mansur [Brésil] ; Moacyr Rosa [Brésil] ; Demetrio O. Rumi [Brésil] ; Egberto R. Barbosa [Brésil] ; Marina Odebrecht Rosa [Brésil] ; Alvaro Pascual-Leone [États-Unis] ; Sélgio Paulo Rigonatti [Brésil] ; Marco A. Marcolin [Brésil] ; Maria Teresa Araujo Silva [Brésil]Effect of repetitive TMS and fluoxetine on cognitive function in patients with parkinson's disease and concurrent depression
001E71 Svenja Happe [Allemagne] ; Martin Sommer [Allemagne] ; Johannes Meller [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Walter Paulus [Allemagne]Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder
001E74 Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]Dopaminergic innervation of the human striatum in Parkinson's disease
001E81 Lisa M. Benrud-Larson [États-Unis] ; Paola Sandroni [États-Unis] ; Anette Schrag [Royaume-Uni] ; Phillip A. Low [États-Unis]Depressive symptoms and life satisfaction in patients with multiple system atrophy
001E84 J. Carsten Moller [Allemagne] ; Mira Rethfeldt [Allemagne] ; Yvonne Körner [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Werner Cassel [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Ida Rissling [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne]Daytime sleep latency in medication-matched parkinsonian patients with and without sudden onset of sleep
001E86 Angelo Quartarone [Italie] ; Sergio Bagnato [Italie] ; Vincenzo Rizzo [Italie] ; Francesca Morgante [Italie] ; Antonino Sant'Angelo [Italie] ; Domenica Crupi [Italie] ; Marcello Romano [Italie] ; Corrado Messina [Italie] ; Alfredo Berardelli [Italie] ; Paolo Girlanda [Italie]Corticospinal excitability during motor imagery of a simple tonic finger movement in patients with writer's cramp
001E91 Ivan Rektor [République tchèque] ; Martin Bares [République tchèque] ; Milan Brazdil [République tchèque] ; Petr Kanovsky [République tchèque] ; Irena Rektorova [République tchèque] ; Daniela Sochurkova [République tchèque] ; Dagmar Kubova [République tchèque] ; Robert Kuba [République tchèque] ; Pavel Daniel [République tchèque]Cognitive- and movement-related potentials recorded in the human basal ganglia
001E93 Sowmya Lakshminarayanan [États-Unis] ; Kanchana Devi Paramasivan [États-Unis] ; Arthur S. Walters [États-Unis] ; Mary L. Wagner [États-Unis] ; Shivani Patel [États-Unis] ; Vandna Passi [États-Unis]Clinically significant but unsuspected restless legs syndrome in patients with sleep apnea
001E98 Panida Piboolnurak [États-Unis] ; Qiping P. Yu [États-Unis] ; Seth L. Pullman [États-Unis]Clinical and neurophysiologic spectrum of orthostatic tremor : Case series of 26 subjects
001F03 Maria V. Recio [États-Unis] ; Robert A. Hauser [États-Unis] ; Elan D. Louis [États-Unis] ; Harsha Radhashakar [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis]Chorea in a patient with cerebral palsy : Treatment with levetiracetam
001F05 Marcello M. Mascia [Italie] ; Josep Valls-Sole [Espagne] ; Maria J. Marti [Espagne] ; Sergio Sanz [Espagne]Chewing pattern in patients with Meige's syndrome
001F14 Frank Skidmore [États-Unis] ; Irene Mikolenko [États-Unis] ; Howard Weiss [États-Unis] ; William Weiner [États-Unis]Camptocormia in a patient with multiple system atrophy
001F17 Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon]Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy
001F34 Kazumasa Shindo [Japon] ; Eri Kaneko [Japon] ; Harue Watanabe [Japon] ; Tetsuhiko Sugimoto [Japon] ; Emiko Ohta [Japon] ; Kenji Ohashi [Japon] ; Takamura Nagasaka [Japon] ; Zenji Shiozawa [Japon]Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I -metaiodobenzylguanidine uptake in patients with Parkinson's disease
001F40 Daniela Berg [Allemagne] ; Marc Niwar [Allemagne] ; Sylvia Maass [Allemagne] ; Alexander Zimprich [Autriche] ; J. Carsten Moller [Allemagne] ; Ullrich Wuellner [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Christine Klein [Allemagne] ; Eng-King Tan [Singapour] ; Ludger Schöls [Allemagne] ; Laura Marsh [États-Unis] ; Ted M. Dawson [États-Unis] ; Bernd Janetzky [Allemagne] ; Thomas Müller [Allemagne] ; Dirk Woitalla [Allemagne] ; Vladimir Kostic [Serbie] ; Peter P. Pramstaller [Italie] ; Wolfgang H. Oertel [Allemagne] ; Peter Bauer [Allemagne] ; Rejko Krueger [Allemagne] ; Thomas Gasser [Allemagne] ; Olaf Riess [Allemagne]Alpha-synuclein and Parkinson's disease : Implications from the screening of more than 1,900 patients
001F50 Yoshihiro Sato [Japon] ; Yoshiaki Honda [Japon] ; Jun Iwamoto [Japon] ; Tomohiro Kanoko [Japon] ; Kei Satoh [Japon]Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients
001F57 Cheryl H. Waters [États-Unis] ; Kapil D. Sethi [États-Unis] ; Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; John M. Bertoni [États-Unis]Zydis selegiline reduces Off time in Parkinson's disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study
001F58 Paul H. Gordon [États-Unis] ; Stanley Fahn [États-Unis] ; Steven Chin [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Timothy Lynch [Irlande (pays)] ; David Eidelberg [États-Unis]Woman with a 26-year history of Parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes
001F65 Judith Junker [Allemagne] ; Christoph Oberwittler [Allemagne] ; Didi Jackson [Allemagne] ; Klaus Berger [Allemagne]Utilization and perceived effectiveness of complementary and alternative medicine in patients with dystonia
001F67 Panda Piboolnurak [États-Unis] ; Seth L. Pullman [États-Unis] ; Elan D. Louis [États-Unis]Unusual forehead tremor in a patient with essential tremor
001F72 Constantine Constantoyannis [Canada] ; Ajit Kumar [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Tremor induced by thalamic deep brain stimulation in patients with complex regional facial pain
001F80 Leo Verhagen Metman [États-Unis] ; Brian Myre [États-Unis] ; Niek Verwey [États-Unis] ; Sharon Hassin-Baer [Israël] ; Jean Arzbaecher [États-Unis] ; Diane Sierens [États-Unis] ; Roy Bakay [États-Unis]Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: An argument against multiple baseline assessments
001F88 Theresa A. Zesiewicz [États-Unis] ; Elan D. Louis [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Martin Menkin [États-Unis] ; Peter B. Dunne [États-Unis] ; Robert A. Hauser [États-Unis]Substantial improvement in a Meige's syndrome patient with levetiracetam treatment
001F98 Stephen Grill [États-Unis]Smothering dystonia in a patient with oromandibular dystonia
002005 Dolores Garcia Arocena [États-Unis] ; Elan D. Louis [États-Unis] ; Flora Tassone [États-Unis] ; T. Conrad Gilliam [États-Unis] ; Ruth Ottman [États-Unis] ; Sébastien Jacquemont [États-Unis] ; Paul J. Hagerman [États-Unis]Screen for expanded FMR1 alleles in patients with essential tremor
002006 Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France]Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study
002009 Alastair Wilkins [Royaume-Uni] ; Jerry M. Brown [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: A case report
002014 Peter Hobson [Royaume-Uni] ; Jolyon Meara [Royaume-Uni]Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom
002028 Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni]Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man
002033 Marcin Zach [Pologne] ; Andrzej Friedman [Pologne] ; Jarosław Sławek [Pologne] ; Mirosława Derejko [Pologne]Quality of life in Polish patients with long-lasting Parkinson's disease
002045 Rainer Linke [Allemagne] ; Ilonka Eisensehr [Allemagne] ; Thomas-Christian Wetter [Allemagne] ; Franz-Josef Gildehaus [Allemagne] ; Gabriele Pöpperl [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Soheyl Noachtar [Allemagne] ; Klaus Tatsch [Allemagne]Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease?
002047 Din-E. Shan [Taïwan] ; Ren-Shyan Liu [Taïwan] ; Chen-Ming Sun [Taïwan] ; Shwn-Jen Lee [Taïwan] ; Kwong-Kum Liao [Taïwan] ; Bing-Wen Soong [Taïwan]Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: Clinical implications
002060 Stefan J. Cano [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] ; Ray Fitzpatrick [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Alan J. Thompson [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Patient-based outcomes of cervical dystonia: A review of rating scales
002061 Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen [Allemagne] ; Erwin Schollmayer [Allemagne] ; J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne]Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of Restless Legs Syndrome: A double-blind, placebo-controlled pilot study
002066 Frédéric Macia [France] ; Caroline Perlemoine [France] ; Irène Coman [France] ; Dominique Guehl [France] ; Pierre Burbaud [France] ; Emmanuel Cuny [France] ; Henri Gin [France] ; Vincent Rigalleau [France] ; Francois Tison [France]Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight
002067 Joseph Wiley [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Sarah Lincoln [États-Unis] ; Lisa Skipper [États-Unis] ; Mary Hulihan [États-Unis] ; David Gosal [Irlande (pays)] ; Gina Bisceglio [États-Unis] ; Jennifer Kachergus [États-Unis] ; John Hardy [États-Unis] ; Matthew J. Farrer [États-Unis]Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with Parkin mutations
002074 Jason D. Warren [Royaume-Uni] ; Michele T. M. Hu [Royaume-Uni] ; Malcolm Galloway [Royaume-Uni] ; Richard J. Greenwood [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni]Observations on the human rejection behaviour syndrome: Denny-Brown revisited
002077 Karin Stiasny-Kolster [Allemagne] ; J. Carsten Möller [Allemagne] ; Johannes Zschocke [Allemagne] ; Oliver Bandmann [Allemagne] ; Werner Cassel [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Georg F. Hoffmann [Allemagne]Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients
002083 Marcelo Merello [Argentine] ; Daniel Cerquetti [Argentine] ; Angel Cammarota [Argentine] ; Eduardo Tenca [Argentine] ; Carlos Artes [Argentine] ; Julio Antico [Argentine] ; Ramon Leiguarda [Argentine]Neuronal globus pallidus activity in patients with generalised dystonia
002084 Luiz C. M. Pereira [Canada] ; Vanessa N. Palter [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada]Neuronal activity in the globus pallidus of multiple system atrophy patients
002087 Willibald Gerschlager [Royaume-Uni, Autriche] ; Alexander Münchau [Allemagne] ; Regina Katzenschlager [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Natural history and syndromic associations of Orthostatic tremor: A review of 41 patients
002099 Meltem Müftüoglu [Turquie] ; Bülent Elibol [Turquie] ; Özlem Dalmizrak [Turquie] ; Ayse Ercan [Turquie] ; Gülnihal Kulaksiz [Turquie] ; Hamdi Ögüs [Turquie] ; Turgay Dalkara [Turquie] ; Nazmi Özer [Turquie]Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
002100 David K. Simon [États-Unis] ; Seiji Nishino [États-Unis] ; Thomas E. Scammell [États-Unis]Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus ("Limp Man Syndrome")
002106 I. Hozumi [Japon] ; Y. S. Piao [Japon] ; T. Inuzuka [Japon] ; Z. Matsuyama [Japon] ; Y. Yamada [Japon] ; A. Hara [Japon] ; T. Hirose [Japon] ; K. Tsuchiya [Japon] ; H. Takahashi [Japon]Marked asymmetry of putaminal pathology in an MSA-P patient with Pisa syndrome
002109 Hubert H. Fernandez [États-Unis] ; Edward M. Donnelly [États-Unis] ; Joseph H. Friedman [États-Unis]Long-term outcome of clozapine use for psychosis in Parkinsonian patients
002110 Peter Haussermann [Allemagne] ; Stefanie Marczoch [Allemagne] ; Christiane Klinger [Allemagne] ; Michael Landgrebe [Allemagne] ; Bastian Conrad [Allemagne] ; Andres Ceballos-Baumann [Allemagne]Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
002112 Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne]Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease
002117 Kathrin Grundmann [Allemagne] ; Ulrike Laubis-Herrmann [Allemagne] ; Dirk Dressier [Allemagne] ; Juliane Vollmer-Haase [Allemagne] ; Peter Bauer [Allemagne] ; Manfred Stuhrmann [Allemagne] ; Thorsten Schulte [Allemagne] ; Ludger Schöls [Allemagne] ; Helge Topka [Allemagne] ; Olaf Riess [Allemagne]Lack of mutations in the epsilon-sarcoglycan gene in patients with different subtypes of Primary dystonias
002127 David E. Hardesty [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Joseph Y. Matsumoto [États-Unis] ; Elan D. Louis [États-Unis]Increased risk of head tremor in women with essential tremor: Longitudinal data from the Rochester Epidemiology Project
002130 Niels Hjort [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark]Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus
002132 Antonio Curra [Italie] ; Rocco Agostino [Italie] ; Loredana Dinapoli [Italie] ; Sergio Bagnato [Italie] ; Mario Manfredi [Italie] ; Alfredo Berardelli [Italie]Impairment of individual finger movements in patients with hand dystonia
002135 Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne]Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes
002138 Jürgen Andrich [Allemagne] ; Carsten Saft [Allemagne] ; Anneliese Arz [Allemagne] ; Birgit Schneider [Allemagne] ; Markus W. Agelink [Allemagne] ; Peter H. Kraus [Allemagne] ; Wilfried Kuhn [Allemagne] ; Thomas Müller [Allemagne]Hyperhomocysteinaemia in treated patients with Huntington's disease
002140 Motasem Al-Yacoub [États-Unis] ; Joseph H. Friedman [États-Unis] ; Hubert H. Fernandez [États-Unis]Hemiballismus from a parietal stroke in a Parkinson patient
002156 Patricia De Carvalho Aguiar [États-Unis, Brésil] ; Melissa Fazzari [États-Unis] ; Joseph Jankovic [États-Unis] ; Laurie J. Ozelius [États-Unis]Examination of the SGCE gene in Tourette's syndrome patients with obsessive-compulsive disorder
002170 Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis]Double-blind, randomized, controlled trial of Rasagiline as monotherapy in early Parkinson's Disease patients
002171 Ida Rissling [Allemagne] ; Frank Geller [Allemagne] ; Oliver Bandmann [Allemagne] ; Karim Stiasny-Kolster [Allemagne] ; Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; J. Carsten Möller [Allemagne]Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks"
002178 Roberto Eleopra [Italie] ; Valeria Tugnoli [Italie] ; Rocco Quatrale [Italie] ; Ornella Rossetto [Italie] ; Cesare Montecucco [Italie]Different types of botulinum toxin in humans
002183 Federico Micheli [Argentine] ; Maria Clara Scorticati [Argentine] ; Silvia Folgar [Argentine] ; Emilia Gatto [Argentine] ; MD [Argentine]Development of Parkinson's disease in patients with blepharospasm
002193 Pierre Payoux [France] ; Kader Boulanouar [France] ; Christine Sarramon [France] ; Nelly Fabre [France] ; Sylvie Descombes [France] ; Monique Galitsky [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Umberto Sabatini [Italie] ; Claude Manelfe [France] ; Francois Chollet [France] ; Laurent Schmitt [France] ; Olivier Rascol [France]Cortical motor activation in akinetic schizophrenic patients: A pilot functional MRI study
002197 Klaus Seppi [Autriche] ; Michael F. H. Schocke [Autriche] ; Eveline Donnemiller [Autriche] ; Regina Esterhammer [Autriche] ; Christian Kremser [Autriche] ; Christoph Scherfler [Autriche] ; Anja Diem [Autriche] ; Werner Jaschke [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
002210 Marianna Capecci [Italie] ; Luca Passamonti [Italie] ; Ferdinanda Annesi [Italie] ; Grazia Annesi [Italie] ; Michele Bellesi [Italie] ; Innocenza Claudia Ciro Candiano [Italie] ; Riccardo Ricciuti [Italie] ; Maurizio Iacoangeli [Italie] ; Massimo Scerrati [Italie] ; Mario Zappia [Italie] ; Patrizia Tarantino [Italie] ; Elvira Valeria De Marco [Italie] ; Donatella Civitelli [Italie] ; Sara Carrideo [Italie] ; Leandro Provinciali [Italie] ; Maria Gabriella Ceravolo [Italie] ; Aldo Quattrone [Italie]Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene
002216 Francesca Romana Pezzella [Italie] ; Maria Grazia Paglia [Italie] ; Carlo Colosimo [Italie]Cerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy
002220 Nicola Pavese [Royaume-Uni] ; Ornella Rimoldi [Royaume-Uni] ; Alexander Gerhard [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Panla Piccini [Royaume-Uni]Cardiovascular effects of methamphetamine in Parkinson's disease patients
002229 Kelvin L. Chou [États-Unis] ; Howard I. Hurtig [États-Unis] ; Jurg L. Jaggi [États-Unis] ; Gordon H. Baltuch [États-Unis]Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor
002235 Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong]Audiovisual cues can enhance sit-to-stand in patients with Parkinson's disease
002240 Ali Sazci [Turquie] ; Emel Ergul [Turquie] ; Kemal Bayulkem [Turquie]Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey
002244 Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Ruth G. B. Schipper [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas]Assessing comorbidity in patients with Parkinson's disease
002263 Stefano Tamburin [Italie] ; Giampietro Zanette [Italie]Abnormalities of sensory processing and sensorimotor interactions in secondary dystonia : A neurophysiological study in two patients
002271 Parkinsonism and Dementia: Synucleinopathies, Tauopathies, and Beyond. Proceedings of the "Movement" Disorder Society-European Division-Sponsored Workshop, Istanbul, Turkey, 9-11 May 2002
002272 Dopamine transporter imaging
002273 Anette Schrag [Royaume-Uni] ; Anna Hovris [Royaume-Uni] ; David Morley [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]Young-versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences
002274 Murat Emre [Turquie]What causes mental dysfunction in Parkinson's disease?
002275 Christian Brenneis [Autriche] ; Klaus Seppi [Autriche] ; Michael F. Schocke [Autriche] ; Jörg Müller [Autriche] ; Elisabeth Luginger [Autriche] ; Sylvia Bosch [Autriche] ; Wolfgang N. Loscher [Autriche] ; Christian Büchel [Allemagne] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy
002276 Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Hidetaka Mitani [Japon] ; Ryuzo Kawahara [Japon] ; Masahiro Miyake [Japon] ; Kenji Nakashima [Japon]Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease
002277 Brian F. O'Donnell [États-Unis] ; Marcia A. Wilt [États-Unis] ; Ann Marie Hake [États-Unis] ; Julie C. Stout [États-Unis] ; Sandra C. Kirkwood [États-Unis] ; Tatiana Foroud [États-Unis]Visual function in Huntington's disease patients and presymptomatic gene carriers
002279 David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni]Use of functional imaging in parkinsonism and dementia
002280 Irene Litvan [États-Unis]Update on epidemiological aspects of progressive supranuclear palsy
002281 Mark Edwards [Royaume-Uni] ; Nicholas Wood [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni]Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature
002283 Gurutz Linazasoro [Espagne] ; Nadège Van Blercom [Espagne] ; Asier Lasa [Espagne]Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease
002284 Regina Katzenschlager [Royaume-Uni] ; Adriana Cardozo [Espagne] ; M. Rosario Avila Cobo [Espagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni]Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders
002285 Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne] ; Florian Kopper [Allemagne] ; Monika Potter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne]Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease
002286 Giovanni Pavesi [Italie] ; Luigi Cattaneo [Italie] ; Elisabetta Chierici [Italie] ; Domenico Mancia [Italie]Trigemino-facial inhibitory reflexes in idiopathic hemifacial spasm
002287 Francisco Cardoso [Brésil] ; Débora Maia [Brésil] ; Mauro César Q. S. Cunningham [Brésil] ; Guilherme Valenca [Brésil]Treatment of sydenham chorea with corticosteroids
002290 Philip C. Su [Taïwan] ; Ham-Min Tseng [Taïwan] ; Hon-Man Liu [Taïwan] ; Ruoh-Fang Yen [Taïwan] ; Horng-Huei Liou [Taïwan]Treatment of advanced Parkinson's Disease by subthalamotomy: One-year results
002291 Francisco Grandas [Espagne] ; Jaime Kulisevsky [Espagne]Treatment of Parkinson's disease in Spain
002293 JAE WOO KIM [Corée du Sud] ; Seoung-Ho Choi [Corée du Sud] ; Wook-Joo Kim [Corée du Sud] ; Sang-Myung Chun [Corée du Sud]Transient ischemic attacks presenting as hemiballism
002294 Ruth H. Walker [États-Unis] ; Paul F. Good [États-Unis] ; P. Shashidharan [États-Unis]TorsinA immunoreactivity in inclusion bodies in trinucleotide repeat diseases
002295 Katia Lin [Brésil] ; Jaime Lin [Brésil] ; Elcio Juliato Piovesan [Brésil] ; Francisco M. B. Germiniani [Brésil] ; Hélio A. G. Teive [Brésil] ; Lineu Cesar Werneck [Brésil]Tongue tremor in a patient with coma after electrical injury
002296 The unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
002297 John M. Walshe [Royaume-Uni]The story of penicillamine: A difficult birth
002299 Dominique Twelves [Royaume-Uni] ; Kate S. M. Perkins [Royaume-Uni] ; Carl Counsell [Royaume-Uni]Systematic review of incidence studies of Parkinson's disease
002302 Aida M. Bertoli-Avella [Pays-Bas, Cuba] ; Jose L. Giroud-Benitez [Cuba] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Eduardo Alvarez-Gonzalez [Cuba] ; Luis Heredero-Baute [Cuba] ; Cornelia M. Van Duijn [Pays-Bas] ; Peter Heutink [Pays-Bas]Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease
002304 Alessandra Pesenti [Italie] ; Alberto Priori [Italie] ; Marco Locatelli [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Filippo Tamma [Italie] ; Elena Caputo [Italie] ; Valentina Chiesa [Italie] ; Sergio Barbieri [Italie]Subthalamic somatosensory evoked potentials in Parkinson's disease
002306 Pedro J. Garcia-Ruiz [Espagne] ; Vicente Villanueva [Espagne] ; Eva Gutierrez-Delicado [Espagne] ; Amaia Echeverria [Espagne] ; Antonio Perez-Higueras [Espagne] ; José M. Serratosa [Espagne]Subthalamic lesion and paroxysmal tonic spasms
002307 CHARULATA SANKHLA SAVANT [Inde] ; B. S. Singhal [Inde] ; Joseph Jankovic [États-Unis] ; Mak Khan [Inde] ; Amin Virani [Inde]Substantia nigra lesions in viral encephalitis
002309 Christopher G. Goetz [États-Unis] ; Peter A. Lewitt [États-Unis] ; Meredith Weidenman [États-Unis]Standardized training tools for the UPDRS Activities of Daily Living scale: Newly available teaching program
002313 YING PENG [États-Unis] ; Roger Crumley [États-Unis] ; John M. Ringman [États-Unis]Spasmodic dysphonia in a patient with the a to G transition at nucleotide 8344 in mitochondrial DNA
002314 Mikko Kuoppam Ki [Royaume-Uni] ; Paula Giunti [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Slowly progressive cerebellar ataxia and cervical dystonia: Clinical presentation of a new form of spinocerebellar ataxia?
002315 Matthew A. Brodsky [États-Unis] ; James Godbold [États-Unis] ; Tom Roth [États-Unis] ; C. Warren Olanow [États-Unis]Sleepiness in Parkinson's disease: A controlled study
002316 Sebastian Paus [Allemagne] ; Hans Michael Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Gert Seeger [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
002317 Klaus L. Leenders [Pays-Bas]Significance of non-presynaptic SPECT tracer methods in Parkinson's disease
002318 Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Takamichi Hattori [Japon] ; Tomonori Yamanishi [Japon]Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon
002320 Wolf-Rüdiger Sch Bitz [Allemagne] ; Katharina Glatz [Allemagne] ; Christian Schuhan [Allemagne] ; Clemens Sommer [Allemagne] ; Christian Berger [Allemagne] ; Markus Schwaninger [Allemagne] ; Marius Hartmann [Allemagne] ; Hans Hilmar Goebel [Allemagne] ; Hans-Michael Meinck [Allemagne]Severe forward flexion of the trunk in Parkinson's disease: Focal myopathy of the paraspinal muscles mimicking camptocormia
002321 Oren Cohen [États-Unis] ; Stanley Fahn [États-Unis] ; Steven J. Frucht [États-Unis]Severe cervical dystonia in pathologically proven Parkinson's disease and dementia
002322 Massimo Cincotta [Italie] ; Alessandra Borgheresi [Italie] ; Lara Balzini [Italie] ; Luca Vannucchi [Italie] ; Gabriele Zeloni [Italie] ; Aldo Ragazzoni [Italie] ; Francesco Benvenuti [Italie] ; Gaetano Zaccara [Italie] ; Graziano Arnetoli [Italie] ; Ulf Ziemann [Allemagne]Separate ipsilateral and contralateral corticospinal projections in congenital mirror movements: Neurophysiological evidence and significance for motor rehabilitation
002324 Giovanni Abbruzzese [Italie] ; Alfredo Berardelli [Italie]Sensorimotor integration in movement disorders
002325 Kirn R. Kessler [Allemagne] ; Gilbert Wunderlich [Allemagne] ; Harald Hefter [Allemagne] ; Rüdiger J. Seitz [Allemagne]Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density
002326 Mark S. Ledoux [États-Unis] ; Kimberly A. Brady [États-Unis]Secondary cervical dystonia associated with structural lesions of the central nervous system
002327 Irene Litvan [États-Unis] ; Kailash P. Bhatia ; David J. Burn ; Christopher G. Goetz ; Anthony E. Lang ; Ian Mckeith ; Niall Quinn ; Kapil D. Sethi ; Cliff Shults ; Gregor K. WenningSIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
002328 Haydeh Payami [États-Unis] ; John Nutt [États-Unis] ; Steven Gancher [États-Unis] ; Thomas Bird [États-Unis] ; Melissa Gonzales Mcneal [États-Unis] ; William K. Seltzer [États-Unis] ; Jennifer Hussey [États-Unis] ; Paul Lockhart [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Amanda A. Singleton [États-Unis] ; Andrew B. Singleton [États-Unis] ; John Hardy [États-Unis] ; Matthew Farrer [États-Unis]SCA2 may present as levodopa-responsive parkinsonism
002329 Alexis Elbaz [France] ; Clotilde Levecque [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Florence Richard [France] ; Jean-René Correze [France] ; Bernard Delemotte [France] ; Philippe Amouyel [France] ; Annick Alperovitch [France] ; Marie-Christine Chartier-Harlin [France] ; Christophe Tzourio [France]S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship
002330 Michele Tinazzi [Italie] ; Tiziana Rosso [Italie] ; Antonio Fiaschi [Italie]Role of the somatosensory system in primary dystonia
002331 Vicky Marshall [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders
002332 Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]Role of dopamine transporter imaging in routine clinical practice
002333 Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
002334 Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne]Role of dopamine transporter SPECT for the practitioner and the general neurologist
002336 Gary W. Thickbroom [Australie] ; Michelle L. Byrnes [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Reversible reorganisation of the motor cortical representation of the hand in cervical dystonia
002337 Pudukode R. Krishnan [Inde] ; Manvir Bhatia [Inde] ; Madhuri Behari [Inde]Restless legs syndrome in Parkinson's disease: A case-controlled study
002338 Carson R. Reider [États-Unis] ; Cheryl A. Halter [États-Unis] ; Peter F. Castelluccio [États-Unis] ; David Oakes [États-Unis] ; William C. Nichols [États-Unis] ; Tatiana Foroud [États-Unis]Reliability of reported age at onset for Parkinson's disease
002340 Wolfgang H. Oertel [Allemagne] ; Tobias W Chter [Allemagne] ; Niall P. Quinn [Royaume-Uni] ; Gudrun Ulm [Allemagne] ; Dirk Brandst Dter [Allemagne]Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type
002341 Cynthia L. Comella [États-Unis] ; Sue Leurgans [États-Unis] ; Joanne Wuu [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Teresa Chmura [États-Unis]Rating scales for dystonia: A multicenter assessment
002343 Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor
002347 Joseph H. Friedman [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Lewis R. Sudarsky [États-Unis]REM Behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3)
002348 Katinka Tuisku [Finlande] ; Matti Mikael Holi [Finlande] ; Kristian Wahlbeck [Finlande] ; Aulikki Johanna Ahlgren [Finlande] ; Hannu Lauerma [Finlande]Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: A controlled study
002350 José L. Molinuevo [Espagne] ; Maria J. Marti [Espagne] ; Rafael Blesa [Espagne] ; Eduardo Tolosa [Espagne]Pure akinesia: An unusual phenotype of Hallervorden-Spatz syndrome
002351 Noëlle G. A. Spliethoff-Kamminga [Pays-Bas] ; Aeilko H. Zwinderman [Pays-Bas] ; Machiel P. Springer [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas]Psychosocial problems in Parkinson's disease: Evaluation of a disease-specific questionnaire
002352 Werner Poewe [Autriche]Psychosis in Parkinson's disease
002354 USHA KANT MISRA [Inde] ; Jayantee Kalita [Inde] ; Anita Mahadevan [Inde] ; SUSARLA KRISHNA SHANKAR [Inde]Pseudoathetosis in a patient with leprosy
002356 Marc G. Weisskopf [États-Unis] ; HONGLEI CHEN [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Ichiro Kawachi [États-Unis] ; Alberto Ascherio [États-Unis]Prospective study of phobic anxiety and risk of Parkinson's disease
002357 Andrew Sharott [Royaume-Uni] ; Jon Marsden [Royaume-Uni] ; Peter Brown [Royaume-Uni]Primary orthostatic tremor is an exaggeration of a physiological response to instability
002359 Tatjana Pekmezovic [Serbie] ; Natasa Ivanovic [Serbie] ; Marina Svetel [Serbie] ; Dragana Nalic [Serbie] ; Tatjana Smiljkovic [Serbie] ; Ranko Raicevic [Serbie] ; Vladimir S. Kostic [Serbie]Prevalence of primary late-onset focal dystonia in the Belgrade population
002364 Carolyn Kwak [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Joseph Jankovic [États-Unis]Premonitory sensory phenomenon in Tourette's syndrome
002365 Daniel S. Sa [Canada] ; Angela Mailis-Gagnon [Canada] ; Keith Nicholson [Canada] ; Anthony E. Lang [Canada]Posttraumatic painful torticollis
002367 Andrew Kertesz [Canada]Pick's complex and FTDP-17
002368 Edith Werber [Israël] ; Colin Klein [Israël] ; Jonathan Grünfeld [Israël] ; José Martin Rabey [Israël]Phenotypic presentation of frontotemporal dementia with parkinsonism-chromosome 17 type p301s in a patient of jewish-algerian origin
002369 Ruth H. Walker [États-Unis] ; Joseph Jankovic [États-Unis] ; Elizabeth O'Hearn [États-Unis] ; Russell L. Margolis [États-Unis]Phenotypic features of Huntington's disease-like 2
002370 Joong-Seok Kim [Corée du Sud] ; Sang-Bong Lee [Corée du Sud] ; Soung-Kyeong Park [Corée du Sud] ; Si-Ryung Han [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud]Periodic limb movement during sleep developed after pontine lesion
002372 Vanessa K. Lim [Nouvelle-Zélande, Allemagne] ; John L. Bradshaw [Australie] ; Michael E. R. Nicholls [Australie] ; Eckart Altenmüller [Allemagne]Perceptual differences in sequential stimuli across patients with musician's and writer's cramp
002375 Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; DU CHU WU [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis]Pathogenic role of glial cells in Parkinson's disease
002379 Andrew Lees (neurologue) [Royaume-Uni]Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings
002381 Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis]Parkinson's disease is associated with hippocampal atrophy
002382 Sarah J. Lincoln [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Rebecca Bounds [États-Unis] ; Mariza De Andrade [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Matthew J. Farrer [États-Unis]Parkin variants in North American Parkinson's disease: Cases and controls
002385 Rainer Dziewas [Allemagne] ; Gregor Kuhlenb Umer [Allemagne] ; Angelika Okegwo [Allemagne] ; Peter Lüdemann [Allemagne]Painless legs and moving toes in a mother and her daughter
002386 Peter Brown [Royaume-Uni]Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease
002387 Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne]One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome?
002389 Christopher Hawkes [Royaume-Uni]Olfaction in neurodegenerative disorder
002390 Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis]Olfaction in essential tremor patients with and without isolated rest tremor
002392 Martin Sommer [Allemagne] ; Stephan Wischer [Allemagne] ; Frithjof Tergau [Allemagne] ; Walter Paulus [Allemagne]Normal intracortical excitability in developmental stuttering
002393 Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
002394 Christopher D. Ward [Royaume-Uni]Neuropsychiatric interpretations of postencephalitic movement disorders
002395 Kurt A. Jellinger [Autriche]Neuropathological spectrum of Synucleinopathies
002398 Sergei N. Illarioshkin [Russie] ; Magali Periquet [France] ; Nina Rawal [France] ; Christoph B. Lücking [France] ; Tatyana B. Zagorovskaya [Russie] ; Pyotr A. Slominsky [Russie] ; Olga V. Miloserdova [Russie] ; Elena D. Markova [Russie] ; Svetlana A. Limborska [Russie] ; Irina A. Ivanova-Smolenskaya [Russie] ; Alexis Brice [France]Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism
002399 Gregor K. Wenning [Autriche] ; Felix Geser [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Francois Tison [Autriche]Multiple system atrophy: An update
002400 Emmanuelle Waubant [France] ; Sophie Tezenas Du Montcel [France] ; Charles Jedynak [France] ; Michael Obadia [France] ; Hassan Hosseini [France] ; Philippe Damier [France] ; Catherine Lubetzki [France] ; Yves Agid [France] ; Jean-Denis DegosMultiple sclerosis tremor and the Stewart-Holmes manoeuvre
002401 Pedro Gonzalez-Alegre [États-Unis] ; Zakaria Ammache [États-Unis] ; Patricia H. Davis [États-Unis] ; Robert L. Rodnitzky [États-Unis]Moyamoya-induced paroxysmal dyskinesia
002403 Josep Valls-Sole [Espagne] ; Jordi MonteroMovement disorders in patients with peripheral facial palsy
002404 Thomas Gasser [Allemagne] ; Susan Bressman [États-Unis] ; Alexandra Dürr [France] ; Joseph Higgins [États-Unis] ; Thomas Klockgether [Allemagne] ; Richard H. Myers [États-Unis]Molecular diagnosis of inherited movement disorders. Movement disorders Society Task Force on Molecular Diagnosis
002405 Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni]Models of Parkinson's disease
002406 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis]Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study
002407 John-Paul Bouffard [États-Unis] ; Hernando Mena [États-Unis] ; Mary Ripple [États-Unis] ; Juan Troncoso [États-Unis]Mesencephalic cryptococcal abscesses presenting with Parkinsonism as an initial manifestation of AIDS
002408 Walter Pirker [Autriche] ; Iris Holler [Autriche] ; Willibald Gerschlager [Autriche] ; Susanne Asenbaum [Autriche] ; Georg Zettinig [Autriche] ; Thomas Brücke [Autriche]Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT
002409 Louis C. Tan [États-Unis] ; Caroline M. Tanner [États-Unis] ; RONG CHEN [États-Unis] ; PIU CHAN [États-Unis] ; Matthew Farrer [États-Unis] ; John Hardy [États-Unis] ; J. William Langston [États-Unis]Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation
002410 Blanka Hejdukova [Suède, République tchèque] ; Nasser Hosseini [Suède] ; Bo Johnels [Suède] ; Pall E. Ingvarsson [Suède] ; Göran Steg [Suède] ; Torsten Olsson [Suède]Manual transport in Parkinson's disease
002411 Jan Herzog [Allemagne] ; Julia Reiff [Allemagne] ; Paul Krack [Allemagne] ; Karsten Witt [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Müller [Allemagne] ; Günther Deuschl [Allemagne]Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease
002413 Mona Ragothaman [Inde] ; Uday A. Murgod [Inde] ; Gopalkrishna Gururaj [Inde] ; Subbakrishna D. Kumaraswamy [Inde] ; Uday Muthane [Inde]Lower risk of Parkinson's disease in an admixed population of European and Indian origins
002415 Stig Rehncrona [Suède] ; Bo Johnels [Suède] ; Hakan Widner [Suède] ; Anna-Lena Törnqvist [Suède] ; Marwan Hariz [Suède] ; Olof Sydow [Suède]Long-term efficacy of Thalamic deep brain stimulation for tremor: Double-blind assessments
002416 Philip V. Theodosopoulos [États-Unis] ; William J. Jr Marks [États-Unis] ; Chadwick Christine [États-Unis] ; Philip A. Starr [États-Unis]Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease
002420 Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada]Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair
002422 David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis]Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease
002423 Carlo Colosimo [Italie, Royaume-Uni] ; Yasushi Osaki [Royaume-Uni] ; Nicola Vanacore [Italie] ; Andrew Lees (neurologue) [Royaume-Uni]Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study
002424 Zelma H. T. Kiss [Canada] ; Marshall Wilkinson [Canada] ; Jerry Krcek [Canada] ; Oksana Suchowersky [Canada] ; BIN HU [Canada] ; William F. Murphy [Canada] ; Doug Hobson [Canada] ; Ron R. Tasker [Canada]Is the target for thalamic deep brain stimulation the same as for thalamotomy?
002425 Ilse M. F. Coulier [Belgique] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration?
002426 Onofre Combarros [Espagne] ; Jon Infante [Espagne] ; Javier Llorca [Espagne] ; José Berciano [Espagne]Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy
002427 Barry M. Seemungal [Royaume-Uni] ; Mary Faldon [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; David S. Zee [États-Unis] ; Adolfo M. Bronstein [Royaume-Uni]Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy
002428 Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ikuko Mizuta [Japon] ; Mitsuhiro Ohta [Japon] ; Hirofumi Maruyama [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon]Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease
002430 Rocco Agostino [Italie] ; Antonio Curra [Italie] ; Morena Giovannelli [Italie] ; Nicola Modugno [Italie] ; Mario Manfredi [Italie] ; Alfredo Berardelli [Italie]Impairment of individual finger movements in Parkinson's disease
002431 Laura Bertolasi [Italie] ; Silvia Romito [Italie] ; Michele Tinazzi [Italie] ; Niccolo Rizzuto [Italie] ; Alberto Priori [Italie]Impaired heteronymous somatosensory motor cortical inhibition in dystonia
002432 Takeshi Morimoto [Japon, États-Unis] ; Takuro Shimbo [Japon] ; John E. Orav [États-Unis] ; Kunihiko Matsui [Japon] ; Masashi Goto [Japon] ; Manabu Takemura [Japon] ; Kenji Hira [États-Unis] ; Tsuguya Fukui [Japon]Impact of social functioning and vitality on preference for life in patients with Parkinson's disease
002433 Christopher G. Goetz [États-Unis] ; Kimberly Janko [États-Unis] ; Lucy Blasucci [États-Unis] ; Jean A. Jaglin [États-Unis]Impact of placebo assignment in clinical trials of Parkinson's disease
002434 John Hardy [États-Unis, Royaume-Uni]Impact of Genetic analysis on Parkinson's disease research
002436 Paul K. Morrish [Royaume-Uni]How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?
002437 Albert F. G. Leentjens [Pays-Bas] ; Marjan Van Den Akker [Pays-Bas] ; Job F. M. Metsemakers [Pays-Bas] ; Richel Lousberg [Pays-Bas] ; Frans R. J. Verhey [Pays-Bas]Higher incidence of depression preceding the onset of Parkinson's disease: A register study
002438 Melih Vural [Turquie] ; Sibel Özekmekci [Turquie] ; Hülya Apaydin [Turquie] ; Attila Altinel [Turquie]High-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy
002439 Anette Schrag [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Jennifer Davis [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Health-related quality of life in patients with progressive supranuclear palsy
002440 Peter Hagell [Suède] ; Diane Whalley [Royaume-Uni] ; Stephen P. Mckenna [Royaume-Uni] ; Olle Lindvall [Suède]Health status measurement in Parkinson's disease: Validity of the PDQ-39 and Nottingham Health profile
002444 John Yianni [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Nir Giladi [Israël] ; Marieta Auca [Israël] ; Ralph Gregory [Royaume-Uni] ; Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; John Stein [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit
002445 Stefan Evers [Allemagne] ; Florian Stögbauer [Allemagne]Genetic association of Huntington's disease and restless legs syndrome? A family report
002446 Marwan I. Hariz [Suède, Royaume-Uni]From functional neurosurgery to "interventional" neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001
002448 Neil Mahant [Australie] ; Dennis J. Cordato [Australie] ; Victor S. C. Fung [Australie]Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: Clinical and neurophysiological features
002449 William G. Ondo [États-Unis] ; Christine Hunter [États-Unis]Flumazenil, a GABA antagonist, may improve features of Parkinson's Disease
002451 Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mandar S. Jog [Canada]Fear of falling and postural control in Parkinson's disease
002452 Niall Quinn [Royaume-Uni] ; Mikko Kuoppam Ki [Royaume-Uni, Finlande]Fast micrographia and pallidal pathology
002454 Giovanni Defazio [Italie] ; Francesco Brancati [Italie] ; Enza Maria Valente [Italie] ; Viviana Caputo [Italie] ; Antonio Pizzuti [Italie] ; Davide Martino [Italie] ; Giovanni Abbruzzese [Italie] ; Paolo Livrea [Italie] ; Alfredo Berardelli [Italie] ; Bruno Dallapiccola [Italie]Familial Blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene
002455 Elan D. Louis [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis]Factors associated with increased risk of head tremor in essential tremor: A community-based study in northern Manhattan
002458 Richard B. Scott [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Sarah Banks [Royaume-Uni] ; Anna Turner [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Nir Giladi [Israël] ; Carol Joint [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Executive cognitive deficits in Primary dystonia
002459 Emma Mcintosh [Royaume-Uni] ; Alastair Gray [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease
002460 Simona Pigullo [Italie] ; Emilio Di Maria [Italie] ; Roberta Marchese [Italie] ; Emilia Bellone [Italie] ; Rossella Gulli [Italie] ; Cesa Scaglione [Italie] ; Stella Battaglia [Italie] ; Paolo Barone [Italie] ; Paolo Martinelli [Italie] ; Giovanni Abbruzzese [Italie] ; Franco Ajmar [Italie] ; Paola Mandich [Italie]Essential tremor is not associated with α-synuclein gene haplotypes
002461 Mark Edwards [Royaume-Uni] ; Geoffrey Schott [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni]Episodic focal lingual dystonic spasms
002463 Shinichi Matsumoto [Japon] ; Masataka Nishimura [Japon] ; Hiroshi Shibasaki [Japon] ; Ryuji Kaji [Japon]Epidemiology of primary dystonias in Japan: Comparison with western countries
002467 Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study
002468 Ryoichi Hayashi [Japon] ; Takao Hashimoto [Japon] ; Tsuyoshi Tada [Japon] ; Shu-Ichi Ikeda [Japon]Effects of unilateral pallidotomy on voluntary movement, and simple and choice reaction times in Parkinson's disease
002473 Kirsten E. Zeuner [États-Unis] ; Fiona M. Molloy [États-Unis] ; Richard O. Shoge [États-Unis] ; Susanne R. Goldstein [États-Unis] ; Robert Wesley [États-Unis] ; Mark Hallett [États-Unis]Effect of ethanol on the central oscillator in essential tremor
002474 Roberta Marchese [Italie] ; Marco Bove [Italie] ; Giovanni Abbruzzese [Italie]Effect of cognitive and motor tasks on postural stability in Parkinson's disease: A posturographic study
002477 Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest Tremor and UPDRS part III in Parkinson's disease
002478 Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie]Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of Drooling in parkinsonism
002479 Carsten Buhmann [Allemagne] ; Alexandra Bussopulos [Allemagne] ; Matthias Oechsner [Allemagne]Dopaminergic response in Parkinsonian phenotype of Machado-Joseph Disease
002480 George R. Uhl [États-Unis]Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism
002481 Paola P. Piccini [Royaume-Uni]Dopamine transporter: Basic aspects and neuroimaging
002482 Richard C. Dodel [Allemagne] ; Helmut Höffken [Allemagne] ; J. Carsten Möller [Allemagne] ; Bernhard Bornschein [Allemagne] ; Thomas Klockgether [Allemagne] ; Thomas Behr [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Uwe Siebert [États-Unis, Allemagne]Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach
002483 Eng-King Tan [Singapour] ; YANNI TAN [Singapour] ; Anthea Chai [Singapour] ; Christopher Tan [Singapour] ; HUI SHEN [Singapour] ; Sau-Ying Lum [Singapour] ; Stephanie M. C. Fook-Cheong [Singapour] ; Mei-Ling Teoh [Singapour] ; YUAN YIH [Singapour] ; Meng-Cheong Wong [Singapour] ; YI ZHAO [Singapour]Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease
002485 Gun-Marie Hariz [Suède] ; Margareta Lindberg [Suède] ; Marwan I. Hariz [Suède] ; A. Tommy Bergenheim [Suède]Does the ADL Part of the Unified Parkinson's Disease Rating Scale Measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation
002486 Craig Henson [Irlande (pays)] ; Hugh Staunton [Irlande (pays)] ; Francesca M. Brett [Irlande (pays)]Does ageing have an effect on midbrain premotor nuclei for vertical eye movements?
002487 Leslie Findley [Royaume-Uni] ; Manjit Aujla [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; Mary Baker [Royaume-Uni] ; Catherine Beech [Royaume-Uni] ; Clive Bowman [Royaume-Uni] ; Jeremy Holmes [Royaume-Uni] ; Wendy K. Kingdom [Royaume-Uni] ; Douglas G. Macmahon [Royaume-Uni] ; Viv Peto [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni]Direct economic impact of Parkinson's disease: A research survey in the United Kingdom
002488 Amy J. Bastian [États-Unis] ; Valerie E. Kelly [États-Unis] ; Fredy J. Revilla [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Jonathan W. Mink [États-Unis]Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's Disease
002489 Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] ; Carles Roig [Espagne] ; Berta Pascual-Sedano [Espagne] ; Antoni Rodriguez-Fornells [Allemagne] ; Pilar Otermin [Espagne]Diagnostic potential of acoustic startle reflex, acoustic blink reflex, and electro-oculography in progressive supranuclear palsy: A prospective study
002490 Keith A. Josephs [États-Unis] ; Dennis W. Dickson [États-Unis]Diagnostic accuracy of progressive supranuclear palsy in the society for Progressive Supranuclear Palsy Brain Bank
002491 Ruth H. Walker [États-Unis] ; P. Shashidharan [États-Unis]Developments in the molecular biology of DYT1 dystonia
002492 Mickie Welsh [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Robert G. Holloway [États-Unis] ; Sandy Plumb [États-Unis] ; Ronald Pfeiffer [États-Unis] ; Jean Hubble [États-Unis]Development and testing of the Parkinson's disease quality of life scale
002493 Durval C. Costa [Royaume-Uni, Portugal] ; Zuzana Walker [Royaume-Uni] ; Rodney W. H. Walker [Royaume-Uni] ; Flavia R. G. Fontes [Royaume-Uni]Dementia with Lewy bodies versus alzheimer's disease: Role of dopamine transporter imaging
002496 Patrice Peran [France] ; Olivier Rascol [France] ; Jean-Francois Demonet [France] ; Pierre Celsis [France] ; Jean-Luc Nespoulous [France] ; Bruno Dubois [France] ; Dominique Cardebat [France]Deficit of verb generation in nondemented patients with Parkinson's disease
002500 Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne]DAT imaging in drug-induced and psychogenic parkinsonism
002501 David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]Current treatment of Dementia with lewy bodies and Dementia associated with Parkinson's disease
002502 Anthony E. Lang [Canada]Corticobasal degeneration: Selected developments
002503 Naida L. Graham [Royaume-Uni] ; Thomas H. Bak ; John R. HodgesCorticobasal degeneration as a cognitive disorder
002504 Walter Pirker [Autriche]Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
002505 Nico J. Diederich [Luxembourg (pays), États-Unis] ; Vannina Pieri [Luxembourg (pays)] ; Christopher G. Goetz [États-Unis]Coping strategies for visual hallucinations in Parkinson's disease
002506 Demetrius M. Maraganore [États-Unis] ; Mariza De Andrade [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Matthew J. Farrer [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Complex interactions in Parkinson's disease: A two-phased approach
002507 Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Dryden Watner [États-Unis]Community-based data on associations of disease duration and age with severity of essential tremor: Implications for disease pathophysiology
002508 Pascal Grosse [Royaume-Uni, Allemagne] ; Andrea Kühn [Royaume-Uni, Allemagne] ; Carla Cordivari [Royaume-Uni] ; Peter Brown [Royaume-Uni]Coherence analysis in the myoclonus of corticobasal degeneration
002511 Maria J. Marti [Espagne] ; Eduardo Tolosa [Espagne] ; Jaume Campdelacreu [Espagne]Clinical overview of the synucleinopathies
002513 Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
002515 Walter Pirker [Autriche] ; Claude Back [Autriche] ; Willibald Gerschlager [Autriche] ; Franco Laccone [Allemagne] ; Francois Alesch [Autriche]Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2
002516 Saeed Bohlega [Arabie saoudite] ; Adel Al-Jishi [Bahreïn] ; Carol Dobson-Stone [Royaume-Uni] ; Luca Rampoldi [Royaume-Uni, Italie] ; Parthasarathi Saha [Arabie saoudite] ; Hatem Murad [Arabie saoudite] ; Abid Kareem [Arabie saoudite] ; George Roberts [Arabie saoudite] ; Anthony P. Monaco [Royaume-Uni]Chorea-acanthocytosis: Clinical and genetic findings in three families from the arabian peninsula
002517 David Mckee [Royaume-Uni] ; Paul Talbot [Royaume-Uni]Chorea as a presenting feature of variant Creutzfeldt-Jakob disease
002519 Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
002520 Björn Holmberg [Suède] ; Bo Johnels [Suède] ; Kaj Blennow [Suède] ; Lars Rosengren [Suède]Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
002522 Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Mariza De Andrade [États-Unis] ; James H. Bower [États-Unis] ; Dena Hernandez [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Case-control study of the α-synuclein interacting protein gene and Parkinson's disease
002525 Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada]Burden of parkinsonism: A population-based study
002527 A. K. M. Moinul Hossain [Japon] ; Yuji Murata [Japon] ; LIN ZHANG [Japon] ; Shin-Ichi Taura [Japon] ; Yukinobu Saitoh [Japon] ; Hidehiro Mizusawa [Japon] ; Kenji Oda [Japon] ; Eisuke Matsushima [Japon] ; Yoshiro Okubo [Japon] ; Hitoshi Shibuya [Japon]Brain perfusion SPECT in patients with corticobasal degeneration: Analysis using statistical parametric mapping
002529 Michela Barichella [Italie] ; Agnieszka M. Marczewska [Italie] ; Claudio Mariani [Italie] ; Andrea Landi [Italie] ; Antonella Vairo [Italie] ; Gianni Pezzoli [Italie]Body weight gain rate in patients with Parkinson's disease and deep brain stimulation
002533 Giuseppe Galardi [Italie] ; Silvestro Micera [Italie] ; Jacopo Carpaneto [Italie] ; Silvana Scolari [Italie] ; Massimo Gambini [Italie] ; Paolo Dario [Italie]Automated assessment of cervical dystonia
002536 Luis M. Barreiro De Madariaga [Argentine] ; José E. Sian [Argentine] ; Ignacio Casas Parera [Argentine] ; Federico Micheli [Argentine]Arm chorea secondary to an unruptured giant aneurysm
002537 Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni]Anatamopathological spectrum of tauopathies
002538 Enza-Maria Valente [Italie] ; Anjum Misbahuddin [Royaume-Uni] ; Francesco Brancati [Italie] ; Mark R. Placzek [Royaume-Uni] ; Barbara Garavaglia [Italie] ; Sergio Salvi [Italie] ; Andrea Nemeth [Royaume-Uni] ; Charles Shaw-Smith [Royaume-Uni] ; Nardo Nardocci [Italie] ; Anna-Rita Bentivoglio [Italie] ; Alfredo Berardelli [Italie] ; Roberto Eleopra [Italie] ; Bruno Dallapiccola [Italie] ; Thomas T. Warner [Royaume-Uni]Analysis of the ∈-sarcoglycan gene in familial and sporadic myoclonus-dystonia: Evidence for genetic heterogeneity
002539 Georg Ebersbach [Allemagne]An artist's view of drug-induced hallucinosis
002540 Ronald D. Chervin [États-Unis] ; Flavia B. Consens [États-Unis] ; Ekrem Kutluay [États-Unis]Alternating leg muscle activation during sleep and arousals: A new sleep-related motor phenomenon?
002542 Graham T. A. Warner [Royaume-Uni] ; John H. Mcauley [Royaume-Uni]Alcohol-induced paroxysmal nonkinesogenic dyskinesia after pallidal hypoxic insult
002543 Christian Prueter [Allemagne] ; Benedikt Habermeyer [Allemagne] ; Christine Norra [Allemagne] ; Christoph M. Kosinski [Allemagne]Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease
002545 Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Nadège Van Blercom [France] ; JING XIE [France] ; Elena Moro [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease
002546 Renato P. Munhoz [Canada] ; Ritsuko Hanajima [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada]Acute effect of transcutaneous electrical nerve stimulation on Tremor
002547 Stefano Tamburin [Italie] ; Antonio Fiaschi [Italie] ; Domenico Idone [Italie] ; Piergiorgio Lochner [Italie] ; Paolo Manganotti [Italie] ; Giampietro Zanette [Italie]Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: A TMS study
002548 John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Donald J. Connor [États-Unis] ; Jose L. Hernandez [États-Unis] ; Terrence D. Lagerlund [États-Unis]Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease
002549 Stephen Butterworth [Royaume-Uni] ; Sue Francis [Royaume-Uni] ; Edward Kelly [États-Unis] ; Francis Mcglone [Royaume-Uni] ; Richard Bowtell [Royaume-Uni] ; Guy V. Sawle [Royaume-Uni]Abnormal cortical sensory activation in dystonia: An fMRI study
002550 Philippe Le Cavorzin [France] ; Guy Carrault [France] ; Francis Chagneau [France] ; Pierre Rochcongar [France] ; Hervé Allain [France]A computer model of rigidity and related motor dysfunction in Parkinson's disease
002551 Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon]0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's Disease
002552 Second European meeting on brain stem reflexes, functions, and related movement disorders, Amsterdam, The Netherlands, April 2001
002553 Management of Parkinson's disease: an evidence-based review
002554 Deep Brain Stimulation for Movement Disorders
002555 Abstracts of the Seventh International Congress of Parkinson's Disease and "Movement" Disorders, November 10-14, 2002, Miami, Florida, USA
002560 Egon Stenager [Danemark] ; Michael Binzer [Danemark]Woman with facial spasm induced exclusively by sound
002561 Thomas Brandt [Allemagne] ; Stefan Glasauer [Allemagne] ; Marianne Dieterich [Allemagne]Vestibular brainstem disorders: Clinical syndromes in roll plane and their model simulation
002563 Francisco Escamilla-Sevilla [Espagne] ; Adolfo Minguez-Castellanos [Espagne] ; Ventura Arjona-Moron [Espagne] ; Jose Maria Martin-Linares [Espagne] ; Juan Carlos Sanchez-Alvarez [Espagne] ; Angel Ortega-Morenoa [Espagne] ; Teresa Garcia-Gomez [Espagne]Unilateral pallidal stimulation for segmental cervical and truncal dystonia: Which side?
002564 Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silbum [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni]Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients
002566 Esmaeil Nikfekr [Royaume-Uni] ; Kathleen Kerr [Royaume-Uni] ; Steve Attfield [Royaume-Uni] ; Diane E. Playford [Royaume-Uni]Trunk movement in Parkinson's disease during rising from seated position
002567 Hanns C. Hopf [Allemagne]Trigeminal reflexes
002568 Jens Ellrich [Allemagne]Trigeminal nociceptive reflexes
002569 Georgio Cruccu [Italie] ; Francesca Galeotti [Italie] ; Gian D. Iannetti [Italie] ; Antonietta Romaniello [Italie, Danemark] ; Andrea Truini [Italie] ; Mario Manfredi [Italie]Trigeminal neuralgia: Update on reflex and evoked potential studies
002571 Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France]Treatment results: Parkinson's disease
002573 Manavdeep Grewal [Canada] ; Raed Hawa [Canada] ; Colin Shapiro [Canada]Treatment of periodic limb movements in sleep with selegiline HCl
002574 Treatment of depression in idiopathic Parkinson's disease
002575 Kin-Lun Tsang [Hong Kong] ; Iris Chi [Hong Kong] ; Shu-Leong Ho [Hong Kong] ; Vivian Weiqun Lou [Hong Kong] ; Tatia M. C. Lee [Hong Kong] ; Leung-Wing Chu [Hong Kong]Translation and validation of the standard Chinese version of PQD-39: A quality-of-life measure for patients with Parkinson's disease
002576 Luigi Michele Romito [Italie] ; Michele Raja [Italie] ; Antonio Daniele [Italie] ; Maria Fiorella Contarino [Italie] ; Anna Rita Bentivoglio [Italie] ; Annalisa Barbier [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie]Transient mania with hypersexuality after surgery for high-frequency stimulation of the subthalamic nucleus in Parkinson's disease
002577 Annie Lannuzel [France] ; Patrick P. Michel [France] ; Dominique Caparros-Lefebvre [France] ; Jacqueline Abaul [France] ; Reynald Hocquemiller [France] ; Merle Ruberg [France]Toxicity of annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe
002580 Peter Brown [Royaume-Uni]The startle syndrome
002581 Tamar C. Rubinstein [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis]The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease
002586 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Lucas Kempf [États-Unis] ; Steven B. Wilkinson [États-Unis] ; William C. Koller [États-Unis]Thalamic stimulation for midbrain tremor after partial hemangioma resection
002588 Andrew Feigin [États-Unis] ; Angelo Antonini [Italie] ; Masafumi Fukuda [États-Unis] ; Roberta De Notaris [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Marc J. Mentis [États-Unis] ; James R. Moeller [États-Unis] ; David Eidelberg [États-Unis]Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of Parkinsonism
002591 Katherine H. O. Deane [Royaume-Uni] ; Caroline Ellis-Hill [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni]Systematic review of paramedical therapies for Parkinson's disease
002592 Claudia Ramaker [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne Margarethe Stiggelbout [Pays-Bas] ; Bob Johannes Van Hilten [Pays-Bas]Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
002593 Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong]Switching of movement direction is central to parkinsonian bradykinesia in sit-to-stand
002594 Dryden Watner [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Elan D. Louis [États-Unis]Survey of essential tremor patients on their knowledge about the genetics of the disease
002595 Surgical treatment for Parkinson's disease: Neural transplantation
002596 Surgical treatment for Parkinson's disease: Deep brain surgery
002597 Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis]Surgery of the motor thalamus: Problems with the present nomenclatures
002599 Kenneth B. Baker [États-Unis] ; Erwin B. Jr Montgomery [États-Unis] ; Ali R. Rezai [États-Unis] ; Richard Burgess [États-Unis] ; Hans O. Lüders [États-Unis]Subthalamic nucleus deep brain stimulus evoked potentials: Physiological and therapeutic implications
002600 H. Christopher Hyson [Canada] ; Andrew M. Johnson [Canada] ; Mandar S. Jog [Canada]Sublingual atropine for sialorrhea secondary to parkinsonism: A pilot study
002602 Hans-Michael Meinck [Allemagne] ; Philip D. Thompson [Australie]Stiff man syndrome and related conditions
002603 Johannes D. Speelman [Pays-Bas] ; Richard Schuurman [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas]Stereotactic neurosurgery for tremor
002604 Hidehiro Hirabayashi [Japon] ; Magnus Tengvar [Suède] ; Marwan I. Hariz [Suède]Stereotactic imaging of the pallidal target
002606 Blas Morales [Espagne] ; Armando Martinez [Espagne] ; Isabel Gonzalo [Espagne] ; Lidice Vidal [Espagne] ; Raquel Ros [Espagne] ; Estrella Gomez-Tortosa [Espagne] ; Alberto Rabano [Espagne] ; Israel Ampuero [Espagne] ; Marina Sanchez [Espagne] ; Janet Hoenicka [Espagne] ; Justo Garcia De Yebenes [Espagne]Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein
002608 Speech therapy in Parkinson's disease
002609 John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Thomas G. Beach [États-Unis] ; Kristi L. Wetjen [États-Unis] ; Richard J. Caselli [États-Unis]Small-amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations
002611 Antoon De Laat [Belgique] ; Giudo M. Macaluso [Italie]Sleep bruxism as a motor disorder
002614 Eric K. Richfield [États-Unis] ; Jean-Paul Vonsattel [États-Unis] ; Marcy E. Macdonald [États-Unis] ; ZHIQIANG SUN [États-Unis] ; Yun-Ping P. Deng [États-Unis] ; Anton Reiner [États-Unis]Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease
002615 Virginia Macdonald [Australie] ; Glenda M. Halliday [Australie]Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease
002616 Jaishri Blakeley [États-Unis] ; Joseph Jankovic [États-Unis]Secondary paroxysmal dyskinesias
002617 Brad A. Racette [États-Unis] ; Mikula Stambuk [États-Unis] ; Joel S. Perlmutter [États-Unis]Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024)
002619 J. C. Rothwell [Royaume-Uni] ; C. D. Mackinnon [Royaume-Uni] ; J. Valls-Sole [Royaume-Uni]Role of brainstem-spinal projections in voluntary movement
002623 Laurent Vercueil [France] ; Paul Krack [France] ; Pierre Pollak [France]Results of deep brain stimulation for dystonia: A critical reappraisal
002624 Peter Hagell [Suède] ; Sara Nordling [Suède] ; Jan Reimer [Suède] ; Martin Grabowski [Suède] ; Ulf Persson [Suède]Resource use and costs in a Swedish cohort of patients with Parkinson's disease
002627 Roger A. Barker [Royaume-Uni]Repairing the brain in Parkinson's disease: Where next?
002628 Didier Flament [États-Unis] ; Mark B. Shapiro [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Charity G. Moore [États-Unis] ; Richard D. Penn [États-Unis] ; Daniel M. Corcos [États-Unis]Reaction time is not impaired by stimulation of the ventral-intermediate nucleus of the thalamus (Vim) in patients with tremor
002629 Padraig O'Suilleabhain [États-Unis] ; Richard B. Jr Dewey [États-Unis]Randomized trial comparing primidone initiation schedules for treating essential tremor
002631 Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's Disease
002632 Joseph O'Neill [États-Unis] ; Norbert Schuff [États-Unis] ; William J. Jr Marks [États-Unis] ; Robert Feiwell [États-Unis] ; Michael J. Aminoff [États-Unis] ; Michael W. Weiner [États-Unis]Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease
002634 Willibald Gerschlager [Royaume-Uni, Autriche] ; Anette Schrag [Royaume-Uni] ; Peter Brown [Royaume-Uni]Quality of life in stiff-person syndrome
002635 Psychosocial counseling in Parkinson's disease
002636 Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada]Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
002637 Mikko Kuoppam Ki [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Progressive delayed-onset dystonia after cerebral anoxic insult in adults
002639 Marie Sarazin [France] ; Bernard Deweer [France] ; Angela Merkl [France] ; Natalia Von Poser [France] ; Bernard Pillon [France] ; Bruno Dubois [France]Procedural learning and striatofrontal dysfunction in Parkinson's disease
002640 Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Byron A. Kakulas [Australie]Prevalence of stroke in Parkinson's disease: A postmortem study
002641 Luis Erik Claveria [Espagne] ; Jacinto Duarte [Espagne] ; Maria Dolores Sevillano [Espagne] ; Angel Perez-Sempere [Espagne] ; Carmen Cabezas [Espagne] ; Fernanda Rodriguez [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède]Prevalence of Parkinson's disease in Cantalejo, Spain: A door-to-door survey
002643 Joseph H. Friedman [États-Unis]Presumed rapid eye movement behavior disorder in Machado-Joseph disease (Spinocerebellar ataxia type 3)
002644 Ann L. Smiley-Oyen [États-Unis] ; Charles J. Worringham [Australie] ; Carol L. Cross [États-Unis]Practice effects in three-dimensional sequential rapid aiming in Parkinson's disease
002646 Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Jan Booij [Pays-Bas] ; Jaap Valk [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Martin Horstink [Pays-Bas]Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway
002647 Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
002648 Patricia Dowsey-Limousin [Royaume-Uni]Postoperative management of Vim DBS for tremor
002652 Pauline L. Lee [États-Unis] ; Terri Gelbart [États-Unis] ; Carol West [États-Unis] ; Carol Halloran [États-Unis] ; Jack C. Sipe [États-Unis] ; Ernest Beutler [États-Unis]Polymorphisms in iron-responsive binding protein 2 and lack of association with sporadic Parkinson's disease
002653 Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Rema Raman [États-Unis]Placebo-associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease
002655 Cumhur Ertekin [Turquie]Physiological and pathological aspects of oropharyngeal swallowing
002656 Physical and occupational therapy in Parkinson's disease
002657 Anna Rita Bentivoglio [Italie] ; Mario Loi [Italie] ; Enza M. Valente [Italie] ; Tamara Ialongo [Italie] ; Pietro Tonali [Italie] ; Alberto Albanese [Italie]Phenotypic variability of DYTI-PTD: Does the clinical spectrum include psychogenic dystonia?
002658 Virgilio Gerald H. Evidente [États-Unis, Philippines] ; Joel Advincula [Philippines] ; Raymund Esteban [Philippines] ; Paul Pasco [Philippines] ; Jhoe Anthony Alfon [Philippines] ; Filipinas F. Natividad [Philippines] ; Joven Cuanang [Philippines] ; Amado San Luis [Philippines] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Dena Hernandez [États-Unis] ; Andrew Singleton [États-Unis]Phenomenology of "Lubag" or X-linked dystonia-parkinsonism
002659 Günther Deuschl [Allemagne] ; Hagai Bergman [Israël]Pathophysiology of nonparkinsonian tremors
002660 Jerrold L. Vitek [États-Unis]Pathophysiology of dystonia: A neuronal model
002661 Hagai Bergman [Israël] ; Günther Deuschl [Allemagne]Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
002662 Alfredo Berardelli [Italie] ; Antonio Curra [Italie]Pathophysiology and treatment of cranial dystonia
002665 Irene Hegeman Richard [États-Unis] ; Michelle Papka [États-Unis] ; Ana Rubio [États-Unis] ; Roger Kurlan [États-Unis]Parkinson's disease and dementia with Lewy bodies: One disease or two?
002669 Stéphanie Thobois [France] ; Pierric Giraud [France] ; Pierre Debat [France] ; Michel Gouttard [France] ; Anne Maurizi [France] ; Armand Perret-Liaudet [France] ; Nicolas Kopp [France] ; Emmanuel Broussolle [France]Orofacial dyskinesias in a patient with primary biliary cirrhosis: A clinicopathological case report and review
002670 Lo Bour [Pays-Bas] ; Bram Ongerboer De Visser [Pays-Bas] ; Majid Aramideh [Pays-Bas] ; Johannes Speelman [Pays-Bas]Origin of eye and eyelid movements during blinking
002671 Ruth Djaldetti [Israël] ; Rivkah Inzelberg [Israël] ; Nir Giladi [Israël] ; Amos D. Korczyn [Israël] ; Yehudit Peretz-Aharon [Israël] ; Martin J. Rahey [Israël] ; Yuval Herishano [Israël] ; Silvia Honigman [Israël] ; Sami Badarny [Israël] ; Eldad Melamed [Israël]Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease
002672 William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]Olanzapine treatment for dopaminergic-induced hallucinations
002674 Adriano Jimenez-Escrig [Espagne] ; Juan M. San-Millan [Espagne] ; Manuel Baron [Espagne]Oculo-auricular phenomenon secondary to vestibular dysfunction
002678 J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Neurosurgical treatment modalities in Parkinson's disease
002679 Bernard Pillon [France]Neuropsychological assessment for management of patients with deep brain stimulation
002681 Nicola Modugno [Italie] ; Yusaku Nakamura [Italie] ; Sven Bestmann [Royaume-Uni] ; Antonio Curra [Italie] ; Alfredo Berardelli [Italie] ; John Rothwell [Italie, Royaume-Uni]Neurophysiological investigations in patients with primary writing tremor
002682 José M. Delgado-Garcia [Espagne] ; Agnès Gruart [Espagne] ; Alejandro Munera [Espagne]Neural organization of eyelid responses
002683 Aman Badhwar [Canada] ; Auli Siren [Canada] ; Eva Andermann [Canada] ; Frederick Andermann [Canada]Myoclonic status epilepticus: Video presentation
002686 Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease
002688 Hans Brunner [Allemagne] ; Thomas C. Wetter [Allemagne] ; Birgit Hoegl [Allemagne] ; Alexander Yassouridis [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Elisabeth Friess [Allemagne] ; MD [Allemagne]Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment
002690 Andres M. Lozano [Canada] ; William D. Hutchison [Canada]Microelectrode recordings in the pallidum
002691 Jong-Hoon Kim [Corée du Sud] ; HEE YEON JUNG [Corée du Sud] ; UNG GU KANG [Corée du Sud] ; SEONG HOON JEONG [Corée du Sud] ; YONG MIN AHN [Corée du Sud] ; Hee-Jung Byun [Corée du Sud] ; Kyoo-Seob Ha [Corée du Sud] ; YONG SIK KIM [Corée du Sud]Metric characteristics of the Drug-Induced extrapyramidal Symptoms Scale (DIEPSS): A practical combined rating Scale for drug-induced movement disorders
002692 Rajeev Kumar [États-Unis]Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia
002693 Gilberto Levy [États-Unis] ; Diane M. Jacobs [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]Memory and executive function impairment predict dementia in Parkinson's disease
002694 Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada]Mechanisms of deep brain stimulation
002695 Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France]Mechanisms of deep brain stimulation
002696 Jerrold L. Vitek [États-Unis]Mechanisms of deep brain stimulation: Excitation or inhibition
002697 Peter Svensson [Danemark]Masseter reflexes modulated by pain
002699 Charles Majoie [Pays-Bas]Magnetic resonance imaging of the brainstem and cranial nerves III-VII
002700 MAO-B inhibitors for the treatment of Parkinson's disease
002702 G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A.-L. Lafontaine [Canada] ; O. Suchowersky [Canada]Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
002703 Juliane Winkelmann [Allemagne] ; Anette Stautner [Allemagne] ; Walter Samtleben [Allemagne] ; Claudia Trenkwalder [Allemagne]Long-term course of Restless legs syndrome in dialysis patients after kidney transplantation
002705 Levodopa
002709 Jong-Min Kim [Corée du Sud] ; KI HYEONG LEE [Corée du Sud] ; Yoon-La Choi [Corée du Sud] ; GI YEONG CHOE [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy
002713 David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada]Large French-Canadian family with Lewy body parkinsonism: Exclusion of known loci
002715 André Parent [Canada]Jules Bernard Luys and the subthalamic nucleus
002716 Paul Morrish [Royaume-Uni]Is it time to abandon functional imaging in the study of neuroprotection?
002717 Kevin C. Brennan [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Blair Ford [États-Unis] ; Seth L. Pullman [États-Unis] ; Elan D. Louis [États-Unis]Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study
002718 XUGUANG LIU [Royaume-Uni] ; Ivan C. Griffin [Royaume-Uni] ; Simon G. Parkin [Royaume-Uni] ; R. Christopher Miall [Royaume-Uni] ; Jeremy G. Rowe [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard B. Scott [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; John F. Stein [Royaume-Uni]Involvement of the medial pallidum in focal myoclonic dystonia: A clinical and neurophysiological case study
002719 Jens Volkmann [Allemagne] ; Jan Herzog [Allemagne] ; Florian Kopper [Allemagne] ; Güntner Deuschl [Allemagne]Introduction to the programming of deep brain stimulators
002721 Abdelhamid Benazzouz [France] ; Sorin Breit [France] ; Adnan Koudsie [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Alim-Louis Benabid [France]Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease
002722 Ira M. Garonzik [États-Unis] ; Sherwin E. Hua [États-Unis] ; Shinji Ohara [États-Unis] ; Frederick A. Lenz [États-Unis]Intraoperative microelectrode and semi-microelectrode recording during the physiological localization of the thalamic nucleus ventral intermediate
002723 Pierre Pollak [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Elena Moro [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France]Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease
002724 Puneet Opal [États-Unis] ; Ron Tintner [États-Unis] ; Joseph Jankovic [États-Unis] ; Joanne Leung [États-Unis] ; Xandra O. Breakefield [États-Unis] ; Jennifer Friedman [États-Unis] ; Laurie Ozelius [États-Unis]Intrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic storm
002726 Martin Sommer [Allemagne] ; Diane Ruge [Allemagne] ; Frithjof Tergau [Allemagne] ; Wolfgang Beuche [Allemagne] ; Eckart Altenmüller [Allemagne] ; Walter Paulus [Allemagne]Intracortical excitability in the hand motor representation in hand dystonia and blepharospasm
002731 Laura Camfield [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Impact of cervical dystonia on quality of life
002732 Alim-Louis Benabid [France] ; Adnan Koudsie [France] ; Abdelhamid Benazzouz [France] ; Jean-Francois Le Bas [France] ; Pierre Pollak [France]Imaging of subthalamic nucleus and ventralis intermedius of the thalamus
002734 Hélio A. G. Teive [Brésil] ; Alessandra Zanatta [Brésil] ; Francisco M. B. Germiniani [Brésil] ; Sérgio M. Almeida [Brésil] ; Lineu C. Werneck [Brésil]Holmes' tremor and neuroparacoccidioidomycosis: A case report
002735 David A. Grimes [Canada] ; Fabin Han [Canada] ; Dennise Bulman [Canada] ; Mary Lou Nicolson [Canada] ; Oksana Suchowersky [Canada]Hereditary chin trembling: A new family with exclusion of the chromosome 9q13-q21 locus
002737 Yoon-Ho Hong [Corée du Sud] ; Tae-Beom Ahn [Corée du Sud] ; Chang Wan Oh [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Hemichorea as an initial manifestation of moyamoya disease: Reversible striatal hypoperfusion demonstrated on single photon emission computed tomography
002738 Chiung-Chu Chen [Taïwan] ; Shih-Tseng Lee [Taïwan] ; Tony Wu [Taïwan] ; Chi-Jen Chen [Taïwan] ; Chin-Chang Huang [Taïwan] ; Chin-Song Lu [Taïwan]Hemiballism after subthalamotomy in patients with Parkinson's disease: Report of 2 cases
002740 Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Hardware-related problems of deep brain stimulation
002742 Katrina Gwinn-Hardy [États-Unis]Genetics of parkinsonism
002743 Sian D. Spacey [Royaume-Uni, Canada] ; Enza-Maria Valente [Royaume-Uni, Italie] ; Gurusidheshwar M. Wali [Inde] ; Thomas T. Warner [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Peter H. Dixon [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni]Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: Evidence for a third EKD gene
002745 Pau Pastor [Espagne] ; Mario Ezquerra [Espagne] ; Eduardo Tolosa [Espagne] ; Esteban Munoz [Espagne] ; Maria José Marti [Espagne] ; Francesc Valldeoriola [Espagne] ; José Luis Molinuevo [Espagne] ; Matilde Calopa [Espagne] ; Rafael Oliva [Espagne]Further extension of the H1 haplotype associated with progressive supranuclear palsy
002746 Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Olof Sydow [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède]Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease
002747 Michael H. Barnett [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Further case of paroxysmal exercise-induced dystonia and some insights into pathogenesis
002748 J. Yelnik [France]Functional anatomy of the basal ganglia
002750 Giovanna Zorzi [Italie] ; Barbara Garavaglia [Italie] ; Federica Invernizzi [Italie] ; Floriano Girotti [Italie] ; Paola Soliveri [Italie] ; Massimo Zeviani [Italie] ; Lucia Angelini [Italie] ; Nardo Nardocci [Italie]Frequency of DYT1 mutation in early-onset primary dystonia in Italian patients
002751 Alain Lagueny [France] ; Pierre Burbaud [France] ; Jean Louis Dubos [France] ; Gwendel Le Masson [France] ; Dominique Guelh [France] ; Frederic Macia [France] ; Corinne Debras [France] ; Francois Tison [France]Freezing of shoulder flexion impeding boule throwing: A form of task-specific focal dystonia in petanque players
002752 Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Nadia Stefanova [Autriche] ; Werner Poewe [Autriche] ; Irene Litvan [États-Unis] ; Gregor K. Wenning [Autriche]Freezing of gait in postmortem-confirmed atypical parkinsonism
002755 Mark A. Hellmann [Israël] ; Eldad Melamed [Israël]Focal dystonia as the presenting sign in Creutzfeldt-Jakob disease
002756 Maria Dolores Sevillano [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède] ; Jacinto Duarte [Espagne] ; Luis Erik Claveria [Espagne]Field validation of a method for population screening of parkinsonism
002757 Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France]Fetal neural grafts for Huntington's disease: A prospective view
002758 Giuseppe Nicoletti [Italie] ; Grazia Annesi [Italie] ; Sara Carrideo [Italie] ; Carmine Tomaino [Italie] ; Alfonso Di Costanzo [Italie] ; Mario Zappia [Italie] ; Aldo Quattrone [Italie]Familial essential tremor is not associated with SCA-12 mutation in Southern Italy
002759 Thomas D. Bird [États-Unis]Familial dyskinesia and facial myokymia
002761 Josep Valls-Sole [Espagne]Facial palsy, postparalytic facial syndrome, and hemifacial spasm
002762 Tricia M. Zawacki [États-Unis] ; Janet Grace [États-Unis] ; Joseph H. Friedman [États-Unis] ; Lewis Sudarsky [États-Unis]Executive and emotional dysfunction in Machado-Joseph disease
002763 Giovanni Fabbrini [Italie] ; Piero Barbanti [Italie] ; Cinzia Aurilia [Italie] ; Nicola Vanacore [Italie] ; Caterina Pauletti [Italie] ; Giuseppe Meco [Italie]Excessive daytime sleepiness in de novo and treated Parkinson's disease
002765 J. Carsten Moller [Allemagne] ; Karin Stiasny [Allemagne] ; Volker Hargutt [Allemagne] ; Werner Cassel [Allemagne] ; Heiko Tietze [Allemagne] ; J. Hermann Peter [Allemagne] ; H.-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne]Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: A pilot study
002766 S. H. Subramony [États-Unis] ; Dena Hernandez [États-Unis] ; Amanda Adam [États-Unis] ; Stephanie Smith-Jefferson [États-Unis] ; Jennifer Hussey [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Timothy Lynch [États-Unis, Irlande (pays)] ; Olga Mcdaniel [États-Unis] ; John Hardy [États-Unis, Royaume-Uni] ; Matt Farrer [États-Unis] ; Andrew Singleton [États-Unis]Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians
002767 Joseph Jankovic [États-Unis]Essential tremor: A heterogenous disorder
002768 Rodger J. Elble [États-Unis]Essential tremor is a monosymptomatic disorder
002769 Giovanni Defazio [Italie] ; Paolo Livrea [Italie]Epidemiology of primary blepharospasm
002770 Alexander Fisher [Australie] ; James Croft-Baker [Australie] ; Michael Davis [Australie] ; Patrick Purcell [Australie] ; Allan J. Mclean [Australie]Entacapone-induced hepatotoxicity and hepatic dysfunction
002771 Ashfaq A. Sharif [États-Unis]Entacapone in restless legs syndrome
002773 Gert Holstege [Pays-Bas]Emotional innervation of facial musculature
002774 Cumhur Ertekin [Turquie] ; Sultan Tarlaci [Turquie] ; Ibrahim Aydogdu [Turquie] ; Nefati Kiylioglu [Turquie] ; Nur Yuceyar [Turquie] ; A. Bulent Turman [Australie] ; Yaprak Secil [Turquie] ; Figen Esmeli [Turquie]Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease
002780 Julie A. Robichaud [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis]Effect of medication on EMG patterns in individuals with Parkinson's disease
002781 Katherine A. Johnson [Australie] ; Ross Cunnington [Australie, Royaume-Uni] ; John L. Bradshaw [Australie] ; Edmond Chiu [Australie] ; Robert Iansek [Australie]Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease
002783 Carla Cordivari [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Peter Brown [Royaume-Uni]EMG-EMG coherence in writer's cramp
002787 Drugs to treat urinary frequency, urgency, and/or urge incontinence
002788 Drugs to treat gastrointestinal motility problems
002789 Drugs to treat dementia and psychosis
002790 Drugs to treat autonomic dysfunction in Parkinson's disease
002792 Oleh Hornykiewicz [Autriche]Dopamine miracle: From brain homogenate to dopamine replacement
002793 Monica J. Ling [Australie] ; Arun Aggarwal [Australie] ; John G. L. Morris [Australie]Dopa-responsive parkinsonism secondary to right temporal lobe haemorrhage
002794 Chin-Song Lu [Taïwan] ; Yah-Huei Wu Chou [Taïwan] ; Tzu-Chen Yen [Taïwan] ; Chon-Haw Tsai [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Hsiu-Chen Chang [Taïwan]Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2
002795 Bettina Schrader [Allemagne] ; Wolfgang Hamel [Allemagne] ; Dieter Weinert [Allemagne] ; H. Maximilian Mehdorn [Allemagne]Documentation of electrode localization
002796 Gilberto Levy [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]Do risk factors for Alzheimer's Disease predict dementia in Parkinson's disease? An exploratory study
002799 EUN AH LEE [Corée du Sud] ; B. Joon Kim [Corée du Sud] ; WON YONG LEE [Corée du Sud]Diagnosing multiple system atrophy with greater accuracy: Combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography
002801 Marina A. J. Tijssen [Royaume-Uni, Pays-Bas] ; Alex Münchau [Royaume-Uni] ; John F. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Peter Brown [Royaume-Uni]Descending control of muscles in patients with cervical dystonia
002802 Paresh K. Doshi [Inde] ; Niraj Chhaya [Inde] ; Mohit H. Bhatt [Inde]Depression leading to attempted suicide after bilateral Subthalamic nucleus stimulation for Parkinson's disease
002803 Michele Tinazzi [Italie] ; Antonio Fiaschi [Italie] ; Emma Frasson [Italie] ; Mirta Fiorio [Italie] ; Feliciana Cortese [Italie] ; Salvatore M. Aglioti [Italie]Deficits of temporal discrimination in dystonia are independent from the spatial distance between the loci of tactile stimulation
002804 Günther Deuschl [Allemagne] ; Peter Bain [Royaume-Uni]Deep brain stimulation for trauma: Patient selection and evaluation
002805 Jens Volkmann [Allemagne] ; Reiner Benecke [Allemagne]Deep brain stimulation for dystonia: Patient selection and evaluation
002806 Anthony E. Lang [Canada] ; Hakan Widner [Suède]Deep brain stimulation for Parkinson's disease: Patient selection and evaluation
002807 Diego Garcia-Borreguero [Espagne] ; Ana B. Caminero [Espagne] ; Yolanda De La Llave [Espagne] ; Oscar Larrosa [Espagne] ; Soledad Barrio [Espagne] ; Juan J. Granizo [Espagne] ; Juan A. Pareja [Espagne]Decreased phasic EMG activity during Rapid eye movement sleep in treatment-naïve Parkinson's disease: Effects of treatment with levodopa and progression of illness
002808 DA agonists: ergot derivatives: Bromocriptine
002809 DA agonists: Non-Ergot derivatives: Ropinirole
002810 DA agonists: Non-Ergot derivatives: Pramipexole
002811 DA agonists: Non-Ergot derivatives: Piribedil
002812 DA agonists: Non-Ergot derivatives: Apomorphine
002813 DA agonists: Ergot derivatives: Pergolide
002814 DA agonists: Ergot derivatives: Lisuride
002815 DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC)
002816 DA agonists: Ergot derivatives: Cabergoline
002818 Mark Hallett [États-Unis]Cortical control of brainstem motor systems
002819 Christoph Pohl [Allemagne] ; Jörg Happe [Allemagne] ; Thomas Klockgether [Allemagne]Cooling improves the writing performance of patients with writer's cramp
002821 Marwan I. Hariz [Suède]Complications of deep brain stimulation surgery
002822 Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
002823 Joanna Seniow [Pologne] ; Thomas Bak [Royaume-Uni] ; Jolanta Gajda [Pologne] ; Renata Poniatowska [Pologne] ; Anna Czlonkowska [Pologne]Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease
002824 Anne Thiriaux [France] ; Anne De St Martin [France] ; Laurent Vercueil [France] ; Fabrice Battaglia [France] ; Jean-Paul Armspach [France] ; Edouard Hirsch [France] ; Christian Marescaux [France] ; Izzie J. Namer [France]Co-occurrence of infantile epileptic seizures and childhood paroxysmal choreoathetosis in one family: Clinical, EEG, and SPECT characterization of episodic events
002825 Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis]Clozapine withdrawal symptoms in a Parkinson's disease patient
002826 Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]Clinical-pathological study of levodopa complications
002827 Valeria Isella [Italie] ; Paola Melzi [Italie] ; Marco Grimaldi [Italie] ; Simona Iurlaro [Italie] ; Roberto Piolti [Italie] ; Carlo Ferrarese [Italie] ; Lodovico Frattola [Italie] ; Ildebrando Appollonio [Italie]Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease
002828 Ruey-Meei Wu [Taïwan] ; Din-E Shan [Taïwan] ; Chen-Ming Sun [Taïwan] ; Ren-Shyan Liu [Taïwan] ; Wuh-Liang Hwu [Taïwan] ; Chun-Hwei Tai [Taïwan] ; Jennifer Hussey [États-Unis] ; Andrew West [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Judy Chen [États-Unis] ; Matt Farrer [États-Unis] ; Sarah Lincoln [États-Unis]Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations
002829 Günther Deuschl [Allemagne] ; Henrik Wilms [Allemagne]Clinical spectrum and physiology of palatal tremor
002830 Jean-Pascal Lefaucheur [France] ; Anne-Catherine Bachoud-Levi [France] ; Catherine Bourdet [France] ; Thierry Grandmougin [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Jean-Denis Degos [France] ; Marc Peschanski [France] ; Fabrice Lisovoski [France]Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease
002831 James H. Bower [États-Unis] ; Dennis W. Dickson [États-Unis] ; Laura Taylor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis]Clinical correlates of the pathology underlying parkinsonism: A population perspective
002836 John L. Goudreau [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Andrew B. Singleton [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease
002838 Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]Cabergoline plasma concentration is increased during concomitant treatment with itraconazole
002839 COMT inhibitors
002840 Dipankar Nandi [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; XUGUANG LIU [Royaume-Uni] ; John F. Stein [Royaume-Uni]Brainstem motor loops in the control of movement
002846 John D. O'Sullivan [Royaume-Uni] ; John Rothwell [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Peter Brown [Royaume-Uni]Bilaterally coherent tremor resembling enhanced physiological tremor: Report of three cases
002848 Pablo Martinez-Martin [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Manuela Pilleri [Espagne] ; José Luis Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne]Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease
002850 David J. Burn [Royaume-Uni]Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease
002852 Peter C. G. Nijssen [Pays-Bas] ; Esther Brusse [Pays-Bas] ; Antonius C. M. Leyten [Pays-Bas] ; J. J. Martin [Belgique] ; Johannes L. J. M. Teepen [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas]Autosomal dominant adult neuronal ceroid lipofuscinosis: Parkinsonism due to both striatal and nigral dysfunction
002853 John G. L. Morris [Australie] ; Padraic Grattan-Smith [Australie] ; Stacey K. Jankelowitz [Australie] ; Victor S. C. Fung [Australie] ; Paul D. Clouston [Australie] ; Michael W. Hayes [Australie]Athetosis. II: The syndrome of mild athetoid cerebral palsy
002854 John G. L. Morris [Australie] ; Stacey K. Jankelowitz [Australie] ; Victor S. C. Fung [Australie] ; Paul D. Clouston [Australie] ; Michael W. Hayes [Australie] ; Padraic Grattan-Smith [Australie]Athetosis. I: Historical considerations
002855 Pierre-Francois Pradat [France] ; Francois Salachas [France] ; Stéphanie Cartalat-Carel [France] ; Lucette Lacomblez [France] ; Nathalie Patte [France] ; Nadine Leforestier [France] ; Véronique Gaura [France] ; Vincent Meininger [France]Association of chorea and motor neuron disease
002857 Francois Tison [France] ; Farid Yekhlef [France] ; Eric Balestre [France] ; Virginie Chrysostome [France] ; Niall Quinn [Royaume-Uni] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Application of the International Cooperative ataxia scale rating in multiple system atrophy
002858 Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
002859 Anticholinergic therapies in the treatment of Parkinson's disease
002860 ZHIGAO HUANG [États-Unis] ; Michael Jacewicz [États-Unis] ; Ronald F. Pfeiffer [États-Unis]Anticardiolipin antibody in vascular parkinsonism
002862 Michele T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Jozef Jarosz [Royaume-Uni] ; Lidia Yaguez [Royaume-Uni] ; David J. Brooks [Royaume-Uni]An imaging study of parkinsonism among African-Caribbean and Indian London communities
002863 Amantadine and other antiglutamate agents
002868 Lavanya Vijayaraghavan [Royaume-Uni] ; Ennapadam S. Krishnamoorthy [Singapour] ; Richard G. Brown [Royaume-Uni] ; Michael R. Trimble [Royaume-Uni]Abulia: A Delphi survey of British neurologists and psychiatrists
002869 JIAN WANG [République populaire de Chine] ; Chun-Ying Zhao [République populaire de Chine] ; Yan-Mei Si [République populaire de Chine] ; Zhuo-Lin Liu [République populaire de Chine] ; BIAO CHEN [République populaire de Chine] ; LONG YU [République populaire de Chine]ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset
002870
002871 Abstracts of the First International Symposium on Mental and Behavioral Dysfunction in Movement Disorders, Montreal, Canada, October 10-13, 2001
002872 Andrea Varrone [États-Unis] ; Kenneth L. Marek [États-Unis] ; Danna Jennings [États-Unis] ; Robert B. Innis [États-Unis] ; John P. Seibyl [États-Unis][123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's Disease and multiple system atrophy
002873 Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Tomiainen [Finlande] ; Kyosti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande][123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients
002874 Matthias F. Nitschke [Allemagne] ; Gunnar Krüger [Allemagne] ; Harald Bruhn [Allemagne] ; Christine Klein [Allemagne] ; Eckart Gehrking [Allemagne] ; Karl Wessel [Allemagne] ; Jens Frahm [Allemagne] ; Peter Vieregge [Allemagne]Voluntary palatal tremor is associated with hyperactivation of the inferior olive: A functional magnetic resonance imaging study
002876 John D. O'Sullivan [Royaume-Uni] ; Peter Browns ; Andrew Lees (neurologue) [Royaume-Uni]Unusual tremor associated with a posterolateral thalamic lesion in a drummer
002877 Jorge Iriarte [Espagne] ; Manuel Alegre [Espagne] ; Javier Arbizu [Espagne] ; Purificacion De Castro [Espagne]Unilateral Periodic limb movements during sleep in corticobasal degeneration
002878 B. Okuda [Japon] ; H. Tanaka [Japon] ; K. Kawabata [Japon] ; H. Tachibana [Japon] ; M. Sugita [Japon]Truncal and limb apraxia in corticobasal degeneration
002880 Frithjof Tergau [Allemagne] ; Stephan Wischer [Allemagne] ; Christian Wolf [Allemagne] ; Walter Paulus [Allemagne]Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine
002881 Han-Cheng Wang [Taïwan] ; YOLOUNG HSIEH [Taïwan]Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
002883 Alessandra Pesenti [Italie] ; Alberto Priori [Italie] ; Guglielmo Scarlato [Italie] ; Sergio Barbieri [Italie]Transient improvement induced by motor fatigue in focal occupational dystonia: The Handgrip test
002884 J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis]Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study
002885 Hilde Risvoll [Norvège] ; Emilia Kerty [Norvège]To test or not? The value of diagnostic tests in cervical dystonia
002886 Lawrence I. Golbe [États-Unis] ; Alice M. Lazzarini [États-Unis] ; John R. Spychala [États-Unis] ; William G. Johnson [États-Unis] ; Edward S. Stenroos [États-Unis] ; Margery H. Mark [États-Unis] ; Jacob I. Sage [États-Unis]The tau A0 allele in Parkinson's disease
002887 M. C. Carboneini [Italie] ; D. Manzoni [Italie] ; S. Strambi [Italie] ; U. Bonuccelli [Italie] ; N. Pavese [Italie] ; P. Andre [Italie] ; B. Rossi [Italie]The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in Parkinsonian bradykinesia
002888 Steven J. Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Paul E. Greene [États-Unis] ; Christopher O'Brien [États-Unis] ; Michael Gelb [États-Unis] ; Daniel D. Truong [États-Unis] ; John Welsh [États-Unis] ; Stewart Factor [États-Unis] ; Blair Ford [États-Unis]The natural history of embouchure dystonia
002889 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]The history of Parkinson's disease : Part 2 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june, 2000
002891 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]The basal ganglia : Part 1 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002892 Markus Kofler [Autriche] ; Jörg Müller [Espagne] ; Gregor K. Wenning [Espagne] ; Laura Reggiani [Espagne] ; Pia Hollosi [Espagne] ; Sylvia Bösch [Espagne] ; Gerhard Ransmayr [Espagne] ; Josep Valls-Sole [Autriche] ; Werner Poewe [Espagne]The auditory startle reaction in Parkinsonian disorders
002893 D. A. Mcfarling [États-Unis]The "ragin' cajuns" of Louisiana
002894 William Ondo [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard K. Simpson [États-Unis]Thalamic deep brain stimulation: Effects on the nontarget limbs
002895 C. Marchini [Italie] ; L. Verriello [Italie] ; M. Mucchiut [Italie] ; G. Tion [Italie] ; P. Bergonzi [Italie]Task-specific dystonia in a horn player
002897 F. Tracik [Allemagne] ; G. Ebersbach [Allemagne]Sudden daytime Sleep onset in Parkinson's disease: Polysomnographic recordings
002898 Arthur Korten [Pays-Bas] ; Jan Lodder [Pays-Bas] ; Fred Vreeling [Pays-Bas] ; Anita Boreas [Pays-Bas] ; Lisette Van Raak [Pays-Bas] ; Fons Kessels [Pays-Bas]Stroke and idiopathic Parkinson's disease : Does a shortage of dopamine offer protection against stroke?
002899 Mahmut Edip Gürol [Turquie] ; Mustafa Ertas [Turquie] ; Hasmet Ayhan Hanagasi [Turquie] ; Hüseyin Alparslan Sahin [Turquie] ; Gencay Gürsoy [Turquie] ; Murat Emre [Turquie]Stiff leg syndrome: Case report
002900 A. Münchau [Royaume-Uni] ; S. R. Filipovic [Royaume-Uni] ; A. Oester-Barkey [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni]Spontaneously changing muscular activation pattern in patients with cervical dystonia
002901 D. B. Vodusek [Slovénie]Sphincter EMG and differential diagnosis of Multiple system atrophy
002902 Elan D. Louis [États-Unis] ; Linda Winfield [États-Unis] ; Stanley Fahn [États-Unis] ; Blair Ford [États-Unis]Speech dysfluency exacerbated by levodopa in Parkinson's disease
002903 Emma Frasson [Italie] ; Alberto Priori [Italie] ; Laura Bertolasi [Italie] ; Francois Mauguiere [France] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie]Somatosensory disinhibition in dystonia
002904 S. Thobois [France] ; E. Broussolle [France] ; L. Toureille [France] ; C. Vial [France]Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy
002906 D. Olga Mcdaniel [États-Unis] ; Bronya Keats [États-Unis] ; V. V. Vedanarayanan [États-Unis] ; S. H. Subramony [États-Unis]Sequence variation in GAA repeat expansions may cause differential penotype display in Friedreich's ataxia
002907 Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis]Seminal figures in the history of movement disorders: Hammond, Osler, and Huntington. Part 11 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002908 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden. Part 12 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002909 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Seminal figures in the history of movement disorders : Sydenham, Parkinson, and Charcot: Part 6 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002910 Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]Rivastigmine in the treatment of Parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial
002912 Ania Winogrodzka [Pays-Bas] ; Robert C. Wagenaar [Pays-Bas] ; Paul Bergmans [Pays-Bas] ; Astrid Vellinga [Pays-Bas] ; Jan Booij [Pays-Bas] ; Eric A. Van Royen [Pays-Bas] ; Richard E. A. Van Emmerik [États-Unis] ; Johannes C. Stoof [Pays-Bas] ; Erik Ch. Wolters [Pays-Bas]Rigidity decreases resting Tremor intensity in Parkinson's disease: A [123I]β-CIT SPECT study in early, nonmedicated patients
002913 Adam Wichniak [Allemagne] ; Ferenc Tracik [Allemagne] ; Peter Geisler [Allemagne] ; Georg Ebersbach [Allemagne] ; Sean P. Morrissey [Allemagne] ; Jürgen Zulley [Allemagne]Rhythmic feet movements while falling asleep
002914 E. K. Tan [Singapour] ; A. Seah [Singapour] ; S. J. See [Singapour] ; E. Lim [Singapour] ; K. K. Koh [Singapour] ; M. C. Wong [Singapour]Restless legs syndrome in an Asian population: A study in Singapore
002915 Georg Berding [Allemagne] ; Per Odin [Allemagne] ; David J. Brooks [Royaume-Uni] ; Guido Nikkhah [Allemagne] ; Cordula Matthies [Allemagne] ; Thomas Peschel [Allemagne] ; Mona Shing [Allemagne] ; Hans Kolbe [Allemagne] ; Jörg Van Den Hoff [Allemagne] ; Harald Fricke [Allemagne] ; Reinhard Dengler [Allemagne] ; Madjid Samii [Allemagne] ; Wolfram H. Knapp [Allemagne]Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the Off and On conditions with [18F]FDG-PET
002917 Joohi Shahed [États-Unis] ; Joseph Jankovic [États-Unis]Re-emergence of Childhood stuttering in Parkinson's disease : A hypothesis
002918 Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande]Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study
002920 J. P. P. Van Vugt [Pays-Bas] ; S. Siesling [Pays-Bas] ; K. K. E. Piet [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; H. A. M. Middelkoop [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas]Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease
002921 Pierre C. Jedynak [France] ; Christine Tranchant [France] ; Diederik Zegers De Beyl [Belgique]Prospective clinical study of Writer's cramp
002923 Hiroshi Ujike [Japon] ; Mitsutoshi Yamamoto [Japon] ; Akihiro Kanzaki [Japon] ; Kazuya Okumura [Japon] ; Manabu Takaki [Japon] ; Shigetoshi Kuroda [Japon]Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease
002924 Jan Ulfberg [Suède] ; Birgitta Nyström [Suède] ; Ned Carter [Suède] ; Christer Edling [Suède]Prevalence of Restless Legs Syndrome among men aged 18 to 64 years: An association with somatic disease and neuropsychiatric symptoms
002925 Hubert H. Fernandez [États-Unis] ; Rowena E. J. Tabamo [États-Unis] ; Raymund R. David [États-Unis] ; Joseph H. Friedman [États-Unis]Predictors of depressive symptoms among spouse caregivers in Parkinson's Disease
002926 K. Biirk [Allemagne] ; M. Skalej [Allemagne] ; J. Dichgans [Allemagne]Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA)
002927 Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni]Poetic talent unmasked by treatment of Parkinson's disease
002928 Emilia Mabel Gatto [Argentine] ; Manuel Maria Fernandez Pardal [Argentine] ; Ricardo Claudio Reisin [Argentine] ; Ana Maria Pardal [Argentine]Playing harp, another unusual task-specific dystonia
002929 Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France]Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
002930 Virgilio Gerald H. Evidente [Philippines]Piribedil for restless legs syndrome: A pilot study
002932 Anna R. Bentivoglio [Italie] ; Pietro Cortelli [Italie] ; Enza M. Valente [Italie] ; Tamara Ialongo [Italie] ; Alessandro Ferraris [Italie] ; Antonio Elia [Italie] ; Pasquale Montagna [Italie] ; Alberto Albanese [Italie]Phenotypic characterisation of autosomal recessive PARK6-linked Parkinsonism in three unrelated Italian families
002934 Joseph H. Friedman [États-Unis] ; Neetha Shettv [États-Unis]Permanent cerebellar toxicity of cytosine arabinoside (ara C) in a young woman
002935 Ilias Papathanasiou [Royaume-Uni] ; Lea Macdonald [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]Perceived stigma in spasmodic torticollis
002936 Marina Svetel [Serbie] ; Nadezda Sternic [Serbie] ; Sanja Pejovic [Serbie] ; Vladimir S. Kostic [Serbie]Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease
002937 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Parkinsonism-plus syndromes: Part 7 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002938 Egberto R. Barbosa [Brésil] ; Maria D. Leiros Da Costa [Brésil] ; Luiz A. Bacheschi [Brésil] ; Milberto Scaff [Brésil] ; Claudia C. Leite [Brésil]Parkinsonism after glycine-derivate exposure
002941 D. Joel [Israël]Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease
002946 J. Hoenicka [Espagne] ; L. Vidal [Espagne] ; M. Godoy [Espagne] ; J. J. Ochoa [Espagne] ; J. Garcia De Yebenes [Espagne]New nonsense mutation in the GTP-cyclohydrolase I gene in L-DOPA responsive dystonia-parkinsonism
002947 Thomas Trottenberg [Allemagne] ; Wassilios Meissner [Allemagne] ; Guy Arnold [Allemagne] ; Karl-Max Einhaupl [Allemagne] ; Andreas Kupsch [Allemagne] ; Christian Kabus [Allemagne] ; Thomas Funk [Allemagne]Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome
002948 Jaime Kulisevsky [Espagne] ; Irene Litvan [États-Unis] ; Marcelo L. Berthier [Espagne] ; Berta Pascual-Sedano [Espagne] ; Jane S. Paulsen [États-Unis] ; Jeffrey L. Cummings [États-Unis]Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders
002950 Georg Becker [Allemagne] ; Daniela Berg [Allemagne]Neuroimaging in basal ganglia disorders : Perspectives for Transcranial ultrasound
002953 James W. Lance [Australie] ; Raymond D. Adams [États-Unis]Negative myoclonus in posthypoxic patients : Historical note
002955 R. Richard Sloop [États-Unis] ; Dorothee Cole [États-Unis] ; Milan C. Patel [États-Unis]Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals
002957 Massimo Pandolfo [Canada]Molecular basis of friedreich ataxia
002959 Mandar S. Jog [Canada] ; Linda Grantier [Canada]Methods for digital Video recording, storage, and communication of movement disorders
002960 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Medical art and photography in the history of movement disorders: Part 13 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002961 Tobias E. Eichhorn [Allemagne] ; Wolfgang H. Oertel [Allemagne]Macrogol 3350/Electrolyte improves constipation in Parkinson's disease and multiple system atrophy
002962 G. Tissingh [Pays-Bas] ; H. W. Berendse [Pays-Bas] ; P. Bergmans [Pays-Bas] ; R. Dewaard [Pays-Bas] ; B. Drukarch [Pays-Bas] ; J. C. Stoof [Pays-Bas] ; E. Ch. Wolters [Pays-Bas]Loss of olfaction in de novo and treated Parkinson's disease : Possible implications for early diagnosis
002963 William C. Koller [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Troster [États-Unis] ; Rajesh Pahwa [États-Unis]Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor
002964 Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
002965 Arthur S. Walters [États-Unis] ; Juliane Winkelmann [Allemagne] ; Claudia Trenkwalder [Allemagne] ; June M. Fry [États-Unis] ; Vandana Kataria [États-Unis] ; Mary Wagner [États-Unis] ; Rakesh Sharma [États-Unis] ; Wayne Hening [États-Unis] ; LIREN LI [États-Unis]Long-term follow-up on restless legs syndrome patients treated with opioids
002967 Brad A. Racette [États-Unis] ; Arie Perry [États-Unis] ; Giovanni D'Avossa [États-Unis] ; Joel S. Perlmutter [États-Unis]Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum
002968 Caroline M. Tanner [États-Unis] ; Jerry Chamberland [Indonésie]Latah in Jakarta, Indonesia
002970 Marie-Hélène Saint-Hilaire [États-Unis] ; Jean-Marc Saint-Hilaire [Canada]Jumping frenchmen of Maine
002971 Birgit Högl [Autriche] ; Md. Klaus Seppi [Autriche] ; Elisabeth Brandauer [Autriche] ; Gregor Wenning [Autriche] ; Werner Poewe [Autriche]Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy: Placebo-controlled, polysomnographic case report
002973 Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie]Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
002975 Ivan Rektor [République tchèque] ; Martin Bares [République tchèque] ; Petr Kanovsky [République tchèque] ; Miloslav Kukleta [République tchèque]Intracerebral recording of readiness potential induced by a complex motor task
002976 D. A. Grimes [Canada] ; D. Bulman [Canada] ; P. St. George-Hyslop [Canada] ; A. E. Lang [Canada]Inherited myoclonus-dystonia : Evidence supporting genetic heterogeneity
002980 Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
002982 Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Teresa A. Chmura [États-Unis]Home alone: Methods to maximize Tic expression for objective Videotape assessments in Gilles de la tourette syndrome
002983 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of tic disorders and Gilles de la Tourette syndrome : Part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002984 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of myoclonus: Part 8 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002985 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002986 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of dystonia : Part 4 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June, 2000
002987 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of chorea : Part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002988 P. Shanahan [Irlande (pays)] ; M. Hutchinson [Irlande (pays)] ; A. Bohan [Irlande (pays)] ; D. O'Donoghue [Irlande (pays)] ; K. Sheahan [Irlande (pays)] ; A. Owens [Irlande (pays)]Hemichorea, moya-moya, and ulcerative colitis
002989 S. Ohara [Japon] ; S. Nakagawa [Japon] ; K. Tabata [Japon] ; T. Hashimoto [Japon]Hemiballism with hyperglycemia and striatal T1-MRI hyperintensity: An autopsy report
002991 Marwan I. Hariz [Suède] ; Folke Johansson [Suède]Hardware failure in Parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency
002992 Nihal Tas [Turquie] ; Gülcin Kaymak Karatas [Turquie] ; Vesile Sepici [Turquie]Hand orthosis as a writing aid in Writer's cramp
002993 Federico M. Farin [États-Unis] ; Yolanda Hitosis [États-Unis] ; Sarah E. Hallagan [États-Unis] ; John Kushleika [États-Unis] ; James S. Woods [États-Unis] ; Patricia S. Janssen [États-Unis] ; Terri Smith-Weller [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Harvey Checkoway [États-Unis]Genetic polymorphisms of superoxide dismutase in Parkinson's disease
002994 Ruth Hardoff [Israël] ; Michael Sula [Israël] ; Ada Tamir [Israël] ; Adrian Soil [Israël] ; Avi Front [Israël] ; Samich Badarna [Israël] ; Silvia Honigman [Israël] ; Nir Giladi [Israël]Gastric emptying time and gastric motility in patients with Parkinson's disease
002995 Robert Jech [République tchèque] ; Dusan Urgosik [République tchèque] ; Jaroslav Tintera [République tchèque] ; Antonin Nebuzelsky [République tchèque] ; Jan Krasensky [République tchèque] ; Roman Liscak [République tchèque] ; Jan Roth [République tchèque] ; Evzen Ruzicka [République tchèque]Functional magnetic resonance imaging during deep brain stimulation: A pilot study in four patients with Parkinson's disease
002996 Zbigniew K. Wszolek [États-Unis] ; Randy H. Kardon [États-Unis] ; Erik Ch. Wolters [Pays-Bas] ; Ronald F. Pfeiffer [États-Unis]Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration
002997 J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis]Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
002998 Neil S. Lava [États-Unis] ; Stewart A. Factor [États-Unis]Focal myopathy as a cause of anterocollis in Parkinsonism
002999 J. H. Friedman [États-Unis] ; H. Friedman [États-Unis]Fatigue in Parkinson's disease: A nine-year follow-up
002A00 E. Apartis [France] ; F. Tison [France] ; P. Arne [France] ; C. P. Jedynak [France] ; M. Vidailhet [France]Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor
002A02 T. Perniola [Italie] ; L. Margari [Italie] ; M. G. De Iaco [Italie] ; A. Presicci [Italie] ; P. Ventura [Italie] ; E. Ferrannini [Italie] ; G. Illiceto [Italie]Familial paroxysmal exercise-induced dyskinesia, epilepsy, and mental retardation in a family with autosomal dominant inheritance
002A04 Elan D. Louis [États-Unis]Etiology of essential tremor: Should we be searching for environmental causes?
002A08 Peter Brown [Royaume-Uni] ; Philip D. Thompson [Australie]Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor
002A10 Joseph H. Friedman [États-Unis]Effects of reviewing DATATOP videotapes on IQ and MMPI in PSG coordinators and investigators, or, whatever happened to tony lang?
002A11 N. Allert [Allemagne] ; J. Volkmann [Allemagne] ; S. Dotse [Allemagne] ; H. Hefter [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne]Effects of Bilateral pallidal or subthalamic stimulation on gait in advanced Parkinson's Disease
002A12 Birgit Högl [Allemagne] ; Cecilia Peralta [Argentine] ; Thomas C. Wetter [Allemagne] ; Oscar Gershanik [Argentine] ; Claudia Trenkwalder [Allemagne]Effect of sleep deprivation on motor performance in patients with Parkinson's Disease
002A14 Marina Svetel [Serbie] ; Dusko Kozic [Serbie] ; Elka Stefanova [Serbie] ; Robert Semnic [Serbie] ; Natasa Dragasevic [Serbie] ; Vladimir S. Kostic [Serbie]Dystonia in Wilson's disease
002A16 L. Alvarez [Cuba] ; R. Macias [Cuba] ; J. Guridi [Espagne] ; G. Lopez [Cuba] ; E. Alvarez [Cuba] ; C. Maragoto [Cuba] ; J. Teijeiro [Cuba] ; A. Torres [Cuba] ; N. Pavon [Cuba] ; M. C. Rodriguez-Oroz [Espagne] ; L. Ochoa [Cuba] ; H. Hetherington [États-Unis] ; J. Juncos [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne]Dorsal subthalamotomy for Parkinson's disease
002A19 Richard Camicioli [États-Unis] ; Sandra J. Grossmann [États-Unis] ; Peter S. Spencer [États-Unis] ; Ken Hudnell [États-Unis] ; W. Kent Anger [États-Unis]Discriminating mild Parkinsonism : Methods for epidemiological research
002A20 Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis]Development of instruments for abnormal movements: Postural sway and gait analyses. Part 10 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002A23 Marcelo Merello [Argentine] ; Angel Cammarota [Argentine] ; Ramon Leiguarda [Argentine] ; Ralph Pikielny [Argentine]Delayed intracerebral electrode infection after bilateral STN implantation for Parkinson's disease: Case report
002A24 G. Wihl [Allemagne] ; J. Volkmann [Allemagne] ; N. Allert [Allemagne] ; R. Lehrke [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne]Deep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro-acanthocytosis
002A25 N. J. Cordato [Australie] ; G. M. Halliday [Australie] ; L. Davies [Australie] ; P. Williamson [Australie] ; M. Fulham [Australie] ; J. G. L. Morris [Australie]Corticobasal syndrome with tau pathology
002A27 Kerstin D. Pfann [États-Unis] ; Aron S. Buchman [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis]Control of movement distance in Parkinson's disease
002A28 Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
002A30 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Tröster [États-Unis] ; John Overman [États-Unis] ; Jennifer Kieltyka [États-Unis] ; William C. Koller [États-Unis]Comparison of thalamotomy to deep brain Stimulation of the thalamus in Essential tremor
002A31 Elan D. Louis [États-Unis] ; Seth L. Pullman [États-Unis]Comparison of clinical vs. electrophysiological methods of diagnosing of Essential tremor
002A32 Lisa M. Shulman [États-Unis] ; Robin Leifert Taback [États-Unis] ; Judy Bean [États-Unis] ; William J. Weiner [États-Unis]Comorbidity of the nonmotor symptoms of Parkinson's disease
002A33 Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis]Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial
002A34 S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni]Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation
002A35 C.-S. Lu [Taïwan] ; J.-C. Wu [Taïwan] ; C.-H. Tsai [Taïwan] ; R.-S. Chen [Taïwan] ; Y.-H. Wu Chou [Taïwan] ; N. Hattori [Japon] ; H. Yoshino [Japon] ; Y. Mizuno [Japon]Clinical and genetic studies on familial parkinsonism : The first report on a Parkin gene mutation in a Taiwanese family
002A37 Lorraine O. Ramig [États-Unis] ; Shimon Sapir [États-Unis] ; Cynthia Fox [États-Unis] ; Stefanie Countryman [États-Unis]Changes in vocal loudness following intensive voice Treatment (LSVT®) in individuals with Parkinson's disease : A comparison with untreated patients and normal age-matched controls
002A38 Silke Wunderlich [Allemagne] ; Karlheinz Reiners [Allemagne] ; Thomas Gasser [Allemagne] ; Markus Naumann [Allemagne]Cervical dystonia in monozygotic twins: Case report and review of the literature
002A39 Christopher O'Brien [États-Unis] ; Allison Brashear [États-Unis] ; Paul Cullis [États-Unis] ; Daniel Truong ; Eric Molho [États-Unis] ; Stephen Jenkins [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Thomas O'Neil [États-Unis] ; Stewart Factor [États-Unis] ; Lauren Seeberger [États-Unis]Cervical Dystonia Severity scale reliability study
002A43 Pierre-Francois Pradat [France] ; Corinne Dupel-Pottier [France] ; Lucette Lacomblez [France] ; Francois Salachas [France] ; Vincent Meininger [France] ; Laurent Spelle [France] ; Isabelle Bonnaud [France] ; Marie Joao Ribeiro [France] ; Philippe Remy [France] ; Yves Samson [France]Case record of pallido-pyramidal disease with supplementary motor area involvement
002A44 JINWHAN CHO [Corée du Sud] ; KON CHU [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injection
002A45 Björn Holmberg [Suède] ; Mika Kallio [Finlande] ; Bo Johnels [Suède] ; Mikael Elam [Suède]Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes
002A46 William J. Weiner [États-Unis]Can peripheral trauma induce dystonia? No!
002A47 Joseph Jankovic [États-Unis]Can peripheral trauma induce dystonia and other movement disorders? Yes!
002A50 Christopher J. Earley [États-Unis] ; Keith Hyland [États-Unis] ; Richard P. Allen [États-Unis]CSF dopamine, serotonin, and biopterin metabolites in patients with Restless Legs Syndrome
002A51 Mareina Kudo [Japon] ; Satoshi Goto [Japon] ; Shigeyuki Nishikawa [Japon] ; Tadashi Hamasaki [Japon] ; Naohiro Soyama [Japon] ; Yukitaka Ushio [Japon] ; Shuji Mita [Japon] ; Yoshifumi Hirata [Japon]Bilateral thalamic stimulation for Holmes' tremor caused by unilateral brainstem lesion
002A52 Bala V. Manyam [États-Unis] ; Arthur S. Walters [États-Unis] ; Koteswara R. Narla [États-Unis]Bilateral striopallidodentate calcinosis : Clinical characteristics of patients seen in a registry
002A53 Daisuke Muta [Japon] ; Satoshi Goto [Japon] ; Shigeyuki Nishikawa [Japon] ; Tadashi Hamasaki [Japon] ; Yukitaka Ushio [Japon] ; Nobuhiro Inoue [Japon] ; Shuji Mita [Japon]Bilateral pallidal stimulation for idiopathic segmental axial dystonia advanced from Meige syndrome refractory to bilateral thalamotomy
002A54 Simon Parkin [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni]Bilateral internal globus pallidus stimulation for the treatment of spasmodic torticollis
002A56 D. Laplane [France] ; B. Dubois [France]Auto-activation deficit: A basal ganglia related syndrome
002A57 G. M. Wali [Inde]Asymmetrical blepharospasm associated with a left frontal cortical infarct
002A58 Bradley F. Boeve [États-Unis] ; Michael H. Silber [États-Unis] ; Tanis J. Ferman [États-Unis] ; John A. Lucas [États-Unis] ; Joseph E. Parisi [États-Unis]Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy
002A59 Armin J. Grau [Allemagne] ; Vera Willig [Allemagne] ; Wolfgang Fogel [Allemagne] ; Egon Werle [Allemagne]Assessment of plasma lactoferrin in Parkinson's disease
002A61 Pau Pastor [Espagne] ; Esteban Munoz [Espagne] ; Mario Ezquerra [Espagne] ; Victor Obach [Espagne] ; Maria José Marti [Espagne] ; Francese Valldeoriola [Espagne] ; Eduard Tolosa [Espagne] ; Rafael Oliva [Espagne]Analysis of the coding and the 5' flanking regions of the α-synuclein gene in patients with Parkinson's disease
002A62 L. Quinn [États-Unis] ; R. Reilmann [États-Unis] ; K. Marder [États-Unis] ; A. M. Gordon [États-Unis]Altered movement trajectories and force control during object transport in Huntington's Disease
002A63 José A. Dominguez-Moran [Espagne] ; Juan M. Callejo [Espagne] ; Luis C. Fernandez-Ruiz [Espagne] ; Juan C. Martinez-Castrillo [Espagne]Acute paroxysmal dystonia induced by fluoxetine
002A64 Anette V. Nieves [Canada] ; Janis M. Miyasaki [Canada] ; Anthony E. Lang [Canada]Acute onset dystonic camptocormia caused by lenticular lesions
002A65 F. Carella [Italie] ; S. Genitrini [Italie] ; M. Bressanelli [Italie] ; P. Soliveri [Italie] ; D. Servello [Italie] ; G. Broggi [Italie] ; S. Piacentini [Italie] ; G. Geminiani [Italie] ; F. Girotti [Italie]Acute effects of bilateral subthalamic nucleus stimulation on clinical and kinematic parameters in Parkinson's disease
002A66 J. A. Burguera [Espagne] ; L. Bataller [Espagne] ; C. Valero [Espagne]Action hand dystonia after cortical parietal infarction
002A67 J. I. Hoff [Pays-Bas] ; A. A. V. D. Plas [Pays-Bas] ; E. A. H. Wagemans [Pays-Bas] ; J. J. Van Hilten [Pays-Bas]Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease
002A68 Satoshi Goto [Japon] ; Naoko Kunitoku [Japon] ; Tadashi Hamasaki [Japon] ; Shigeyuki Nishikawa [Japon] ; Yukitaka Ushio [Japon]Abolition of postapoplectic hemichorea by Vo-complex thalamotomy: Long-term follow-up study
002A69 Alice Nieuwboer [Belgique] ; René Dom [Belgique] ; Willy De Weerdt [Belgique] ; Kaat Desloovere [Belgique] ; Steffen Fieuws [Belgique] ; Eva Broens-Kaucsik [Belgique]Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease
002A70 Terence D. Sanger [États-Unis] ; Daniel Tarsy [États-Unis] ; Alvaro Pascual-Leone [États-Unis]Abnormalities of spatial and temporal sensory discrimination in Writer's cramp
002A71 Elan D. Louis [États-Unis] ; Livia Barnes [États-Unis] ; Kristin J. Wendt [États-Unis] ; Blair Ford [États-Unis] ; Maria Sangiorgio [États-Unis] ; Samer Tabbal [États-Unis] ; Linda Lewis [États-Unis] ; Petra Kaufmann [États-Unis] ; Carol Moskowitz [États-Unis] ; Cynthia L. Comella [États-Unis] ; Christopher C. Goetz [États-Unis] ; Anthony E. Lang [Canada]A Teaching videotape for the assessment of Essential Tremor
002A72 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; LEE CYN ANG [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche]69-year-old man with gait disturbance and parkinsonism
002A73
002A74 Posthypoxic Myoclonus
002A75 Abstracts of the sixth international congress of Parkinson's disease and movement disorders, Barcelona, Spain, June 11-15, 2000
002A76 Abstracts from International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, USA, November 16-18, 1999
002A78 C. W. Olanow [États-Unis] ; A. H. V. Schapira [Royaume-Uni] ; T. Roth [États-Unis]Waking up to sleep episodes in Parkinson's disease
002A79 Gaetan Garraux [Belgique] ; Eric Salmon [Belgique] ; Philippe Peigneux [Belgique] ; Alexandre Kreisler [France] ; Christian Degueldre [Belgique] ; Christian Lemaire [Belgique] ; Alain Destée [France] ; Georges Franck [Belgique]Voxel-based distribution of metabolic impairment in corticobasal degeneration
002A83 D. S. Latchman [Royaume-Uni] ; R. S. Coffin [Royaume-Uni]Viral vectors in the treatment of Parkinson's disease
002A85 E. D. Louis [États-Unis] ; L. F. Barnes [États-Unis] ; K. J. Wendt [États-Unis] ; S. M. Albert [États-Unis] ; S. L. Pullman [États-Unis] ; QIPING YU [États-Unis] ; F. R. Schneier [États-Unis]Validity and test-retest reliability of a Disability Questionnaire for Essential Tremor
002A86 E. D. Louis [États-Unis] ; E. Yousefzadeh [États-Unis] ; L. F. Barnes [États-Unis] ; QIPING YU [États-Unis] ; S. L. Pullman [États-Unis] ; K. J. Wendt [États-Unis]Validation of a portable instrument for assessing tremor severity in epidemiologic field studies
002A92 R. A. Hauser [États-Unis] ; W. C. Koller [États-Unis] ; J. P. Hubble [États-Unis] ; T. Malapira [États-Unis] ; K. Busenbark [États-Unis] ; C. W. Olanow [États-Unis]Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's Disease
002A97 Roberta Marchese [Italie] ; Manuela Diverio [Italie] ; Francesca Zucchi [Italie] ; Carmelo Lentino [Italie] ; Giovanni Abbruzzese [Italie]The role of sensory cues in the rehabilitation of parkinsonian patients : A comparison of two physical therapy protocols
002A99 Evelyn Jaros [Royaume-Uni] ; David J. Burn [Royaume-Uni]The pathogenesis of multiple system atrophy : Past, present, and future
002B01 T. Klockgether [Allemagne] ; U. Wüllner [Allemagne] ; A. Spauschus [Royaume-Uni] ; B. Evert [Allemagne]The molecular biology of the autosomal-dominant cerebellar ataxias
002B03 C. Ramaker [Pays-Bas] ; W. J. T. Van De Beek [Pays-Bas] ; M. J. J. Finken [Pays-Bas] ; B. J. J. Van Hilten [Pays-Bas]The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications : A systematic review
002B05 I. Reuter [Royaume-Uni] ; S. Harder [Allemagne] ; M. Engelhardt [Allemagne] ; H. Baas [Allemagne]The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
002B08 C. N. Homann [Royaume-Uni] ; K. Suppan [Royaume-Uni] ; K. Wenzel [Royaume-Uni] ; G. Giovannoni [Royaume-Uni] ; G. Ivanic [Royaume-Uni] ; S. Horner [Royaume-Uni] ; E. Ott [Royaume-Uni] ; H. P. Hartung [Royaume-Uni]The bradykinesia akinesia incoordination test (BRAIN TEST©), an objective and user-friendly means to evaluate patients with parkinsonism
002B09 Christoph Kamm [Allemagne] ; Markus Naumann [Allemagne] ; Joerg Mueller [Autriche] ; Norbert Mai [Allemagne] ; Leonhard Riedel [Allemagne] ; Joerg Wissel [Autriche] ; Thomas Gasser [Allemagne]The DYT1 GAG deletion is infrequent in sporadic and familial writer's cramp
002B12 F. Birklein [Allemagne] ; F. Erbguth [Allemagne]Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A : A preliminary observation
002B14 M. H. Silber [États-Unis] ; S. Levine [États-Unis]Stridor and death in multiple system atrophy
002B20 C. Mcrae [États-Unis] ; G. Diem [États-Unis] ; A. Vo [États-Unis] ; C. O'Brien [États-Unis] ; L. Seeberger [États-Unis]Schwab & England : Standardization of administration
002B23 Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
002B24 W. Ondo [États-Unis] ; ENG KING TAN [États-Unis] ; J. Mansoor [États-Unis]Rheumatologic serologies in secondary restless legs syndrome
002B27 E. H. Aylward [États-Unis] ; A.-M. Codori [États-Unis] ; A. Rosenblatt [États-Unis] ; M. Sherr [États-Unis] ; J. Brandt [États-Unis] ; O. C. Stine [États-Unis] ; P. E. Barta [États-Unis] ; G. D. Pearlson [États-Unis] ; C. A. Ross [États-Unis]Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease
002B29 H. M. Bronte-Stewart [États-Unis] ; LONG DING [États-Unis] ; C. Alexander [États-Unis] ; YI ZHOU [États-Unis] ; G. P. Moore [États-Unis]Quantitative digitography (QDG) : A sensitive measure of digital motor control in idiopathic Parkinson's disease
002B36 R. A. Hauser [États-Unis] ; L. Gauger [États-Unis] ; W. M. Anderson [États-Unis] ; T. A. Zesiewicz [États-Unis]Pramipexole-induced somnolence and episodes of daytime sleep
002B38 S. Vanhatalo [Finlande] ; R. Paetau [Finlande] ; K. Mustonen [Finlande] ; J. Hernesniemi [Finlande] ; R. Riikonen [Finlande]Posttraumatic tremor and arnold chiari malformation : No sign of compression, but cure after surgical decompression
002B41 J. J. Higgins [États-Unis] ; K. Kluetzman [États-Unis] ; J. Berciano [Espagne] ; O. Combarros [Espagne] ; J. M. Loveless [États-Unis]Posterior column ataxia and retinitis pigmentosa : A distinct clinical and genetic disorder
002B42 M. Hallett [États-Unis]Physiology of human posthypoxic myoclonus
002B47 A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis]Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A
002B48 José Antonio Molina [Espagne] ; Maria José Sainz-Artiga [Espagne] ; Talicia Fraile [Espagne] ; Félix Javier Jimenez-Jimenez [Espagne] ; Clara Villanueva [Espagne] ; Miguel Orti-Pareja [Espagne] ; Félix Bermeio-P [Espagne]Pathologic gambling in Parkinson's disease : A behavioral manifestation of pharmacologic treatment?
002B49 P. R. Jarman [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. Davie [Royaume-Uni] ; S. J. R. Heales [Royaume-Uni] ; N. Turjanski [Royaume-Uni] ; S. D. Taylor-Robinson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Paroxysmal dystonic choreoathetosis : Clinical features and investigation of pathophysiology in a large family
002B50 P. E. Greene [États-Unis] ; S. B. Bressman [États-Unis] ; B. Ford [États-Unis] ; K. Hyland [États-Unis]Parkinsonism, dystonia, and hemiatrophy
002B54 V. S. C. Fung [Australie] ; J. A. Burne [Australie] ; J. G. L. Morris [Australie]Objective quantification of resting and activated parkinsonian rigidity : A comparison of angular impulse and work scores
002B55 Federica Provini [Italie] ; Pasquale Montagna [Italie] ; Giuseppe Plazzi [Italie] ; Elio Lugaresi [Italie]Nocturnal frontal lobe epilepsy: A wide spectrum of seizures
002B56 JIAN WANG [République populaire de Chine] ; ZHUOLIN LIU [République populaire de Chine]No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a chinese population
002B59 Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada]Neuropsychologic assessment of patients for movement disorder surgery
002B62 J. Raethjen [Allemagne] ; M. Lindemann [Allemagne] ; H. Schmaljohann [Allemagne] ; R. Wenzelburger [Allemagne] ; G. Pfister [Allemagne] ; G. Deuschl [Allemagne]Multiple oscillators are causing parkinsonian and essential tremor
002B64 R. Kurlan [États-Unis] ; I. H. Richard [États-Unis] ; M. Papka [États-Unis] ; F. Marshall [États-Unis]Movement disorders in Alzheimer's disease : More rigidity of definitions is needed
002B65 F. Alarcon [Royaume-Uni] ; G. Duenas [Royaume-Uni] ; N. Cevallos [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Movement disorders in 30 patients with tuberculous meningitis
002B66 A. Curra [Italie] ; A. Berardelli [Italie] ; R. Agostino [Italie] ; M. Giovannelli [Italie] ; G. Koch [Italie] ; M. Manfredi [Italie]Movement cueing and motor execution in patients with dystonia : A kinematic study
002B68 E. B. Jr Montgomery [États-Unis] ; K. B. Baker [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Motor initiation and execution in essential tremor and Parkinson's disease
002B70 Ikuko Mizuta [Japon] ; Eiji Mizuta [Japon] ; Shunzou Yamasaki [Japon] ; Sadako Kuno [Japon] ; Minoru Yasuda [Japon] ; Chikako Tanaka [Japon]Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan
002B74 Matt Farrer [États-Unis, France] ; Alain Destée [France] ; Estelle Becquet ; Fabienne Wavrant-De Vrieze [États-Unis] ; Vincent Mouroux ; Florence Richard ; Luc Defebvre [France] ; Sarah Lincoln [États-Unis] ; John Hardy [États-Unis] ; Philippe Amouyel ; Marie-Christine Chartier-HarlinLinkage exclusion in French families with probable Parkinson's disease
002B77 J. A. Bueri [Argentine] ; G. Saposnik [Argentine] ; J. Maurino [Argentine] ; R. Saizar [Argentine] ; N. S. Garretto [Argentine]Lazarus' sign in brain death
002B78 Ida Tonolli [France] ; Roselyne Aurenty [France] ; Robert George Lee [France, Canada] ; Francois Viallet [France] ; Jean Massion [France]Lateral leg raising in patients with Parkinson's disease : Influence of equilibrium constraint
002B87 Ruth H. Walker [États-Unis] ; Fabio O. Danisi [États-Unis] ; David M. Swope [États-Unis] ; Robert R. Goodman [États-Unis] ; Isabelle M. Germano [États-Unis] ; Mitchell F. Brin [États-Unis]Intrathecal baclofen for dystonia: Benefits and complications during six years of experience
002B89 J. M. Hurtado [États-Unis] ; J.-P. Lachaux [États-Unis] ; D. J. Beckley [États-Unis] ; C. M. Gray [États-Unis] ; K. A. Sigvardt [États-Unis]Inter- and intralimb oscillator coupling in parkinsonian tremor
002B90 James H. Bower [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Walter A. Rocca [États-Unis]Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease
002B93 M. D. Welsh [États-Unis] ; T. Dorflinger [États-Unis] ; D. Chernik [États-Unis] ; C. Waters [États-Unis]Illness Impact and Adjustment to Parkinson's disease : Before and after treatment with tolcapone
002B96 Anette Schrag [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]How does Parkinson's Disease affect quality of life? A comparison with quality of life in the general population
002B99 H. H. Fernandez [États-Unis] ; K. L. Lapane [États-Unis] ; B. R. Ott [États-Unis] ; J. H. Friedman [États-Unis]Gender differences in the frequency and treatment of behavior problems in Parkinson's disease
002C00 W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; K. Dat Vuong [États-Unis] ; K. Schwartz [États-Unis] ; Joseph Jankovic [États-Unis]Gabapentin for Essential tremor : A multiple-dose, double-blind, placebo-controlled trial
002C03 R. A. Wright [États-Unis] ; J. E. Ahlskog [États-Unis]Focal shoulder-elevation dystonia
002C13 E. B. Jr Montgomery [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Early detection of probable idiopathic Parkinson's disease : II. A prospective application of a diagnostic test battery
002C14 E. B. Jr Montgomery [États-Unis] ; W. C. Koller [États-Unis] ; T. J. K. Lamantia [États-Unis] ; M. C. Ii Newman [États-Unis] ; A. W. Kaszniak [États-Unis] ; K. Lyons [États-Unis]Early detection of probable idiopathic Parkinson's disease : I. Development of a diagnostic test battery
002C15 Canan Ozsancak [France] ; Pascal Auzou [France] ; Didier Hannequin [France]Dysarthria and orofacial apraxia in corticobasal degeneration
002C18 Deborah J. Serrien [Suisse] ; Jean-Marc Burgunder [Suisse] ; Mario Wiesendanger [Suisse]Disturbed sensorimotor processing during control of precision grip in patients with writer's cramp
002C19 R. Leiguarda [Argentine] ; M. Merello [Argentine] ; J. Balej [Argentine] ; S. Starkstein [Argentine] ; M. Nogues [Argentine] ; C. D. Marsden [Royaume-Uni]Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy
002C21 C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis]Differential progression of motor impairment in levodopa-treated Parkinson's Disease
002C22 John G. Nutt [États-Unis] ; Eric S. Lea ; Laura Van Houten ; Robert A. Schuff ; Gary J. SextonDeterminants of tapping speed in normal control subjects and subjects with Parkinson's disease : Differing effects of brief and continued practice
002C23 N. L. W. Keijsers [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; J. I. Hoff [Pays-Bas] ; C. C. A. M. Gielen [Pays-Bas]Detection and assessment of the severity of levodopa-induced dyskinesia in patients with Parkinson's disease by neural networks
002C24 O. Bandmann [Royaume-Uni] ; J. R. Vaughan [Royaume-Uni] ; P. Holmans [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease
002C27 Hiroshi Morita [Japon] ; Masaomi Shindo [Japon] ; Shu-Ichi Ikeda [Japon] ; Nobuo Yanagisawa [Japon]Decrease in presynaptic inhibition on heteronymous monosynaptic Ia terminals in patients with Parkinson's disease
002C28 Harvey S. Singer [États-Unis]Current issues in tourette syndrome
002C29 A. D. Siderowf [États-Unis] ; R. G. Holloway [États-Unis] ; M. B. Stern [États-Unis]Cost-effectiveness analysis in Parkinson's disease : Determining the value of interventions
002C30 H. T. S. Benamer [Royaume-Uni] ; J. Patterson [Royaume-Uni] ; D. J. Wyper [Royaume-Uni] ; D. M. Hadley [Royaume-Uni] ; G. J. A. Macphee [Royaume-Uni] ; D. G. Grosset [Royaume-Uni]Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake
002C31 Andrew Gillies [Royaume-Uni] ; Gordon Arbuthnott [Royaume-Uni]Computational models of the basal ganglia
002C32 H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis]Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
002C36 Sergei N. Illarioshkin [Russie] ; Irina A. Ivanova-Smolenskaya [Russie] ; Rahmatullo A. Rahmonov [Russie] ; Elena D. Markova [Russie] ; Giovanni Stevanin [France] ; Alexis Brice [France]Clinical and genetic study of familial essential tremor in an isolate of Northern Tajikistan
002C37 J. Kulisevsky [Espagne] ; C. Garcia-Sanchez [Espagne] ; M. L. Berthier [Espagne] ; M. Barbanoj [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; A. Estevez-Gonzalez [Espagne]Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease : A two-year follow-up study of previously untreated patients
002C41 D. M. Maraganore [États-Unis] ; M. J. Farrer [États-Unis] ; J. A. Hardy [États-Unis] ; S. K. Mcdonnell [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis]Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease
002C47 D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni]Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay
002C51 A. Schrag [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Benign hereditary chorea : Entity or syndrome?
002C52 E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bosch [Autriche] ; Werner Poewe [Autriche]Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's Disease
002C53 K. Ray Chaudhuri [Royaume-Uni] ; M. T. M. Hu [Royaume-Uni] ; D. J. Brooks [Royaume-Uni]Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK
002C54 J. H. Friedman [États-Unis] ; S. A. FactorAtypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
002C55 M. Michaud [Canada] ; A. Chabli [Canada] ; G. Lavigne [Canada] ; J. Montplaisir [Canada]Arm restlessness in patients with restless legs syndrome
002C56 E. Cubo [États-Unis] ; G. T. Stebbins [États-Unis] ; L. I. Golbe [États-Unis] ; A. V. Nieves [États-Unis] ; S. Leurgans [États-Unis] ; C. G. Goetz [États-Unis] ; K. Kompoliti [États-Unis]Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy : Factor analysis of the motor scale
002C57 Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Apomorphine : An underutilized therapy for Parkinson's disease
002C58 M. Shiba [États-Unis] ; J. H. Bower [États-Unis] ; D. M. Maraganore [États-Unis] ; S. K. Mcdonnell [États-Unis] ; B. J. Peterson [États-Unis] ; J. E. Ahlskog [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis]Anxiety disorders and depressive disorders preceding Parkinson's disease : A case-control study
002C67 V. G. H. Evidente [États-Unis, Philippines] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; J. G. Hentz [États-Unis] ; K. Gwinn-Hardy [États-Unis]Amantadine is beneficial in restless legs syndrome
002C69 L. Grevle [Norvège] ; C. Güzey [Norvège] ; H. Hadidi [Norvège] ; R. Brennersted [Norvège] ; J. R. Idle [Norvège] ; J. Aasly [Norvège]Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease
002C70 Silvia Buervenich [Suède] ; Olof Sydow [Suède] ; Andrea Carmine [Suède] ; ZHIPING ZHANG [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède]Alcohol dehydrogenase alleles in Parkinson's disease
002C74 H. T. S. Benamer [Royaume-Uni, Allemagne] ; J. Patterson [Royaume-Uni] ; D. G. Grosset [Royaume-Uni] ; J. Booij ; K. De Bruin ; E. Van Royen ; J. D. Speelman [Pays-Bas] ; M. H. I. M. Horstink [Pays-Bas] ; T. J. W. A. Sips [Pays-Bas] ; R. A. Dierckx [Belgique] ; J. Versijpt [Belgique] ; D. Decoo [Belgique] ; C. Van Der Linden [Belgique] ; D. M. Hadley [Royaume-Uni] ; M. Doder [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. C. Costa [Royaume-Uni] ; S. Gacinovic [Royaume-Uni] ; W. H. Oertel [Allemagne] ; O. Pogarell [Allemagne] ; H. Hoeffken [Allemagne] ; K. Joseph [Allemagne] ; K. Tatsch [Belgique] ; J. Schwarz [Allemagne] ; V. Ries [Allemagne]Accurate differentiation of parkinsonism and essential tremor using Visual assessment of [123I]-FP-CIT SPECT imaging : The [123I]-FP-CIT study group
002C75 A. Filla [Italie] ; G. De Michele [Italie] ; G. Coppola [Italie] ; A. Federico [Italie] ; G. Vita [Italie] ; A. Toscano [Italie] ; A. Uncini [Italie] ; P. Pisanelli [Italie] ; P. Barone [Italie] ; V. Scarano [Italie] ; A. Perretti [Italie] ; L. Santoro [Italie] ; A. Monticelli [Italie] ; F. Cavalcanti [Italie] ; G. Caruso [Italie] ; S. Cocozza [Italie]Accuracy of clinical diagnostic criteria for Friedreich's Ataxia
002C77 B. M. Ross [Canada] ; K. Eder [Allemagne] ; A. Moszczynska [Canada] ; N. Mamalias [Canada] ; J. Lamarche [Canada] ; LEE ANG [Canada] ; M. Pandolfo [Canada] ; G. Rouleau [Canada] ; M. Kirchgessner [Allemagne] ; S. J. Kish [Canada]Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1
002C80 Susan H. Fox [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease
002C81 D. J. Lanska [États-Unis]19th-century American contributions to the recording of tremors
002C82 K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis] ; S. Leurgans [États-Unis] ; M. Morrissey [États-Unis] ; I. M. Siegel [États-Unis]"On" freezing in Parkinson's disease : Resistance to visual cue walking devices
002C83
002C84 Dyskinesias
002C86 G. Ebersbach [Autriche] ; M. Stöck [Autriche] ; J. Müller [Autriche] ; G. Wenning [Autriche] ; J. Wissel [Autriche] ; Werner Poewe [Autriche]Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration
002C87 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis]Worsening of motor features of Parkinsonism with olanzapine
002C88 F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France]Worsening of levodopa-induced dyskinesias by motor and mental tasks
002C89 M. Schwartz [Israël] ; S. Badarny [Israël] ; S. Gofman [Israël] ; S. Hocherman [Israël]Visuomotor performance in patients with essential tremor
002C90 M. H. Thaut [États-Unis] ; R. Miltner [Allemagne] ; H. W. Lange [Allemagne] ; C. P. Hurt [États-Unis] ; V. Hoemberg [Allemagne]Velocity modulation and rhythmic synchronization of gait in Huntington's disease
002C91 G. D. Mellick [Australie] ; D. D. Buchanan [Australie] ; S. J. Mccann [Australie] ; K. M. James [Australie] ; A. G. Johnson [Australie] ; D. R. Davis [Australie] ; N. Liyou [Australie] ; D. Chan [Australie] ; D. G. Le Couteur [Australie]Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease
002C92 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; R. Ottman [États-Unis]Validity of family history data on essential tremor
002C94 R. M. A. De Bie [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; P. S. De Haan [Pays-Bas] ; D. A. Bosch [Pays-Bas] ; J. D. Speelman [Pays-Bas]Unilateral pallidotomy in advanced Parkinson's disease : A retrospective study of 26 patients
002C95 J. Wissel [Autriche] ; J. Müller [Autriche] ; G. Ebersbach [Autriche] ; Werner Poewe [Autriche]Trick maneuvers in cervical dystonia : Investigation of movement- and touch-related changes in polymyographic activity
002C96 P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; M. Bares [République tchèque] ; H. Hortova [République tchèque]Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A : Evidence of a long-lasting effect
002C97 J. L. Montastruc [France] ; Olivier Rascol [France] ; J.-M. Senard [France]Treatment of Parkinson's disease should begin with a dopamine agonist
002C98 S. A. Factor [États-Unis] ; E. S. Molho [États-Unis]Transient benefit of amantadine in Parkinson's disease : The facts about the myth
002C99 F. Cardoso [Brésil] ; R. Faleiro [Brésil]Tourette syndrome : Another cause of movement disorder of the ear
002D00 J. Y. Matsumoto [États-Unis] ; D. W. Dodick [États-Unis] ; L. N. Stevens [États-Unis] ; R. C. Newman [États-Unis] ; P. E. Caskey [États-Unis] ; W. Fjerstad [États-Unis]Three-dimensional measurement of essential tremor
002D02 A. E. Kingsbury [Royaume-Uni] ; D. Marsden [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni]The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis : An in situ hybridization study
002D03 M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
002D04 W. J. Weiner [États-Unis]The initial treatment of Parkinson's disease should begin with levodopa
002D06 C. D. Hardman [Australie] ; G. M. Halliday [Australie]The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy
002D07 J. E. Ahlskog [États-Unis] ; R. J. Uitti [États-Unis] ; M. K. O'Connor [États-Unis] ; D. M. Maraganore [États-Unis] ; J. Y. Matsumoto [États-Unis] ; K. F. Stark [États-Unis] ; M. F. Turk [États-Unis] ; O. L. Burnett [États-Unis]The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
002D08 A. Schrag [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The dancing larynx : A variant of palatal tremor?
002D10 M. D. Hill [Canada] ; R. Kumar [Canada] ; A. Lozano [Canada] ; C. H. Tator [Canada] ; P. Ashby [Canada] ; A. E. Lang [Canada]Syringomyelic dystonia and athetosis
002D12 A. Lazzarini [États-Unis] ; A. S. Walters [États-Unis] ; K. Hickey [États-Unis] ; G. Coccagna [Italie] ; E. Lugaresi [Italie] ; B. L. Ehrenberg [États-Unis] ; D. L. Picchietti [États-Unis] ; M. F. Brin [États-Unis] ; E. S. Stenroos [États-Unis] ; T. Verrico [États-Unis] ; W. G. Johnson [États-Unis]Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees
002D13 C. Dentresangle [France] ; L. Veyre [France] ; D. Le Bars [France] ; C. Pierre [France] ; F. Lavenne [France] ; Pierre Pollak [France] ; J. Guerin [France] ; J.-C. Froment [France] ; E. Brousolle [France]Striatal D2 dopamine receptor status in Parkinson's disease : An [18F]dopa and [11C]raclopride PET study
002D15 A. Dalvi [États-Unis] ; L. Winfield [États-Unis] ; QIPING YU [États-Unis] ; L. Cote [États-Unis] ; R. R. Goodman [États-Unis] ; S. L. Pullman [États-Unis]Stereotactic posteroventral pallidotomy : Clinical methods and results at 1-year follow up
002D17 A. Thomas [Italie] ; M. Onofrj [Italie]Sporadic acetazolamide-responsive episodic ataxia
002D18 MYUNG SIK LEE [Corée du Sud] ; YOUNG DUK KIM [Corée du Sud] ; WON CHAN KIM [Corée du Sud] ; CHUL HYOUNGL YOO [Corée du Sud]Slow rhythmic dyskinesia of the shoulder : One idiopathic and two symptomatic cases
002D19 G. M. Wali [Inde]Shoulder girdle dyskinesia following local surgery
002D20 G. M. Wali [Inde]Shoulder girdle dyskinesia associated with a thalamic infarct
002D22 A. Churchyard [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Selegiline-induced postural hypotension in Parkinson's disease : A longitudinal study on the effects of drug withdrawal
002D24 R. Kumar [Canada] ; R. Chen [Canada] ; P. Ashby [Canada]Safety of transcranial magnetic stimulation in patients with implanted deep brain stimulators
002D25 D. Mathen [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni]SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia
002D28 V. G. H. Evidente [États-Unis, Philippines] ; K. Gwinn-Hardy [États-Unis] ; J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis]Risperidone is effective in severe hemichorea/hemiballismus
002D29 H. D. Rosas [États-Unis] ; W. J. Koroshetz [États-Unis] ; B. G. Jenkins [États-Unis] ; Y. I. Chen [États-Unis] ; D. L. Hayden [États-Unis] ; M. F. Beal [États-Unis] ; M. E. Cudkowicz [États-Unis]Riluzole therapy in Huntington's Disease (HD)
002D30 W. Meissner [Allemagne] ; T. Schmidt [Allemagne] ; A. Kupsch [Allemagne] ; T. Trottenberg [Allemagne] ; T. Lempert [Allemagne]Reversible leucopenia related to olanzapine
002D32 A. Schrag [Royaume-Uni] ; L. Schelosky [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche]Reduction of parkinsonian signs in patients with parkinson's disease by dopaminergic versus anticholinergic single-dose challenges
002D33 C. G. Goetz [États-Unis]Rating scales for dyskinesias in Parkinson's disease
002D36 P. R. Burkhard [États-Unis] ; H. Shale [États-Unis] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis]Quantification of dyskinesia in Parkinson's disease : Validation of a novel instrumental method
002D37 H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis]Punding on L-dopa
002D39 G. K. Wenning [Autriche] ; G. Ebersbach [Autriche] ; M. Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; K. Jellinger [Autriche] ; A. Mckee [États-Unis] ; Werner Poewe [États-Unis] ; I. Litvan [États-Unis]Progression of falls in postmortem-confirmed Parkinsonian disorders
002D40 A. Minguez-Castellanos [Espagne] ; C. Carnero-Pardo [Espagne] ; A. Gomez-Camello [Espagne] ; A. Ortega-Moreno [Espagne] ; T. Garcia-Gomez [Espagne] ; V. Arjona [Espagne] ; J. M. Martin-Linares [Espagne]Primary writing tremor treated by chronic thalamic stimulation
002D42 J. M. Errea [Espagne] ; J. R. Ara [Espagne] ; C. Aibar [Espagne] ; J. De Pedro-Cuesta [Espagne, Suède]Prevalence of Parkinson's disease in Lower Aragon, Spain
002D43 A. G. E. M. De Boer [Pays-Bas] ; M. A. G. Sprangers [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; H. C. J. M. De Haes [Pays-Bas]Predictors of health care use in patients with Parkinson's disease : A longitudinal study
002D44 G. K. Wenning [Autriche] ; E. Luginger [Autriche] ; U. Sailer [Autriche] ; Werner Poewe [Autriche] ; E. Donnemiller [Autriche] ; G. Riccabona [Autriche]Postoperative parkinsonian tremor in a patient with a frontal meningioma
002D45 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis]Possible tardive dystonia resulting from clozapine therapy
002D50 F. Cardoso [Brésil] ; A. P. Vargas [Brésil] ; L. D. Oliveira [Brésil] ; A. A. Guerra [Brésil] ; S. V. Amaral [Brésil]Persistent Sydenham's chorea
002D51 G. J. Brewer [États-Unis]Penicillamine should not be used as initial therapy in Wilson's disease
002D52 J. M. Walshe [Royaume-Uni]Penicillamine : The treatment of first choice for patients with Wilson's disease
002D53 A. Berardelli [Italie] ; J. Noth [Allemagne] ; P. D. Thompson [Australie] ; E. L. E. M. Bollen [Pays-Bas] ; A. Curra [Italie] ; G. Deuschl [Allemagne] ; J. G. Van Dijk [Pays-Bas] ; R. Töpper [Allemagne] ; T. Schwarz [Allemagne] ; R. A. C. Roos [Pays-Bas]Pathophysiology of chorea and bradykinesia in Huntington's disease
002D54 P. J. Bedard [Canada] ; P. J. Blanchet [Canada] ; D. Levesque [Canada] ; J.-J. Soghomonian [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; F. Calon [Canada] ; P. Falardeau [Canada] ; B. Gomez-Mancilla [Canada] ; J.-P. Doucet [Canada] ; G. S. Robertson [Canada] ; T. Dipaolo [Canada]Pathophysiology of L-Dopa-induced dyskinesias
002D58 M. G. Cerosimo [Argentine] ; F. Micheli [Argentine]Paroxysmal dyskinesia and gonadal sex hormones
002D61 R. H. Walker [États-Unis] ; H. Spiera [États-Unis] ; M. F. Brin [États-Unis] ; C. W. Olanow [États-Unis]Parkinsonism associated with Sjögren's syndrome : Three cases and a review of the literature
002D64 P. K. Kulkarni [Inde] ; U. B. Muthane [Inde] ; A. B. Taly [Inde] ; P. N. Jayakumar [Inde] ; R. Shetty [Inde] ; H. Sathyanarayana Swamy [Inde]Palatal tremor, progressive multiple cranial nerve palsies, and cerebellar ataxia : A case report and review of literature of palatal tremors in neurodegenerative disease
002D65 B. Jabbari [États-Unis] ; A. Salardini [Australie]Painful tonic/dystonic spasms in Sjogren's syndrome
002D66 J. Pitagoras De Mattos [Brésil] ; M. Oliveira Py [Brésil] ; C. Andre [Brésil]Painful legs and moving toes associated with neuropathy in HIV-infected patients
002D67 D. Tarsy [États-Unis] ; E. R. First [États-Unis]Painful cervical dystonia : Clinical features and response to treatment with botulinum toxin
002D70 P.-A. Fall [Suède] ; M. Fredrikson [Suède] ; O. Axelson [Suède] ; A.-K. Granerus [Suède]Nutritional and occupational factors influencing the risk of parkinson's disease : A case-control study in southeastern Sweden
002D72 Pierre Pollak [France]Neurosurgical treatment of dyskinesias : Pathophysiological consideration
002D73 H. R. Morris [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Neurofibrillary tangle Parkinsonian disorders : Tau pathology and Tau genetics
002D74 J. Kimber [Royaume-Uni] ; L. Watson ; C. J. MathiasNeuroendocrine responses to levodopa in multiple system atrophy (MSA)
002D75 T. Yanagisawa [Japon] ; H. Sugihara [Japon] ; K. Shibahara [Japon] ; T. Kamo [Japon] ; K. Fujisawa [Japon] ; M. Murayama [Japon]Natural course of combined limb and palatal tremor caused by cerebellar-brain stem infarction
002D76 K. R. Müller-Vahl [Allemagne] ; U. Schneider [Allemagne] ; H. M. Emrich [Allemagne]Nabilone increases choreatic movements in Huntington's disease
002D77 S. Nagamitsu [Japon] ; T. Matsuishi [Japon] ; K. Hashimoto [Japon] ; Y. Yamashita [Japon] ; M. Aihara [Japon] ; K. Shimizu [Japon] ; M. Mizuguchi [Japon] ; H. Iwamoto [Japon] ; S. Saitoh [Japon] ; Y. Hirano [Japon] ; H. Kato [Japon] ; Y. Fukuyama [Japon] ; M. Shimada [Japon]Multicenter study of paroxysmal dyskinesias in Japan : Clinical and pedigree analysis
002D80 K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis] ; D. C. Gajdusek [France] ; E. Cubo [États-Unis]Movement disorders in Kuru
002D82 L. J. P. Defebvre [France] ; P. Derambure [France] ; J.-L. Bourriez [France] ; F. Cassim [France] ; J. D. Guieu [France] ; A. Destee [France]Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease : A spatiotemporal study of event-related desynchronization
002D83 D. A. Grimes [Canada] ; C. B. Bergeron [Canada] ; A. E. Lang [Canada]Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration
002D84 P. Praamstra [Pays-Bas] ; E. M. Plat [Pays-Bas] ; A. S. Meyer [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas]Motor cortex activation in Parkinson's disease : Dissociation of electrocortical and peripheral measures of response generation
002D86 N. Giladi [Israël] ; H. Shabtai [Israël]Melatonin-induced withdrawal emergent dyskinesia and akathisia
002D89 B. Jabbari [États-Unis] ; K. Khajevi [États-Unis] ; K. Rao [États-Unis]Medullary dystonia
002D90 J. Winkelmann [Allemagne] ; D. P. Auer [Allemagne] ; C. Lechner [Allemagne] ; G. Elbel [Allemagne] ; C. Trenkwalder [Allemagne]Magnetic resonance imaging findings in corticobasal degeneration
002D91 L. Baum [Hong Kong] ; Z.-Y. Dong [République populaire de Chine] ; H.-K. Ng [Hong Kong] ; L. K. Law [Hong Kong] ; J. Woo [Hong Kong] ; CHI PUI PANG [Hong Kong]Low-density lipoprotein receptor-related protein (LRP) gene 766T polymorphism and Parkinson's disease
002D92 K. L. Tsang [Hong Kong] ; K. Y. Fong [Hong Kong] ; S. L. Ho [Hong Kong]Localized neuromyotonia of neck muscles after radiotherapy for nasopharyngeal carcinoma
002D94 P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; J. Dufek [République tchèque] ; V. Znojil [République tchèque] ; P. Daniel [République tchèque] ; I. Rektor [République tchèque]Lateralization of the P22/N30 precentral cortical component of the median nerve somatosensory evoked potentials is different in patients with a tonic or tremulous form of cervical dystonia
002D95 D. C. C. Wan [Hong Kong] ; L. K. Law [Hong Kong] ; D. T. M. Ip [Hong Kong] ; W. T. Cheung [Hong Kong] ; W. K. K. Ho [Hong Kong] ; K. W. K. Tsim [Hong Kong] ; R. Kay [Hong Kong] ; J. Woo [Hong Kong] ; C. P. Pang [Hong Kong]Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a chinese population
002D96 Olivier Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approach
002D98 E. Cassetta [Italie] ; N. Del Grosso [Italie] ; A. R. Bentivoglio [Italie] ; E. M. Valente [Italie, Royaume-Uni] ; M. Frontali [Italie] ; A. Albanese [Italie, Suisse]Italian family with cranial cervical dystonia : Clinical and genetic study
002D99 V. G. H. Evidente [Philippines] ; J. N. Caviness [Philippines] ; B. Jamieson [États-Unis] ; A. Weaver [États-Unis] ; N. Joshi [États-Unis]Intersubject variability and intrasubject reproducibility of the bereitschaftspotential
002E00 G. Ebersbach [Allemagne] ; M. Heijmenberg [Allemagne] ; L. Kindermann [Allemagne] ; T. Trottenberg [Allemagne] ; J. Wissel [Autriche] ; Werner Poewe [Autriche]Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson's disease : Evidence for impaired locomotor pattern generation in early Parkinson's disease
002E01 P. Barbanti [Italie] ; G. Fabbrini [Italie] ; A. Ricci [Italie] ; R. Cerbo [Italie] ; E. Bronzetti [Italie] ; B. Caronti [Italie] ; C. Calderaro [Italie] ; L. Felici [Italie] ; F. Stocchi [Italie] ; G. Meco [Italie] ; F. Amenta [Italie] ; G. L. Lenzi [Italie]Increased expression of dopamine receptors on lymphocytes in Parkinson's disease
002E02 F. Stocchi [Italie] ; C. Farina [Italie] ; G. Nordera [Italie] ; S. Ruggieri [Italie]Implantable venous access system for apomorphine infusion in complicated Parkinson's disease
002E03 T. Kato [France, Canada] ; J. Y. Montplaisir [France, Canada] ; P. J. Blanchet [Canada] ; J. P. Lund [Canada] ; G. J. Lavigne [France, Canada]Idiopathic myoclonus in the oromandibular region during sleep : A possible source of confusion in sleep bruxism diagnosis
002E05 S. Diaz [Argentine] ; M. C. Scorticati [Argentine] ; F. Micheli [Argentine]Hereditary chin tremor/myoclonus : A report from Latin America
002E06 E. Marchioni [Italie] ; D. Soragna [Italie] ; M. Versino [Italie] ; L. Sibilla [Italie] ; E. Alfonsi [Italie] ; A. Romani [Italie] ; R. Manni [Italie] ; F. Savoldi [Italie] ; C. Messa [Italie] ; A. D'Amico [Italie] ; F. Fazio [Italie]Hemiparkinsonism-hemiatrophy with brain hemihypoplasia
002E07 H. Miwa [Japon] ; A. Yoritaka [Japon] ; Y. Mizuno [Japon]Hemifacial spasm in Parkinson's disease
002E08 L. D. Oliveira [Brésil] ; F. Cardoso [Brésil] ; A. P. Vargas [Brésil]Hemifacial spasm and arterial hypertension
002E12 C. Kamm [Allemagne] ; E. Castelon-Konkiewitz [Allemagne] ; M. Naumann [Allemagne] ; F. Heinen [Allemagne] ; M. Brack [États-Unis] ; A. Nebe [Allemagne] ; A. Ceballos-Baumann [Allemagne] ; T. Gasser [Allemagne]GAG deletion in the DYT1 gene in early limb-onset idiopathic torsion dystonia in Germany
002E15 T. Brannan [États-Unis] ; M. D. Yahr [États-Unis]Focal tremor following striatal infarct: A case report
002E17 G. T. Stebbins [Canada] ; C. G. Goetz [Canada] ; A. E. Lang [Canada] ; E. Cubo [Canada]Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state
002E18 E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège]Excessive daytime sleepiness and sleep benefit in Parkinson's disease : A community-based study
002E19 K. A. Reardon [Australie] ; M. Shiff [Australie] ; P. A. Kempster [Australie]Evolution of motor fluctuations in Parkinson's disease : A longitudinal study over 6 years
002E22 A.-M. Kuopio [Finlande] ; R. J. Marttila [Finlande] ; H. Helenius [Finlande] ; U. K. Rinne [Finlande]Environmental risk factors in Parkinson's disease
002E23 W. C. Koller [États-Unis] ; K. E. Lyons [États-Unis] ; S. B. Wilkinson [États-Unis] ; R. Pahwa [États-Unis]Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor
002E26 R. Chen [États-Unis, Canada] ; B. I. Karp [États-Unis] ; S. R. Goldstein [États-Unis] ; W. Bara-Jimenez [États-Unis] ; Z. Yaseen [États-Unis] ; M. Hallett [États-Unis]Effect of muscle activity immediately after botulinum toxin injection for writer's cramp
002E27 J. S. P. Van Den Berg [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; F. H. J. Van Den Hoogen [Pays-Bas] ; W. J. G. Oyen [Pays-Bas]Dystonia; a central nervous system presentation of Sjögren's syndrome
002E30 P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France]Dyskinesias assessment in phase II studies
002E31 P. Brown [Royaume-Uni] ; A. Manson [Royaume-Uni]Dyskinesias assessment and ambulatory devices
002E32 H. Widner [Suède] ; G.-L. Defer [France]Dyskinesias assessment : From CAPIT to CAPSIT
002E33 Y. Furukawa [Canada] ; S. J. Kish [Canada]Dopa-responsive dystonia : Recent advances and remaining issues to be addressed
002E34 M. M. Pinter [Autriche] ; M. Murg [Autriche] ; F. Alesch [Autriche] ; B. Freundl [Autriche] ; R. J. Helscher [Autriche] ; H. Binder [Autriche]Does deep brain stimulation of the nucleus ventralis intermedius affect postural control and locomotion in Parkinson's disease?
002E35 A. H. Nemeth [Royaume-Uni] ; K. R. Mills [Royaume-Uni] ; J. S. Elston [Royaume-Uni] ; A. Williams [Royaume-Uni] ; E. Dunne [Royaume-Uni] ; N. M. Hyman [Royaume-Uni]Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature
002E38 N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; E. Chiu [Australie] ; A. Tudor [Australie] ; L. O'Gorman [Australie] ; J. G. Phillips [Australie]Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
002E41 I. Vermes [Pays-Bas] ; E. N. H. J. Steur [Pays-Bas] ; C. Reutelingsperger [Pays-Bas] ; C. Haanen [Pays-Bas]Decreased concentration of annexin v in parkinsonian cerebrospinal fluid : Speculation on the underlying cause
002E43 G.-L. Defer [France] ; H. Widner [Suède] ; R.-M. Marie [France] ; P. Remy [France] ; M. Levivier [Belgique]Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
002E45 T. Rosolacci [France] ; V. Neuville [France] ; R. Huric [France] ; P. Dobbelaere [France]Complex hyperkinesias ipsilateral to right frontoparietal cortical infarction
002E46 T. Mezaki [Japon] ; R. Kaji [Japon] ; M. F. Brin [États-Unis] ; M. Hirota-Katayama [Japon] ; T. Kubori [Japon] ; T. Shimizu [Japon] ; J. Kimura [Japon]Combined use of type A and F botulinum toxins for blepharospasm : A double-blind controlled trial
002E47 C. Junque [Suède] ; M. Alegret [Suède] ; F. A. Nobbe [Espagne] ; F. Valldeoriola [Espagne] ; R. Pueyo [Suède] ; P. Vendrell [Suède] ; E. Tolosa [Espagne] ; J. Rumia [Espagne] ; J. M. Mercader [Espagne]Cognitive and behavioral changes after unilateral posteroventral pallidotomy : Relationship with lesional data from MRI
002E50 P. Chariot [France] ; P. Brugieres [France] ; M.-C. Eliezer-Vanerot [France] ; C. Geny [France] ; M. Binaghi [France] ; P. Cesaro [France]Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy
002E51 H. R. Siebner [Allemagne] ; A. Ceballos-Baumann [Allemagne] ; H. Standhardt [Autriche] ; C. Auer [Allemagne] ; B. Conrad [Allemagne] ; F. Alesch [Autriche]Changes in handwriting resulting from bilateral high-frequency stimulation of the subthalamic nucleus in Parkinson's disease
002E52 O. Lindvall [Suède]Cerebral implantation in movement disorders : State of the art
002E55 G. Northoff [Allemagne] ; A. Koch [Allemagne] ; J. Wenke [Allemagne] ; J. Eckert [Allemagne] ; H. Böker [Allemagne] ; B. Pflug [Allemagne] ; B. Bogerts [Allemagne]Catatonia as a psychomotor syndrome : A rating scale and extrapyramidal motor symptoms
002E57 N. Sabbagh [France] ; A. Brice [France] ; D. Marez [France] ; A. Dürr [France] ; M. Legrand [France] ; J.-M. Lo Guidice [France] ; A. Destee [France] ; Yves Agid [France] ; F. Broly [France]CYP2D6 polymorphism and Parkinson's disease susceptibility
002E58 G. Cicarelli [Italie] ; M. T. Pellecchia [Italie] ; F. Maiuri [Italie] ; P. Barone [Italie]Brain stem cystic astrocytoma presenting with "pure" parkinsonism
002E60 R. Kaji [Japon] ; M. Katayama-Hirota [Japon] ; N. Kohara [Japon] ; Y. Kojima [Japon] ; QING YANG [Japon] ; J. Kimura [Japon]Blepharospasm induced by an LED flashlight
002E61 E. K. Tan [États-Unis] ; Joseph Jankovic [États-Unis]Bilateral hemifacial spasm : A report of five cases and a literature review
002E62 H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] ; J. V. Centofanti [États-Unis]Benedikt's syndrome with delayed-onset rubral tremor and hemidystonia : A complication of tic douloureux surgery
002E64 E. D. Louis [États-Unis] ; K. Marder [États-Unis] ; C. Moskowitz [États-Unis] ; P. Greene [États-Unis]Arm elevation in Huntington's disease : Dystonia or levitation?
002E67 E. Moro [Italie] ; A. Albanese [Italie, Suisse]Apomorphine and levodopa challenge in patients with a focal midbrain lesion
002E69 A. Spissu [Italie] ; A. Cannas [Italie] ; P. Ferrigno [Italie] ; A. E. Pelaghi [Italie] ; M. Spissu [Italie]Anatomic correlates of painful tonic spasms in multiple sclerosis
002E72 C. G. Goetz [États-Unis] ; E. J. Pappert [États-Unis] ; E. D. Louis [États-Unis] ; R. Raman [États-Unis] ; S. Leurgans [États-Unis]Advantages of a modified scoring method for the rush video-based tic rating scale
002E73 R. Ceravolo [Italie] ; S. Salvetti [Italie] ; P. Piccini [Royaume-Uni] ; C. Lucetti [Italie] ; G. Gambaccini [Italie] ; U. Bonuccelli [Italie]Acute and chronic effects of clozapine in essential tremor
002E74 M. Onofrj [Italie] ; A. Thomas [Italie]Acetazolamide-responsive periodic ataxia induced by amiodarone
002E75 O. Joost [États-Unis] ; C. A. Taylor [États-Unis] ; C. A. Thomas [États-Unis] ; L. A. Cupples [États-Unis] ; M. H. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; C. T. Baldwin [États-Unis] ; R. H. Myers [États-Unis]Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease
002E76 M. W. Hayes [Australie] ; S. Graham [Australie] ; P. Heldorf [Australie] ; G. De Moore [Australie] ; J. G. L. Morris [Australie]A video review of the diagnosis of psychogenic gait : Appendix and commentary
002E77 J. I. Hoff [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas]A review of the assessment of dyskinesias
002E78 J.-L. Montastruc [France] ; M. Ziegler [France] ; Olivier Rascol [France] ; M. Malbezin [France]A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
002E80 W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; M. Almaguer [États-Unis] ; Joseph Jankovic [États-Unis]A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease
002E81 R. J. Caselli [États-Unis] ; G. E. Stelmach [États-Unis] ; J. N. Caviness [États-Unis] ; D. Timmann [Allemagne] ; T. Royer [États-Unis] ; B. F. Boeve [États-Unis] ; J. E. Parisi [États-Unis]A kinematic study of progressive apraxia with and without dementia
002E83 M. Fukuda [Japon] ; O. Hashimoto [Japon] ; S. Nagakubo [Japon] ; A. Hata [Japon]A family with an atonic variant of paroxysmal kinesigenic choreoathetosis and hypercalcitoninemia
002E84 J. M. Graham [Royaume-Uni] ; BSC [Royaume-Uni] ; H. J. Sagar [Royaume-Uni] ; DM [Royaume-Uni]A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease : Identification of three distinct subtypes
002E85 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; H. Lee [États-Unis] ; H. Andrews [États-Unis]A comparison of different bedside tests for essential tremor
002E87 K. Bötzel [Allemagne] ; K. J. Werhahn [Allemagne]A case of myoclonic cortical tremor after extirpation of a parietal meningioma
002E89 Tremor: basic mechanisms and clinical aspects
002E91 A. Schrag [Royaume-Uni] ; Y. Ben-Shlomo [Royaume-Uni] ; R. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. Quinn [Royaume-Uni]Young-onset Parkinson's disease revisited : Clinical features, natural history, and mortality
002E93 I. Shoulson [États-Unis]Where do we stand on neuroprotection? Where do we go from here?
002E94 C. Klein [Allemagne] ; E. Gehrking [Allemagne] ; P. Vieregge [Allemagne]Voluntary palatal tremor in two siblings
002E95 M. R. Trimble [Royaume-Uni] ; R. Whurr [Royaume-Uni] ; G. Brookes [Royaume-Uni] ; M. M. Robertson [Royaume-Uni]Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections
002E97 C. Sankhla [États-Unis] ; Joseph Jankovic [États-Unis] ; D. Duane [États-Unis]Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections
002E98 O. Lindvall [Suède]Update on fetal transplantation : The Swedish experience
002E99 G. Ebersbach [Autriche] ; L. Schelosky [Allemagne] ; A. Schenkel [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche]Unilateral painful legs and moving toes syndrome with moving fingers : Evidence for distinct oscillators
002F00 S. Siesling [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. A. H. Zwinderman [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas]Unified Huntington's disease rating scale : A follow up
002F02 P. Krack [France] ; A. Benazzouz [France] ; Pierre Pollak [France] ; P. Limousin [France] ; B. Piallat [France] ; D. Hoffmann [France] ; JING XIE [France] ; Alim-Louis Benabid [France]Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation
002F03 J. Winkelmann [Allemagne] ; T. C. Wetter [Allemagne] ; K. Stiasny [Allemagne] ; W. H. Oertel [Allemagne] ; C. Trenkwalder [Allemagne]Treatment of restless leg syndrome with pergolide : An open clinical trial
002F04 M. Bakar [Turquie] ; M. Zarifoglu [Turquie] ; I. Bora [Turquie] ; F. Turan [Turquie] ; C. Sen [Turquie] ; E. Ogul [Turquie]Treatment of hereditary trembling chin with botulinum toxin
002F06 Y.-C. Liu [Taïwan] ; Z.-A. Wu ; S.-J. Wang ; D.-E. Shan ; K.-P. LinTransient syndrome of continuous muscle fiber activity associated with staphylococcal infection
002F08 M. C. Rodriguez [Espagne] ; O. J. Guridi [Espagne] ; L. Alvarez [Cuba] ; K. Mewes [États-Unis] ; R. Macias [Cuba] ; J. Vitek [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne]The subthalamic nucleus and tremor in Parkinson's disease
002F09 S. Hua [États-Unis] ; S. G. Reich ; A. T. Zirh ; V. Perry ; P. M. Dougherty ; F. A. LenzThe role of the thalamus and basal ganglia in parkinsonian tremor
002F10 T. Van Laar [Pays-Bas] ; B. Van Hilten [Pays-Bas] ; C. Neef [Pays-Bas] ; A. W. F. Rutgers [Pays-Bas] ; S. Pavel [Pays-Bas] ; J. A. Bruijn [Pays-Bas]The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease : A histologic study
002F12 E. A. Chrischilles [États-Unis] ; L. M. Rubenstein [États-Unis] ; M. D. Voelker [États-Unis] ; R. B. Wallace [États-Unis] ; R. L. Rodnitzky [États-Unis]The health burdens of Parkinson's disease
002F13 A. S. Buchman [États-Unis] ; C. L. Comella [États-Unis] ; S. Leurgans [États-Unis] ; G. T. Stebbins [États-Unis] ; C. G. Goetz [États-Unis]The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD)
002F14 J. D. Speelman [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; D. A. Bosch [Pays-Bas]Thalamic surgery and tremor
002F16 D. J. Burn [Royaume-Uni] ; A. Coulthard [Royaume-Uni] ; S. Connolly [Royaume-Uni] ; N. E. F. Cartlidge [Royaume-Uni]Tardive diaphragmatic flutter
002F17 P. Sachdev [Australie]Tardive blepharospasm
002F18 G. De Boo [Pays-Bas] ; A. Tibben [Pays-Bas] ; J. Hermans [Pays-Bas] ; A. Maat [Pays-Bas] ; R. A. C. Roos [Pays-Bas]Subtle involuntary movements are not reliable indicators of incipient Huntington's disease
002F20 J. C. Detoledo [États-Unis] ; R. Dow [États-Unis]Sternomastoid function during hemispheric suppression by amytal : Insights into the inputs to the spinal accessory nerve nucleus
002F22 S. L. Pullman [États-Unis]Spiral analysis : A new technique for measuring tremor with a digitizing tablet
002F23 M. S. Ledoux [États-Unis] ; L. J. Mcgill ; W. A. Pulsinelli ; R. F. Pfeiffer ; G. Deuschl [Allemagne] ; A. Siderowf [États-Unis] ; R. Kurlan [États-Unis] ; K. Sethi [États-Unis]Severe bilateral tremor in a liver transplant recipient taking cyclosporine
002F24 A. Kupsch [Allemagne] ; W. H. Oertel [Allemagne]Selegiline, pregnancy, and Parkinson's disease
002F25 A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie]Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study
002F26 Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study
002F27 R. C. Duvoisin [États-Unis]Role of genetics in the cause of Parkinson's disease
002F28 I. Ziv [Israël] ; E. MelamedRole of apoptosis in the pathogenesis of Parkinson's disease : A novel therapeutic opportunity?
002F29 J. Sunden-Cullberg [Suède] ; J. Tedroff [Suède] ; S.-M. Aquilonius [Suède]Reversible chorea in primary antiphospholipid syndrome
002F30 J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Resurgence of functional neurosurgery for Parkinson's disease : A historical perspective
002F33 C. P. Pang [Hong Kong] ; JUN ZHANG [Hong Kong] ; T. Woo [Hong Kong] ; D. Chan [Hong Kong] ; L. K. Law [Hong Kong] ; S. F. Tong [Hong Kong] ; T. Kwok [Hong Kong] ; T. Kay [Hong Kong]Rarity of debrisoquine hydroxylase gene polymorphism in chinese patients with Parkinson's disease
002F34 F. Blandini [Italie] ; G. Nappi [Italie] ; J. T. Greenamyre [États-Unis]Quantitative study of mitochondrial complex I in platelets of parkinsonian patients
002F36 MEE OHK KIM [Corée du Sud] ; J.-H. Im [Corée du Sud] ; CHOONG GON CHOI [Corée du Sud] ; MYOUNG CHONG LEE [Corée du Sud]Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia
002F37 S. E. Johnson [Norvège] ; A. Dahl [Norvège] ; O. Sjaastad [Norvège]Progressive pseudobulbar paresis, early choreiform movements, and later rigidity : Appearance in two sets of dizygotic twins in the same family
002F38 R. E. Burke [États-Unis]Programmed cell death and Parkinson's disease
002F39 A. Chio [Italie] ; C. Magnani [Italie] ; D. Schiffer [Italie]Prevalence of Parkinson's disease in Northwestern Italy : Comparison of tracer methodology and clinical ascertainment of cases
002F40 D. J. Cordato [Australie] ; M. J. Fulham [Australie] ; C. Yiannikas [Australie]Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease
002F41 P. Hagell [Suède] ; P. Odin [Allemagne] ; E. Vinge [Suède]Pregnancy in Parkinson's disease : A review of the literature and a case report
002F43 P. C. Jacob [Oman] ; R. Pratap Chand [Oman]Posttraumatic rubral tremor responsive to clonazepam
002F44 R. Kurlan [États-Unis]Postprandial (reactive) hypoglycemia and restless leg syndrome : Related neurologic disorders?
002F46 A. D. Siderowf [États-Unis] ; S. L. Galetta [États-Unis] ; H. I. Hurtig [États-Unis] ; G. T. Liu [États-Unis]Posey and Spiller and progressive supranuclear palsy : An incorrect attribution
002F47 T. C. Wetter [Allemagne] ; K. Stiasny [Allemagne] ; R. Kohnen [Allemagne] ; W. H. Oertel [Allemagne] ; C. Trenkwalder [Allemagne]Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome
002F48 C. Colosimo [Italie]Pisa syndrome in a patient with multiple system atrophy
002F49 H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël]Physiology of MPTP tremor
002F50 J. C. Rothwell [Royaume-Uni]Physiology and anatomy of possible oscillators in the central nervous system
002F51 P. G. Wasielewski [États-Unis] ; J. M. Burns [États-Unis] ; W. C. Koller [États-Unis]Pharmacologic treatment of tremor
002F52 M. Vidailhet [France] ; C.-P. Jedynak [France] ; Pierre Pollak [France] ; Yves Agid [France]Pathology of symptomatic tremors
002F55 H. R. Morris [Royaume-Uni] ; Neville F. Moriabadi [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. J. Dick [États-Unis] ; Nora F. Moriabadi [Royaume-Uni] ; D. Turjanski [Royaume-Uni]Parkinsonism following electrical injury to the hand
002F56 F. Simonetti [Italie] ; P. Pergami [Italie] ; K. M. Aktipi [Italie] ; G. Giardini [Italie] ; M. Ceroni [Italie] ; P. Lattuada [Italie] ; G. Valenti [Italie]Paraneoplastic "rubral" tremor : A case report
002F57 E. J. Skalabrin [États-Unis] ; E. R. Jr Laws [États-Unis] ; J. P. Jr Bennett [États-Unis]Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease
002F60 R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada]Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease
002F61 A. G. Riedl [Royaume-Uni] ; P. M. Watts [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]P450 enzymes and Parkinson's disease : The story so far
002F62 P. Jenner [Royaume-Uni]Oxidative mechanisms in nigral cell death in Parkinson's disease
002F63 M. Hallett [États-Unis]Overview of human tremor physiology
002F64 J. Volkmann [Allemagne]Oscillations of the human sensorimotor system as revealed by magnetoencephalography
002F66 C. H. Adler [États-Unis] ; K. A. Gwinn [États-Unis] ; S. Newman [États-Unis]Olfactory function in restless legs syndrome
002F68 D. Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Nicotine nasal spray is not reliable treatment for blepharospasm : Results of a pilot study
002F70 R. Töpper [Allemagne] ; M. Schwarz [Allemagne] ; H. W. Lange [Allemagne] ; H. Hefter [Allemagne] ; J. Noth [Allemagne]Neurophysiological abnormalities in the Westphal variant of Huntington's disease
002F71 J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; C. W. Olanow [États-Unis]Neuropathology of fetal nigral grafts in patients with Parkinson's disease
002F72 M. S. Schwartz [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; J. Filshie [Royaume-Uni]Neuromyotonia in a muscle flap producing a convulsing breast : Successful treatment with botulinum toxin
002F73 O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne]Neural transplantation in Parkinson's disease and its effects on rest tremor : A review of the literature
002F74 V. P. Calabrese [Canada] ; K. A. Lloyd [Canada] ; P. Brancazio [Canada] ; E. Cefali [États-Unis] ; P. Martin [États-Unis] ; J. Jr Wall [États-Unis] ; D. Sica [États-Unis]N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism
002F75 C. Carnero-Pardo [Espagne] ; J. C. Sanchez-Alvarez [Espagne] ; A. Gomez-Camello [Espagne] ; A. Minguez-Castellanos [Espagne] ; F. J. Hernandez-Ramos [Espagne] ; T. Garcia-Gomez [Espagne]Myoclonus associated with thoracodorsal neuropathy
002F78 S. Ohara [Japon] ; R. Hayashi [Japon] ; H. Momoi [Japon] ; J. Miki [Japon] ; N. Yanagisawa [Japon]Mexiletine in the treatment of spasmodic torticollis
002F79 S. Przedborski [États-Unis] ; V. Jackson-Lewis [États-Unis]Mechanisms of MPTP toxicity
002F80 S. Spieker [Allemagne] ; A. Boose [Allemagne] ; S. Breit [Allemagne] ; J. Dichgans [Allemagne]Long-term measurement of tremor
002F81 Alim-Louis Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; Pierre Pollak [France]Long-term electrical inhibition of deep brain targets in movement disorders
002F82 J. H. Carter [États-Unis] ; B. J. Stewart [États-Unis] ; P. G. Archbold [États-Unis] ; I. Inoue [États-Unis] ; J. Jaglin [États-Unis] ; M. Lannon [États-Unis] ; E. Rost-Ruffner [États-Unis] ; M. Tennis [États-Unis] ; M. P. Mcdermott [États-Unis] ; D. Amyot [Canada] ; R. Barter [États-Unis] ; L. Cornelius [États-Unis] ; C. Demong [Canada] ; J. Dobson [États-Unis] ; J. Duff [Canada] ; J. Erickson [États-Unis] ; N. Gardiner [États-Unis] ; L. Gauger [États-Unis] ; P. Gray [Canada] ; B. Kanigan [Canada] ; B. Kiryluk [États-Unis] ; P. Lewis [États-Unis] ; K. Mistura [États-Unis] ; T. Malapira [États-Unis] ; M. Pay [États-Unis] ; C. Sheldon [États-Unis] ; L. Winfield [États-Unis] ; K. Wolfington-Shallow [États-Unis] ; K. Zoog [États-Unis]Living with a person who has Parkinson's disease : The spouse's perspective by stage of disease
002F83 G. Denes [Italie] ; M. C. Mantovan [Italie] ; A. Gallana [Italie] ; J. Y. Cappelletti [Italie]Limb-kinetic apraxia
002F84 P. Duffey [Royaume-Uni] ; A. Coulthard ; D. J. BurnLate observation of the Goutières Aicardi syndrome
002F87 E. C. Hirsch [France] ; B. A. Faucheux [France]Iron metabolism and Parkinson's disease
002F92 B. Holmberg [Suède] ; L. Rosengren [Suède] ; J.-E. Karlsson [Suède] ; B. Johnels [Suède]Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease
002F95 J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; C. Geny [France] ; P. Cesaro [France]Improvement of action tremor by chronic cortical stimulation
002F98 R. M. Oliveira [Royaume-Uni, Brésil] ; J. M. Gurd [Royaume-Uni] ; P. Nixon ; J. C. Marshall [Royaume-Uni] ; R. E. Passingham [Royaume-Uni]Hypometria in Parkinson's disease : Automatic versus controlled processing
003000 K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis]Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome
003001 E. Silber [Afrique du Sud] ; J. Kromberg [Afrique du Sud] ; J. A. Temlett [Afrique du Sud] ; A. Krause [Afrique du Sud] ; D. Saffer [Afrique du Sud]Huntington's disease confirmed by genetic testing in five African families
003002 E. D. Louis [États-Unis] ; R. Ottman [États-Unis] ; W. A. Hauser [États-Unis]How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world
003005 P. Krack [Allemagne] ; S. Schneider [Allemagne] ; G. Deuschl [Allemagne]Geste device in tardive dystonia with retrocollis and opisthotonic posturing
003006 O. Bandmann [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Genetic aspects of Parkinson's disease
003008 J. M. Hausdorff [États-Unis] ; M. E. Cudkowicz [États-Unis] ; R. Firtion [États-Unis] ; J. Y. Wei [États-Unis] ; A. L. Goldberger [États-Unis]Gait variability and basal ganglia disorders : Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease
003009 S. Palliyath [États-Unis] ; M. Hallett ; S. L. Thomas ; M. K. Lebiedowska [États-Unis]Gait in patients with cerebellar ataxia
003010 M. Van Zagten [Pays-Bas] ; J. Lodder [Pays-Bas] ; F. Kessels [Pays-Bas]Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions
003011 J. D. O'Sullivan [Australie] ; C. M. Said [Australie] ; L. C. Dillon [Australie] ; M. Hoffman [Australie] ; A. J. Hughes [Australie]Gait analysis in patients with Parkinson's disease and motor fluctuations : Influence of levodopa and comparison with other measures of motor function
003012 S.-L. Ho [Hong Kong] ; M. H. W. Kung [Hong Kong]G209A mutation in the α-synuclein gene is rare and not associated with sporadic Parkinson's disease
003014 H. Boecker [Royaume-Uni, Allemagne] ; D. J. Brooks [Royaume-Uni]Functional imaging of tremor
003015 E. M. Gatto [Argentine] ; M. C. Zurru [Argentine] ; C. Rugilo [Argentine] ; S. Mitre [Argentine] ; A. M. Pardal [Argentine] ; M. Martinez [Argentine] ; M. M. Fernandez Pardal [Argentine]Focal myoclonus associated with posterior thalamic hematoma
003016 J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; E.-Y. Chen [États-Unis] ; E. J. Mufson [États-Unis] ; P. R. Sanberg [États-Unis] ; R. A. Hauser [États-Unis] ; B. Snow [Canada] ; C. W. Olanow [États-Unis]Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
003017 C. Klein [Allemagne] ; P. Vieregge [Allemagne]Fahr's disease : Far from a disease
003019 R. Djaldetti [Israël] ; I. Ziv ; E. MelamedExtreme anticipation in young-onset Parkinson's disease
003020 P. E. Greene [États-Unis] ; S. Bressman [États-Unis]Exteroceptive and interoceptive stimuli in dystonia
003021 C. L. Comella [États-Unis] ; K. M. Shannon [États-Unis] ; J. Jaglin [États-Unis]Extensor truncal dystonia : Successful treatment with botulinum toxin injections
003022 J. J. Higgins [États-Unis] ; J. M. Loveless [États-Unis] ; Joseph Jankovic [États-Unis] ; P. I. Patel [États-Unis]Evidence that a gene for essential tremor maps to chromosome 2p in four families
003024 V. G. H. Evidente [États-Unis] ; C. H. Adler [États-Unis] ; C. Giannini [États-Unis] ; C. R. Conley [États-Unis] ; J. E. Parisi [États-Unis] ; G. P. Fletcher [États-Unis]Erdheim-chester disease with extensive intraaxial brain stem lesions presenting as a progressive cerebellar syndrome
003025 M. F. Brin [États-Unis] ; W. Koller [États-Unis]Epidemiology and genetics of essential tremor
003026 C. S. Lu [Taïwan] ; A. Ikeda [Japon] ; K. Terada [Japon] ; T. Mima [Japon] ; T. Nagamine [Japon] ; H. Fukuyama [Japon] ; N. Kohara [Japon] ; Y. Kojima [Japon] ; Y. Yonekura [Japon] ; R. S. Chen [Taïwan] ; C. H. Tsai [Taïwan] ; N. S. Chu [Taïwan] ; J. Kimura [Japon] ; H. Shibasaki [Japon]Electrophysiological studies of early stage corticobasal degeneration
003028 V. G. H. Evidente [États-Unis] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; K. A. Gwinn [États-Unis]Effective treatment of orthostatic tremor with gabapentin
003029 C. M. Gudex [Danemark] ; M. R. Hawthorne [Royaume-Uni] ; A. G. Butler [Royaume-Uni] ; P. Duffey [Royaume-Uni]Effect of dystonia and botulinum toxin treatment on health-related quality of life
003032 V. G. H. Evidente [États-Unis] ; K. A. Gwinn [États-Unis] ; J. N. Caviness [États-Unis] ; M. Muenter [États-Unis] ; D. W. Mulder [États-Unis]Early cinematographic cases of postencephalitic parkinsonism and other movement disorders
003035 R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; J. P. Hubble [États-Unis] ; K. Busenbark [États-Unis] ; J. D. Rienerth [États-Unis] ; A. Pahwa [États-Unis] ; W. C. Koller [États-Unis]Double-blind controlled trial of gabapentin in essential tremor
003036 H. L. Ryoo [États-Unis] ; D. Pierrotti [États-Unis] ; J. N. Joyce [États-Unis]Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
003037 I. Delalande [France] ; J. C. Hache [France] ; G. Forzy [France] ; M. Bughin [France] ; J. Benhadjali [France] ; A. Destee [France]Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy?
003040 G. Logroscino [États-Unis, Italie] ; K. Marder [États-Unis] ; J. Graziano [États-Unis] ; G. Freyer [États-Unis] ; V. Slavkovich [États-Unis] ; N. Lojacono [États-Unis] ; L. Cote [États-Unis] ; R. Mayeux [États-Unis]Dietary iron, animal fats, and risk of Parkinson's disease
003042 S. E. Starkstein [Argentine] ; G. Petracca [Argentine] ; E. Chemerinski [Argentine] ; A. Teson [Argentine] ; L. Sabe [Argentine] ; T. Merello [Argentine] ; T. Leiguarda [Argentine]Depression in classic versus akinetic-rigid Parkinson's disease
003043 B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France]Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum
003045 A. E. Kingsbury [Royaume-Uni] ; C. D. Mardsen [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni]DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?
003046 C. W. Olanow [États-Unis] ; C. Mytilineou [États-Unis] ; W. Tatton [États-Unis]Current status of selegiline as a neuroprotective agent in Parkinson's disease
003047 R. C. Dodel [Allemagne] ; K. M. Eggert [Allemagne] ; M. S. Singer [Allemagne] ; T. E. Eichhorn [Allemagne] ; O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne]Costs of drug treatment in Parkinson's disease
003048 J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis] ; S. Newman [États-Unis] ; R. J. Caselli [États-Unis] ; M. D. Muenter [États-Unis]Cortical myoclonus in levodopa-responsive Parkinsonism
003049 M. Kofler [Autriche] ; G. K. Wenning [Autriche] ; Werner Poewe [Autriche]Cortical and brain stem hyperexcitability in striatonigral degeneration
003051 G. Deuschl [Allemagne] ; P. Bain [Royaume-Uni] ; M. Brin [États-Unis]Consensus statement of the movement disorder society on tremor
003053 M. Merello [Argentine] ; A. Cammarota [Argentine] ; M. I. Nouzeilles [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine]Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test
003054 I. M. Bronner [Pays-Bas] ; J. A. L. Vanneste [Pays-Bas]Complex movement disorder associated with fluvoxamine
003055 A. Brashear [États-Unis] ; W. T. Ambrosius [États-Unis] ; G. J. Eckert [États-Unis] ; E. R. Siemers [États-Unis]Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A
003056 D. Tarsy [États-Unis]Comparison of acute- and delayed-onset posttraumatic cervical dystonia
003057 R. M. Trosch [États-Unis] ; J. H. Friedman [États-Unis] ; M. C. Lannon [États-Unis] ; R. Pahwa [États-Unis] ; D. Smith [États-Unis] ; L. C. Seeberger [États-Unis] ; C. F. O'Brien [États-Unis] ; P. A. Lewitt [États-Unis] ; W. C. Koller [États-Unis]Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience
003060 P. G. Bain [Royaume-Uni]Clinical measurement of tremor
003061 R. Agostino [Italie] ; A. Berardelli ; A. Curra ; N. Accornero ; M. ManfrediClinical impairment of sequential finger movements in Parkinson's disease
003062 E. S. Molho [États-Unis] ; P. J. Feustel [États-Unis] ; S. A. Factor [États-Unis]Clinical comparison of tardive and idiopathic cervical dystonia
003063 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; G. Cameron [États-Unis]Clinical characteristics of essential tremor : Data from a community-based study
003064 C. Potagas [France] ; G. Dellatolas [France] ; M. Ziegler [France] ; J. Leveteau [France] ; N. Bathien [France] ; P. Macleod [France] ; P. Rondot [France]Clinical assessment of olfactory dysfunction in Parkinson's disease
003065 J. F. Marti-Masso [Espagne] ; J. J. Poza [Espagne]Cinnarizine-induced Parkinsonism : Ten years later
003066 A. Kluge [Allemagne] ; B. Kettner [Allemagne] ; R. Zschenderlein [Allemagne] ; D. Sandrock [Allemagne] ; D. L. Munz [Allemagne] ; S. Hesse [Allemagne] ; H. Meierkord [Allemagne]Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia
003067 P. Katlovsky [République tchèque] ; H. Streitova [République tchèque] ; J. Dufek [République tchèque] ; V. Znojil [République tchèque] ; P. Daniel [République tchèque] ; I. Rektor [République tchèque]Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A
003068 M. Tanaka [Japon] ; S. Hirai [Japon] ; S. Kondo [Japon] ; X. Sun [Japon] ; T. Nakagawa [Japon] ; S. Tanaka [Japon] ; K. Hayashi [Japon] ; K. Okamoto [Japon]Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis : A combined PET and MRI study
003069 T. Odergren [Suède] ; S. Stone-Elander [Suède] ; M. Ingvar [Suède]Cerebral and cerebellar activation in correlation to the action-induced dystonia in Writer's cramp
003070 D. W. Anderson [États-Unis] ; W. A. Rocca [États-Unis] ; M. C. De Rijk [Pays-Bas] ; F. Grigoletto [Italie] ; M. O. Melcon [Argentine] ; M. B. Breteler [Pays-Bas] ; D. M. Maraganore [États-Unis]Case ascertainment uncertainties in prevalence surveys of Parkinson's disease
003071 K. Eder [Allemagne] ; S. J. Kish [Canada] ; M. Kirchgessner [Allemagne] ; B. M. Ross [Canada]Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1
003073 M. Miranda [Chili] ; A. Millar [Chili]Blepharospasm associated with bilateral infarcts confined to the thalamus : Case report
003074 P. Thajeb [Taïwan]Bibrachial sensory athetosis and dystonia in delayed postirradiation myelopathy
003076 C. Singer [États-Unis] ; N. J. Schatz [États-Unis] ; B. Bowen [États-Unis] ; D. Eidelberg [États-Unis] ; K. Kazumata [États-Unis] ; L. Sternau [États-Unis] ; L. M. Shulman [États-Unis] ; W. J. Weiner [États-Unis]Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst
003077 G.-M. Hariz [Suède] ; A. T. Bergenheim [Suède] ; M. I. Hariz [Suède] ; M. Lindberg [Suède]Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor
003079 J. D. O'Sullivan [Australie] ; A. J. Hughes [Australie]Apomorphine-induced penile erections in Parkinson's disease
003080 M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003081 M. Gassen [Israël] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003082 T. Van Laar [Pays-Bas] ; G.-J. Lammers [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; J. J. Gerritsen [Pays-Bas] ; A. E. Meinders [Pays-Bas]Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion
003084 J. W. Lance [Australie] ; I. Hickie [Brésil] ; D. Wakefield [Australie] ; J. G. Colebatch [Australie] ; F. Cardoso [Brésil] ; M. Vidailhet [France]An akinetic-rigid syndrome, depression, and stereotypies in a young man
003086 S. Rona [Italie] ; A. Berardelli ; L. Vacca ; M. Inghilleri ; M. ManfrediAlterations of motor cortical inhibition in patients with dystonia
003087 M. F. Mendez [États-Unis] ; A. MireaAdult head-banging and stereotypic movement disorders
003088 J. M. Brotchie [Royaume-Uni]Adjuncts to dopamine replacement : A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
003090 H.-C. Wang [Taïwan] ; P. Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Acute movement disorders with bilateral basal ganglia lesions in uremia
003091 P. Brown [Royaume-Uni] ; D. M. Corcos [Royaume-Uni, États-Unis] ; J. C. Rothwell [Royaume-Uni]Action tremor and weakness in Parkinson's disease : A study of the elbow extensors
003092 MYUNG SIK LEE [Corée du Sud] ; YOUNG DUK KIM [Corée du Sud] ; JEONG TAEK KIM [Corée du Sud] ; CHUL HYUNG LYOO [Corée du Sud]Abrupt onset of transient pseudochoreoathetosis associated with proprioceptive sensory loss as a result of a thalamic infarction
003093 M. Morris [Australie] ; R. Iansek [Australie] ; T. Matyas [Australie] ; J. Summers [Australie]Abnormalities in the stride length-cadence relation in parkinsonian gait
003094 L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; P. Van Den Munckhof [États-Unis] ; P. Del Dotto [États-Unis] ; R. Natte [États-Unis] ; T. N. Chase [États-Unis]A trial of dextromethorphan in Parkinsonian patients with motor response complications
003097 R. B. Jr Dewey [États-Unis] ; D. M. Maraganore [États-Unis] ; J. E. Ahlskog [États-Unis] ; J. Y. Matsumoto [États-Unis]A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease
003098 E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège]A community-based study of sleep disorders in patients with Parkinson's disease
003099 F. Delecluse [Belgique] ; J. A. Elosegi [Belgique] ; J.-M. Gerard [Belgique]A case of tardive tremor successfully treated with clozapine
003100 M. Naumann [Allemagne] ; M. Warmuth-Metz [Allemagne] ; C. Hillerer [Allemagne] ; L. Solymosi [Allemagne] ; K. Reiners [Allemagne]1H magnetic resonance spectroscopy of the lentiform nucleus in primary focal hand dystonia
003101 G. K. Wenning [Autriche] ; E. Donnemiller [Autriche] ; R. Granata [Autriche] ; G. Riccabona [Autriche] ; Werner Poewe [Autriche]123I-β-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease
003102 J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser [Allemagne] ; G. Arnold [Allemagne] ; O. Pogarell [Allemagne] ; G. Künig [Allemagne] ; W. H. Oertel [Allemagne]123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism
003103
003104
003105
003106 J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser ; G. Arnold ; W. H. Oertel[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy
003107 M. Naumann [Allemagne] ; W. Pirker [Autriche] ; K. Reiners [Allemagne] ; K. Lange [Allemagne] ; G. Becker [Allemagne] ; T. Brücke [Autriche][123I]β-CIT single-photon emission tomography in DOPA-responsive dystonia
003108 H. Rickards [Royaume-Uni] ; M. M. Robertson [Royaume-Uni]Vomiting and retching in Gilles de la Tourette syndrome: A report of ten cases and a review of the literature
003109 L. M. Shulman [États-Unis]Viewpoint : Reductionism and the study of neurodegenerative disorders
003110 S. Spieker [Allemagne] ; V. Ströle [Allemagne] ; A. Sailer [Allemagne] ; A. Boose [Allemagne] ; J. Dichgans [Allemagne]Validity of long-term electromyography in the quantification of tremor
003111 A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
003112 F. Micheli [Argentine] ; N. Granana [Argentine] ; M. C. Scorticati [Argentine] ; R. J. Giannaula [Argentine] ; G. Reboredo [Argentine]Unilateral postural and action tremor resulting from thalamic toxoplasmosis in a patient with acquired immunodeficiency syndrome
003113 G. Fenelon [France] ; J.-L. Houeto [France]Unilateral parkinsonism following a large infarct in the territory of the lenticulostriate arteries
003114 C. E. Clarke [Royaume-Uni] ; M. Lowry [Royaume-Uni] ; A. Horsman [Royaume-Uni]Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy
003115 P. J. Koehler [Pays-Bas] ; A. KeyserTremor in Latin texts of Dutch physicians : 16th-18th centuries
003116 S. Ohara [Japon] ; J. Miki [Japon] ; H. Momoi [Japon] ; H. Unno [Japon] ; M. Shindo [Japon] ; N. Yanagisawa [Japon]Treatment of spasmodic torticollis with mexiletine : A case report
003117 A. R. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; C. Wolsley [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Torticollis due to disinhibition of the vestibulo-collic reflex in a patient with Steele-Richardson-Olszewski syndrome
003118 E. Dupont [Danemark] ; J.-M. Burgunder [Suisse] ; L. J. Findley [Royaume-Uni] ; J.-E. Olsson [Suède] ; E. Dorflinger [États-Unis]Tolcapone added to levodopa in stable parkinsonian patients : A double-blind placebo-controlled study
003119 J. K. Krauss [États-Unis] ; Joseph Jankovic [États-Unis]Tics secondary to craniocerebral trauma
003120 R. Eleopra [Italie] ; V. Tugnoli [Italie] ; D. De Grandis [Italie]The variability in the clinical effect induced by botulinum toxin type A : The role of muscle activity in humans
003121 E. J. Pappert [États-Unis] ; J. W. Lipton [États-Unis] ; C. G. Goetz [États-Unis] ; Z. D. Ling [États-Unis] ; G. T. Stebbins [États-Unis] ; P. M. Carvey [États-Unis]The stability of carbidopa in solution
003122 E. D. Louis [États-Unis]The shaking palsy, the first forty-five years : A journey through the British literature
003123 E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]The role of the immune system in neurodegenerative disorders
003125 P. Lewitt [États-Unis] ; D. Oakes [États-Unis] ; L. Cui [États-Unis]The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol
003126 S. A. Factor [États-Unis] ; J. H. Friedman [États-Unis]The emerging role of clozapine in the treatment of movement disorders
003127 J. P. Larsen [Norvège] ; J. Boas [Danemark]The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability : An interim analysis of a Norwegian-Danish 5-year study
003129 F. Lobbezoo [Canada] ; G. J. Lavigne [Canada] ; R. Tanguay [Canada] ; J. Y. Montplaisir [Canada]The effect of the catecholamine precursor L-dopa on sleep bruxism : A controlled clinical trial
003131 K. J. Werhahn [Royaume-Uni] ; P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The clinical features and prognosis of chronic posthypoxic myoclonus
003133 F. Valldeoriola [Espagne] ; J. Valls-Sole [Espagne] ; E. Tolosa [Espagne] ; F. A. Nobbe [Espagne] ; J. E. Munoz [Espagne] ; J. Marti [Espagne]The acoustic startle response is normal in patients with multiple system atrophy
003134 K. R. Kessler [Allemagne] ; R. Benecke [Allemagne]The EDB test : A clinical test for the detection of antibodies to botulinum toxin type A
003135 S. Kösel [Allemagne] ; R. Egensperger [Allemagne] ; N. M. Schnopp [Allemagne] ; M. B. Graeber [Allemagne]The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction
003136 C. Klein [Royaume-Uni] ; R. Brown [Royaume-Uni] ; G. Wenning [Royaume-Uni] ; N. Quinn [Royaume-Uni]The "cold hands sign" in multiple system atrophy
003137 C. L. Comella [États-Unis] ; G. T. Stebbins [États-Unis] ; C. G. Goetz [États-Unis] ; T. A. Chmura [États-Unis] ; S. B. Bressman [États-Unis] ; A. E. Lang [Canada]Teaching tape for the motor section of the Toronto Western spasmodic torticollis scale
003138 E. Storey [Australie] ; J. Lloyd [Australie]Tardive tremor
003139 G. Ebersbach [Autriche] ; F. Tracik [Autriche] ; J. Wissel [Autriche] ; Werner Poewe [Autriche]Tardive jaw tremor
003140 A. Meyer-Lindenberg [Allemagne] ; B. Krausnick [Allemagne]Tardive dyskinesia in a neuroleptic-naive patient with bipolar-I disorder : Persistent exacerbation after lithium intoxication
003141 E. G. Gonera [Pays-Bas] ; M. Van'T Hof [Pays-Bas] ; H. J. C. Berger [Pays-Bas] ; C. Van Weel [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas]Symptoms and duration of the prodromal phase in Parkinson's disease
003142 T. E. Kimber [Australie] ; P. D. Thompson [Australie]Symptomatic hyperekplexia occurring as a result of pontine infarction
003143 N. J. Diederich [Luxembourg (pays), États-Unis] ; C. L. Comella [États-Unis] ; G. Matge [Luxembourg (pays)] ; G. Becker [Luxembourg (pays)] ; F. Schiltz [Luxembourg (pays)] ; H. Metz [Luxembourg (pays)]Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia : A 2-year follow-up study
003144 M. Poyurovsky [Israël] ; M. Schneidman [Israël] ; A. Weizman [Israël]Successful treatment of fluoxetine-induced dystonia with low-dose mianserin
003145 A. A. Yorio [Argentine] ; J. C. Mesri [Argentine] ; M. A. Pagano [Argentine] ; G. Lera [Argentine]Stereotypies in Wilson's disease
003146 A. Burleigh-Jacobs [États-Unis] ; F. B. Horak [États-Unis] ; J. G. Nutt [États-Unis] ; J. A. Obeso [Espagne]Step initiation in Parkinson's disease : Influence of levodopa and external sensory triggers
003147 P. Brown [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; D. Barnes [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Spinal rigidity following acute myelitis
003148 B. Ford [États-Unis] ; S. L. Pullman [États-Unis] ; A. Khandji [États-Unis] ; R. Goodman [États-Unis]Spinal myoclonus induced by an intrathecal catheter
003149 M. Svetel [Serbie] ; N. Sternic [Serbie] ; S. Filipovic [Serbie] ; V. Kostic [Serbie]Spasmodic torticollis associated with multiple sclerosis : Report of two cases
003150 M. Merello [Argentine] ; A. Hughes [Australie] ; C. Colosimo [Argentine] ; M. Hoffman [Australie] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine]Sleep benefit in Parkinson's disease
003151 J. Lyytinen [Finlande] ; S. Kaakkola [Finlande] ; S. Ahtila [Finlande] ; P. Tuomainen [Finlande] ; H. Ter V Inen [Finlande]Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with Parkinson's disease
003152 M. Zappia [Italie] ; R. Montesanti [Italie] ; R. Colao [Italie] ; D. Branca [Italie] ; G. Nicoletti [Italie] ; U. Aguglia [Italie] ; A. Quattrone [Italie]Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease
003153 V. Müller [Allemagne] ; B. Mohr [Allemagne] ; R. Rosin [Allemagne] ; F. Pulvermüller [Allemagne] ; F. Müller [Allemagne] ; N. Birbaumer [Allemagne, Italie]Short-term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease : A controlled clinical study
003154 M. Welsh [États-Unis] ; L. Hung [États-Unis] ; C. H. Waters [États-Unis]Sexuality in women with Parkinson's disease
003155 D. Dressler [Allemagne] ; R.-O. Oeljesch Ger [Allemagne] ; E. Rüther [Allemagne]Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration
003156 A. Albanese ; G. Maria [Italie] ; A. Bentivoglio ; T. Brisinda [Italie] ; E. Cassetta [Italie] ; P. TonaliSevere constipation in Parkinson's disease relieved by botulinum toxin
003157 R. A. Hauser [États-Unis] ; T. A. Zesiewicz [États-Unis]Sertraline for the treatment of depression in Parkinson's disease
003158 G. Abbruzzese [Italie] ; R. Marchese [Italie] ; C. Trompetto [Italie]Sensory and motor evoked potentials in multiple system atrophy : A comparative study with Parkinson's disease
003159 A. Straube [Allemagne] ; J.-B. Mennicken [Allemagne] ; M. Riedel [Allemagne] ; T. Eggert [Allemagne] ; N. Müller [Allemagne]Saccades in Gilles de la Tourette's syndrome
003160 K. A. Gwinn [États-Unis] ; J. N. Caviness [États-Unis]Risperidone-induced tardive dyskinesia and parkinsonism
003161 G. Meco [Italie] ; A. Alessandri [Italie] ; P. Giustini [Italie] ; V. Bonifati [Italie]Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study
003162 L. Derex [France] ; P. Trouillas [France]Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy
003163 J. Federlein [Allemagne] ; T. Postert [Allemagne] ; A. Allgeier [Allemagne] ; V. Hoffmann [Allemagne] ; D. Pöhlau [Allemagne] ; H. Przuntek [Allemagne]Remitting parkinsonism as a symptom of multiple sclerosis and the associated magnetic resonance imaging findings
003164 A. Strafella [Canada] ; P. Ashby [Canada] ; A. E. Lang [Canada]Reflex myoclonus in cortical-basal ganglionic degeneration involves a transcortical pathway
003165 S. Avissar [Israël] ; L. Barki-Harrington [Israël] ; Y. Herishanu [Israël] ; G. Schreiber [Israël]Reduced Gs protein function and Gαs levels in leukocytes of patients with Parkinson's disease
003166 J. Wissel [Allemagne, Autriche] ; F. Masuhr [Allemagne] ; L. Schelosky [Allemagne] ; G. Ebersbach [Allemagne, Autriche] ; Werner Poewe [Autriche]Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
003167 C. A. Davie [Royaume-Uni] ; G. J. Barker [Royaume-Uni] ; C. Machado [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome
003168 F. Federico [Italie] ; I. L. Simone [Italie] ; V. Lucivero [Italie] ; G. Iliceto [Italie] ; M. De Mari [Italie] ; P. Giannini [Italie] ; D. M. Mezzapesa [Italie] ; A. Tarantino [Italie] ; P. Lamberti [Italie]Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders
003169 P. Montagna [Italie] ; F. Provini [Italie] ; G. Plazzi [Italie] ; R. Liguori [Italie] ; E. Lugaresi [Italie]Propriospinal myoclonus upon relaxation and drowsiness : A cause of severe insomnia
003171 A. Creange [France] ; F. Sedel [France] ; P. Brugieres [France] ; M.-C. Voisin [France] ; J.-D. Degos [France]Primary Sjögren's syndrome presenting as progressive Parkinsonian syndrome
003172 M. O. Melcon [Argentine] ; D. W. Anderson [États-Unis] ; R. H. Vergara [Argentine] ; W. A. Rocca [États-Unis]Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina
003173 J. K. Krauss [Allemagne, Suisse] ; R. Tr Nkle [Allemagne] ; K.-H. Kopp [Allemagne]Posttraumatic movement disorders after moderate or mild head injury
003174 K. Ray Chaudhuri [Royaume-Uni] ; C. Ellis ; S. Love-Jones ; T. Thomaides ; S. Clift ; C. J. Mathias ; J. D. ParkesPostprandial hypotension and parkinsonian state in Parkinson's disease
003175 C. I. Blake [États-Unis] ; E. Spitz [États-Unis] ; M. Leehey [États-Unis] ; B. J. Hoffer [États-Unis] ; S. J. Boyson [États-Unis]Platelet mitochondrial respiratory chain function in Parkinson's disease
003177 MYUNG SIK LEE [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; WON CHAN KIM [Corée du Sud] ; HO JEONG KANG [Corée du Sud]Periodic bursts of rhythmic dyskinesia associated with spinal anesthesia
003178 A. Curra [Italie] ; A. Berardelli ; R. Agostino ; N. Modugno ; C. Conti Puorger ; N. Accornero ; M. ManfrediPerformance of sequential arm movements with and without advance knowledge of motor pathways in Parkinson's disease
003179 D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; M. A. Gresty [Royaume-Uni]Perception of spatial orientation in spasmodic torticollis. Part 2 : The visual vertical
003180 D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Perception of spatial orientation in spasmodic torticollis part I: The postural vertical
003181 K. P. Bhatia [Royaume-Uni] ; V. L. Soland [Royaume-Uni] ; M. H. Bhatt [Inde] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Paroxysmal exercise-induced dystonia : Eight new sporadic cases and a review of the literature
003183 N. Turjanski [Royaume-Uni] ; B. Pentland [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. J. Brooks [Royaume-Uni]Parkinsonism associated with acute intracranial hematomas : An [18F]dopa positron-emission tomography study
003184 P. K. Morrish [Royaume-Uni]Parkinson's disease is not a long-latency illness
003185 M. W. Kellett [Royaume-Uni] ; G. R. Young [Royaume-Uni] ; N. A. Fletcher [Royaume-Uni]Painful tonic spasms and pure motor hemiparesis due to lacunar pontine infarct
003186 A. H. Rajput [Canada] ; J. D. Mchattie [Canada]Ophthalmoplegia and leg myorhythmia in Whipple's disease : Report of a case
003187 J. Valls-Sole [Espagne] ; E. S. Tolosa [Espagne] ; F. Nobbe [Espagne] ; E. Dieguez [Espagne] ; E. Munoz [Espagne] ; P. Sanz [Espagne] ; F. Valldeoriola [Espagne]Neurophysiological investigations in patients with head tremor
003188 T. Stojkovic [France] ; L. Defebvre [France] ; X. Quilliet [France] ; E. Eveno [France] ; A. Sarasin [France] ; M. Mezzina [France] ; A. Destee [France]Neurological manifestations in two related xeroderma pigmentosum group D patients: Complications of the late-onset type of the juvenile form
003189 F. Carella [Italie] ; C. Ciano [Italie] ; F. Panzica [Italie] ; V. Scaioli [Italie]Myoclonus in corticobasal degeneration
003190 G. K. Wenning [Royaume-Uni, Autriche] ; F. Tison [Royaume-Uni] ; Y. Ben Shlomo [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni]Multiple system atrophy : A review of 203 pathologically proven cases
003192 C. E. Clarke [Royaume-Uni] ; C. Sampaio [Portugal]Movement disorders cochrane collaborative review group
003194 J. G. Nutt [États-Unis] ; J. H. Carter [États-Unis] ; E. S. Lea [États-Unis] ; W. R. Woodward [États-Unis]Motor fluctuations during continuous Levodopa infusions in patients with Parkinson's disease
003195 S. A. Factor [États-Unis] ; K. D. Barron [États-Unis]Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism
003196 M. Gu [Royaume-Uni] ; M. T. Gash [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. H. V. Schapira [Royaume-Uni]Mitochondrial respiratory chain function in multiple system atrophy
003197 G. M. G. Shepherd [Norvège] ; E. Tauböll [Norvège] ; S. J. Bakke [Norvège] ; R. Nyberg-Hansen [Norvège]Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage
003199 A. Prochazka [Canada] ; D. J. Bennett [Canada] ; M. J. Stephens [Canada] ; S. K. Patrick [Canada] ; R. Sears-Duru [Canada] ; T. Roberts [Canada] ; J. H. Jhamandas [Canada]Measurement of rigidity in Parkinson's disease
003200 G. K. Wenning [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni]Magnetic brain stimulation in multiple system atrophy
003201 J. H. Friedman [États-Unis]Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone
003202 W. H. Jost [Allemagne] ; K. Schimrigk [Allemagne]Long-term results with cisapride in Parkinson's disease
003203 A. Antonini [Suisse] ; J. Schwarz [Suisse] ; W. H. Oertel [Suisse] ; O. Pogarell [Suisse] ; K. L. Leenders [Suisse, Allemagne]Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride
003204 W. Ondo [États-Unis]Lingual dystonia following electrical injury
003206 E. Waubant [France] ; M. Simonetta-Moreau [France] ; M. Clanet [France] ; I. Berry [France] ; A. Bonafe [France]Left arm monoballism as a relapse in multiple sclerosis
003207 P. Kanovsky [République tchèque] ; H. Streitova ; J. Dufek ; I. RektorLateralization of the P22/N30 component of somatosensory evoked potentials of the median nerve in patients with cervical dystonia
003208 H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; I. Daum [Allemagne] ; G. Scharf [Allemagne] ; S. Spieker [Allemagne]Kinematic analysis of articulatory movements in central motor disorders
003209 A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; S. Birdi [Canada] ; R. Macaulay [Canada]Is levodopa toxic to human substantia nigra?
003210 S. P. Swinnen [Belgique] ; L. Van Langendonk [Belgique] ; S. Verschueren [Belgique] ; G. Peeters [Belgique] ; R. Dom [Belgique] ; W. De Weerdt [Belgique]Interlimb coordination deficits in patients with Parkinson's disease during the production of two-joint oscillations in the sagittal plane
003211 A. Strafella [Canada] ; P. Ashby [Canada] ; M. Munz [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada]Inhibition of voluntary activity by thalamic stimulation in humans : Relevance for the control of tremor
003212 P. Krack [Allemagne] ; H. Porschke [Allemagne] ; W. De Decker [Allemagne] ; G. Deuschl [Allemagne]Inability to close eyelids as a feature of palpebral dystonia
003213 J. K. Krauss [États-Unis] ; R. G. Grossman [États-Unis] ; Joseph Jankovic [États-Unis]Improvement of Parkinsonian signs after vascular lesions of the basal ganglia circuitry
003214 M. Stojanovic [Serbie] ; V. Kostic [Serbie] ; P. Stankovic [Serbie] ; N. Sternic [Serbie]Improvement in laryngeal dystonia with background noise
003215 N. Georgiou [Australie] ; J. G. Phillips [Australie] ; J. L. Bradshaw [Australie] ; R. Cunnington [Australie] ; E. Chiu [Australie]Impairments of movement kinematics in patients with Huntington's disease : A comparison with and without a concurrent task
003216 S. Frucht [États-Unis] ; D. Eidelberg [États-Unis]Imipenem-induced myoclonus
003217 P. A. Lewitt [États-Unis] ; R. M. Trosch [États-Unis]Idiosyncratic adverse reactions to intramuscular botulinum toxin type a injection
003218 K. Ikeda [Japon] ; M. Kinoshita [Japon] ; K. Aoki [Japon] ; A. Tomatsuri [Japon]Hydrocephalic parkinsonism due to Paget's disease of bone : Dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy
003219 R. Fitzpatrick [Royaume-Uni] ; V. Peto [Royaume-Uni] ; C. Jenkinson [Royaume-Uni] ; R. Greenhall [Royaume-Uni] ; N. Hyman [Royaume-Uni]Health-related quality of life in Parkinson's disease : A study of outpatient clinic attenders
003220 G. Deuschl [Allemagne] ; F. Heinen [Allemagne] ; B. Guschlbauer [Allemagne] ; S. Schneider [Allemagne] ; F. X. Glocker [Allemagne] ; C. H. Lücking [Allemagne]Hand tremor in patients with spasmodic torticollis
003222 R. Rosin [Allemagne] ; H. Topka [Allemagne] ; J. Dichgans [Allemagne]Gait initiation in Parkinson's disease
003223 P. Chana [Chili] ; A. De Marinis [Chili] ; N. Barrientos [Chili]Gabapentin and motor fluctuations in Parkinson's disease
003224 T. Xie [Hong Kong] ; S. L. Ho [Hong Kong] ; L. S. W. Li [Hong Kong] ; O. C. K. Ma [Hong Kong]G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease
003225 B. Leube [Allemagne] ; K. R. Kessler [Allemagne] ; T. Goecke [Allemagne] ; G. Auburger [Allemagne] ; R. Benecke [Allemagne]Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family
003227 K. Terada [Japon] ; A. Ikeda [Japon] ; T. Mima [Japon] ; K. Kimura [Japon] ; Y. Nagahama [Japon] ; Y. Kamioka [Japon] ; I. Murone [Japon] ; J. Kimura [Japon] ; H. Shibasaki [Japon]Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus
003228 S. B. Blunt [Royaume-Uni] ; N. M. Khalil [Royaume-Uni] ; G. D. Perkin [Royaume-Uni]Facial myokymia in multiple system atrophy
003229 J. J. Higgins [États-Unis] ; L. T. Pho [États-Unis] ; S. E. Ide [États-Unis] ; L. E. Nee [États-Unis] ; M. H. Polymeropoulos [États-Unis]Evidence for a new spinocerebellar ataxia locus
003230 L. Almasy [États-Unis] ; S. Bressman [États-Unis] ; D. De Leon [États-Unis] ; N. Risch [États-Unis]Ethnic variation in the clinical expression of idiopathic torsion dystonia
003231 T. Postert [Allemagne] ; G. Amoiridis [Allemagne] ; D. Pöhlau [Allemagne] ; V. Hoffmann [Allemagne] ; H. Przuntek [Allemagne]Episodic undulating hyperkinesias of the tongue associated with brainstem ischemia
003233 K. A. Gwinn [États-Unis] ; J. N. Caviness [États-Unis]Electrophysiological observations in idiopathic opsoclonus-myoclonus syndrome
003234 C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis] ; M. S. Grobman [États-Unis]Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease
003235 J. P. Hubble [États-Unis] ; K. L. Busenbark [États-Unis] ; S. Wilkinson [États-Unis] ; R. Pahwa [États-Unis] ; G. W. Paulson [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Effects of thalamic deep brain stimulation based on tremor type and diagnosis
003236 I. Soykan [États-Unis] ; I. Sarosiek [États-Unis] ; J. Shifflett [États-Unis] ; G. F. Wooten [États-Unis] ; R. W. Mccallum [États-Unis]Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease
003239 J. N. Joyce [États-Unis] ; G. Smutzer [États-Unis] ; C. J. Whitty [États-Unis] ; A. Myers [États-Unis] ; M. J. Bannon [États-Unis]Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease
003240 W. L. Scheider [États-Unis] ; L. A. Hershey [États-Unis] ; J. E. Vena [États-Unis] ; T. Holmlund [États-Unis] ; J. R. Marshall [États-Unis] ; J. L. Freudenheim [États-Unis]Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
003242 M. W. Becher [États-Unis] ; D. C. Rubinsztein [Royaume-Uni] ; J. Leggo [Royaume-Uni] ; M. V. Wagster [États-Unis] ; O. C. Stine [États-Unis] ; N. G. Ranen [États-Unis] ; M. L. Franz [États-Unis] ; M. H. Abbott [États-Unis] ; M. Sherr [États-Unis] ; J. C. Macmillan [Royaume-Uni] ; L. Barron [Royaume-Uni] ; M. Porteous [Royaume-Uni] ; P. S. Harper [Royaume-Uni] ; C. A. Ross [États-Unis]Dentatorubral and pallidoluysian atrophy (DRPLA) : Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
003243 I. Moroo [Japon] ; K. Hirayama [Japon] ; M. Nakajima [Japon]Delayed onset postural tremor caused by parietal lesion
003244 K. Itoh [Allemagne] ; S. Weis [Allemagne] ; P. Mehraein [Allemagne] ; J. Müller-Höcker [Allemagne]Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease : An immunohistochemical and morphometric study
003245 C. Teo [États-Unis] ; L. Rasco [États-Unis] ; K. Al-Mefty [États-Unis] ; T. D. Skinner [États-Unis] ; F. A. Boop [États-Unis] ; E. Garcia-Rill [États-Unis]Decreased habituation of midlatency auditory evoked responses in Parkinson's disease
003246 C. Sampaio [Portugal] ; J. J. Ferreira [Portugal] ; F. Simoes [Portugal] ; M. J. Rosas [Portugal] ; M. Magalhaes [Portugal] ; A. P. Correia [Portugal] ; A. Bastos-Lima [Portugal] ; R. Martins [Portugal] ; A. Castro-Caldas [Portugal]DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1
003247 J. N. Caviness [États-Unis] ; M. Kurth [États-Unis]Cortical myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential
003248 M. I. Nouzeilles [Argentine] ; M. Merello [Argentine]Correlation between results of motor section of UPDRS and Webster scale
003249 J. Konczak [Allemagne] ; H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; S. Spieker [Allemagne] ; J. Dichgans [Allemagne]Control of repetitive lip and finger movements in Parkinson's disease : Influence of external timing signals and simultaneous execution on motor performance
003250 W. Ashraf [États-Unis] ; R. F. Pfeiffer [États-Unis] ; F. Park [États-Unis] ; J. Lof [États-Unis] ; E. M. M. Quigley [États-Unis]Constipation in Parkinson's disease : Objective assessment and response to psyllium
003251 A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; A. Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada]Concordance of common movement disorders among familial cases
003252 G. Becker [Allemagne] ; M. Naumann [Allemagne] ; M. Scheubeck [Allemagne] ; E. Hofmann [Allemagne] ; M. Deimling [Allemagne] ; A. Lindner [Allemagne] ; G. Gahn [Allemagne] ; C. Reiners [Allemagne] ; K. V. Toyka [Allemagne] ; K. Reiners [Allemagne]Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis
003253 B. T. Johnston [États-Unis] ; J. A. Castell [États-Unis] ; S. Stumacher [États-Unis] ; T. Colcher [États-Unis] ; R. M. Gideon [États-Unis] ; Q. Li [États-Unis] ; D. O. Castell [États-Unis]Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy
003254 R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; D. Mcguire [États-Unis] ; P. Silverstein [États-Unis] ; F. Zwiebel [États-Unis] ; M. Robischon [États-Unis] ; W. C. Koller [États-Unis]Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease : Pharmacokinetic and quality-of-life measures
003255 D. Tarsy [États-Unis]Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin
003256 C.-C. Huang [Taïwan] ; N.-S. Chu [Taïwan] ; C.-S. Lu [Taïwan] ; D. B. Calne [Canada]Cock gait in manganese intoxication
003257 V. S. C. Fung [Australie] ; J. G. L. Morris [Australie] ; T. Leicester [Australie] ; Y. S. Soo [Australie] ; L. Davies [Australie]Clonic perseveration following thalamofrontal disconnection : A distinctive movement disorder
003258 J. Montplaisir [Canada] ; S. Boucher [Canada] ; G. Poirier [Canada] ; G. Lavigne [Canada] ; O. Lapierre [Canada] ; P. Lesperance [Canada]Clinical, polysomnographic, and genetic characteristics of restless legs syndrome : A study of 133 patients diagnosed with new standard criteria
003259 S. B. Blunt [Royaume-Uni] ; R. J. M. Lane [Royaume-Uni] ; N. Turjanski [Royaume-Uni] ; G. D. Perkin [Royaume-Uni]Clinical features and management of two cases of Encephalitis lethargica
003260 J. P. Hubble [États-Unis] ; K. L. Busenbark [États-Unis] ; R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Clinical expression of essential tremor : Effects of gender and age
003261 G. Gomez Arevalo [Argentine] ; R. Jorge [Argentine] ; S. Garcia [Argentine] ; O. Scipioni [Argentine] ; O. Gershanik [Argentine]Clinical and pharmacological differences in early- versus late-onset Parkinson's disease
003262 J. G. Heckmann [Allemagne] ; C. J. G. Lang [Allemagne] ; A. Druschky [Allemagne] ; D. Claus [Allemagne] ; O. Bartels [Allemagne] ; B. Neundörfer [Allemagne]Chorea resulting from paraneoplastic encephalitis
003263 F. Cardoso [Brésil] ; C. Eduardo [Brésil] ; A. P. Silva [Brésil] ; C. C. C. Mota [Brésil]Chorea in fifty consecutive patients with rheumatic fever
003264 J. K. Krauss [Allemagne, États-Unis] ; W. Seeger [Allemagne] ; Joseph Jankovic [États-Unis]Cervical dystonia associated with tumors of the posterior fossa
003265 E. J. Munoz [Espagne] ; N. Vila [Espagne] ; J. Valls-Sole [Espagne] ; E. Tolosa [Espagne]Cervical and facial myoclonus associated with dolichoectasia of the left vertebral artery
003266 S. Magyar-Lehmann [Suisse] ; A. Antonini [Suisse] ; U. Roelcke [Suisse] ; R. P. Maguire [Suisse] ; J. Missimer [Suisse] ; M. Meyer [Suisse] ; K. L. Leenders [Suisse]Cerebral glucose metabolism in patients with spasmodic torticollis
003267 Y. Nagahama [Japon] ; H. Fukuyama [Japon] ; N. Turjanski [Royaume-Uni] ; A. Kennedy [Royaume-Uni] ; H. Yamauchi [Japon] ; Y. Ouchi [Japon] ; J. Kimura [Japon] ; D. J. Brooks [Royaume-Uni] ; H. Shibasaki [Japon]Cerebral glucose metabolism in corticobasal degeneration : Comparison with progressive supranuclear palsy and normal controls
003268 G. K. Wenning [Royaume-Uni] ; E. Kraft [Royaume-Uni] ; R. Beck [Royaume-Uni] ; C. J. Fowler [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; A. E. Harding [Royaume-Uni]Cerebellar presentation of multiple system atrophy
003269 B. Wild [Allemagne, États-Unis] ; D. M. Corcos [États-Unis]Cerebellar hypermetria: Reduction in the early component of the antagonist electromyogram
003270 P. Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Cerebellar axial postural tremor
003272 R. Liguori [Italie] ; C. Cordivari [Italie] ; E. Lugaresi [Italie] ; P. Montagna [Italie]Botulinum toxin a improves muscle spasms and rigidity in Stiff-Person syndrome
003273 D. D. Truong [États-Unis] ; P. A. Cullis [États-Unis] ; C. F. O'Brien [États-Unis] ; M. Koller [États-Unis] ; T. P. Villegas [États-Unis] ; J. D. Wallace [États-Unis]BotB (botulinum toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study)
003275 P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients
003276 D. G. Le Couteur [Australie] ; P. W. Leighton [Australie] ; S. J. Mccann [Australie] ; S. M. Pond [Australie]Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease
003277 M. Aramideh [Pays-Bas] ; I. H. Kwa [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; J. D. Speelman [Pays-Bas] ; B. W. Ongerboer De Visser [Pays-Bas] ; B. Jr Verbeeten [Pays-Bas]Apraxia of eyelid closure accompanied by denial of eye opening
003279 A. R. Bentivoglio [Italie] ; S. B. Bressman [États-Unis] ; E. Cassetta [Italie] ; D. Carretta [Italie] ; P. Tonali [Italie] ; A. Albanese [Italie]Analysis of blink rate patterns in normal subjects
003280 X. Liu [Royaume-Uni] ; R. C. Miall [Royaume-Uni] ; T. Z. Aziz [Royaume-Uni] ; J. A. Palace [Royaume-Uni] ; P. N. Haggard [Royaume-Uni] ; J. F. Stein [Royaume-Uni]Analysis of action tremor and impaired control of movement velocity in multiple sclerosis during visually guided wrist-tracking tasks
003285 F. Ghika-Schmid [Suisse] ; J. Ghika [Suisse] ; P. Vuadens [Suisse] ; J. Bogousslavsky [Suisse] ; F. Regli [Suisse] ; P. A. Despland [Suisse]Acute reversible myoclonic encephalopathy associated with fluoxetine therapy
003286 A. Gambardella [Italie] ; M. Zappia [Italie] ; P. Valentino [Italie] ; U. Aguglia [Italie] ; F. Fera [Italie] ; K. Pardatscher [Italie] ; A. Quattrone [Italie]Action palatal tremor in a patient with primary intestinal lymphoma
003287 C.-H. Tsai [Taïwan] ; R.-S. Chen [Taïwan] ; H.-C. Chang [Taïwan] ; C.-S. Lu [Taïwan] ; K.-K. Liao [Taïwan]Acanthocytosis and spinocerebellar degeneration : A new association?
003288 J. Maher [Canada] ; S. Choudhri [Canada] ; W. Halliday [Canada] ; C. Power [Canada] ; A. Nath [Canada]AIDS dementia complex with generalized myoclonus
003289 S. Siesling [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas]A shortened version of the motor section of the unified Huntington's disease rating scale
003292 G. Ballan [France] ; F. Tison [France]A historical case of probable corticobasal degeneration?
003293 J. J. Higgins [États-Unis] ; L. T. Pho [États-Unis] ; L. E. Nee [États-Unis]A gene (ETM) for essential tremor maps to chromosome 2p22-p25
003294 N. Andreu [France] ; C. Damase-Michel [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; J.-L. Montastruc [France]A dose-ranging study of selegiline in patients with Parkinson's disease : Effect on platelet monoamine oxidase activity
003295 P. G. Como [États-Unis] ; A. J. Rubin [États-Unis] ; C. F. O'Brien [États-Unis] ; K. Lawler [États-Unis] ; C. Hickey [États-Unis] ; A. E. Rubin [États-Unis] ; R. Henderson [États-Unis] ; M. P. Mcdermott [États-Unis] ; T. Mcdermott [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis]A controlled trial of fluoxetine in nondepressed patients with Huntington's disease
003296 G. M. Petzinger [États-Unis] ; S. B. Bressman [États-Unis]A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment
003299
003300
003301
003302 Cortical-basal ganglionic degeneration (CBGD) and its relationship to other asymmetrical cortical degeneration syndromes (ACDs)
003303 A. Brashear [États-Unis] ; M. R. Farlow [États-Unis] ; I. J. Butler ; E. J. Kasarskis ; W. B. DobynsVariable phenotype of rapid-onset dystonia-parkinsonism
003304 P. Girlanda [Italie] ; A. Quartarone ; S. Sinicropi ; C. Nicolosi ; C. MassinaUnilateral injection of botulinum toxin in blepharospasm : single fiber electromyography and blink reflex study
003305 J. Kulisevsky [Espagne] ; M. L. Berthier [Espagne] ; A. Avila [Espagne] ; C. Roig [Espagne]Unilateral Parkinsonism and stereotyped movements following of right lenticular infarction
003306 Unified Huntington's Disease Rating Scale : Reliability and consistency
003307 F. Qureshi [États-Unis] ; A. Morales [États-Unis] ; R. J. Elble [États-Unis]Tremor due to infarction in the ventrolateral thalamus
003308 R. Lindeboom [Pays-Bas] ; R. J. De Haan ; M. Aramideh [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; J. D. Speelman [Pays-Bas]Treatment outcomes in cervical dystonia : A clinimetric study
003309 B. L. Scott [États-Unis] ; R. W. Evans [États-Unis] ; Joseph Jankovic [États-Unis]Treatment of palatal myoclonus with sumatriptan
003310 J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Treatment of nonoccupational limb and trunk dystonia with botulinum toxin
003311 F. Stocchi [Italie] ; M. F. De Pandis [Italie] ; F. A. Delfino [Italie] ; T. Anselmo [Italie] ; D. Frongillo [Italie]Transient atrial fibrillation after subcutaneous apomorphine bolus
003312 M. Y. Neufeld [Israël] ; P. Nisipeanu [Israël] ; V. Chistik [Israël] ; A. D. Korczyn [Israël]The electroencephalogram in acetazolamide-responsive periodic ataxia
003313 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] ; G. D. Podskalny ; D. Brown [États-Unis]The effect of dancing on dystonia
003314 M. Raja [Italie] ; G. Maisto [Italie] ; M. C. Altavista [Italie] ; A. Albanese [Italie]Tardive lingual dystonia treated with clozapine
003315 R. Bordet [France] ; J. Benhadjali [France] ; A. Destee [France] ; J. F. Hurtevent [France] ; J. L. Bourriez [France] ; J. D. Guieu [France]Sympathetic skin response and R-R interval variability in multiple system atrophy and idiopathic Parkinson's disease
003316 C. Armon [États-Unis] ; J. W. Swanson [États-Unis] ; J. M. Mclean [États-Unis] ; P. R. Westbrook [États-Unis] ; H. Okazaki [États-Unis] ; P. J. Kurtin [États-Unis] ; U. P. Kalyan-Raman [États-Unis] ; M. Rodriguez [États-Unis]Subacute encephalomyelitis presenting as Stiff-Person syndrome : Clinical, polygraphic, and pathologic correlations
003317 G. Kiziltan [Turquie] ; M. A. Akalin [Turquie]Stuttering may be a type of action dystonia
003318 F. Cicchetti [Canada] ; A. Parent [Canada]Striatal interneurons in Huntington's disease : Selective increase in the density of calretining-immunoreactive medium-sized neurons
003319 C. Raftopoulos [Belgique] ; S. Dethy ; M. A. Laute ; S. Goldman ; A. B. Naini ; S. Przedborski ; J. HildebrandSlow increase of homovanillic acid in cerebrospinal fluid after levodopa administration
003320 M. S. Lee [Corée du Sud] ; Y. C. Choi [Corée du Sud] ; S. H. Lee [Corée du Sud] ; S. B. Lee [Corée du Sud]Sleep-related periodic leg movements associated with spinal cord lesions
003321 J. K. Krauss [États-Unis] ; Joseph Jankovic [États-Unis]Severe motor tics causing cervical myelopathy in Tourette's syndrome
003322 E. Bollen [Pays-Bas] ; E. Van Exel [Pays-Bas] ; E. A. Van Der Velde [Pays-Bas] ; P. Buytels [Pays-Bas] ; J. Bastiaanse [Pays-Bas] ; J. G. Van Dijk [Pays-Bas]Saccadic eye movements in idiophatic blepharospasm
003323 M. H. Thaut [États-Unis] ; G. C. Mcintosh ; R. R. Rice ; R. A. Miller [États-Unis] ; J. Rathbun [États-Unis] ; J. M. Brault [États-Unis]Rhythmic auditory stimulation in gait training for Parkinson's disease patients
003327 P. Santens [Belgique] ; L. Crevits [Belgique] ; C. Van Der Linden [Belgique]Raynaud's phenomenon in a case of multiple system atrophy
003329 J. C. M. Zijlmans [Pays-Bas] ; P. J. E. Poels [Pays-Bas] ; J. Duysens [Pays-Bas] ; J. Van Der Straaten [Pays-Bas] ; T. Thien [Pays-Bas] ; M. A. Van'T Hof [Pays-Bas] ; H. O. M. Thijssen [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas]Quantitative gait analysis in patients with vascular parkinsonism
003330 R. J. Elble [États-Unis] ; M. Brilliant ; K. Leffler ; C. HigginsQuantification of essential tremor in writing and drawing
003331 A. Schulze-Bonhage [Allemagne] ; H. Knott ; A. FerbertPure stimulus-sensitive truncal myoclonus of propriospinal origin
003332 S. D. Taylor-Robinson [Royaume-Uni] ; R. A. Weeks ; D. J. Bryant [Royaume-Uni] ; J. Sargentoni [Royaume-Uni] ; C. D. Marcus [Royaume-Uni] ; A. E. Harding ; D. J. BrooksProton magnetic resonance spectroscopy in Huntington's disease : Evidence in favour of the glutamate excitotoxic theory ?
003333 A. Freese [États-Unis] ; M. Stern [États-Unis] ; M. G. Kaplitt ; W. M. O'Connor [États-Unis] ; M. V. Abbey ; M. J. O'Connor [États-Unis] ; M. J. During [États-Unis]Prospects for gene therapy in Parkinson's disease
003335 F. Picard [France] ; A. De Saint-Martin [France] ; E. Salmon [Belgique] ; E. Hirsch [France] ; C. Marescaux [France]Postencephalitic stereotyped involuntary movements responsive to L-Dopa
003336 R. Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel ; P. Silverstein ; R. Ward ; W. C. Koller [États-Unis]Pharmacokinetic comparison of Sinemet and atamet (generic carbidopa/levodopa) : A single-dose study
003337 A. Straube [Allemagne] ; N. Mai [Allemagne] ; E. Walther [Allemagne] ; M. Mayer [Allemagne]Persisting "writer's cramp" as a result of compensation of a temporary palsy due to a hereditary neuropathy with liability to pressure palsies
003338 C. H. Adler [États-Unis] ; R. S. Zimmerman ; M. K. Lyons ; F. Simeone ; M. F. BrinPerioperative use of botulinum toxin for movement disorder-induced cervical spine disease
003340 D. E. Riley [États-Unis]Paroxysmal kinesigenic dystonia associated with a medullary lesion
003342 J. V. H Gglund [Suède] ; S.-M. AquiloniusParkinson's disease after open-heart surgery
003343 M. E. R. Pla [États-Unis] ; T. R. Dillingham ; N. T. Spellman ; E. Colon ; B. JabbariPainful legs and moving toes associated with tarsal tunnel syndrome and accessory soleus muscle
003345 G. K. Wenning [Royaume-Uni] ; F. Tison [Royaume-Uni] ; L. Elliott ; N. P. Quinn [Royaume-Uni] ; S. E. DanielOlivopontocerebellar pathology in multiple system atrophy
003347 W. A. Rocca [États-Unis] ; D. W. Anderson ; F. Meneghini ; F. Grigoletto ; L. Morgante ; A. Reggio ; G. Savettieri ; R. Di PerriOccupation, education, and Parkinson's disease : A case-control study in an Italian population
003348 E. M. Gatto [Argentine] ; M. C. Carreras ; G. A. Pargament ; N. A. Riobo ; C. Reides ; M. Repetto ; M. M. Fernandez Pardal [Argentine] ; S. Llesuy ; J. J. PoderosoNeutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disese
003349 M. Grasso [Italie] ; L. Mazzini [Italie] ; M. SchieppatiMuscle relaxation in Parkinson's disease : A reaction time study
003350 C. M. Haw [Royaume-Uni] ; T. R. E. Barnes ; K. Clark ; P. Chrichton ; D. KohenMovement disorder in down's syndrome : A possible marker of the severity of mental handicap
003351 T. Gasser [Allemagne] ; B. Bereznai [Allemagne] ; B. Müller ; R. Pruszak-Seel ; R. Damrich ; G. Deuschl ; W. H. Oertel [Allemagne]Linkage studies in alcohol-responsive myoclonic dystonia
003352 E. J. Pappert [États-Unis] ; C. Buhrfiend ; J. W. Lipton ; P. M. Carvey ; G. T. Stebbins ; C. G. GoetzLevedopa stability in solution : time course, environmental effects, and practical recommendations for clinical use
003353 C. H. Adler [États-Unis] ; L. Wrabetz [États-Unis]Lesch-Nyhan variant : Dystonia, ataxia, near-normal intelligence, and no self-mutilation
003354 J. Galazka-Friedman [Pologne] ; E. R. Bauminger ; A. Friedman ; M. Barcikowska ; D. Hechel ; I. NowikIron in parkinsonian and control substantia nigra : a Mössbauer spectroscopy study
003355 S. H. Subramony [États-Unis] ; R. D. Currier [États-Unis]Intrafamilial variability in Machado-Joseph disease
003356 L. M. Shulman [États-Unis] ; C. Singer [États-Unis] ; J. A. Bean ; W. J. Weiner [États-Unis]Internal tremor in patients with Parkinson's disease
003357 B. R. Bloem [Pays-Bas] ; D. J. Beckley [États-Unis] ; J. G. Van Dijk [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; M. P. Remler [États-Unis] ; R. A. C. Roos [Pays-Bas]Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
003358 C. Geny [France] ; J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; F. Ricolfi [France] ; P. Cesaro [France] ; J.-D. Degos [France]Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation
003359 M. Jauss [Allemagne] ; P. Krack [Allemagne] ; M. Franz [Allemagne] ; R. Klett [Allemagne] ; R. Bauer [Allemagne] ; B. Gallhofer [Allemagne] ; W. Dorndorf [Allemagne]Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome
003360 P. J. Tuite [Canada] ; C. Navarette [Canada] ; V. Bril [Canada] ; A. E. Lang [Canada]Idiopathic generalized myokymia (Isaacs' syndrome) with hand posturing resembling dystonia
003361 J. P. P. Van Vugt [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas]Hypokinesia in Huntington's disease
003362 D. J. Werring [Royaume-Uni] ; K. Ray ChaudhuriHuman immunodeficiency virus-related progressive multifocal leukoencephalopathy presenting with an akinetic rigid syndrome
003363 V. L. Soland [Canada] ; K. P. Bhatia [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Hereditary geniospasm : Two new families
003364 P. Pantano [Italie] ; S. Di Cesare ; M. Ricci [Italie] ; G. F. Gualdi ; U. Sabatini [Italie] ; V. Di PieroHemichorea after a striatal ischemic lesion : Evidence of thalamic disinhibition using single-photon emission computed tomography : A case report
003365 F. Ghika-Schmid [Suisse] ; J. Ghika [Suisse] ; F. Regli [Suisse] ; N. Dworak [Suisse] ; J. Bogousslavsky [Suisse] ; C. St Dler [Suisse] ; L. Portmann [Suisse] ; P. A. Despland [Suisse]Hashimoto's myoclonic encephalopathy : An underdiagnosed treatable condition ?
003366 T. Gasser [États-Unis] ; C. M. Bove [États-Unis] ; L. J. Ozelius [États-Unis] ; M. Hallett ; M. E. Charness ; F. H. Hochberg ; X. O. Breakefield [États-Unis]Haplotype analysis at the DYT1 locus in Ashkenazi Jewish patients with occupational hand dystonia
003367 S. B. Blunt [Royaume-Uni] ; P. G. Richards [Royaume-Uni] ; N. Khalil [Royaume-Uni]Foot dystonia and lumbar canal stenosis
003368 V. L. Soland [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; M. A. Volonte [Italie] ; C. D. Marsden [Royaume-Uni]Focal task-specific tremors
003369 O. C. Cockerell [Royaume-Uni] ; P. Rudge [Royaume-Uni]Focal dystonia secondary to superficial siderosis
003370 D. T. Schloesser [États-Unis] ; T. N. Ward [États-Unis] ; P. D. Williamson [États-Unis]Familial paroxysmal dystonic choreoathetosis revisited
003371 D. S. Sax [États-Unis] ; R. Powsner [États-Unis] ; A. Kim [États-Unis] ; S. Tilak [États-Unis] ; R. Bhatia [États-Unis] ; L. A. Cupples [États-Unis] ; R. H. Myers [États-Unis]Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography
003372 J. Green [États-Unis] ; J. L. Woodard ; B. E. Sirockman ; G. O. Zakers ; C. L. Maier ; R. C. Green ; R. L. WattsEvent-related potential P3 change in mild Parkinson's disease
003373 N. P. Quinn [Royaume-Uni]Essential myoclonus and myoclonic dystonia
003374 G. De Michele [Italie] ; A. Filla [Italie] ; G. Volpe [Italie] ; V. De Marco [Italie] ; A. Gogliettino [Italie] ; G. Ambrosio [Italie] ; R. Marconi ; A. E. Castellano ; G. Campanella [Italie]Environmental and genetic risk factors in Parkinson's disease : a case-control study in southern Italy
003375 P. Gatev [États-Unis] ; S. Thomas [États-Unis] ; J.-S. Lou [États-Unis] ; M. Lim [États-Unis] ; M. Hallett [États-Unis]Effects of diminished and conflicting sensory information on balance in patients with cerebellar deficits
003376 F. Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France]Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
003377 L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis]Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
003378 K. D. Pfann [États-Unis] ; R. D. Penn ; K. M. Shannon ; M. B. Shapiro ; D. M. Corcos [États-Unis]Effect of stimulation in the ventral intermediate nucleus of the thalamus on limb control in Parkinson's disease : A case study
003380 S. H. Subramony [États-Unis] ; J. D. Fratkin ; B. V. Manyam ; R. D. Currier [États-Unis]Dominantly inherited cerebello-olivary atrophy is not due to a mutation at the spinocerebellar ataxia-I, Machado-Joseph disease, or dentato-rubro-pallido-luysian atrophy locus
003381 J. E. Nielsen [Danemark] ; S. A. S Rensen [Danemark] ; L. Hasholt [Danemark] ; A. N Rrem Lle [Danemark]Dentatorubral-pallidoluysian atrophy. Clinical features of a five-generation Danish family
003382 J. H. Friedman [États-Unis] ; W. StoneDelayed-onset dystonia secondary to unilateral schizencephaly
003384 L. J. Born [États-Unis] ; R. H. Harned ; L. F. Fikkers ; R. F. Pfeiffer [États-Unis] ; E. M. M. Quigley [États-Unis]Cricopharyngeal dysfunction in Parkinson's disease : role in dysphagia and response to myotomy
003385 Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD)
003386 T. E. Eichhorn [Allemagne] ; T. Gasser [Allemagne] ; N. Mai [Allemagne] ; C. Marquardt ; G. Arnold [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne]Computational analysis of open loop handwriting movements in Parkinson's disease : A rapid method to detect dopamimetic effects
003387 K. J. Bharucha [États-Unis] ; K. D. Sethi [États-Unis]Complex movement disorders induced by fluoxetine
003388 A. Ikeda [Japon] ; .. Shibasaki [Japon] ; K. Tashiro [Japon] ; Y. Mizuno [Japon] ; J. Kimura [Japon]Clinical trial of piracetam in patients with myoclonus : nationwide multiinstitution study in Japan
003389 C. Trenkwalder [Allemagne] ; V. Collado Seidel [Allemagne] ; T. Gasser ; W. H. OertelClinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome
003390 R. A. C. Roos [Pays-Bas] ; J. C. F. Jongen [Pays-Bas] ; E. A. Van Der VeldeClinical course of patients with idiopathic Parkinson's disease
003391 I. Daum [Allemagne] ; M. M. Schugens [Allemagne] ; C. Breitenstein [Allemagne] ; H. Topka [Allemagne] ; S. Spieker [Allemagne]Classical eyeblink conditioning in Parkinson's disease
003392 P. Maggi [Italie] ; M. De Mari ; R. De Blasi ; S. Armenise ; C. Romanelli [Italie] ; C. Andreula ; G. Zimatore ; G. Angarano [Italie]Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis
003393 G. D. Ppodskalny [États-Unis] ; S. A. Factor [États-Unis]Chorea caused by lithium intoxication : A case report and literature review
003394 M. A. Nance [États-Unis] ; G. Sanders [États-Unis]Characteristics of individuals with Huntington disease long-term care
003395 T. Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis]Cervical dystonia as the initial presentation of Huntington's disease
003397 G. Geminiani [Italie] ; V. Fetoni [Italie] ; S. Genitrini [Italie] ; P. Giovannini [Italie] ; F. Tamma [Italie] ; T. Caraceni [Italie]Cabergoline in Parkinson's disease complicated by motor fluctuations
003398 P. D. Clouston [Australie] ; C. L. Lim [Australie] ; V. Fung [Australie] ; C. Yiannikas [Australie] ; J. G. L. Morris [Australie]Brainstem myoclonus in a patient with non-dopa-responsive parkinsonism
003399 D. M. Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsch [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery : A description of two cases and review of the literature
003400 L. Bettendorff [Belgique] ; F. Mastrogiacomo ; J. Lamarche ; S. Dozic ; S. J. KishBrain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1
003401 G. W. Paulson [États-Unis] ; W. Gill [États-Unis]Botulinum toxin is unsatisfactory therapy for fibromyalgia
003403 S. Salloway [États-Unis] ; C. F. Stewart [États-Unis] ; L. Israeli ; X. Morales ; S. Resmussen [États-Unis] ; A. Blitzer [États-Unis] ; M. F. Brin [États-Unis]Botulinum toxin for refractory vocal tics
003404 R. S. Briellmann [Suisse] ; K. M. Rösler [Suisse] ; C. W. Hess [Suisse]Blink reflex excitability is abnormal in patients with periodic leg movements in sleep
003405 F. X. Glocker [Allemagne] ; G. Deuschl [Allemagne] ; B. Volk [Allemagne] ; J. Hasse [Allemagne] ; C. H. Lücking [Allemagne]Bilateral myoclonus of the trapezius muscles after distal lesion of an accessory nerve
003406 S. Jain [Inde] ; S. K. Tamer [Inde] ; S. Hiran [Inde]Beneficial effect of alcohol in hereditary cerebellar ataxia with myoclonus (progressive myoclonic ataxia) : Report of two siblings
003408 F. Q. Ye [Canada] ; P. S. Allen [Canada] ; W. R. W. MartinBasal ganglia iron content in Parkinson's disease measured with magnetic resonance
003409 L. E. Abrey [États-Unis] ; C. H. Waters [États-Unis]Basal ganglia calcification after mumps encephalitis
003410 C. Klein [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Ataxia without telangiectasia masquerading as benign hereditary chorea
003411 A. Feigin [États-Unis] ; K. Kieburtz [États-Unis] ; P. Como [États-Unis] ; C. Hickey [États-Unis] ; K. Claude [États-Unis] ; D. Abwender [États-Unis] ; C. Zimmerman [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis]Assessment of coenzyme Q10 tolerability in Huntington's disease
003412 A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; F. Garcia [Espagne] ; C. Cabezas [Espagne] ; F. Coria [Espagne] ; L. E. Claveria [Espagne]An estimate of the risk of movement disorders associated with the chronic use of clebopride
003414 K. Jendroska [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; S. E. Daniel [Royaume-Uni]Amyloid β-peptide and the dementia of Parkinson's disease
003416 P. J. Blanchet [États-Unis] ; L. V. Metman [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis]Acute pharmacologic blockade of dyskinesias in Parkinson's disease
003417 F. Valldeoriola [Espagne] ; J. Gonzalez [Espagne] ; N. Vila [Espagne] ; J. Valls-Sole [Espagne] ; M. Sole ; F. Graus [Espagne] ; E. Tolosa [Espagne]Action myoclonus as an early clinical sign of carcinomatous meningitis
003418 A. Ikeda [Japon] ; H. Shibasaki [Japon] ; R. Kaji [Japon] ; K. Terada [Japon] ; T. Nagamine [Japon] ; M. Honda [Japon] ; T. Hamano [Japon] ; J. Kimura [Japon]Abnormal sensorimotor integration in Writer's cramp : Study of contingent negative variation
003419 P. Limousin [France] ; Pierre Pollak [France] ; D. Hoffmann [France] ; ABDELHAMID BENAZZOUZ [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France]Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients
003420 Joseph Jankovic [États-Unis] ; K. Schwartz [États-Unis] ; W. Clemence [États-Unis] ; A. Aswad ; J. MordauntA randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
003421 T. Van Laar [Pays-Bas] ; C. Neef [Pays-Bas] ; M. Danhof [Pays-Bas] ; K. I. Roon [Pays-Bas] ; R. A. C. Roos [Pays-Bas]A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
003422 M. Samuel [Royaume-Uni] ; M. Manford [Royaume-Uni] ; G. Sheean [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]A neuromyotonic process in a transposed latissimus dorsi muscle stemming from radiotherapy and peripheral surgery
003423 K. Kieburtz [États-Unis] ; A. Feigin ; M. Mcdermott ; P. Como ; D. Abwender ; C. Zimmerman ; C. Hickey ; C. Orme ; K. Claude ; J. Sotack ; J. T. Greenamyre ; C. Dunn ; I. ShoulsonA controlled trial of remacemide hydrochloride in Huntington's disease
003424 N. G. Ranen [États-Unis] ; C. E. Peyser [États-Unis] ; J. T. Coyle [États-Unis] ; F. W. Bylsma [États-Unis] ; M. Sherr [États-Unis] ; L. Day [États-Unis] ; M. F. Folstein [États-Unis] ; J. Brandt [États-Unis] ; C. A. Ross [États-Unis] ; S. E. Folstein [États-Unis]A controlled trial of idebenone in Huntington's disease
003425
003427 G. Pezzoli [Italie] ; A. Antonini ; S. Barbieri [Italie] ; M. Canesi [Italie] ; L. Perbellini ; A. Zecchinelli [Italie] ; C. B. Mariani [Italie] ; A. Bonetti [Italie] ; K. L. Leendersn-Hexane-induced Parkinsonism : pathogenetic hypotheses
003428 E. R. P. Brunt [Pays-Bas] ; T. W. Van Weerden ; J. Pruim ; J. W. P. F. Lakke [Pays-Bas]Unique myoclonic pattern in corticobasal degeneration
003429 G. Staude [Allemagne] ; W. Wolf [Allemagne] ; M. Ott ; W. H. Oertel ; R. DenglerTremor as a factor in prolonged reaction times of Parkinsonian patients
003430 A. S. WaltersToward a better definition of the Restless Legs Syndrome
003431 Joseph Jankovic [États-Unis] ; T. AshizawaTourettism associated with Huntington's disease
003432 W. Van Der Kamp [Royaume-Uni] ; J. C. Rothwell ; P. D. Thompson ; B. L. Day ; C. D. MarsdenThe movement-related cortical potential is abnormal in patients with idiopathic torsion dystonia
003433 J. N. Caviness [États-Unis] ; P. A. Forsyth [États-Unis] ; D. D. Layton ; T. J. Mcphee [États-Unis]The movement disorder of adult opsoclonus
003434 E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; E. G. Nessler [Norvège] ; T. Riise ; J. A. AarliThe epidemiology of Parkinson's disease in the county of Rogaland, Norway
003435 W. Diaz Neira [Espagne] ; V. Sanchez ; M. A. Mena ; J. G. De YebenesThe effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease
003436 R. Lindeboom [Pays-Bas] ; R. De Haan ; M. Aramideh ; J. D. SpeelmanThe blepharospasm disability scale : an instrument for the assessment of functional health in blepharospasm
003437 M. Vidailhet [Royaume-Uni] ; P. R. Atchison ; F. Stocchi ; P. D. Thompson ; J. C. Rothwell ; C. D. MarsdenThe bereitschaftspotential preceding in patients with isolated gait ignition failure
003438 R. Stell [Australie] ; G. W. Thickbroom ; F. L. MastagliaThe audiogenic startle response in Tourette's syndrome
003439 R. K. B. Pearce [Royaume-Uni] ; C. H. Hawkes ; S. E. Daniel [Royaume-Uni]The anterior olfactory nucleus in Parkinson's disease
003440 M. Onofrj [Italie] ; T. Fulgente [Italie] ; G. Malatesta [Italie] ; F. Ferracci [Italie] ; A. Thomas [Italie] ; L. Curatola ; F. Bollettini ; M. RagnoThe abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations
003442 K. J. Bharucha [États-Unis] ; K. D. SethiTardive tourettism after exposure to neuroleptic therapy
003443 F. Valldeoriola [Espagne] ; J. Valls-Sole ; E. S. Tolosa ; M. J. MartiStriated anal sphincter denervation in patients with progressive supranuclear palsy
003444 XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada]Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy
003445 F. A. Lenz [États-Unis] ; S. L. Normand ; H. C. Kwan ; D. Andrews ; L. H. Rowland [États-Unis] ; M. W. Jones ; M. Seike [États-Unis] ; Y. C. Lin [États-Unis] ; R. R. Tasker ; J. O. Dostrovsky ; Y. E. Lenz [États-Unis]Statistical prediction of the optimal site for thalamotomy in Parkinsonian tremor
003448 J. H. T. M. Koelman [Pays-Bas] ; R. B. Willemse ; L. J. Bour ; A. A. J. Hilgevoord ; J. D. Speelman ; B. W. Ongerboer De VisserSoleux H-reflex tests in dystonia
003449 J. C. Garcia-Monco [Espagne] ; A. Padierna ; M. G. BeldarrainSelegiline, fluoxetine, and depression in Parkinson's disease
003450 J. Duarte [Espagne] ; L. E. Claveria [Espagne] ; J. De Pedro-Cuesta ; A. P. Sempere [Espagne] ; F. Coria [Espagne] ; D. B. CalneScreening Parkinson's disease : a validated questionnaire of high specificity and sensitivity
003451 M. A. J. Tijssen [Pays-Bas] ; E. Bollen ; E. Van Exel ; J. G. Van DijkSaccadic eye movements in hyperekplexia
003452 B. M. S. Dash [Inde]Role of peripheral inputs in cerebellar tremor
003454 A. Verma [États-Unis] ; J. R. Berger [États-Unis] ; B. C. Bowen ; J. Sanchez-Ramos [États-Unis]Reversible Parkinsonian syndrome complicating cysticercus midbrain encephalitis
003456 N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; J. G. Phillips [Australie] ; E. Chiu ; J. A. Bradshaw [Australie]Reliance on advance information and movement sequencing in Huntington's disease
003457 ROU-SHAYN CHEN [Taïwan] ; CHON-HAW TSAI ; CHIN-SONG LUReciprocal inhibition in Writer's cramp
003458 G. J. Rey [États-Unis] ; R. Tomer [États-Unis] ; B. E. Levin [États-Unis] ; J. Sanchez-Ramos [États-Unis] ; B. Bowen ; J. H. BrucePsychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration
003459 K. Nakashima [Japon] ; M. Kusumi [Japon] ; Y. Inoue ; K. Takahashi [Japon]Prevalence of focal dystonias in the Western area of Tottori Prefecture in Japan
003460 S. S. Palmer [États-Unis] ; J. T. HuttonPostural finger tremor exhibited by Parkinson patients and age-matched subjects
003461 B. Bonnefoi-Kyriacou [France] ; E. Trouche [France] ; E. Legallet [France] ; F. Viallet [France]Planning and execution of pointing movements in cerebellar patients
003462 T. Van Laar [Pays-Bas] ; E. N. H. Jansen ; C. Neef ; M. Danhof ; R. A. C. RoosPharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease : a study of five different suppositories
003463 S. Przedborski [Belgique] ; M. Levivier ; C. Raftopoulos ; A. B. Naini ; J. Hildebrand [Belgique]Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans
003464 H. S. Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox ; C. D. Marsden ; D. C. CostaPatterns of regional cerebral blood flow in corticobasal degeneration studies using HMPAO SPECT ; comparison with Parkinson's disease and normal controls
003467 D. A. Simpson [États-Unis] ; R. Wishnow ; R. B. Gargulinski ; A. M. PawlakOculofacial-skeletal myorhythmia in central nervous System Whipple's disease : additional case and review of the literature
003468 J. E. Ahlskog [États-Unis] ; R. J. Uitti ; P. A. Low [États-Unis] ; G. M. Tyce ; K. K. Nickander [États-Unis] ; R. C. Petersen [États-Unis] ; E. Kokmen [États-Unis]No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease
003470 K. Westermark [Suède] ; J. Tedroff ; K.-A. Thuomas ; P. Hartvig ; B. Langström ; Y. Andersson ; K. Hörnfeldt ; S.-M. AquiloniusNeurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers
003471 H. Nogaki [Japon] ; T. Fukusako ; F. Sasabe ; K. Negoro ; M. MiromatsuMuscle strength in early Parkinson's disease
003472 C. Tranchant [France] ; K. P. Bhatia ; C. D. MarsdenMovement disorders in multiple sclerosis
003473 R. Haaxma [Pays-Bas] ; A. Van Boxtel ; W. H. Brouwer ; L. N. H. Goeken ; J. J. Denier Van Der Gon ; J. G. Colebatch ; A. Martin ; D. J. Brooks ; J. Noth ; C. D. MarsdenMotor function in a patient with bilateral lesions of the globus pallidus
003474 K. Jendroska [Royaume-Uni] ; M. N. Rossor ; C. J. Mathias ; S. E. Daniel [Royaume-Uni]Morphological overlap between corticobasal degeneration and Pick's disease : a clinicopathological report
003475 R. A. Maricle [États-Unis] ; J. G. Nutt ; J. H. CarterMood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion : preliminary findings
003476 J. Valls-Sole [Espagne] ; M. HallettModulation of electromyographic activity of wrist flexor and extensor muscles in patients with Writer's cramp
003477 G. Fabbrini [Italie] ; F. Baronti ; S. Ruggieri ; G. L. LenziMeningioma-induced loss of antiparkinsonian response to levodopa
003479 J. Kulisevsky [Espagne] ; M. L. Berthier ; A. AvilaLongitudinal evolution of prefrontral leucotomy in Tourette's syndrome
003480 R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. KorczynLong-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
003481 B. R. Bloem [Pays-Bas] ; D. J. Beckley ; J. P. P. Van Vugt [Pays-Bas] ; J. G. Van Dijk [Pays-Bas] ; M. P. Remler ; J. W. Langston ; R. A. C. Roos [Pays-Bas]Long latency postural reflexes are under supraspinal dopaminergic control
003482 D. Smith [États-Unis] ; T. Ishikawa ; V. Dhawan ; J. S. Winterkorn ; D. Eidelberg [États-Unis]Lid opening apraxia is associated with medial frontal hypometabolism
003483 J. J. Poza [Espagne] ; J. F. Marti Masso [Espagne] ; E. AmatoLate onset familial periodic cerebellar ataxia
003484 J. M. Cooper [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden ; A. H. V. Schapira [Royaume-Uni]L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brain
003485 J. Opacka-Juffry [Royaume-Uni] ; D. J. BrooksL-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory roles
003486 A. Lagueny [France] ; P. Burbaud ; G. Le Masson ; F. X. Bergouignan ; X. Ferrer ; J. JulienInvolvement of respiratory muscles in adult-onset dystonia : a clinical and electrophysiological study
003487 A. Salmaggi [Italie] ; F. Carella ; C. Ciano ; S. Binelli ; P. Giovannini ; E. Palazzini ; F. GirottiIntrathecal immune activation in three patients with progressive myoclonic ataxia
003488 R. D. Penn [États-Unis] ; J. M. Gianino ; M. M. YorkIntrathecal baclofen for motor disorders
003489 W. H. Oertel [Allemagne] ; R. C. DodelInternational guide to drugs for Parkinson's disease
003490 Joseph Jankovic [États-Unis]International classification of diseases, tenth revision : neurological adaptation (ICD-10 NA) : extrapyramidal and movement disorders
003491 J. J. Van Hilten [Pays-Bas] ; E. A. M. Braat [Pays-Bas] ; E. A. Van Der Velde ; H. A. M. Middelkoop [Pays-Bas] ; J. G. Van Dijk [Pays-Bas] ; G. J. Ligthart ; R. A. C. Roos [Pays-Bas]Hypokinesia in Parkinson's disease : influence of age, disease severity, and disease duration
003492 G. Ebersbach [Allemagne] ; C. Kabus ; L. Schelosky [Allemagne] ; L. Terstegge ; Werner Poewe [Allemagne]Hemimasticatory spasm in hemifacial atrophy : diagnostic and therapeutic aspects in two patients
003495 J. M. Wojcieszek [Canada] ; A. E. LangGestes antagonistes in the suppression of tics : "tricks for tics"
003496 A. Feigin [États-Unis] ; K. Kieburtz ; K. Bordwell ; P. Como ; K. Steinberg ; J. Sotack ; C. Zimmerman ; C. Hickey ; C. Orme ; I. ShoulsonFunctional decline in Huntington's disease
003497 K. Bötzel [Allemagne] ; M. Mayer [Allemagne] ; W. H. Oertel [Allemagne] ; W. PaulusFrontal and parietal premovement slow brain potentials in Parkinson's disease and aging
003498 S. Bohlega [Arabie saoudite] ; B. Stigsby [Arabie saoudite] ; M. Z. Al-Kawi [Arabie saoudite] ; D. R. Mclean [Arabie saoudite] ; P. Ozand ; S. Omer [Arabie saoudite] ; P. CoatesFamilial tremulous and myoclonic dystonia with white matter changes in brain magnetic resonance imaging
003499 S. Iannaccone [Italie] ; M. Zucconi ; P. Marchettini ; L. Ferini-Strambi ; R. Nemni ; A. Quattrini ; S. Palazzi ; M. Lacerenza ; F. Formaglio ; S. SmirneEvidence of peripheral axonal neuropathy in primary restless legs syndrome
003500 D. W. Claypool [États-Unis] ; D. D. Duane ; D. M. Ilstrup [États-Unis] ; L. J. Melton [États-Unis]Epidemiology an outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota
003501 T. L. Davis [États-Unis] ; M. Roznoski ; R. S. BurnsEffects of tolcapone in Parkinson's patients taking L-dihydroxyphenalalanine/carbidopa and selegiline
003503 R. Djaldetti [Israël] ; M. Koren ; ILAN ZIV ; A. Achiron ; ELDAD MELAMEDEffect of cisapride on response fluctuations in Parkinson's disease
003505 R. Cole [États-Unis] ; M. Hallett ; L. G. CohenDouble-blind trial of botulinum toxin for treatment of focal hand dystonia
003506 C. E. Clarke [Royaume-Uni]Does levodopa therapy delay death in Parkinson's disease ? A review of the evidence
003507 J.-L. Montastruc [France] ; N. Fabre [France] ; O. Blin [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; A. Rascol [France]Does fluoxetine aggravate Parkinson's disease ? A pilot prospective study
003508 J. Garcia De Yebenes [Espagne]Did Robert Schumann have dystonia ?
003509 J. D. Clark [États-Unis] ; RAJESH PAHWA [États-Unis] ; W. C. Koller [États-Unis] ; D. MoralesDiabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosis
003510 J. G. Colebatch [Australie] ; V. Di Lazzaro ; A. Quartarone ; J. C. Rothwell ; M. GrestyClick-evoked vestibulocollic reflexes in torticollis
003511 M. S. Jog [Canada] ; A. E. LangChronic acquired hepatocerebral degeneration : case reports and new insights
003513 A. Cammarota [Argentine] ; O. S. Gershanik ; S. Garcia ; G. LeraCervical dystonia due to spinal cord ependymoma : involvement of cervical cord segments in the pathogenesis of dystonia
003514 L. M. Shulman [États-Unis] ; A. E. Lang ; Joseph Jankovic [États-Unis] ; N. J. David [États-Unis] ; W. J. Weiner [États-Unis]Case 1, 1995 : psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction
003515 V. Plante-Bordeneuve [Royaume-Uni] ; O. Bandmann ; G. Wenning ; N. P. Quinn ; S. E. Daniel ; A. E. HardingCYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy
003516 D. Claus [Allemagne] ; A. Druschky ; F. ErbguthBotulinum toxin : influence on respiratory heart rate variation
003517 D. Tarsy [États-Unis] ; S. C. SchachterBotulinum toxin treatmenty is not effective for epilepsy partialis continua
003518 M. F. Gordon [États-Unis] ; R. I. Abrams ; D. B. Rubin ; W. B. Barr ; D. D. CorreaBismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus
003519 M. H. Mark [États-Unis] ; J. I. Sage ; A. S. Walters ; R. C. Duvoisin ; D. C. MillerBinswanger's disease presenting as levodopa-responsive parkinsonism : clinicopathologic study of three cases
003520 P. Limousin [France] ; Pierre Pollak [France] ; ABDELHAMID BENAZZOUZ [France] ; D. Hoffmann [France] ; E. Broussolle [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France]Bilateral subthalamic nucleus stimulation for severe Parkinson's disease
003521 O. Suchowersky [Canada] ; S. Furtado ; G. RohsBeneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease
003522 G. Northoff [Allemagne] ; J. Wenke ; W. Krill ; B. PflugBall experiments in 32 acute akinetic catatonic patients : deficits of internal initiation and generation of movements
003523 G. W. Rebok [États-Unis] ; F. W. Bylsma ; P. M. Keyl ; J. Brandt ; S. E. FolsteinAutomobile driving in Huntington's disease
003524 N. J. Scolding [Royaume-Uni] ; S. M. Smith [Royaume-Uni] ; S. Sturman ; G. B. Brookes [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Auctioneer's jaw : a case of occupational oromandibular hemidystonia
003525 R. Sprengelmeyer [Allemagne] ; A. G. M. Canavan ; H. W. Lange ; V. HömbergAssociative learning in degenerative neostriatal disorders : contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases
003526 S. Kuwabara [Japon] ; T. Fukutake ; N. Kasahata ; Y. Shimoe ; I. Yamanaka ; K. HirayamaAssociated movement as a sequel to thoracotomy : aberrant regeneration to the latissimus dorsi muscle
003527 S. T. Gancher [États-Unis] ; J. G. Nutt [États-Unis] ; W. R. WoodwardApomorphine infusional therapy in Parkinson's disease : clinical utility and lack of tolerance
003529 WASEEM ASHRAF [États-Unis] ; Z. K. Wszolek ; R. F. Pfeiffer ; M. Normand ; K. Maurer ; F. Srb [États-Unis] ; L. L. Edwards ; E. M. M. Quigley [États-Unis]Anorectal function in fluctuating (on-off) Parkinson's disease : evaluation by combined anorectal manometry and electromyography
003530 M. T. Dotti [Italie] ; A. FedericoAmiodarone-induced Parkinsonism : a case report and pathogenetic discussion
003531 C. H. Stuppaeck [Autriche] ; C. H. Miller [Autriche] ; H. Ehrmann [Autriche] ; W. W. Fleischhacker [Autriche] ; S. Felber ; Werner Poewe [Autriche]Akathisia induced by necrosis of the basal ganglia after carbon monoxide intoxication
003532 A. Priori [Italie] ; L. Bertolasi ; A. Berardelli ; M. ManfrediActe dystonic reaction to ectasy
003533 A. Hufschmidt [Allemagne] ; C.-H. LückingAbnormalities of tracking behavior in Parkinson's disease
003534 Olivier Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France]Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease
003535 C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. GarnettA probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain
003536 A. Ishikawa [Japon] ; T. MiyatakeA family with hereditary juvenile dystonia-parkinsonism
003537 T. Klockgether [Allemagne] ; M. Borutta ; H. Rapp ; S. Spieker ; J. DichgansA defect of kinesthesia in Parkinson's disease
003538 G. Glosser [États-Unis] ; C. Clark ; B. Freundlich ; L. Kliner-Krenzel ; P. Flaherty ; M. SternA controlled investigation of current and premorbid personality : characteristics of Parkinson's disease patients
003539 G. K. Wenning [Royaume-Uni] ; M. T. O'Connell ; P. N. Patsalos ; N. P. QuinnA clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease
003540 A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
003542 N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France]"Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study
003543 C. Pacchetti [Italie] ; G. Albani ; E. Martignoni ; L. Godi ; E. Alfonsi ; G. Nappi"Off" painful dystonia in Parkinson's disease treated with botulinum toxin
003544
003545
003546
003547 G. K. Wenning [Royaume-Uni] ; N. Quinn ; M. Magalhaes ; C. Mathias ; S. E. Daniel«Minimal change» multiple system atrophy
003548 A. E. Lang [Canada]Withdrawal akathisia: case reports and a proposed classification of chronic akathisia
003549 J. Wojcieszek [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; P. Greene ; J. DeckWhat is it? Case 1, 1994: rapidly progressive aphasia, apraxia, dementia, myoclonus, and Parkinsonism
003550 B. A. Haug [Allemagne] ; C. Trenkwalder [Allemagne] ; G. B. Arden ; W. H. Oertel ; W. PaulusVisual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease
003551 T. Klockgether [Allemagne] ; J. DichgansVisual control of arm movement in Parkinson's disease
003552 K. P. Bhatia [Royaume-Uni] ; G. Lera [Royaume-Uni] ; P. J. Luthert ; C. D. Marsden [Royaume-Uni]Vascular chorea: case report with pathology
003553 S. Micheli [Argentine] ; M. Fernandez-Pardal ; P. Quesada ; T. Brannan ; J. A. ObesoVariable onset of adult inherited focal dystonia: a problem for genetic studies
003554 C. G. Goetz [États-Unis] ; G. T. Stebbins ; H. M. Shale ; A. E. Lang ; D. A. Chernik ; T. A. Xhmura ; J. E. Ahlskog ; E. E. DorflingerUtility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment
003555 G. Pavesi [Italie] ; D. Medici [Italie] ; G. M. Macaluso ; P. Ventura [Italie] ; I. Allegri [Italie] ; F. Gemignani [Italie]Unusual synkinetic movements between facial muscles and respiration in hemifacial spasm
003556 J. N. Caviness [Royaume-Uni] ; A. Gabellini ; C. S. Kneebone ; P. D. Thompson ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenUnusual focal dyskinesias: the ears, the shoulders, the back, and the abdomen
003557 P. Martinez-Martin [Espagne] ; A. Gil-Nagel [Espagne] ; L. Morlan Gracia [Espagne] ; J. Balseiro Gomez [Espagne] ; J. Martinez-Sarries [Espagne] ; F. BermejoUnified Parkinson's disease rating scale characteristics and structure
003558 V. Plante-Bordeneuve [Royaume-Uni] ; M. B. Davis ; D. M. Maraganore ; C. D. Marsden ; A. E. HardingTyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease
003559 J. M. Trugman [États-Unis] ; R. Leadbetter ; M. E. Zalis ; R. O. Burgdorf ; G. F. Wooten [États-Unis]Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis
003560 D. Dressler [Royaume-Uni] ; P. D. Thompson ; R. F. Gledhill [Royaume-Uni] ; C. D. MarsdenThe syndrome of painful legs and moving toes
003561 E. Beghi [Italie] ; M. L. Monticelli [Italie] ; A. Sessa ; P. SimoneThe prevalence of Parkinsonism in Italy: an epidemiological survey of the disease in general practice
003562 J. O. Rinne [Royaume-Uni] ; S. E. Daniel ; F. Scaravilli ; M. Pires ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The neuropathological features of neuroacanthocytosis
003563 R. J. Elble [États-Unis] ; C. Moody ; K. Leffler ; RAJ SINHAThe initiation of normal walking
003565 F. O. Walker [États-Unis] ; J. R. AbsherThe clinton effect and hemiballism
003566 K. Nakashima [Japon] ; M. Shimoda ; N. Kuno ; K. TakahashiTemporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease
003568 T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. GrimesSymptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride
003569 G. Deuschl [États-Unis] ; C. Toro ; M. HallettSymptomatic and essential palatal tremor. II: Differences of palatal movements
003570 J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. SchuhSuppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction
003571 Y. River [Israël] ; S. Honigman ; J. M. Gomori ; A. RechesSuperficial hemosiderosis of the central nervous system
003572 V. M. S. De Bruin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases
003574 I. Kono [Japon] ; Y. Ueda [Japon] ; K. Araki [Japon] ; K. Nakajima [Japon] ; H. ShibasakiSpinal myoclonus resembling Belly dance
003575 R. Mayeux [États-Unis] ; MING-XIN TANG [États-Unis] ; K. Marder [États-Unis] ; L. J. Cote ; Y. Stern [États-Unis]Smoking and Parkinson's disease
003576 T. R. Jr Zimmerman [États-Unis] ; J. I. Sage ; A. E. Lang ; M. H. MarkSevere evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment
003577 E. C. Lauterbach [États-Unis]Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease
003578 H. Reichmann [Allemagne] ; M. Naumann ; S. Hauck ; B. JanetzkyRespiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia
003579 M. Richards [États-Unis] ; K. Marder [États-Unis] ; L. Cote ; R. Mayeux [États-Unis]Reliability of symptom onset assessment in Parkinson's disease
003580 G. Defazio [Italie] ; V. Lepore [Italie] ; G. Abbruzzese ; E. Barontini ; A. Berardelli ; T. Caraceni ; F. Carella ; P. Girlanda ; M. Manfredi ; C. Messina ; S. Maurri ; E. Ferrari [Italie] ; P. Livrea [Italie]Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia : a multicenter study
003581 J. J. Van Hilten [Pays-Bas] ; A. D. Van Der Zwan [Pays-Bas] ; A. H. Zwinderman ; R. A. C. Roos [Pays-Bas]Rating impairment and disability in Parkinson's Disease: evaluation of the Unified Parkinson's Disease rating Scale
003582 R. K. Mosewich [Canada] ; A. H. Rajput [Canada] ; A. Shuaib [Canada] ; B. Rozdilsky ; L. AngPulmonary embolism: an under-recognized yet frequent cause of death in Parkinsonism
003583 P. Brown [Royaume-Uni] ; J. C. Rothwell ; P. D. Thompson ; C. D. MarsdenPropriospinal myoclonus: evidence for spinal pattern generators in humans
003584 N. Biary [Arabie saoudite] ; B. Singh ; Y. Bahou ; S. M. Al Deeb ; H. SharifPosttraumatic paroxysmal nocturnal hemidystonia
003585 M. P. Caligiuri [États-Unis]Portable device for quantifying parkinsonian wrist rigidity
003586 J. Hermsdörfer [Allemagne] ; K. Wessel ; N. Mai [Allemagne] ; C. Marquardt [Allemagne]Perturbation of precision grip in Friedreich's ataxia and late-onset cerebellar ataxia
003587 M. Scarpa [Italie] ; U. CastielloPerturbation of a prehension movement in Parkinson's disease
003588 G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. MoscarelliPergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study
003589 A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; J. M. Palomares ; F. Coria ; L. E. ClaveriaParkinsonism and tardive dyskinesia after chronic use of clebopride
003590 T. Curran [Canada] ; A. E. LangParkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses
003591 A. T. M. Hageman [Pays-Bas] ; M. W. I. M. HorstinkParkinson due to a subdural hematoma
003593 M. S. Lee [Corée du Sud] ; C. D. MarsdenNeurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings
003594 Olivier Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. RascolNaltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease
003596 M. S. Lee [Royaume-Uni] ; C. D. MarsdenMovement disorders following lesions of the thalamus or subthalamic region
003597 R. J. Labutta [États-Unis] ; R. B. Miles [États-Unis] ; J. N. Sanes ; M. Hallett [États-Unis]Motor program memory storage in Parkinson's disease patients tested with a delayed response task
003598 L. V. Metman [États-Unis] ; V. H. Sethy ; J. R. Roberts ; D. Bravi ; J. I. Hoff ; M. M. Mouradian ; T. N. ChaseMotor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (Preclamol) in Parkinson's disease
003599 J. M. Olive [Espagne] ; L. Masana ; J. GonzalezMeperidine and reversible parkinsonism
003600 M. Merello [Argentine] ; H. Garcia ; M. Nogues ; R. LeiguardaMasticatory muscle spasms in a non-japanese patient with satoyoshi syndrome successfully treated with botulinum toxin
003601 D. Tarsy [États-Unis] ; L. Sudarsky ; M. E. CharnessLimb dystonia following electrical injury
003602 R. Marconi [France] ; D. Lefebvre-Caparros ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] ; Yves Agid [France]Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
003603 S. S. Rich [États-Unis] ; F. OvsiewLeuprolide acetate for exhibitionism in Huntington's disease
003604 J. A. P. Hiel [Pays-Bas] ; C. M. R. Weemaes ; D. F. C. M. Smeets ; C. J. W. Van De Vlasakker ; M. W. I. M. Horstink [Pays-Bas]Late-onset telangiectasia in two brothers presenting with juvenile resting tremor
003605 C. Singer [États-Unis] ; B. A. Green ; J. H. Bruce ; B. C. Woben ; W. J. Weiner [États-Unis]Late presentation of congenital muscular torticollis: use of MR imaging and CT scan in diagnosis
003606 G. K. Wenning [Royaume-Uni] ; R. J Ger [Royaume-Uni] ; B. Kendall ; D. Kingsley [Royaume-Uni] ; S. E. Daniel ; N. P. Quinn [Royaume-Uni]Is cranial computerized tomography useful in the diagnosis of multiple system atrophy?
003607 M. Richards [États-Unis] ; K. Marder ; L. Cote ; R. MayeuxInterrater reliability of the Unified Parkinson's Disease Rating Scale motor examination
003609 D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. MarsdenIncreated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study
003611 G. S. Hotamisligil [États-Unis] ; A. S. Girmen [États-Unis] ; J. S. Fink [États-Unis] ; E. Tivol [États-Unis] ; C. Shalish [États-Unis] ; J. Trofatter [États-Unis] ; J. Baenziger ; S. Diamond ; C. Markham ; J. Sullivan ; J. Growdon [États-Unis] ; X. O. Breakefield [États-Unis]Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
003612 F. Tison ; C. Coutelle [France] ; P. Henry [France] ; A. CassaigneGlutathion S-transferase (class μ) phenotype in Parkinson's disease
003613 C. Singer [États-Unis] ; J. Sanchez-Ramos ; W. J. WeinerGait abnormality in essential tremor
003614 L. Verhagen Metman [États-Unis] ; J. Hoff ; M. M. Mouradian ; T. N. ChaseFluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
003615 P. Nisipeanu [Israël] ; A. Kuritzky ; A. D. Korczyn [Israël]Familial levodopa-responsive parkinsonian-pyramidal syndrome
003616 F. Micheli [Argentine] ; M. C. Scorticati ; E. Gatto ; G. Cersosimo ; J. AdiFamilial hemifacial spasm
003617 R. J. Elble [États-Unis] ; C. Higgins ; K. Leffler ; L. HughesFactors influencing the amplitude and frequency of essential tremor
003618 JAU-SHIN LOU [États-Unis] ; J. Valls-Sole ; C. Toro ; M. HallettFacial action myoclonus in patients with olivopontocerebellar atrophy
003619 F. Carella [Italie] ; C. Ciano ; M. Musicco ; V. ScaioliExteroceptive reflexes in dystonia: a study of the recovery cycle of the R2 component of the blink reflex and of exteroceptive suppression of the contracting sternocleidomastoid muscle in blepharospasm and torticollis
003621 A. H. V. Schapira [Royaume-Uni]Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal
003622 A. Priori [Italie] ; A. Berardelli ; M. Inghilleri ; L. Polidori ; M. ManfrediElectromyographic silent period after transcranial brain stimulation in Huntington's disease
003623 K. B. Polo [États-Unis] ; BAHMAN JABBARIEffectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin
003624 U. B. Muthane [Inde] ; H. S. Swamy [Inde] ; P. Satishchandra [Inde] ; M. N. Subhash ; S. Rao ; D. SubbakrishnaEarly onset Parkinson's disease: are juvenile- and young-onset different?
003627 M. Kyllerman [Suède] ; O. H. Skjeldal ; M. Lundberg ; I. Holme ; E. Jellum ; U. Von Döbeln ; A. Fossen ; G. CarlssonDystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations
003629 P. D. Thompson [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; P. Brown [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. Pires ; N. P. Quinn [Royaume-Uni] ; P. Luthert ; M. Honovar ; M. D. P'Brien ; C. D. Marsden [Royaume-Uni] ; A. E. Harding [Royaume-Uni]Cortical myoclonus in Huntington's disease
003631 J. H. Friedman [États-Unis]Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases
003632 M. Aramideh [Pays-Bas] ; B. W. Ongerboer De Visser [Pays-Bas] ; J. H. T. M. Koelman [Pays-Bas] ; L. J. Bour [Pays-Bas] ; P. P. Devriese ; J. D. SpeelmanClinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure
003634 J. G. Phillips [Australie] ; J. L. Bradshaw ; E. Chiu ; J. A. BradshawCharacteristics of handwriting of patients with Huntington's disease
003635 C. H. Adler [États-Unis] ; L. Wrabetz ; M. F. Brin ; H. I. Hurtig [États-Unis]Cerebellar ataxia, dystonia, and tremor within a family: variable phenotypes of a single genetic disorder?
003636 M. F. Gordon [États-Unis] ; W. J. Weiner ; W. C. Koller ; T. H. Rao [États-Unis] ; V. Chehebar [États-Unis] ; D. W. DisksonCase 2, 1994 : parkinsonism and cognitive impairment
003637 Joseph Jankovic [États-Unis]Botulinum toxin in the treatment of dystonic tics
003638 R. M. Trosch [États-Unis] ; S. L. PullmanBotulinum toxin A injections for the treatment of hand tremors
003639 J. Kulisevsky [Espagne] ; M. Lima De Freitas ; L. Barraquer-BordasBilateral akinesia in drug-induced parkinsonism after a subthalamic lesion
003640 D. Caparros-Lefebvre [France] ; J. F. Deleume ; N. Bradai ; H. PetitBiballism caused by bilateral infarction in the substantia nigra
003641 T. T. Warner [Royaume-Uni] ; G. G. Lennox ; I. Janota ; A. E. Harding [Royaume-Uni]Autosomal-dominant dentatorubropallidoluysian atrophy in the United Kingdom
003642 R. Pratap Chand [Royaume-Uni] ; D. M. ParkAtypical blepharospasm responsive to sodium valproate
003643 W. Ashraf [États-Unis] ; R. F. Pfeiffer ; E. M. M. Quigley [États-Unis]Anorectal manometry in the assessment of anorectal function in parkinson's disease : a comparison with chronic idiopathic constipation
003644 R. Agostino [Italie] ; A. Berardelli ; A. Formica ; F. Stocchi ; N. Accornero ; M. ManfrediAnalysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease
003645 C. L. Comella [États-Unis] ; C. G. GoetzAkathisia in Parkinson's disease
003647 L. Mazzini [Italie] ; M. Zaccala ; C. BalzariniAbnormalities of somatosensory evoked potentials in spasmodic torticollis
003649 C. Hertzman [Canada] ; M. Wiens ; B. Snow ; S. Kelly ; D. CalneA case-control study of Parkinson's disease in a horticultural region of British Columbia
003650 P. Krack [Allemagne] ; M. H. Marion"apraxia of lid opening," a focal eyelid dystonia : clinical study of 32 patients
003651
003652
003653
003654
003655 R. A. Hauser [États-Unis] ; C. W. Olanoworobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease
003656 Joseph Jankovic [États-Unis] ; A. H. Rajput [États-Unis] ; L. I. Golbe [États-Unis] ; J. C. GoodmanWhat is it? Case 1. 1993: Parkinsonism, dysautonomia, and ophthalmoparesis
003657 U. B. Muthane [Inde] ; P. Satishchandra [Inde] ; M. N. SubhashVisual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites
003659 M. De Mari [Italie] ; R. De Blasi ; P. Lamberti ; A. Carella ; E. FerrariUnilateral pallidal lesion after acute disulfiram intoxication: a clinical and magnetic resonance study
003660 J. Kulisevsky [Espagne] ; A. Avila ; C. Roig ; A. EscartinUnilateral blepharospasm stemming from a thalamomesencephalic lesion
003661 A. Ferbert [Allemagne] ; M. GerwigTremor due to stroke
003662 D. Bravi [États-Unis] ; T. L. Davis ; M. M. Mouradian ; T. N. ChaseTreatment of Parkinson's disease with the partial dopamine agonist EMD 49980
003663 C. G. Garner [Allemagne] ; A. Straube ; T. N. Witt ; T. Gasser ; W. H. OertelTime course of distant effects of local injections of botulinum toxin
003665 P. R. Atchison [Royaume-Uni] ; P. D. Thomson [Royaume-Uni] ; R. S. J. Frackowiak ; C. D. Marsden [Royaume-Uni]The syndrome of gait ignition failure: a report of six cases
003666 J. Guridi [Espagne] ; M. R. Luquin ; M. T. Herrero ; J. A. ObesoThe subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease
003667 M. B. H. Youdim [Israël] ; P. RiedererThe relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease
003668 M. B. H. Youdim [Israël] ; D. Ben-Shachar [Israël] ; P. RiedererThe possible role of iron in the etiopathology of Parkinson's disease
003670 G. V. Sawle [Royaume-Uni]The detection of preclinical Parkinson's disease: what is the role of positron emission tomography?
003672 C. Pacchetti [Italie] ; E. Martignoni [Italie] ; P. Bruggi [Italie] ; L. Godi [Italie] ; B. Aufdembrinke ; C. Miltenburger ; B. Voet ; G. Nappi [Italie]Terguride in fluctuating Parkinsonian patients: a double-blind study versus placebo
003673 P. Sachdev [Australie]Tardive and chronically recurrent oculogyric crises
003674 H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France]Symptomatic effect of selegiline in De Novo Parkinsonian patients
003675 SHUU JIUN WANG [Taïwan] ; JONG LING FUH ; D. E. Shan ; KWONG KUM LIAO ; KON PING LIN ; CHING PIAO TSAI ; ZIN AN WUSympathetic skin response and R-R interval variation in Parkinson's disease
003677 A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. SternSubcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years
003678 K. Kaneko [Japon] ; T. Yuasa [Japon] ; T. Miyatake ; S. Tsuji [Japon]Stereotyped hand clasping: an unusual tardive movement disorder
003679 W. Klostermann [Allemagne] ; P. Vieregge ; D. KömpfSpasmodic torticollis in multiple sclerosis: significance of an upper cervical spinal cord lesion
003680 B. Johnels [Suède] ; P. E. Ingvarsson [Suède] ; B. Holmberg ; M. Matousek [Suède] ; G. Steg [Suède]Single-dose L-dopa response in early parkinson's disease : measurements with optoelectronic recording technique
003682 V. V. Myllyl [Finlande] ; K. A. Sotaniemi ; J. A. Vuorinen ; E. H. HeinonenSelegiline in De Novo Parkinsonian patients: the finnish study
003683 W. G. Tatton [Canada]Selegiline can mediate neuronal rescue rather than neuronal protection
003684 S. Goldman [Belgique] ; D. Amrom ; H. B. Szliwowski ; D. Detemmerman ; S. Goldman ; L. M. Bidaut [Belgique] ; E. Stanus [Belgique] ; A. Luxen [Belgique]Reversible striatal hypermetabolism in a case of Sydenham's chorea
003686 E. Broussolle [France] ; L. Cinotti [France] ; Pierre Pollak [France] ; P. Landais [France] ; D. Le Bars [France] ; G. Galy [France] ; F. Lavenne [France] ; Y. Khalfallah ; G. Chazot [France] ; F. Mauguiere [France]Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease
003687 M. A. Hely [Australie] ; T. Chey [Australie] ; A. Wilson ; P. M. Williamson ; D. J. O'Sullivan ; D. Rail ; J. G. L. Morris [Australie]Reliability of the Columbia scale for assessing signs of Parkinson's disease
003688 F. Ishizaki [Japon] ; T. Harada ; S. Katayama ; H. Abe ; S. NakamuraRelationship between osteopenia and clinical characteristics of Parkinson's disease
003689 R. Larumbe [Espagne] ; J. Vaamonde ; J. Artieda ; J. L. Zubieta ; J. A. ObesoReflex blepharospasm associated with bilateral basal ganglia lesion
003690 A. Mazzucchi [Italie] ; E. Sinforiani ; L. Ludovico [Italie] ; M. Turla ; C. Pacchetti ; R. Brianti [Italie] ; M. Parma [Italie] ; G. NappiReaction time responses in Parkinsonian and Hemiparkinsonian patients
003691 D. Dykstra [États-Unis] ; C. Ellingham ; A. Belfie ; T. Baxter ; M. Lee ; A. VoelkerQuantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin
003692 R. E. A. Van Emmerik [Pays-Bas] ; R. L. Sprague ; K. M. NewellQuantification of postural sway patterns in tardive dyskinesia
003693 M. M. Schugens [Allemagne] ; I. Daum ; S. Richter ; E. Scholz ; A. G. M. CanavanProximal and distal reaction times (RTs) are not differentially affected in Parkinson's disease
003694 A. Achiron [Israël] ; I. Ziv ; M. Goren ; H. Goldberg ; Y. Zoldan ; H. Sroka ; E. MelamedPrimary progressive freezing gait
003695 J. Huttunen [Finlande] ; H. Ter V InenPre- and postcentral cortical somatosensory evoked potentials in hemiparkinsonism
003696 A. Feve [France] ; B. Angelard [France] ; G. Fenelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-GuilyPostneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin
003697 M. B. Harrison [États-Unis] ; G. R. Lyons ; E. R. LandowPhenytoin and dyskinesias : a report of two cases and review of the literature
003698 F. Javier Jimenez-Jimenez [Espagne] ; F. Cabrera-Valdivia ; L. Ayuso-Peralta ; J. Tejeiro ; A. Vaquero ; E. Garcia-AlbeaPersistent parkinsonism and tardive dyskinesia induced by clebopride
003699 P. A. Lewitt [États-Unis] ; A. Walters ; W. Hening ; D. MchalePersistent movement disorders induced by buspirone
003700 A. Lagueny [France] ; E. Ellie ; P. Burbaud ; P. Le Collen ; P. DeliacParoxysmal stimulus-sensitive spasmodic torticollis
003701 B. A. Rybicki [États-Unis] ; C. Cole Johnson [États-Unis] ; J. Uman [États-Unis] ; J. M. GorellParkinson's disease mortality and the industrial use of heavy metals in Michigan
003703 J. O. Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. Nagren ; J. Bergman ; U. RuotsalainenPET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease
003704 M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; M. T. Smith ; D. A. Di Monte [États-Unis]PCR analysis of platelet mtDNA : lack of specific changes in parkinson's disease
003705 K. Bhatia [Royaume-Uni] ; S. E. Daniel ; C. D. MarsdenOrofacial dystonia and rest tremor in a patient with normal brain pathology
003706 G. Linazasoro [Espagne] ; J. F. Marti Masso ; J. A. SuarezNocturnal akathisia in Parkinson's disease: treatment with clozapine
003707 J. O. Rinne [Finlande]Nigral degeneration in Parkinson's disease
003709 S. E. Starkstein [Argentine] ; R. LeiguardaNeuropsychological correlates of brain atrophy in parkinson's disease : a CT-scan study
003711 A. Ferbert [Allemagne] ; R. Biniek [Allemagne] ; J. Kindler ; N. MaurinMyoclonus and tremor induced acutely by administration of tumor necrosis factor in a patient with Ehlers-Danlos syndrome
003712 A. Nath [Canada] ; D. E. Hobson [Canada] ; A. RussellMovement disorders with cerebral toxoplasmosis and AIDS
003713 G. J. Gomez Arevalo [Argentine] ; O. S. GershanikModulator effect of clozapine on levodopa response in Parkinson's disease: a preliminary study
003714 M. E. Giuffra [États-Unis] ; V. H. Sethy ; T. L. Davis ; M. M. Mouradian ; T. N. ChaseMilacemide therapy for Parkinson's disease
003715 R. Nakamura [Japon] ; K. Kamakura [Japon] ; Y. Tadano [Japon] ; Y. Hosoda [Japon] ; N. Nagata [Japon] ; K. Tsuchiya ; M. Iwata ; H. ShibasakiMR imaging findings of tremors associated with lesions in cerebellar outflow tracts: report of two cases
003716 D. Conway [Royaume-Uni] ; P. G. Bain ; T. T. Warner ; M. B. Davis ; L. J. Findley ; P. D. Thompson ; C. D. Marsden ; A. E. HardingLinkage analysis with chromosome 9 markers in hereditary essential tremor
003717 H. P. H. Kremer [Pays-Bas] ; G. T. A. M. BotsLewy bodies in the lateral hypothalamus: do they imply neuronal loss ?
003718 J. Vaamonde [Suède] ; I. Legarda [Suède] ; J. Jimenez-Jimenez ; J. L. Zubieta [Suède] ; J. A. Obeso [Suède]Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism
003719 JONG SUNG KIM [Corée du Sud] ; MYOUNG CHONG LEELeg tremor mimicking orthostatic tremor as an initial manifestation of Parkinson's disease
003720 R. Inzelberg [Israël] ; N. Zilber ; E. Kahana ; A. D. Korczyn [Israël]Laterality of onset in idiopathic torsion dystonia
003721 M. Merello [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; R. Leiguarda [Royaume-Uni] ; J. Guevara [Royaume-Uni] ; M. Nogues [Royaume-Uni]Inverse masticatory muscle activity due to syringobulbia
003722 J. P. Hubble [États-Unis] ; R. Pahwa [États-Unis] ; D. K. Michalek [États-Unis] ; C. Thomas ; W. C. Koller [États-Unis]Interactive video conferencing: a means of providing interim care to Parkinson's disease patients
003723 W. S. Metzer [États-Unis] ; S. R. Paige ; J. E. O. NewtonInefficacy of propranolol in attenuation of drug-induced parkinsonian tremor
003724 A. Weindl [Allemagne] ; T. Kuwert ; K. L. Leenders ; M. Poremba [Allemagne] ; H. Gr Fin ; H. Von Einsiedel ; A. Antonini ; H. Herzog ; D. Scholz [Allemagne] ; L. E. Feinendegen ; B. ConradIncreased striatal glucose consumption in Sydenham's chorea
003725 V. Leuzzi [Italie] ; V. Ricciotti ; A. PellicciaHemiplegic dystonia associated with regional cortical dysplasia (Pachygyria)
003727 A. Danek [Allemagne]Geniospasm: hereditary chin trembling
003728 L. Edwards [États-Unis] ; E. M. M. Quigley ; R. Hofman [États-Unis] ; R. F. Pfeiffer [États-Unis]Gastrointestinal symptoms in parkinson disease : 18-month follow-up study
003729 V. S. Kostic [Serbie] ; Z. Marinkovic ; S. Filipovic ; D. MomcilovicFunction of dopamine receptors in young-onset Parkinson's disease: prolactin response
003730 P. Martinelli [Italie] ; S. Giuliani [Italie] ; M. Ippoliti [Italie] ; A. Martinelli ; A. Sforza [Italie] ; S. FerrariFamilial idiopathic strio-pallido-dentate calcifications with late onset extrapyramidal syndrome
003731 A. L. Burleigh [États-Unis] ; F. B. Horak [États-Unis] ; K. J. Burchiel ; J. G. NuttEffects of thalamic stimulation on tremor, balance, and step initiation: a single subject study
003732 P. Brown [Royaume-Uni] ; M. J. Steiger [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; M. Salama ; T. Waegemans ; C. D. Marsden [Royaume-Uni]Effectiveness of piracetam in cortical myoclonus
003734 P. Lamberti [Italie] ; M. De Mari ; G. Iliceto ; M. Caldarola ; L. SerlengaEffect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia
003735 S. A. Factor [États-Unis] ; W. J. WeinerEarly combination therapy with bromocriptine and levodopa in Parkinson's disease
003736 P. G. Strange [Royaume-Uni]Dopamine receptors in the basal ganglia: relevance to Parkinson's disease
003737 J. G. Nutt [États-Unis] ; J. H. Carter ; W. Woodward ; J. P. Hammerstad ; S. T. GancherDoes tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions
003738 S. Sveinbjornsdottir [Danemark] ; H. Pakkenberg ; L. WerdelinDevelopmental stuttering followed by intermittent jaw opening dystonia
003739 L. Schelosky [Allemagne] ; J. Hierholzer ; J. Wissel ; M. Cordes ; Werner Poewe [Autriche]Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT
003740 T. Kuwert [Allemagne] ; J. Noth ; D. Scholz [Allemagne] ; M. Schwarz ; H. W. Lange ; R. Töpper ; H. Herzog [Allemagne] ; A. Aulich ; L. E. Feinendegen [Allemagne]Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease
003741 F. E. C. Cardoso [États-Unis] ; Joseph Jankovic [États-Unis]Cocaine-related movement disorders
003742 W. H. Jost [Allemagne] ; K. SchimrigkCisapride treatment of constipation in Parkinson's disease
003743 K. Nakashima [Japon] ; K. Takahashi [Japon] ; M. OtaCessation of writer's cramp after stroke
003744 B. Wild [Allemagne] ; J. DichgansCerebellar ataxia in ataxis hemiparesis ? A kinematic and EMG analysis
003745 S. Przedborski [Belgique] ; S. Goldman ; M. Levivier ; N. Giladi ; L. M. Bidaut ; J. Hildebrand [Belgique] ; E. Stanus ; D. Labar ; A. LuxenBrain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome
003746 G. Pauletti [Italie] ; A. Berardelli ; G. Cruccu ; R. Agostino ; M. ManfrediBlink reflex and the masseter inhibitory reflex in patients with dystonia
003748 E. S. Molho [États-Unis] ; S. A. FactorBasal ganglia infarction as a possible cuase of cervical dystonia
003749 A. P. Feve [France] ; G. Fenelon ; C. Wallays ; P. Remy ; A. GuillardAxial motor disturbances after hypoxic lesions of the globus pallidus
003750 J. H. Friedman [États-Unis] ; A. WeitbergAtaxia without telangiectasia
003751 J. L. Saver [États-Unis] ; P. Greenstein ; M. Ronthal ; M.-M. MesulamAsymmetric catalepsy after right hemisphere stroke
003752 F. W. Bylsma [États-Unis] ; J. Rothlind ; M. R. Hall ; S. E. Folstein ; J. BrandtAssessment of adaptive functioning in Huntington's disease
003754 U. Bonuccelli [Italie] ; P. Piccini [Italie] ; P. Del Dotto [Italie] ; G. Rossi ; G. U. Corsini ; A. Muratorio [Italie]Apomorphine test for dopaminergic responsiveness: a dose assessment study
003755 E. R. Siemers [États-Unis] ; A. Shekhar ; K. Quaid ; H. DicksonAnxiety and motor performance in Parkinson's disease
003758 R. J. Uitti [États-Unis] ; D. M. MaraganoreAdult onset familial cervical dystonia: report of a family including monozygotic twins
003760 M. V. Solbrig [États-Unis] ; L. NashefAcute parkinsonism in suspected herpes simplex encephalitis
003761 M. Vidailhet [France] ; C. Bouchard [France] ; P. J. Jedynak [France] ; M. Serdaru [France]Acute and long-term response to apomorphine in cranial dystonia
003762 S. A. Factor [États-Unis]Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease
003763 C. W. Olanow [États-Unis]A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease
003764 M. S. Lee [Corée du Sud] ; S. A. Lee ; J. H. Heo ; I. S. ChoiA patient with a resting tremor and a lacunar infarction at the border between the thalamus and the internal capsule
003765 F. Sellal [France] ; E. Hirsch [France] ; P. Barth [France] ; S. Blond [France] ; C. Marescaux [France]A case of symptomatic hemidystonia improved by ventroposterolateral thalamic electrostimulation
003766 G. Broggi [Italie] ; S. Brock ; A. Franizini ; G. GeminianiA case of posttraumatic tremor treated by chronic stimulation of the thalamus
003767
003768
003769 Andrew Lees (neurologue) [Royaume-Uni]When did Ray Kennedy's Parkinson's disease begin?
003770 P. D. Thompson [Royaume-Uni] ; J. G. Colebatch ; P. Brown ; J. C. Rothwell ; B. L. Day ; J. A. Obeso ; C. D. MarsdenVoluntary stimulus-sensitive jerks and jumps mimiching myoclonus or pathological startle syndromes
003771 N. L. Mcnair [États-Unis] ; K. J. MeadorThe undulating toe flexion sign in brain death
003772 H.-C. Diener [Allemagne] ; J. Dichgans ; B. Guschlbauer ; M. Bacher ; H. Rapp ; T. KlockgetherThe coordination of posture and voluntary movement in patients with cerebellar dysfunction
003773 W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Temporary deterioration in Parkinsonian signs after modest alcohol intake
003774 M. Stacy [États-Unis] ; Joseph Jankovic [États-Unis]Tardive tremor
003775 P. C. G. Nijssen [Pays-Bas] ; C. C. TijssenStimulus-sensitive paroxysmal dyskinesias associated with a thalamic infarct
003776 W. R. G. Gibb [Royaume-Uni] ; L. Kilford ; C. D. MarsdenSevere generalised dystonia associated with a mosaic pattern of striatal gliosis
003778 J. H. Friedman [États-Unis]Rubral' tremor induced by a neuroleptic drug
003781 F. Javier Jimenez-Jimenez [Espagne] ; E. Garcia-Albea ; J. A. Vaquero-Ruiperez ; J. Tejeiro ; F. Cabrera-Valdivia ; L. Ayuso-PeraltaReading as a trick for relieving blepharospasm
003783 F. J. Jimenez-Jimenez [Espagne] ; D. Mateo ; S. Gimenez-RoldanPremorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study
003784 R. S. C. Alves [Brésil] ; E. R. Barbosa ; M. ScaffPostvaccinal parkinsonism
003785 A. Albanese [Italie] ; A. Daniele ; M. Lo Monaco ; V. Di Lazzaro ; D. Restuccia ; M. Milone ; P. TonaliPostural axial tremor in a patient with cerebellar atrophy
003786 B. Jabbari [États-Unis] ; J. Paul ; B. Scherokman ; B. Van DamPosttraumatic segmental axial dystonia
003787 L. G. Miller [États-Unis] ; Joseph Jankovic [États-Unis]Persistent dystonia possibly induced by flecainide
003788 F. Tison [France] ; C. Louvet-Giendaj ; P. Henry ; A. Lagueny [France] ; E. GaujardPermanent Bruxism as a manifestation of the oculo-facial syndrome related to systemic Whipple's disease
003789 H.-C. Diener [Allemagne] ; J. DichgansPathophysiology of cerebellar ataxia
003790 P. Vieregge [Allemagne] ; W. Klostermann ; H. BrückmannParkinsonism in multiple sclerosis
003791 P. Montagna [Italie] ; A. S. Gabellini ; L. Monari ; E. LugaresiParkinsonian syndrome after long-term treatment with clebopride
003792 R. Djaldetti [Israël] ; I. Ziv ; A. Achiron ; E. MelamedParkinson's disease in a patient with mitochondrial myopathy: is there a causative relationship?
003793 A. S. Walters [États-Unis] ; W. A. HeningNoise-induced psychogenic tremor associated with post-traumatic stress disorder
003795 D. M. Maraganore [États-Unis] ; W. N. Folger ; J. W. Swanson ; J. E. AhlskogMovement disorders as sequelae of central pontine myelinolysis : report of three cases
003796 J. Schwarz [Allemagne] ; K. Tatsch ; T. Vogl ; C. M. Kirsch ; C. Trenkwalder ; G. Arnold ; T. Gasser ; W. H. OertelMarked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia
003797 R. N. Rosenberg [États-Unis]Machado-Joseph disease : an autosomal dominant motor system degeneration
003798 L. Sudarsky [États-Unis] ; L. Corwin ; D. M. AwsonMachado-Joseph disease in New England : clinical description and distinction from the olivopontocerebellar atrophies
003799 M. R. Luquin [Espagne] ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J. A. ObesoLevopoda-induced dyskinesias in Parkinson's disease : clinical and pharmacological classification
003800 J.-F. De Saint Victor [France] ; C.-L. GervasonLevopoda-induced diphasic dyskinesias improved by subcutaneous apomorphine
003801 M Contin [Italie] ; R. Riva ; P. Martinelli ; A. BaruzziKinetic-dynamic relationship of oral levopoda : possible biphasic response after sequential doses in Parkinson's disease
003802 J. M. Gobernado [Espagne] ; M. Galarreta ; G. De Blas ; A. Jimenez-Escrig ; A. HernandezIsolated continuous rhythmic lingual myoclonus
003803 H. Meierkord [Royaume-Uni] ; D. R. Fish ; S. J. M. Smith ; C. A. Scott ; S. D. Shorvon ; C. D. MarsdenIs nocturnal paroxysmal dystonia a form of frontal lobe epilepsy ?
003804 F. Stocchi [Italie] ; S. Ruggieri ; A. Carta ; J. Ryatt ; N. Quinn ; P. Jenner ; C. D. Marsden ; A. AgnoliIntravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease
003805 J.-A. C. Lazarus [États-Unis] ; G. E. StelmachInterlimb coordination in Parkinson's disease
003806 I. Rektor [République tchèque] ; M. Svejdova ; C. Silva-Barrat ; C. MeniniInfluence of cholinergic systems on myoclonus in myoclonic epilepsies
003807 S. Przedborski [Belgique] ; A. Liard ; J. HildebrandInduction of mania by apomorphine in a depressed Parkinsonian patient
003808 R. D. Jones [Nouvelle-Zélande] ; I. M. Donaldson ; P. L. TimmingImpairment of high-constrast visual acuity in Parkinson's disease
003810 P. Martinelli [Italie] ; S. Giuliani ; M. IppolitiHemifacial spasm due to peripheral injury of facial nerve : a nuclear syndrome?
003811 J. M. Bejar [États-Unis] ; J. Kepes ; W. C. KollerHemiballism and tremor due to ependymal cyst
003812 M. J. Steiger [Royaume-Uni] ; M. Pires ; F. Scaravilli ; N. P. Quinn ; C. D. MarsdenHemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration
003813 P. Sachdev [Australie]Golfers' cramp: clinical characteristics and evidence against it being an anxiety disorder
003814 A. Guala [Italie] ; D. Mittino ; P. Fabbrocini ; T. GhiniFamilial metoclopramide-induced dystonic reactions
003815 F. Javier Jimenez-Jimenez [Espagne] ; D. Mateo ; S. Gimenez-RoldanExposure to well water and pesticides in Parkinson's disease : a case-control study in the Madrid area
003816 E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. BedardEthosuximide and tremor in Parkinson's disease : a pilot study
003817 L. Christenson [États-Unis] ; D. F. Emerich ; P. R. SanbergEncapsulated cell implatation for Parkinson's disease
003818 M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease
003820 D. Bravi [États-Unis] ; J. J. Anderson ; F. Dagani ; T. L. Davis ; R. Feerari ; M. Gillespie ; T. N. ChaseEffect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease
003822 J. K. Krauss [Allemagne] ; M. Mohadjer ; D. F. Braus ; A. K. Wakhloo ; F. Nobbe ; F. MundingerDystonia followng head trauma : a report of nine patients and review of the literature
003823 C. E. Clarke [Royaume-Uni] ; J. M. Bamford ; A. HouseDyskinesia in Creutzfeldt-Jakob disease precipitated by antidepressant therapy
003824 V. M. S. De Bruin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; S. E. DanielDiffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report
003825 P. J. Morrison [Royaume-Uni] ; V. H. PattersonCranial dystonia (Meige syndrome) in postencephalitic Parkinsonism
003826 J. Blin [France] ; M.-J. Vidailhet [France] ; B. Pillon [France] ; B. Dubois [France] ; J.-R. Feve [France] ; Yves Agid [France]Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET
003827 J. Artieda [Espagne] ; J. Muruzabal ; R. Larumbe ; C. Garcia De Casasola ; J. A. ObesoCortical mechanisms mediating asterixis
003829 S. A. Factor [États-Unis] ; D. BrownClozapine prevents recurrence of psychosis in Parkinson's disease
003830 R. A. Wrigth [Nouvelle-Zélande] ; M. Pollock ; I. Mcg. DonaldsonChorea and tuberous sclerosis
003832 A. Nieoullon [France] ; KERKERIAN-LE GOFFCellular interactions in the striatum involving neuronal systems using classical' neurotransmitters: possible functional implications
003834 J. Kulisevsky [Espagne] ; J. Marti-Fabregas ; A. Escartin ; J. PradasBrachial plexus palsy associated with spasmodic torcicolis in a patient with tomaculous neuropathy
003836 J. B. M. Van De Biezenbos [Pays-Bas] ; M. W. I. M. Hortsink ; C. J. W. Van De Vlasakker ; B. G. M. Van Engelen ; O. R. Van Eikema Hommes ; F. BarkhofA case of bilateral alternating hemifacial spasms
003837
003838
003839
003840 J. Rivest ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenWriter's cramp : treatment with botulinum toxin injections
003843 A. E. Lang [Canada] ; K. D. Sethi ; J. P. Provias ; J. H. DeckWhat is it? Case 1, 1991 : a severe and fatal systemic illness first presenting with a movement disorder
003844 E. Mohr ; P. Browers ; J. J. Claus ; U. M. Mann ; P. Fedio ; T. N. ChaseVisuospatial cognition in Huntington's disease
003845 A. Berardelli ; P. D. Thompson ; M. Zaccagnini ; O. Giardini ; P. D'Eufemia ; R. Massoud ; M. MandrediTwo sisters with generalized dystonia associated with homocystinuria
003846 C. P. Jedynak ; A. M. Bonnet ; Yves Agid [France]Tremor and idiopathic dystonia
003847 I. T. Lorentz [Australie] ; S. Shanthi Subramaniam ; C. YiannikasTreatment of idiopathic spasmodic torticollis with botulinum toxin A : a double-blind study on twenty-three patients
003848 R. C. Peatfield ; B. R. BoothmanTransient myoclonus after exposure to oven cleaner
003849 S. Rittig ; J. Arentsen ; K. Soêrensen ; T. Matthiesen ; E. DupontThe hemodynamic effects of triglycyl-lysine-vasopressin (glypressin) in patients with parkinsonism and orthostatic hypotension
003850 P. Blum ; Joseph Jankovic [États-Unis]Stiff-Person syndrome : an autoimmune disease
003852 M. J. Steiger ; N. P. Quinn ; C. D. MarsdenSickness due to levodopa-induced neck dyskinesias in Parkinson's disease
003854 A. S. Walters ; W. A. Hening ; SUDHANSU CHOKROVERTYReview and videotape recognition of idiopathic restless legs syndrome
003855 E. Sasso ; E. Perucca ; R. Fava ; S. CalzettiQuantitative comparison of barbiturates in essential hand and head tremor
003856 J. S. Duncan ; P. Brown ; C. D. MarsdenProgressive myoclonus and histidinaemia
003857 E. Siemers [États-Unis] ; V. ReddyProfile of patients enrolled in a new movement disorder clinic
003858 E. Siemers [États-Unis] ; V. ReddyProfile of patients enrolled in a new movement disorder clinic
003859 S. A. Factor ; W. J. WeinerPrior history of head trauma in Parkinson's disease
003860 A. J. Hughes ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenParoxysmal dystonic head tremor
003861 P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. MarsdenParoxysmal axial spasms of spinal origin
003862 V. P. Calabrese ; M. G. HadfieldParkinsonism and extraocular motor abnormalities with unusual neuropathological findings
003863 P. M. Fitzgerald ; Joseph Jankovic [États-Unis]Orthostatic tremor : an association with essential tremor
003865 M. J. Steiger ; N. P. Quinn ; B. Toone ; C. D. MarsdenOff-period screaming accompanying motor fluctuations in Parkinson's disease
003866 W. R. G. Gibb ; T. Scott ; Andrew Lees (neurologue) [Royaume-Uni]Neuronal inclusions of Parkinson's disease
003868 G. Abbruzzese ; M. Tabaton ; M. Morena ; D. Dall'Agata ; E. FavaleMotor and sensory evoked potentials in progressive supranuclear palsy
003869 I. J. Mitchell ; J. M. Brotchie ; G. D. A. Brown ; A. R. CrossmanModeling the functional organization of the basal ganglia : a parallel distributed processing approach
003872 A. Lagueny ; P. Caix ; P. Schuermans ; J. JulienJaw dystonia triggered by biting into hard food
003873 D. E. Robertson-Hoffman ; M. H. Mark ; J. I. SageIsolated lingual/palatal dystonia
003874 J. Grafman ; L. G. Cohen ; M. HallettIs focal hand dystonia associated with psychopathology?
003876 N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. MarsdenIntrafamilial correlation in idiopathic torsion dystonia
003877 G. Geminiani [Italie] ; B. M. Cesana ; F. Tamma ; P. Contri ; C. Pacchetti ; F. Carella ; R. Piolti ; E. Martignoni ; P. Giovannini ; F. Girotti ; T. CaraceniInterobserver reliability between neurologists in training of Parkinson's disease rating scales : A multicenter study
003879 J. Elble [États-Unis]Inhibition of forearm EMG by palatal myoclonus
003881 A. J. Hughes [Royaume-Uni] ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni]Idiopathic Parkinson's disease combined with multiple system atrophy : A clinicopathological report
003882 J. Vaamonde ; J. Artieda ; J. A. ObesoHereditary paroxysmal ataxia with neuromyotonia
003884 M. B. SternHead trauma as a risk factor for Parkinson's disease
003885 L. L. Edwards ; R. F. Pfeiffer ; E. M. M. Quigley ; R. Hofman ; M. BalluffGastrointestinal symptoms in Parkinson's disease
003886 C. F. Tolge ; S. A. FactorFocal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome
003887 M. Hallett [États-Unis]Extending the concept of ballistic movement orverflow myoclonus
003888 K. R. Nair ; R. Bhaskaran ; C. D. MarsdenEssential tremor associated with paroxysmal kinesigenic dystonia
003889 M. B. SternElectroconvulsive therapy in untreated Parkinson's disease
003890 R. Faber [États-Unis] ; M. R. TrimbleElectroconvulsive therapy in Parkinson's disease and other movement disorders
003891 P. Giovannini ; I. Piccolo ; S. Genitrini ; P. Soliveri ; F. Girotti ; G. Geminiani ; G. Scigliano ; T. CaraceniEarly-onset Parkinson's disease
003893 M. J. Merello ; M. A. Nogues ; R. C. Leiguarda ; C. Lopez SaubidetDystonia and reflex sympathetic dystrophy induced by ergotamine
003894 J. K. Krauss [Allemagne] ; M. Mohadjer ; A. K. Wakhloo ; F. MundingerDystonia and akinesia due to pallidoputaminal lesions after disulfiram intoxication
003895 U. Bonuccelli ; A. Nocchiero ; A. Napolitano ; A. M. Paoletti ; G. B. Melis ; G. U. Corsini ; A. MuratorioDomperidone-induced acute dystonia and polycystic ovary syndrome
003896 F. X. Tison ; X. Ferrer ; J. JulienDelayed onset movement disorders as a complication of central pontine myelinolylis
003897 K. D. Sethi ; D. C. HessCreutzfeldt-Jakob's disease presenting with ataxia and a movement disorder
003898 S. M. Papa ; J. Artieda ; J. A. ObesoCortical activity preceding self-initiated and externally triggered voluntary movement
003900 A. Rapoport ; H. Braun ; A. Aviv ; I. SarovaCombined resting-postural tremor of the head with a changing axis
003901 V. E. Drory ; M. Y. Neufeld ; A. D. KorczynCarpal tunnel syndrome : a complication of idiopathic torsion dystonia
003904 S. T. Gancher ; J. G. Nutt ; W. R. WoodwardAbsorption of apomorphine by various routes in parkinsonism
003905 B.-U. Meyer [Allemagne] ; T. C. Britton ; C. Bischoff ; J. Machetanz ; R. Benecke ; B. ConradAbnormal conduction in corticospinal pathways in Wilson's disease : investigation of nine cases with magnetic brain stimulation
003906 P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. MarsdenA therapeutic trial of milacemide in myoclonus and the Stiff-Person syndrome
003907 M. Hallett ; J. Ravits ; R. M. Dubinsky ; M. M. Gillespie ; AMIR MOINFARA double-blind trial of isoniazid for essential tremor and other action tremors
003908 D. M. Maraganore ; A. E. Harding ; C. D. MarsdenA clinical and genetic study of familial Parkinson's disease
003909 N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. MarsdenA case-control study of idiopathic torsion dystonia
003910 P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. MarsdenA case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus
003911 First international congress of movement disorders: abstracts, Washington DC, April 25-27, 1990
003912 A. J. Lewis ; M. J. Gaweldiffuse lewy body disease with dementia and oculomotor dysfunction
003913 J. Rivest ; N. Quinn ; J. Gibbs ; C. D. MarsdenUnilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar infarction
003914 C. J. Hunker ; J. H. AbbsUniform frequency of Parkinsonian resting tremor in the lips, jaw, tongue, and index finger
003915 W. G. Johnson ; S. E. Hodge ; R. DuvoisinTwin studies and the genetics of Parkinson's disease ― a reappraisal
003916 J. Rivest ; C. D. MarsdenTrunk and head tremor as isolated manifestations of dystonia
003918 R. Silvestri ; P. De Domenico ; A. E. Di Rosa ; P. Bramanti ; S. Serra ; R. Di PerriThe effect of nocturnal physiological sleep on various movement disorders
003919 A. Achiron ; E. MelamedTardive eating dystonia
003920 J. M. Cedarbaum ; M. Clark ; L. H. Toy ; A. Green-ParsonsSustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease : evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation
003921 L. G. Miller ; Joseph Jankovic [États-Unis]Sulpiride-induced tardive dystonia
003924 B. S. Koppel ; M. DarasRubral tremor due to midbrain toxoplasma abscess
003926 R. Ranawaya ; D. Riley ; A. LangPsychogenic dyskinesias in patients with organic movement disorders
003927 R. J. Elble ; C. Moody ; C. HigginsPrimary writing tremor: a form of focal dystonia?
003929 U. K. Rinne ; A. Laihinen ; J. O. Rinne ; K. Nagren ; J. Bergman ; U. RuotsalainenPositron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease
003931 A. Camac ; P. Greene ; A. KhandjiParoxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct
003932 M. Shandling ; P. L. Carlen ; A. E. LangParkinsonism in alcohol withdrawal: a follow-up study
003933 B. V. ManyamParalysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise
003934 R. Kurlan ; J. Kersun ; H. T. Jr Ballantine ; E. D. CaineNeurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome
003936 M. E. Rodriguez ; M. R. Luquin ; G. Lera ; G. Delgado ; J. M. Salazar ; J. A. ObesoNeuroleptic malignant syndrome treated with subcutaneous lisuride infusion
003938 D. Truong ; A. E. Harding ; F. Scaravilli ; S. J. M. Smith ; J. A. Morgan-Hughes ; C. D. MarsdenMovement disorders in mitochondrial myopathies: a study of nine cases with two autopsy studies
003939 M. A. Menza ; J. Sage ; E. Marshall ; R. Cody ; R. DuvoisinMood changes and on-off phenomena in Parkinson's disease
003940 A. H. V. Schapira ; I. J. Holt ; M. Sweeney ; A. E. Harding ; P. Jenner ; C. D. MarsdenMitochondrial DNA analysis in Parkinson's disease
003941 J. N. Sanes ; M. HallettLimb positioning and magnitude of essential tremor and other pathological tremors
003942 A. Berardelli ; M. Inghilleri ; A. Priori ; P. D. Thompson ; S. Fabri ; C. Fieschi ; M. ManfrediInvolvement of corticospinal tract in Wilson's disease : a study of three cases with transcranial stimulation
003944 G. Abbruzzese ; D. Dall'Agata ; M. Morena ; L. Spadavecchia ; S. Ratto ; E. FavaleImpaired habituation of long-latency stretch reflexes of the wrist muscles in Huntington's disease
003945 K. Hawker ; A. E. LangHypoxic-ischemic damage of the basal ganglia : case reports and a review of the literature
003946 J. B. Jr Penney ; A. B. Young ; I. Shoulson ; S. Starosta-Rubenstein ; S. R. Snodgrass ; J. Sanchez-Ramos ; M. Ramos-Arroyo ; F. Gomez ; G. Penchaszadeh ; J. Alvir ; J. Esteves ; I. Dequiroz ; N. Marsol ; H. Moreno ; P. M. Conneally ; E. Bonilla ; N. S. WexlerHuntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals
003948 L. W. SvensonGeographic distribution of deaths due to Parkinson's disease in Canada : 1979-1986
003949 J. Artieda ; M. R. Luquin ; J. Vaamonde ; J. Laguna ; J. A. ObesoGeneralized reflex myoclonus in a patient with alcohol-sensitive spontaneous myoclonus and an abnormal gait
003950 K. D. Sethi ; D. C. Hess ; R. C. Harbour ; G. L. HolmesGaze-evoked involuntary movements
003951 L. I. Golbe ; T. M. Farrell ; P. H. DavisFollow-up study of early-life protective and risk factors in Parkinson's disease
003953 M. A. Dietz ; C. G. Goetz ; G. T. StebbinsEvaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes
003954 U. J. Povlsen ; H. PakkenbergEffect of intravenous injection of biperiden and clonazepam in dystonia
003955 J. Vaamonde ; M. R. Luquin ; J. A. ObesoDopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
003956 P. Montagna ; G. Procaccianti ; A. Lugaresi ; M. Zucconi ; E. LugaresiDiurnal variability in cranial dystonia
003957 G. Iliceto ; P. D. Thompson ; B. L. Day ; J. C. Rothwell ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenDiaphragmatic flutter, the moving umbilicus syndrome and "Belly dancer's" dyskinesia
003958 V. S. Kostic ; N. Covickovic-Sternic ; L. Beslac-Bumbasirevic ; G. Ocic ; D. Pavlovic ; M. NikolicDexamethasone suppression test in patients with Parkinson's disease
003959 R. F. Pfeiffer ; R. D. MccombDentatorubro-pallidoluysian atrophy of the myoclonus epilepsy type with posterior column degeneration
003960 A. Ferbert ; H. B. Rickert ; R. Biniek ; H. BrückmannComplex hyperkinesia during recovery from left temporoparietal cortical infarction
003961 J. H. Friedman ; M. C. LannonClozapine-responsive tremor in Parkinson's disease
003962 R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. WilsonClozapine for psychosis in Parkinson's disease
003963 V. Hoêmberg ; H. W. LangeCentral motor conduction to hand and leg muscles in Huntington's disease
003965 M. Gatto ; F. Micheli ; M. F. PardalBlepharoclonus and parkinsonism associated with aqueductal stenosis
003966 Werner Poewe [Autriche] ; G. Luef ; B. Kleedorfer ; M. EmreAntiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease
003967 L. HerzbergAn essay on the shaking palsy: reviews and notes on the journals in which they appeared
003968 M. Kyllerman ; L. Forsgren ; G. Sanner ; G. Holmgren ; J. Wahlstroêm ; U. DruggeAlcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation
003969 C. Waters ; H. H. Itabashi ; M. L. J. Apuzzo ; L. P. WeinerAdrenal to caudate transplantation - Postmortem study
003970 K. Marder ; P. Flood ; L. Cote ; R. MayeuxA pilot study of risk factors for dementia in Parkinson's disease
003971 J. B. Winer ; D. R. Fish ; D. Sawyers ; C. D. MarsdenA movement disorder as a presenting feature of recurrent hypoglycaemia
003972 A. R. CrossmanA hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment
003973 M. Sano ; Y. Stern ; K. Marder ; R. MayeuxA controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
003975 M. Bhatt ; E. Wolters ; J. Tsui ; B. J. Snow ; D. B. CalneA case of rabies in North America
003977 W. C. Koller ; N. M. BiaryVolitional control of involuntary movements
003978 F. Andermann ; S. Berkovic ; S. Carpenter ; E. AndermannViewpoints on the Ramsay hunt syndrome. II: The Ramsay Hunt syndrome is no longer a useful diagnostic category
003979 A. E. HardingViewpoints on the Ramsay Hunt syndrome. III: Ramsay Hunt syndrome, Unverricht-Lundborg disease, or what?
003980 C. D. Marsden ; J. A. ObesoViewpoints on the Ramsay Hunt syndrome. I: the Ramsay hunt syndrome is a useful clinical entity
003981 B. Jabbari ; B. Scherokman ; C. H. Gunderson ; M. L. Rosenberg ; J. MillerTreatment of movement disorders with trihexylphenidyl
003983 Fh. McdowellThe use of glutethimide for treatment of essential tremor
003986 R. J. Coleman ; K. W. Lange ; N. P. Quinn ; A. E. Loper ; J. V. Bondi ; M. Hitchens ; S. M. Stahl ; C. D. MarsdenThe antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+ PHNO): preliminary results
003988 M. GrestyStability of the head in pitch (neck flexion-extension): studies in normal subjects and patients with axial rigidity
003989 M. H. Marion ; R. F. Gledhill ; P. D. ThompsonSpasms of amputation stumps: a report of 2 cases
003990 G. T. Plant ; A. G. Kermode ; E. P. G. H. Du Boulay ; W. I. McdonaldSpasmodic torticollis due to a midbrain lesion in a case of multiple sclerosis
003991 U. Andersson ; J.-E. Haggstrom ; E. D. Levin ; U. Bondesson ; M. Valverius ; L. M. GunneReduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia
003992 N. P. Quinn ; P. Luthert ; M. Honavar ; C. D. MarsdenPure akinesia due to Lewy body Parkinson's disease: a case with pathology
003993 W. C. Koller ; G. F. Wong ; A. LangPostraumatic movement disorders: a review
003994 C. H. Adler ; M. B. Stern ; M. L. BrooksParkinsonism secondary to bilateral striatal fungal abscesses
003995 L. I. Golbe ; D. C. Miller ; R. C. DuvoisinParaneoplastic degeneration of the substantia nigra with dystonia and parkinsonism
003997 P. A. Kempster ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Crichton ; J. P. Fkankel ; P. ShorvonOff-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine
003998 F. E. Micheli ; M. M. Fernandez Pardal ; R. Giannaula ; M. Gatto ; I. Casas Parera ; G. Paradiso ; M. Torres ; R. Pikielny ; J. Fernandez PardalMovement disorders and depression due to flunarizine and cinnarizine
003999 P. M. Fitzgerald ; Joseph Jankovic [États-Unis]Lower body Parkinsonism: evidence for vascular etiology
003A01 M. J. M. Dupuis ; P. J. Delwaide ; D. Boucquey ; R. E. GonsetteHomolateral disappearance of essential tremor after cerebellar stroke
003A02 J. R. Sanchez-Ramos ; S. A. Factor ; W. J. Weiner ; J. MarquezHemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis
003A03 R. M. Dubinsky ; M. Greenberg ; G. Di Chiro ; M. Baker ; M. HallettHemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose
003A04 W. S. Metzer ; J. E. O. Newton ; R. W. Steele ; M. Claybrook ; S. R. Paige ; D. E. Mcmillan ; S. HaysHLA Antigens in drug-induced Parkinsonism
003A05 A. Friedman ; Z. Jamrozik ; J. BojakowskiFamilial hemifacial spasm
003A06 L. I. Golbe ; P. H. Davis ; F. E. LeporeEyelid movement abnormalities in progressive supranuclear palsy
003A07 E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France]Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease
003A08 E. Mohr ; G. Fabbrini ; J. Williams ; J. Schlegel ; C. Cox ; P. Fedio ; T. N. ChaseDopamine and memory function in Parkinson's disease
003A09 Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander LindenComparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations
003A10 F. Grandas ; J. Artieda ; J. A. ObesoClinical and CT scan findings in a case of cyanide intoxication
003A11 MOHAMMAD REZA SAMIE ; A. K. AshtonChoresathetosis induced by cyproheptadine
003A14 R. F. Pfeiffer ; L. H. Herrera ; C. S. Glaeske ; R. E. HofmanCQP A01-403 in Parkinson's disease: an open-label pilot study
003A15 M. DeahlBetel nut-induced ectrapyramidal syndrome: an unusual drug interaction
003A16 L. E. Adler ; M. Pecevich ; H. NagamotoBereitschaftspotential in tardive dyskinesia
003A17 R. Stell ; A. M. Bronstein ; G. T. Plant ; A. E. HardingAtaxia telangiectasia: a reappraisal of the ocular motor features and their value in the diagnosis of atypical cases
003A18 J. A. Temlett ; N. P. Quinn ; P. G. Jenner ; C. D. Marsden ; E. Pourcher ; A.-M. Bonnet ; Y. Acid ; R. Markstein ; X. LatasteAntiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease
003A20 C. Singer ; J. Sanchez-Ramos ; W. J. WeinerA case of post-traumatic tic disorder
003A22 R. C. Harrington ; A. Wieck ; I. M. Marks ; C. D. MarsdenWriter's cramp: not associated with anxiety
003A23 J. M. WalsheWilson's disease: yesterday, today, and tomorrow
003A25 L. I. Golbe ; J. PaeValidity of a mailed epidemiological questionnaire and physical self-assessment in Parkinson's disease
003A26 S. A. Factor ; J. Sanchez-Ramos ; W. J. WeinerTrauma as an etiology of Parkinsonism: a historical review of the concept
003A28 R. Mayeux ; Y. Stern ; M. Sano ; J. B. W. Williams ; L. J. CoteThe relationship of serotonin to depression in Parkinson's disease
003A29 S. Fagioli ; A. Berardelli ; M. Hallett ; N. Accornero ; M. ManfrediThe first agonist and antagonist burst in patients with an upper motor neuron syndrome
003A34 R. L. Albin ; A. B. YoungSomatosensory phenomena in Huntington's disease
003A35 Werner Poewe [Autriche] ; B. Kleedorfer ; J. Willeit ; F. GerstenbrandPrimary CNS lymphoma presenting as a choreic movement disorder followed by segmental dystonia
003A36 W. R. G. Gibb ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenPathological report of four patients presenting with cranial dystonias
003A37 S. M. Papa ; O. S. GershanikOrthostatic tremor: an essential tremor variant?
003A38 C. Hausser-Hauw ; E. Roullet ; R. Robert ; R. MarteauOculo-facio-skeletal myorhythmia as a cerebral complication of systemic Whipple's disease
003A41 CHI-CHEN MAO ; S. T. Gancher ; R. M. HerndonMovement disorders in multiple sclerosis
003A42 J. Kulisevsky ; M. J. Marti ; I. Ferrer ; E. TolosaMeige syndrome: neuropathology of a case
003A43 G. Pezzoli ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. ScarlatoMadopar HBS in fluctuating Parkinsonian patients: two-year treatment
003A44 F. Viallet ; D. Gambarelli ; B. Alonzo ; R. Sedan ; R. KhalilLong-term follow-up after stereotaxic basal ganglia surgery in Parkinsonism: a neuroanatomical study of a case showing unusual postural disorders
003A45 O. S. Gershanik ; M. R. Luquin ; O. Scipioni ; J. A. ObesoIsoniazid therapy in Parkinson's disease
003A46 D. Riley ; A. E. LangHemiballism in multiple sclerosis
003A48 V. P. Misra ; M. Baraitser ; A. E. HardingGenetic prediction in Huntington's disease: what are the limitations imposed by pedigree structure?
003A49 J. G. Nutt ; M. D. Muenter ; A. AronsonEpidemiology of focal and generalized dystonia in Rochester, Minnesota
003A50 M. Hietanen ; H. TeravainenDementia and treatment with L-dopa in Parkinson's disease
003A51 S. A. Factor ; J. Sanchez-Ramos ; W. J. WeinerDelayed-onset dystonia associated with corticospinal tract dysfunction
003A52 N. A. Fletcher ; R. Stell ; A. E. Harding ; C. D. MarsdenDegenerative cerebellar ataxia and focal dystonia
003A53 J. M. Maloteaux ; E. C. Laterre ; P. M. Laduron ; F. Javoy-Agid ; Yves Agid [France]Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy
003A54 Z. Wszolek ; H. Monsour ; P. Smith ; R. PfeifferCryptococcal meningoencephalitis with Parkinsonian features
003A55 J. P. Ter Bruggen ; C. C. TijssenCrural and axial myoclonic dystonia following meralgia paraesthetica
003A56 R. Agostino ; A. Berardelli ; G. Cruccu ; G. Pauletti ; F. Stocchi ; M. ManfrediCorrelation between facial involuntary movements and abnormalities of blink and corneal reflexes in Huntington's chorea
003A57 E. Lehkuniec ; F. Micheli ; R. De Arbelaiz ; M. Torres ; G. ParadisoConcurrent hypnogenic and reflex paroxysmal dystonia
003A59 R. L. Albin ; M. B. Bromberg ; J. B. Penney ; R. KnappChorea and dystonia: a remote effect of carcinoma
003A60 E. Tolosa ; L. Montserrat ; A. BayesBlink reflex studies in focal dystonias: enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis
003A61 S. Behrman ; D. F. ScottBlepharoclonus provoked by voluntary eye closure
003A63 R. G. Brown ; C. D. MarsdenAn investigation of the phenomenon of "set" in Parkinson's disease
003A64 R. L. Albin ; A. K. Silverman ; C. N. Ellis ; J. J. Voorhees ; J. W. AlbersA new syndrome of axial muscle rigidity associated with etretinate therapy
003A65 N. Quinn ; P. Critchley ; C. D. MarsdenYoung onset Parkinson's disease
003A67 I. Landan ; P. A. CullisTorticollis following radiation therapy
003A70 J. T. Little ; Joseph Jankovic [États-Unis]Tardive myoclonus
003A72 M. Guttman ; A. E. Lang ; E. S. Garnett ; C. Nahmias ; G. Firnau ; F. J. Tyndel ; A. S. GordonRegional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea
003A73 F. A. Luque ; J. B. Selhorst ; P. PetruskaParkinsonism induced by high-dose cytosine arabinoside
003A75 M. R. SamieNeuroleptic malignant-like syndrome induced by metoclopramide
003A77 M. R. Samie ; M. A. Dannenhoffer ; S. RozekLife-threatening tardive dyskinesia caused by metoclopramide
003A78 J. L. Montastruc ; P. Celsis ; A. Agniel ; J. F. Demonet ; B. Doyon ; M. Puel ; J. P. Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease: lack of correlation with clinical or neuropsychological improvements
003A80 C. Diener ; E. Scholz ; B. Guschlbauer ; J. DichgansIncreased shortening reaction in parkinson's disease reflects a difficulty in modulating long loop reflexes
003A82 R. Kurlan ; J. Behr ; I. ShoulsonHereditary myoclonus and chorea: the spectrum of hereditary nonprogressive hyperkinetic movement disorders
003A83 K. D. Sethi ; F. T. Nichols ; F. YaghmaiGeneralized chorea due to basal ganglia lacunar infarcts
003A84 P. D. Thompson ; C. D. MarsdenGait disorder of subcortical arteriosclerotic encephalopathy: Binswenger's disease
003A85 R. Kurlan ; J. Behr ; L. Medved ; I. ShoulsonFamilial paroxysmal dystonic choreoathetosis: a family study
003A86 N. Biary ; W. C. KollerEssential tongue tremort
003A87 B. Jabbari ; M. Rosenberg ; B. Scherokman ; C. H. Gunderson ; J. W. Mcburney ; W. McclintockEffectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction
003A89 R. Agostino ; A. Berardelli ; G. Cruccu ; F. Stocchi ; M. ManfrediCorneal and blink reflexes in Parkinson's disease with "on-off" fluctuations
003A91 S. M. Schonfeld ; L. I. Golbe ; J. I. Sage ; J. N. Safer ; R. C. DuvoisinComputed tomographic findings in progressive supranuclear palsy: correlation with clinical grade
003A92 A. M. Bonnet ; G. Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire ; Y. De Smet ; Yves Agid [France]Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
003A93 G. SternCentral stridor from an ependymoma
003A94 Joseph Jankovic [États-Unis] ; B. M. PattenBlepharospasm and autoimmune diseases
003A95 P. R. Palakurthy ; V. IyerBlepharospasm accompanying hypoxic encephalopathy
003A96 F. Grandas ; N. Quinn ; P. Critchley ; A. Rohan ; C. D. Marsden ; S. M. StahlAntiparkinsonian activity of a single oral dose of PHNO
003A98 M. Nomoto ; P. D. Thompson ; M. P. Sheehy ; N. P. Quinn ; C. D. MarsdenAnticholinergic-induced chorea in the treatment of focal dystonia
003A99 H. Teravainen ; J. HuttunenAdrenergic Beta2-selective blocker in isoprenaline-enhanced essential trmor
003B00 J. H. Friedman ; P. A. HollmannAcetazolamide responsive hereditary paroxysmal ataxia
003B01 L. G. Cohen ; M. Hallett ; L. SudarskyA single family with writer's cramp, essential tremor, and primary writing tremor
003B02 W. J. Weiner ; S. A. Factor ; J. Sanchez-Ramos ; J. BergerA double-blind evaluation of ciladopa in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024